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Introduction: With the worldwide demographic change of increased longevity, the 
prevalence of osteoporosis is set to rise exponentially, particularly in developing 
countries.  Hip fractures, perhaps the most serious complication of osteoporosis, are 
associated with significant morbidity, mortality and health care costs.  There is a 
wide geographic and ethnic variation in the burden of osteoporosis and hip fractures.  
Data on the incidence of osteoporotic hip fractures, their risk factors and outcomes 
have been well documented in developed countries and used to inform screening, 
diagnosis and treatment protocols.  Scant data exists for Africa including South 
Africa (SA), however it is predicted that the number of hip fractures will increase 
exponentially with increasing longevity. 
 
Methodology: In a prospective case control study in the public sector hospitals of 
eThekwini, 277 consecutive subjects aged 60 years and over and admitted with 
minimal trauma hip fractures, 230 of which were documented in a one year period (1 
August 2010 - 31 July 2011), were enrolled.  Two hundred (200) subjects with hip 
fractures consented to participate in a longitudinal one year study and further 200 
age, gender and ethnic matched controls were recruited. 
The crude incidence, age, gender and ethnic adjusted incidence rates were 
calculated using the population of eThekwini and SA, as determined by Statistics SA 






A questionnaire, clinical examination and biochemical investigations were 
undertaken in the 200 hip fracture and control subjects to evaluate the demographic 
characteristics, risk factors and functional activity levels between hip fracture and 
matched control subjects, male and female hip fracture subjects and Indian and 
African hip fracture subjects.  The Student’s t - test and Chi-square test was used to 
compare means and categorical data, respectively.  In the case control study, 
matched conditional logistic regression was used to determine association between 
outcome and risk factors.  All significant variables (p < 0.05) were entered into a 
multiple regression analysis model to determine significance. 
Hip fracture subjects were followed up for one year to determine mortality and 
morbidity and predictors for mortality were determined by comparing survivors to 
subjects who had died using logistic regression analysis.  
Health care costs for acute hip fracture management were calculated using the 
bottom up method and compared to normative costs.  The duration of hospital stay, 
number of days before surgery, anaesthetic and surgical procedure used and 
medication prescribed were recorded for each subject.  Costing was calculated using 
the 2010 KwaZulu-Natal Department of Health billing and tariff guides and 







Demographic characteristics: The mean age of the 277 hip fracture subjects was 
75.9 ± 9.2 years with a female to male ratio of 2.8:1.  Men were significantly younger 
than women; (72.2 ± 9.3 years vs. 77.2 ± 8.6 years; p < 0.0001).  The majority of 
subjects were Indians (51.3%), followed by Africans (32.1%), Whites (14.1%) and 
least were Coloureds (2.5%). 
Incidence rates: The crude incidence rate in persons over 60 year olds for eThekwini 
was 97.4 per 100 000 persons.  The age adjusted incidence rate for South Africa in 
persons over 60 year olds was 109 per 100 000 persons.  Incidence rates increased 
with age and the highest rate was seen in the 80 - 84 year age group at 346.8 per 
100 000 persons.  The rate was higher in women than men (133 per 100 000 vs 68.5 
per 100 000).  The highest rate in the different population groups was observed in 
Indian subjects at 201.1 per 100 000 persons while African subjects had a lower rate 
at 63.7 per 100 000 persons.  The rate in the White (women only) and Coloured 
population group was 91.6 per 100 000 and 77.4 per 100 000 persons respectively.  
This lower rate is probably due to differences in utilisation of health care facilities for 
the former and small total percentage of Coloureds in the eThekwini area for the 
latter. 
Risk factors: In the 200 subjects enrolled in the case control study, hip fracture 
subjects were less likely to have had formal education (37% vs. 12.5 %; p < 0.0001; 
OR 11.560, 95%CI 4.38-30.49) but were more likely to be smokers (18% vs. 10.5%; 





OR 11.0, 95%CI 2.59-46.78).  Hip fracture subjects were also more likely to have a 
lower body weight (54.7 ± 13.7 kg vs. 72 ± 16.2 kg; p < 0.0001; OR 0.906, 95%CI 
0.87-0.94), lower BMI (22.7 ± 5.6 kg/cm2 vs. 29.2 ± 6.1 kg/cm2; p < 0.0001; OR 
0.786, 95%CI 0.71-0.87), higher frequency of prior fragility fractures (27.5% vs. 
8.5%; p < 0.0001; OR 4.083, 95%CI 2.27-7.34), a sideways fall (31.5% vs. 21%; p = 
0.016; OR 3.5, 95%CI 1.15-10.6), poor memory (39% vs. 22.5%; p = 0.001; OR 
2.000, 95%CI 1.29-3.1) and better self-reported activity levels (37.5% vs. 12%; p < 
0.0001; OR 5.118, 95%CI 2.42-10.85).  Morphometric vertebral fractures were 
significantly more commonly seen in subjects with hip fractures (32.7% vs. 20.3%; p 
< 0.0001). 
The mean vitamin D level was lower in hip fracture subjects (38.9 ± 22.4 nmol/L 
vs.51.4 ± 24.2 nmol/L; p < 0.0001) as was the bone mineral density (BMD) at 
femoral neck and spine (0.518 ± 0.106 g/cm2 vs. 0.713 ± 0.127 g/cm2; p < 0.0001 
and 0.701  ± 0.173 g/cm2 vs. 0.848  ± 0.183 g/cm2; p < 0.0001) respectively.  There 
was a significant negative correlation between hip BMD and age (p < 0.0001), weight 
(p < 0.0001) and BMI (p < 0.0001) in the hip fracture group. 
There was no difference in number of falls, caffeine use, self-reported sunlight 
exposure and dietary calcium intake. 
The age of menarche (13.7 ± 1.6 years vs. 14.0 ± 1.8 years; p = 0.290) and 
menopause (47.9 ± 6.2 years vs. 47.3 ± 6.8 years; p = 0.992) was not significantly 
different but hormone replacement therapy was a significant protective factor in 





Hip fracture subjects reported a significantly greater difficulty with physical self-
maintenance prior to the fracture with lower total mean scores (13.4 ± 1.9 vs. 13.8 ± 
1.1; p = 0.001), instrumental activities of daily living (IADL) (22.1 ± 4.8 vs. 25.2 ± 3.7; 
p < 0.0001), poorer quality of life (QoL) with higher scores (6.3 ± 1.7 vs. 5.9 ± 1.2; p 
= 0.003). 
In the multiple regression model significant risk factors for hip fracture were low BMI 
(p < 0.0001), lower education level (p < 0.0001), history of a prior fracture (p = 
0.001), higher self-reported activity level (p = 0.002), impaired IADL (p = 0.002) and 
QoL score (p = 0.038).  In addition hip fractures subjects had a significantly lower 
haemoglobin (p = 0.011) and albumin (p < 0.0001) and significantly higher white cell 
count (p < 0.0001) and C-reactive protein (CRP) (p = 0.005) respectively. 
Outcomes:  The majority of subjects were treated surgically (86.5%) and the mean 
length of hospital stay was 21.9 days with a mean delay before admission of 4.2 
days.  The mean number of days before surgery was 11.3 days.  The mortality rate 
at one year was 36.4%; subjects who died were significantly older (76.2 ± 9.7 years 
vs. 73.4 ± 8.2 years; p = 0.048).  Mortality was higher in men than women (41.1% vs. 
30.6%; p = 0.34), but this was not significant.  In the multiple regression model 
predictors of mortality were African ethnicity (p = 0.031), low body weight (p = 0.004), 
low BMI (p = 0.023), higher educational level (p = 0.003), impaired mobility (p = 
0.007), inability to cook, (p = 0.004) take medication (p = 0.006), and manage 
finances (p = 0.006) prior to the hip fracture, low serum albumin levels (p = 0.008), 





In survivors there was a significant deterioration in the ability to perform daily 
activities from pre-fracture in the first three months which persisted to one year later 
with decrease in the mean Physical Self-Maintenance score (13.5 ± 1.6 vs. 11.5 ± 
3.6; p < 0.0001) and IADL (22.5 ± 4.6 vs. 16.8 ± 5.1; p < 0.0001).  The scores for the 
QoL (6.2 ± 1.7 vs. 8.7 ± 2.6; p < 0.0001), Oswestry Disability Index (ODI) (29.7 ± 
14.4 vs. .55 ± 18.1; p < 0.0001) and Visual Analogue Score (VAS) for pain (1.4 ± 1.3 
vs. 4 ± 2; p < 0.0001) were all significantly increased at one year in keeping with 
deterioration in functional ability. 
Health care costs: The actual costing of acute hip fracture treatment was almost one 
third higher than the normative costing as calculated using National Osteoporosis 
Foundation of South Africa (NOFSA) hip fracture guidelines (R62 891.65 vs. 
R39 895). 
 
Conclusions: This study is the first to report hip fractures in all ethnic groups in SA 
and to examine risk factors and outcomes.  Compared to developed countries, the 
mean age of hip fracture subjects was lower.  In addition, men were significantly 
younger than women in keeping with findings from other developing countries.  The 
female to male ratio, however was similar to developed countries. 
Despite the fact the study was only undertaken in the public sector; important trends 
in incidence rates can be inferred, especially for the Indian and African groups.  Hip 
fractures are more common than previously reported in the South African population 





Specifically, the rate in Africans was significantly higher compared to the historic 
study by Solomon in 1968 (5.2 per 100 000 African persons). 
In this first report of hip fractures in Indians in SA, the data suggests that Indians 
may be at a higher risk than other ethnic groups.  The low incidence rate in Whites is 
probably an underestimation and reflects their lower utilisation of the public sector 
hospitals compared to the other ethnic groups. 
The risk factors identified in our subjects are similar to the published literature and 
support the use of clinical risk factors for the identification of persons at risk for hip 
fractures, especially since bone densitometry may not be readily available in the 
public sector.  This study also confirms the high prevalence of morphometric 
vertebral fractures in both the hip fracture and control groups as previously reported 
in SA. 
A significant mortality rate of 36.4% which is comparable to other developing 
countries was seen.  The significant delay in admission and surgery with a prolonged 
hospital stay is not within the current international and national management 
recommendations and needs urgent attention.  Contributing factors to mortality were 
an older age, low body weight, poor pre-fracture functioning, and low serum albumin 
and raised CRP.  In addition, the significant deterioration in function seen at three 
months in survivors, persisted to one year. 
This study was only able to calculate the costs of the acute management of hip 
fractures and the calculated expenditure was a one third greater than normative cost 





Study Limitations: A limitation of the study is the disproportionate representation of 
the different ethnic groups due to differences in utilization of public sector hospitals.  
Whites are under-represented and their incidence rate underestimated.  Furthermore 
Coloureds make up a very small percentage of the population in the eThekwini 
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Chapter 1 Background to the study 
1.1 Introduction 
Osteoporosis, with its consequence of fragility fractures, is a common and serious 
public health problem in older persons.  In the United States of America (USA) it is 
estimated that one in three women and one in five men over the age of 50 years will 
experience an osteoporotic fracture during their lifetime [1, 2].  Osteoporotic fractures 
account for 0.83% of global burden of non-communicable diseases (NCD), 
increasing to 1.75% in Europe [3]. 
With the worldwide demographic change of increased longevity, the prevalence of 
osteoporosis and osteoporotic fractures is projected to rise in both developed and 
developing countries.  Worldwide estimates predict that the number of hip fractures 
will increase from 1.26 million in 1990 to 2.6 million in year 2015 and almost double 
to 4.5 million by the year 2050 [4]. 
Common sites for fragility fractures include the wrist, spine and hip [1, 2].  Wrist 
fractures after minor trauma, usually occur at an earlier age, are associated with an 
increased risk of hip fractures in later life and are therefore important clinical 
indicators of osteoporosis.  However, only a small number of patients are 
investigated for osteoporosis at the time of the wrist fracture [5].  Vertebral fractures 
(VF) occur in about 25% of women aged 50 years and over with the prevalence 
increasing with age.  The fractures may be spontaneous or occur after minimal 





fractures are often missed, either because radiographs are not taken or because the 
deformity is not identified [6, 7].  Even when a radiographic deformity has been 
reported, the majority of subjects are not treated for osteoporosis [8].  Vertebral 
fractures (VF) are a strong indicator for subsequent VF [9] and hip fractures [10] and 
are associated with a significant mortality and morbidity [11, 12]. 
Unlike wrist and VF, the presentation of a hip fracture is usually a dramatic event 
preceded by a fall, often in an older individual with multiple comorbidities.  The 
majority of patients will seek immediate attention and require hospitalization and 
surgery.  Hip fractures are associated with a significant mortality, morbidity and 
health care costs.  Estimates of mortality rate vary from 20 to 30% depending on 
access to health care and available resources.  A higher mortality rate is associated 
with older age, male gender, multiple co-existing illnesses and a poor level of 
functioning prior to the fracture [13-17].  The risk of death although highest in the first 
six months, persists for at least a year in women and even longer in men.  Following 
a fracture, the majority of patients experience a marked decline in function with up to 
40% not being able to live independently and up to 60% requiring assistance a year 
later [18, 19]. 
Osteoporotic fractures contribute significantly to health care costs.  Hip fractures are 
the most expensive to treat and are estimated to cost three times more than treating 
a patient without a hip fracture.  In the USA, the cost of treating a hip fracture has 
been estimated to be between 8 358 and 32 195 US dollars (USD).  Costs are 
greatest in the first six months post fracture and hospitalization accounts for up to 





factors influencing costs are patient’s age, functional status and duration of hospital 
stay [23].  Rehabilitation costs, during hospital admission and up to a year later 
contribute significantly to direct and indirect costs [24]. 
With the increasing incidence of hip fractures, the economic burden of osteoporosis 
has risen proportionately.  The annual health care cost attributed to osteoporotic 
fractures in the USA was between 5 - 10 billion USD in 1995 [25] and doubled to 20 
billion USD by 2002 [26].  Between 1990 - 2011 the medical and hospital cost of 
treating patients post fracture was 1.6 - 6.2 fold and 2.2 - 3.5 fold greater 
respectively, than treating matched controls [21].  With population ageing, a further 
doubling or tripling of the cost by 2040 is projected [27]. 
The acute cost of treating a hip fracture in South Africa (SA) is estimated to be R170 
000 (24 000 USD), with an average hospital stay of 7 - 9 days, in the private sector 
[28].  There is no recent data on the cost of the acute management of hip fractures in 
the public sector, nor is there data on long term and indirect costs.  In a country with 
an increasing number of older persons and limited health resources the cost of 
treating osteoporosis becomes of extreme importance, as prevention of fractures will 
result in significant health savings. 
Despite the serious consequences of osteoporosis, this condition often remains 
undiagnosed, and unfortunately even in patient’s presenting with fragility fractures, is 
often untreated.  In a systematic review the majority of patients sustaining fragility 





fractures [29].  Approximately 5 - 10% of patients will experience a second hip 
fracture usually within 3.3 years [30]. 
To develop appropriate strategies for the prevention, screening and treatment of 
osteoporosis and the prevention and treatment of osteoporotic fractures, an 
understanding of the epidemiology of and risk factors for osteoporotic fractures is 
vital.  Internationally, several initiatives have been adopted to increase the 
identification of individuals at high risk for fractures, to develop country specific 
intervention thresholds and start to fracture registries [31]. 
 
1.2 Epidemiology of osteoporotic hip fractures 
There is a wide geographic, ethnic and gender variation in the incidence of hip 
fractures.  While the incidence of hip fractures has been extensively reported in 
developed countries, data from developing countries are limited.  The highest rates 
of osteoporotic hip fractures are seen in Norway, Sweden and the USA [32-34].  
There is a north to south gradient with latitude with decreasing incidence 
southwards.  Intermediate rates have been reported in Latin America [4] and Asia 
[35, 36], and the lowest rates in Africa [37-40] and the Middle East [28].  In Europe 
and America the prevalence of fractures is greater in women, with the lifetime risk for 
sustaining a hip fracture for a women being 15% and for men 5% [41].  In contrast, in 
the developing world the prevalence of hip fractures is similar for both men and 





Varying hip fracture rates have been reported in Asia.  In a recent study from India 
the crude hip fracture incidence rate in over 50 year olds was 129 per 100 000 
persons and rates of 105 per 100 000 and 159 per 100 000 in men and women 
respectively, were reported [43].  The rate increased exponentially with age to reach 
962 per 100 000 in the 90 - 94 year age group.  Despite a lower incidence, 
osteoporotic fractures occur 10 - 20 years earlier in Indians as compared to 
Caucasians [44].  While the above rates are similar to those from South East Asia, 
they are lower than that seen in more developed Asian countries such as Japan or 
Singapore and that in northern Europe and North America (NA) [36, 42]. 
 
1.2.1 Hip fractures in Africa 
There are few published studies from Africa and early studies failed to document a 
significant hip fracture incidence.  The first study from rural Gambia found that 
African women had lower bone mineral density (BMD) compared to United Kingdom 
(UK) women but no hip fractures were noted [45].  A further study confirmed the 
lower rate of hip and forearm fractures in Nigeria compared to the USA [40].  
Possible reasons postulated for the lower incidence include reduced longevity in 
developing nations and a possible under-reporting [40, 46-48]. 
Recent studies show that incidence rates have increased nine-fold for women and 
five fold for men with age specific incidence rates increasing exponentially.  The 
rates however remain lower than in Europe [49].  In contrast to Europe and USA the 





The first study to report a change in hip fracture trends in Africa was a study from 
Morocco in 2002, in which the rate of hip fractures was 52.1 per 100 000 persons 
[50].  Although higher than previously reported this was still not comparable to the 
USA (80.5 per 100 000 persons).  A subsequent retrospective hip fracture study from 
Nigeria (2002 - 2008) found the mean age of fracture remained younger compared to 
developed countries.  The female to male incidence rate had also changed to 1.7:1 
unlike earlier studies which showed a similar incidence rate in men and women in 
Africa [37, 40, 51]. 
The only longitudinal hip fracture study in Africa from Rabat, Morocco (2006 – 2009) 
reported that age and sex specific hip fracture incidence trends were stable, but 
projected that a doubling would occur in the period between 2010 and 2030 [47].  In 
keeping with previous studies from Cameroon men were significantly younger (73.3 
± 11.0 years vs. 75.0 ± 10.7 years; p = 0.014) and hip fracture rates increased with 
age. 
 
1.2.2 Osteoporotic hip fractures in South Africa 
In SA although studies have looked at risk factors and prevalence of osteoporosis in 
the different ethnic groups, few studies have documented incidence rates or risk 
factors for hip fractures.  In the landmark study by Solomon, published over forty 
years ago, an extremely low prevalence of hip fractures in Africans (5.2 per 100 000 
persons) was seen [39].  The reason for this was not well understood, as a 





Whites [52].  Schnaid et al., in 2000 reported a higher rate of hip fractures in 
Nelspruit, but this study had several limitations as it excluded subjects with 
osteoporosis and was limited to small geographic area [39, 52, 53]. 
However, a recent study showed a similar prevalence of VF’s in African and White 
subjects suggests that the pattern of osteoporosis may be changing [54]. 
In keeping with the worldwide demographic change, the older population of SA is 
expected to increase exponentially despite population growth remaining static.  The 
number of elderly will increase from the present 8 million (16%) aged 50 years and 
over and 1.6 million (3%) aged 70 years and over to 13.6 million (28%) and 4 million 
(8%) respectively by the year 2050 [28].  In addition there is significant urbanization 
and change in dietary and lifestyle factors.  It is therefore expected that there will be 
a commensurate increase in osteoporotic fracture rates. 
The effects of urbanization on osteoporosis are well documented.  In Asia, 
urbanization has had a marked increase in the rate of hip fractures [55].  A high 
protein diet is associated with a negative calcium balance and there is strong 
correlation between animal protein intake and hip fracture rates [49, 50].  In post-
apartheid SA, there has been a massive shift from rural to urban areas with 
associated lifestyle and dietary changes.  Whilst the intake of calcium has decreased 
there has been an associated increase in the intake of animal protein.  This 
combined with a decrease in physical exercise may contribute to a decrease in bone 





population and the inherent genetic predisposition can counteract the urbanization 
effects needs further study [56]. 
 
1.3 BMD and clinical risk factors for osteoporosis 
Central to the concept of osteoporosis is a decrease in bone strength as reflected by 
a decrease in bone mass and quality.  Bone mass or BMD is currently the only 
readily measurable skeletal risk factor and the relationship of BMD to bone strength 
has been extensively studied.  BMD is able to predict 75 - 90% of variance seen in 
bone strength; a 10% loss of vertebral bone mass is associated with a doubling of 
the risk of a spinal fracture while a 10% bone loss in the hip will result in a 2.5 fold 
increase in hip fracture risk [57]. 
In 1994, the World Health Organization (WHO) defined osteoporosis in White post-
menopausal women as a BMD, measured by dual energy x-ray absorptiometry 
(DXA), which is 2.5 standard deviations (SD) or more below that of a young adult (T - 
score of less than - 2.5), while severe osteoporosis is a T - score of less than - 2.5 
with the presence of one or more fractures usually at the wrist, hip or spine [58].  
Based on epidemiological study data obtained from the Third National Health and 
Nutritional Study (NHANESIII), a reference range for BMD has been established 
[59]. 
While there is a relationship between BMD and fracture risk, there are several 
limitations.  The relationship is continuous and there is no absolute value below 





sensitivity and significant proportions of subjects who fracture have either a normal 
or low bone mass and do not fulfil the diagnostic criteria for osteoporosis [32, 58, 60].  
Other limitations include the fact that the WHO criteria do not consider changes in 
bone quality and other risk factors for osteoporosis [51].  Furthermore these criteria 
are not applicable to pre-menopausal women, men and different ethnic populations. 
 
1.3.1 Ethnic differences in BMD 
In the last decade, a number of studies have tried to explain the observed ethnic 
differences in BMD.  Studies in the USA, show that African Americans have higher 
BMD independent of weight, and a lower rates of hip fractures than Whites 
Americans [61].  Postulated reasons for these differences include lower bone 
turnover rates, lower rates of bone loss in early menopause [62], shorter vertebra 
and wider, longer bones with shorter hip axis length (HAL) in African Americans [63].  
Additionally the higher prevalence of obesity in African-Americans is thought to 
increase skeletal loading during walking and provide an endogenous oestrogen 
source post menopause, which may be protective factors [64]. 
In contrast, although Asian woman have a high rate of metabolic bone disease and a 
15% lower bone mass [44], their incidence of hip fractures is lower compared to 
Whites.  This difference in BMD is also seen in Asian women residing in America 
[44, 63, 65].  In a further study, although Indo-Asian women had a lower BMD and 
shorter HAL, bone mineral apparent density (BMAD) was similar to Whites [44, 66].  





as the actual depth is not considered in areal BMD measurements and further 
longitudinal studies may be required [44, 66]. 
In SA, in an attempt to understand and explain the differences in fracture rates, 
several studies have compared bone mass and geometry in SA Africans and Whites.  
After adjusting for differences in body size, higher femoral neck and proximal femur 
BMD but a lower BMD at the lumbar spine has been reported in African women 
compared to White women [67, 68].  In addition, vertebral bone size was 
paradoxically smaller and HAL shorter in Africans compared to Whites [69].  
Histomorphometric analysis of iliac cortical crest, showing thicker trabeculae, better 
osteoid seam thickness, greater endocortical mineral apposition rates and better 
bone formation in Africans, suggests stronger bone microarchitecture in Africans 
[70]. 
There is only one study on BMD measurement in the Indian population in SA and 
Indians had a lower BMD than Africans [71]. It therefore may be postulated that if 
international trends are followed, SA Indians may have a lower bone mass and 







1.3.2 Clinical risk factors for osteoporotic fractures 
Apart from a low BMD there are multiple well established risk factors for osteoporotic 
hip fractures, including body composition (weight, height, and bone mass), 
underlying comorbid illness, family history of osteoporosis or hip fractures, smoking, 
alcohol, prior fractures, diet, level of physical activity, dietary calcium intake, sunlight 
exposure, seasonal, genetics and fall risk [33, 72-77].  Several large epidemiological 
studies have established the relationship between these clinical risk factors (CRF) 
and fracture risk in much of NA, Europe, Australia, and parts of Asia and the Middle 
East [78-82]. 
Similar risk factors, including a premature menopause, low calcium intake, smoking, 
physical inactivity, low levels of female sex hormones, eating disorders, diabetes 
mellitus, steroid use and low levels of vitamin D have been previously documented in 
SA [68, 83, 84].  In addition the association between excessive alcohol and 
osteoporosis has also been documented [85].  African men who consumed high 
levels of alcohol have been shown to have increased erosions, femoral neck 
fractures at younger age and severe osteoporosis as compared to Whites [53]. 
The combination of CRF and BMD vastly improves the quantification of fracture risk.  
A major advance for risk assessment is the introduction of the Fracture Risk 
Assessment Tool (FRAX®) which uses CRF with or without BMD to compute a 10 
year probability of a major and hip fracture.  This information is then employed to 





tool is however country specific and depends on local incidence, mortality rates and 
health economics [31, 86]. 
In SA, while national guidelines for the diagnosis and management of osteoporosis 
and for the acute management of hip fractures have been developed [87, 88], 
osteoporosis is not a primary medical benefit (PMB), and therefore does not need to 
be reimbursed for by medical insurance companies.  This limits access to both 





1.4 Problem statement 
From historical studies the prevalence of hip fractures documented in the African 
South African population is thought to be extremely low.  The exact reasons for this 
low rate are not well understood and may have been due to a constellation of 
factors.  However, more recent studies suggest that this may no longer hold true.  
While international studies also suggest a lower incidence of hip fractures in Indians 
compared to Whites, there is no data in SA. 
As the country emerges from 20 years of democracy; the effects of urbanization, 
decreasing physical activity and dietary changes have led to the rapid increase of 
non-communicable diseases [89], particularly as the life expectancy increases. 
It is therefore postulated that the previous findings no longer hold true and the rate of 
osteoporosis and hip fractures may have risen in Africans in SA, and that hip 






The risk factors and outcomes of osteoporotic hip fractures are similar in the different 
ethnic groups. 
The cost of treatment for osteoporotic hip fractures is underestimated in South Africa 
and screening will be an effective intervention tool. 
 
1.6 Objectives 
1. To document and compare the demographic profile and risk factors in subjects 
with minimal trauma hip fractures in the different ethnic groups. 
2. To determine the incidence rate of hip fractures in the public sector in the 
eThekwini Metropolitan area. 
3. To determine the prevalence of silent vertebral fractures in subjects presenting 
with hip fractures and control subjects. 
4. To determine the mortality and morbidity of hip fracture subjects at three months, 
six months and one year. 






A descriptive study, documenting the incidence and demographic characteristics 
(age, gender and ethnicity) of hip fracture subjects older than 60 years old 
presenting with minimal trauma hip fractures in the public health sector of eThekwini 
area, SA was undertaken.  Two hundred hip fractures subjects and 200 control 
subjects who consented to participate in the study were enrolled in a one year 
prospective case control study to determine risk factors and outcomes post hip 
fracture.  Using a bottom up approach the health care costs associated with acute 
hip fracture management were determined. 
Study data was collected using a standard data form, standardized clinical 
examination and haematological and biochemical investigations.  The Student’s t 
test and Chi-square test was used to compare means and categorical data, 
respectively.  In the case control study, matched conditional logistic regression was 
used to determine association between outcome and risk factors.  All significant 









1.8 Significance of study 
 There is limited data on hip fractures from Africa and this is the first study 
since 1968 to describe the profile of subjects presenting with hip fractures to 
the public sector hospitals in eThekwini, South Africa. 
 The study will be able to provide important epidemiological insights into the 
burden posed by osteoporotic hip fractures, risk factors, outcomes post hip 
fracture and associated costs in SA.   
 The acute management of hip fractures, including cost, is documented and 
can be compared to national and international guidelines. 
 The health care gaps in the management of osteoporosis will be identified and 
will inform future health care policies.  This will include review of current 
screening and treatment guidelines for osteoporosis, referral pathways, 
staffing needs, access to operating theatres and rehabilitation facilities for hip 
fracture subjects. 
 The study will result in increased knowledge and awareness of osteoporosis 





1.9 Outline of the study 
Chapter 2 Reviews the literature relating to the epidemiology, risk factors and 
outcomes and health care costs of osteoporotic hip fractures.  The review highlights 
the burden posed by osteoporotic hip fractures in developing countries and the 
associated excessive mortality and morbidity post hip fracture. 
Chapter 3 Presents the methodological framework of the overall study, and outlines 
the study sample, inclusion and exclusion criteria, data collection, management and 
analysis methods, as well as reliability, validity and ethical considerations of the 
study. 
Chapter 4 The results are presented in the subsections as demographic 
characteristics, incidence, risk factors for osteoporotic fractures in hip fracture and 
matched control subjects (stratified into gender and ethnic groups), outcomes in hip 
fracture subjects (mortality and one year functional outcome) and health care costs 
associated with the acute management of hip fractures. 
Chapter 5 Discusses the results and comparison is made to international and local 
literature.  Similarities and differences are highlighted allowing for recommendations 
for the SA population and for future research. 
Chapter 6 Concludes this thesis and presents the key findings, conclusions and 
study limitations.  Possible areas for future research are identified and proposals 
recommended for increasing the awareness of osteoporotic fractures in the 





Chapter 2 Literature review 
2.1 Background 
Hip fractures are the most devastating consequence of osteoporosis and are 
associated with significant morbidity, mortality and health care costs [90].  With 
advances in the understanding of the pathogenesis and epidemiology of 
osteoporosis and the risk factors for fractures, integrated screening tools [31] and 
treatment guidelines [91-93] for osteoporosis have been generated for much of the 
developed world.  Despite this, treatment is not always instituted even in patients at 
highest risk, namely those with a previous fragility fracture.  This prompted the 
International Osteoporosis Foundation (IOF) to launch the global “Capture the 
Fracture Campaign” which targets this high risk group of patients and aims to 
increase awareness of osteoporotic fractures, improve the acute management of hip 
fractures and ensure appropriate screening and treatment post fracture [94]. 
Little is known of the incidence, risk factors and outcomes of hip fractures in 
developing countries, especially in Africa.  In a review of the worldwide incidence of 
hip fractures, the lowest incidence is reported in Nigeria and SA.  In the case of the 
latter this is based on a single study undertaken more than 40 years ago [36]. 
Developing countries, including SA, are faced with the challenges of coping with a 
quadruple burden of disease, (communicable and NCD, perinatal and maternal and 
injury related conditions) [89], and limited resources.  It is not entirely surprising then, 
that not much emphasis is placed on a condition perceived to be uncommon and 





2.2 Structure of bone 
Bone as a metabolically active tissue, has the ability to adapt to variations in load 
and to repair damage, in order to carry out its functions of supporting body weight, 
acting as a site for the attachment of muscles and as a metabolic reservoir for 
minerals.  Specialized bone cells, osteoblasts, osteoclasts and osteocytes, are 
embedded in an organic matrix of type 1 collagen fibres and proteins, strengthened 
by calcium, phosphate and carbonate in the form of hydroxyapatite crystals [95].  Of 
the two types of bone cortical bone found predominantly in the shaft of long bones 
and flat bones, provides strength and resistance to bending and torsion [96, 97].  In 
contrast, trabecular or cancellous bone found mainly in the axial skeleton and 
arranged as interconnecting plates and rods, provides flexibility and plays an 
important role in the metabolic functions of bone [98]. 
 
2.3 Bone growth, modeling and remodeling 
Bone undergoes longitudinal and radial growth and modeling during adolescence 
and young adulthood until skeletal maturity is reached.  Bone modeling, in which 
bone formation and resorption are not tightly coupled, results in a change in bone 
shape and size.  Bone remodeling in contrast, is a continuous ongoing renewal 
process, in which trabecular micro-damage is repaired.  Discrete units of old bone 
are removed and replaced by new  bone in a closely interrelated cycle [95] in a bone 





6 months to complete and is regulated by cytokines, growth factors and mechanical 
stimuli [95]. 
Activation of the cycle occurs when monocytes are attracted to resting bone by 
stimuli including hormones and cytokines.  Matrix metalloproteinases digest the thin 
collagenous membrane.  Thereafter osteoclasts are recruited, bone is resorbed 
forming a cavity known as the “Howship lacunae” and calcium is released into blood.  
This process occurs takes approximately 2 - 4 weeks [99].  In the reversal phase 
unknown cells repair the erosion by lining it with a thin layer of cement.  
Subsequently osteoblasts lay down a new matrix which is then mineralized.  In the 




Activation   Resorption    Reversal 
 
Resting    Formation 
Figure 2.1 Diagrammatic summary of the 5 cycles in bone remodeling 






2.3.1 Regulation of bone growth, modeling and remodeling 
Cells involved in bone modeling and remodeling 
Osteoblasts, derived from pluripotent stromal stem cells, are the bone lining cells 
responsible for the synthesis and secretion of the organic bone matrix and bone 
mineralization.  Their growth and functioning is controlled by core binding factor A1 
and Indian hedgehog [95, 100], which regulate the expression of osteoblast specific 
genes including osteocalcin, osteopontin, bone sialoprotein, and receptor activator of 
nuclear factor-κβ ligand (RANKL).  Osteoblasts express receptors for parathyroid 
hormone (PTH) and 1, 25 - dihydroxyvitamin D (1, 25 (OH)2 D) which play an 
important role in calcium homeostasis [99]. 
Osteocytes act as mechanosensors and initiate the remodeling process via nitric 
oxide (NO), insulin like growth factor (IGF) and glucose-6-dehydrogenase [101].  
They also respond to changes in PTH and calcitonin levels, and therefore play a role 
in maintaining body calcium levels [95]. 
Osteoclasts are large multinucleated cells derived from the monocyte/macrophage 
lineage cells and are responsible for bone resorption [95, 102, 103].  Their 
development and growth is regulated by macrophage colony stimulating factor (m-
CSF) and RANKL found on osteoblast progenitor cells and stromal fibroblasts.  The 
binding of RANKL to its receptor activator of nuclear factor-κβ (RANK), expressed by 
osteoclasts, initiates and stimulates osteoclast differentiation.  In contrast, when 
RANKL binds to osteoprotegerin (OPG), a soluble decoy receptor secreted by 





OPG/RANKL is critical in determining bone mass and lower levels of OPG are 
associated with decreased bone mass.  Osteoprotegerin levels decrease with age, at 
menopause and in glucocorticoid induced osteoporosis.  Osteoclast apoptosis is 
inhibited by PTH, 1, 25 (OH)2 D, interleukin 1(IL1), interleukin 6 (IL6), m-CSF, tumour 
necrosis factor alpha (TNF-α) and RANKL while transforming growth factor beta 
(TGF-β) and OPG stimulate osteoclast apoptosis [106]. 
Physical stimuli and muscle action both influence bone remodeling and according to 
Wolff’s law, “bone accommodates the load placed on it by altering its mass and 
distribution of mass” [107].  There is a positive linear relationship between physical 
activity and bone mass, namely chronically increased mechanical load on bone 
increases bone mass, while a decreased load results in bone loss. 
Vitamin D is important for homeostasis and bone metabolism.  It maintains 
extracellular calcium concentrations by controlling absorption of calcium and by 
direct effects on bone and on PTH secretion.  Parathyroid hormone acts directly and 
indirectly on the osteoclasts to increase bone resorption and skeletal calcium 
mobilization [108].  In the kidney it decreases calcium excretion and increases the 
formation of 1, 25 (OH)2 D3 which in turn, increases intestinal calcium absorption.  
Continuous administration of PTH leads to bone loss but intermittent administration 
has an anabolic effect [95]. 
Calcitonin directly inhibits bone resorption by its action on both precursor and mature 
osteoclasts by decreasing the ruffled borders of osteoclasts and increasing cyclic 






Oestrogen inhibits bone resorption by acting directly on receptors found on 
osteoclasts to enhance osteoclast apoptosis and indirectly by blocking pro-
inflammatory cytokines.  It also acts directly on osteoblasts to increase OPG [101, 
109, 110] and indirectly on osteocytes, bone marrow megakaryocytes and 
mononuclear cells [111].  Oestrogen actions on bone include decreasing the pro-
resorptive cytokines, RANKL and TNF-α, increasing antagonists IL1, TGF- β and 
OPG, and increasing serum calcium by increasing intestinal calcium absorption and 
decreasing renal calcium excretion.  Oestrogen deficiency results in rapid bone loss 
especially after menopause due to an increase in the rate of bone remodeling with 
an imbalance between resorption and formation of BSU, leading to formation of 
unfilled bone cavities [112]. 
Testosterone acts directly on bone via androgen receptors found on osteoblasts and 
is responsible for the increase skeletal growth seen at puberty in boys.  In males 
oestrogens derived from androgen are important for normal bone development 
similar to oestrogen in women.  The importance of oestrogen for normal skeletal 
growth in males is supported by the failure to achieve normal skeletal growth in 
males with oestrogen receptor (ER) resistance despite normal testosterone levels 
[95].  Oestrogen is also important in the maintenance of normal bone mass in older 
men [113]. 
Glucocorticoids (GC) have direct and indirect effects on bone via GC receptors.  





and decreasing osteoclast apoptosis.  This results in an increase in RANKL and 
decrease in OPG levels [95, 114, 115]. 
Other systemic hormones which influence bone metabolism include growth hormone 
(GH), thyroid hormone and leptin.  Growth hormone acts primarily via IGF to 
increase bone turnover and bone mass [95].  Excess thyroid hormone levels 
stimulate bone resorption, hypercalcaemia and decrease PTH and vitamin D levels 
[95].  While leptin, an adipocyte derived hormone, increases osteoblast 
differentiation and inhibits osteoclasts, its relevance in humans has not been proven 
[116-118]. 
 
2.4 Changes in bone mass with ageing 
The rapid and linear bone growth in childhood bone stops in the second decade of 
life, whilst appositional bone growth continues till peak bone mass (PBM) is attained 
by the age of 18-25 years.  Peak bone mass is largely determined by genetic factors 
(75-80%) [119], with a smaller contribution by environmental factors and is higher in 
males than females.  This difference is most likely due to differences in gonadal 
hormones rather than genetic factors as shown in male-female twin studies [120, 
121].  Bone mass remains fairly stable thereafter until age associated bone loss of 
approximately 0.7 - 1% per annum commences during the fourth decade of life 
(Figure 2.2) [122].  In women accelerated bone loss of approximately 2 - 5% per 
annum occurs in the first five years after menopause, slowing thereafter to the same 












Figure 2.2 Changes in bone mass with age in men and women. 






2.5 Definition of osteoporosis 
Although historically the term “osteoporosis” was first used in 19th century to describe 
the porous quality of aged bone [123], Sir Astley Cooper had earlier described 
fractures secondary to a decreased bone mass with ageing occurring more 
commonly in women and at sites of increased trabecular bone mass [104].  Later, 
Albright defined osteoporosis as “vertebral fracture syndrome in women 20 years 
within menopause” [124].  However this definition excluded men and persons with 
low bone mass who were yet to sustain a fracture [123]. 
It was only in 1991 that the WHO defined osteoporosis as a “systemic skeletal 
disease, characterized by low bone mass and micro architectural deterioration of 
bone tissue with a resultant increase in bone fragility and susceptibility to fracture” 
[125].  This definition was further modified by the National Institute of Health (NIH) in 
2000 to a “skeletal disorder characterized by compromised bone strength 
predisposing to an increased risk of fracture”.  This now addressed both bone mass 







2.6 Pathogenesis of osteoporosis  
The main mechanisms for low bone mass is either a failure to achieve PBM or 
increased bone loss.  Causes of bone loss include increased bone turnover and or a 
remodeling imbalance in which bone resorption is greater than formation [95]. 
Failure to attain genetic bone potential is often multifactorial and due to inter-
dependent environmental factors, such as low calcium intake, inadequate exercise 
and physical activity [127].  Ethnic and gender differences also exist.  African men 
have the heaviest skeleton, followed by White men and African women with White 
women having the lightest skeleton [128].  Fracture trends follow a similar pattern 
[61].  While an increase of 10% in PBM decreases fracture risk by 50%, a low PBM 
increases fracture risk once age related bone loss commences [129]. 
Bone loss occurs due to either a remodeling imbalance or increased turnover.  In 
remodeling imbalance, there is an uncoupling of bone formation and resorption.  
Bone formation within a BSU is decreased compared to resorption resulting in an 
increase in the erosion depth and/or a reduction in the amount of bone formed.  The 
latter is due to a failure of osteoblast attraction.  This type of bone loss is irreversible 
[95, 130]. 
In increased bone turnover states the activation frequency of bone remodeling is 
greater i.e. there is an increase in the number of sites (BSUs), at which bone 
resorption followed by formation occurs.  The net deficit of bone that occurs during 
remodeling, due to under-filled cavities, increases as the number of BSUs increase.  





trabecular plates.  In addition there are larger amounts of immature and incompletely 
mineralized bone than normal.  Increased bone turnover in seen in postmenopausal 
osteoporosis, hyperparathyroidism and with prolonged immobilization [130]. 
 
2.7 Classification of osteoporosis 
Osteoporosis is classified as primary, which is either age-related postmenopausal, or 
secondary. 
2.7.1 Age related bone loss 
Age is one of the most important determinants of bone mass.  While men attain a 
higher PBM than women and bone mass is usually 15% lower in women than men in 
all life stages and all sites [103], a similar degree of age related bone mass occurs in 
both men and women independent of disease after the fourth decade [131].  The 
bone loss which starts in trabecular bone and affects cortical bone 5 - 10 years later 
is gradual, at approximately 0.7 - 1% per year.  Due to the higher bone turnover rate 
larger losses occur in trabecular bone.  Age related bone loss is estimated to 
account for 25% of bone loss seen in both cortical and trabecular bone. 
The main mechanism for this age related bone loss is a remodeling imbalance due 
to the ageing osteoblast [132, 133].  Resorption cavities are of normal or even 
decreased depth but osteoblasts fail to fill these cavities resulting in thinning of 
trabeculae, however trabecular connectivity is maintained.  The decreased 





occurs; rather it is probably due to impaired regulation of osteoblastic activity by 
systemic or local growth factors, including IGF-1 and GH, which are decreased by 
almost 50% with ageing.   
The second factor potentially causing age related bone loss is the decreased 
calcium absorption and transport which occurs, especially after the age of 70 years 
possibly due to decreased 1, 25 (OH)2 D levels.  With aging there is a decreased 
absorption and dermal synthesis of vitamin D and a decreased renal conversion of 
25 (OH) D to 1, 25(OH)2 D3.  The net effect is secondary hyperparathyroidism which 
increases the bone turnover rate and bone loss [98, 132]. 
 
2.7.2 Postmenopausal bone loss 
Bone loss associated with menopause was first proposed by Albright et al., [124] and 
is due to both increased turnover and a remodeling imbalance [134].  Oestrogen 
affects bone metabolism directly through receptors expressed on osteoblasts, 
osteocytes and osteoclasts, and indirectly through cytokines and growth factors 
[135].  Oestrogen enhances osteoclast apoptosis via increased production of TGF- 
β.  When oestrogen deficiency occurs at menopause, there is an increase in IL1 and 
IL6 production by osteoblasts, which stimulate the recruitment and differentiation, 
and survival of osteoclasts.  In addition, osteoblast differentiation and activity is 
inhibited and there is increased apoptosis of osteoblasts through cytokines such as 





Bone loss is sequential; the rate is highest within the first few years after menopause 
with a 3 - 10% loss in trabecular bone, and decreases thereafter to the rate seen 
with ageing [131].  During menopause, women will lose up to 25% of trabecular, 10% 
of cortical and up to 15% of spinal bone mass [95].  With combined age-related and 
postmenopausal bone loss, women between the ages of 30 and 80 years lose 
approximately 35% of cortical mass and 50% of trabecular bone mass [138] 
compared to men, who lose 15 - 20% of their cortical bone and 25 - 30% of 
trabecular bone [139].   
While the rate of menopausal bone loss in Indian [140] and African American women 
has been reported to be similar to Caucasian women in the early postmenopausal 
period in some studies,  [141, 142], [143] other studies have reported a slower  
decline in BMD with ageing [69, 144, 145] in African American and SA African 
women compared to Whites.  Bone loss is however slower in obese women who 
have higher circulating levels of oestrogen from increased peripheral conversion of 
androstenedione in fat [103]. 
Hormone replacement therapy (HRT) significantly decreases the rate of peri and 







2.7.3 Secondary osteoporosis 
Secondary osteoporosis refers to osteoporosis not due to merely ageing or 
menopausal bone loss.  A specific pathological mechanism is identified for the failure 
to achieve PBM or increase bone loss.  The causes are often multifactorial and 
significant overlap often exists between primary and secondary causes of 
osteoporosis [147].  It is important however to screen for these conditions especially 
in young subjects or men presenting with osteoporosis. 
The most common conditions usually are glucocorticoid use, hypogonadism, 
malignancy and autoimmune diseases.  Table 2.1 highlights diseases frequently 





Table 2.1 Secondary causes of osteoporosis 
Endocrine diseases Hyperthyroidism   Hyperparathyroidism 
Diabetes mellitus   Acromegaly 
Addison disease    Cushing disease 
Ovarian agenesis   Prolactinoma 
Hypogonadism Premature menopause  Delayed puberty 
Anorexia nervosa   Bulimia 
Athlete’s amenorrhoea  Turner’s syndrome 
Klinefelter’s syndrome  Kallman syndrome  
Gastrointestinal Diseases Inflammatory bowel disease Chronic liver disease  
Pancreatic disease   Gastric bypass 
Coeliac disease    Gastrectomy 
Bone marrow disorders Multiple myeloma   Leukaemia 
Lymphoma    Thalassemia 





Rheumatoid arthritis  
Psoriasis 
Systemic lupus erythematosus 
Ankylosing spondylitis 
Drugs Corticosteroids   Anticonvulsants 
Lithium    Heparin 
Miscellaneous Alcoholism    Malignancy 
Sarcoidosis    Parental nutrition 
Organ failure    Amyloidosis 
Post-transplant bone disease 
Pregnancy associated osteoporosis 
Prolonged immobilization 





2.8 Consequences of osteoporosis 
The most devastating consequence of osteoporosis is a fragility fracture, defined as 
a “fracture caused by an injury that would be insufficient to fracture normal bone: the 
result of reduced compressive and / or torsional strength of bone” [148], or clinically 
as a fracture resulting from minimal trauma e.g. a fall from standing height [149].  
The most common sites for osteoporotic fractures are the hip, distal forearm and 
spine [18, 150]. 
In the USA, 1.5 million fractures occur annually with the majority being VFs 
(650 000), followed by hip fractures (250 000) and distal forearm fractures (200 000).  
A 50 year old white woman in the USA has a life time risk of 17% for hip fracture, 
16% for wrist, and 15.6% for clinically evident VF and 39.7% for combination of all 
three sites, whilst these risks are halved in African and Asian women [2].  It is 
estimated that one in two women above the age of 50 years will experience a VF 
and one in three women will experience a hip fracture in their lifetime.  These 
projections are based on a stable age adjusted rate and may over  or under estimate 
the health impact of osteoporotic fractures [151]. 
Wrist fractures are more common in women than men with a ratio of 4:1 and usually 
occur in the early postmenopausal period and plateau thereafter (Figure 2.3).  In 
contrast wrist fractures rates in men are fairly stable between the ages of 20 - 80 
years.  Compared to hip and VF, wrist fractures are usually easily treatable and do 
not impact significantly on long term quality of life or functioning or mortality [96].  












Figure 2.3: Annual incidence of osteoporotic fractures in women  
Adapted from Wasnich RD et al. Osteoporosis Int. [153] 
 
The majority of VFs (75%), unlike other fragility fractures, occur without any 
associated trauma and are due to daily activities e.g. lifting or bending, and often 
remain undetected clinically.  In a multi-national study, 68% of postmenopausal 
women with osteoporosis had undiagnosed VFs [3].  The usual sites for VFs are the 
mid thoracic or thoraco-lumbar transition zone with most fractures occurring between 
the eleventh thoracic to first lumbar vertebrae [154].  Especially if multiple, VFs can 
result in chronic pain, deformities and cardiorespiratory limitations and increased 
mortality.  The increased risk of death with VFs varies widely from between 20 - 90% 





Hip fracture incidence increases exponentially with age (Fig 2.3).  A white woman 
has a 15% lifetime risk at age of 60 years for a hip fracture, which equals the 
combined risk of breast, endometrial and ovarian cancer.  Similarly in men the 5% 
risk equates to risk of prostate cancer [41].  Several well established risk factors for 
hip fractures exist [76] and include age, ethnicity, gender, genetic, family history 
[157], prior fractures, smoking [158] and alcohol [85, 147].  Post fracture individuals 
have significant loss of function in multiple domains [159].  The higher mortality 
persists for over a year post fracture and is greater in older persons, males and in 
non-White individuals [13, 61, 160-162]. 
Several longitudinal studies suggest that osteoporosis per se increases mortality by 
1.5 times for each SD decrease in BMD.  More importantly, compared to the general 
population, mortality is significantly higher with any osteoporotic fracture and highest 






Figure 2.4 Mortality rates in major osteoporotic and hip fractures compared to 
the general population. 






2.9 Diagnosis of osteoporosis 
Traditionally the diagnosis of osteoporosis was based on the presence of a fragility 
fracture.  This definition however, did not take into account the underlying cause of 
the fracture, namely the decreased bone mass.  With advances in the measurement 
of bone mass, especially with the development of DXA, diagnostic criteria for 
osteoporosis based on BMD were introduced. 
 
2.9.1 WHO diagnostic criteria for osteoporosis 
It is well accepted that fracture risk increases as BMD decreases [58], and with 
increasing age [33, 86, 167].  Bone mineral density in the population follows a 
normal or Gaussian distribution.  Epidemiological studies have determined that the 
“fracture threshold”, beyond which the risk of fractures increases, is 1.0g/cm2.  This 
level represents the lower limit of the normal distribution of BMD, namely that it is 
two standard deviations (SD) below the mean of a young normal individual [25]. 
In 1994, the expert panel of the WHO, introduced diagnostic criteria for osteoporosis, 
based on the BMD as measured by DXA [168].  The updated version (2008) 
recommends a diagnostic threshold of BMD or bone mineral content (BMC) more 
than 2.5 SD below the mean value of young gender matched individual at the hip be 
used to define osteoporosis i.e. a T -  score of  -2.5 (Table 2.2) [169].  This would 
identify 15 - 20% of postmenopausal women as having osteoporosis.  If DXA 





identify 30% of postmenopausal women as having osteoporosis, approximating the 
lifetime risk of fractures. 
 
Table 2.2 World Health organization diagnostic criteria for the diagnosis of 
osteoporosis, based on bone mineral density, measured by dual energy x-ray 
absorptiometry 
World Health organization [168]168] 
 
Although widely used, these criteria have several limitations.  Used as a single 
criterion, BMD has a low sensitivity to predict fractures [170].  While the rate of 
fractures increases as the BMD decreases, the majority of fractures occur at a BMD 
which is in the normal or osteopaenic range [171].   
Definition Criteria 
Normal 
BMD or BMC value (measured with DXA at either the spine, 
total hip or femur neck) within 1 SD of the young adult 
reference mean ( T - score at or above -1.0) 
Low Bone Mass 
BMD or BMC value more than 1 SD, but less than 2.5 SD 
below the young adult mean (T - score between -1.0 and -
2.5) 
Osteoporosis 






The criteria are based solely on BMD and do not consider other risk factors for 
osteoporotic fractures such as fall risk, secondary causes and bone quality.  
Furthermore the criteria were developed for post-menopausal White women and 
may not be applicable to men and other ethnic groups. 
 
2.10 Measurement of bone mineral density 
The gold standard for the measurement of BMD is with DXA.  The older method 
such as single photon absorptiometry (SPA), used to measure changes in the rates 
of bone loss in the 1980’s, is seldom used today as it does not measure 
appendicular skeleton bone mass [62].  Conventional radiography [172], quantitative 
computed tomography (QCT) [173, 174] and quantitative ultrasound (QUS) [2] have 
specific advantages, but are not recommended for the diagnosis of osteoporosis.  
Biochemical markers of bone turnover have several limitations [175], and have no 
value in the diagnosis of osteoporosis, and bone biopsy has very limited indications 
[176]. 
 
2.10.1 Dual energy x-ray absorptiometry (DXA) 
This technique measures the attenuation of transmission of x-rays of two different 
energy levels through the body, one of which measures soft tissue density and the 
other both soft tissue and bone.  This allows for bone mineral (hydroxyapatite) to be 





measured and expressed as BMD in grams of mineral per unit projected area of 
bone (areal bone density) [177].  Dual energy x-ray absorptiometry can be performed 
for the entire skeleton or at specific sites which have been identified as high risk for 
fracture e.g. hip and wrist. 
Dual energy x-ray absorptiometry is the most widely validated instrument in 
measuring bone mass and interpretation has been standardized with development of 
a standard international reference range.  It is one of the least invasive and most 
accurate devices available presently.  The radiation dose is less than one tenth 
compared to a standard radiograph, and the procedure fairly short.  Dual energy x-
ray absorptiometry is fairly accurate and has greater than 90% accuracy at 
measuring bone mass at the hip.  The precision error with DXA for spine, proximal 
femur and forearm is about 1 - 2% [178]. 
Potential error sources include osteoarthritis, soft tissue calcification, osteomalacia, 
previous fracture, scoliosis, extreme obesity, contrast use, overlying metal objects 
and untrained operators.  Dual energy x-ray absorptiometry is the gold standard for 
BMD for the diagnosis of osteoporosis, monitoring the natural history of the disease 
and treatment response and predicting fracture risk [174, 179]. 
The main disadvantage of DXA is that as the relationship between volume and area 
is non-linear, the BMD calculated by DXA only provides a two dimensional areal 
measurement.  The normal distribution of BMD, allows for it to be expressed in 
relation to a reference population in SD units.  The T - score is areal BMD expressed 





while the Z - score compares BMD of the individual to that of age and gender 
matched adults [174].  The reference range recommended by the IOF is the 
NHANES III database III [80]. 
Lateral vertebral assessment (LVA) from DXA scans also provide detailed analysis 
from T 7 – L4 [180].  It has significant advantages over lateral thoracic and lumbar 
radiographs, as it uses both digital x-rays and parallel beam geometry, and is 
therefore able to measure vertebral height and detect VFs [181].  The dose of 
radiation is lower and the procedure can be combined with conventional DXA scan 
avoiding the need for two imaging procedures.  The main limitations are that a 
narrower view is obtained than radiographs, other potential pathologies may be 
missed, upper thoracic vertebrae are excluded and the spatial resolution is inferior to 
plain radiographs [182]. 
 
2.10.2 Conventional radiology 
Although inexpensive and simple to perform, plain radiographs are an insensitive 
method for detecting osteoporosis [172].  Approximately 30 - 40% bone needs to be 
lost before it can be detected on plain radiographs.  Furthermore up to 25% of 
individuals diagnosed with osteopenia on radiographs will have a normal BMD on 
further testing. 
Lateral radiographs of the spine however, are of value in the older individual, 
particularly in the presence of loss of height, to detect clinically silent VF and 





can be classified as wedge, biconcave or crush [184].  A number of methods have 
been used to classify VFs [185].  These include quantitative measures [186, 187], 
semi-quantitative [188], or an algorithm based qualitative method [154, 189].  The 
Genant’s semi-quantitative method of staging is most widely used and has been 
validated and has good intra-and inter-rater reliability and predictability [185]. 
 
2.10.3 Quantitative ultrasound (QUS) 
Ultrasound variables, broadband ultrasound attenuation (BUA), speed of sound 
(SOS) and ultrasound critical angle reflectometry have also been used to measure 
skeletal status [95].  The SOS measures the time taken for a sound wave to travel 
through bone and is proportionate to bone mass.  The BUA determines the amount 
of sound absorbed in bone and increases with solidity of bone.  While QUS is a 
relatively inexpensive method, free from radiation, can be used at various sites and 
may provide information on bone quality, there are limitations to its use.  The main 
disadvantage is that the correlation between fracture risk and QUS values are not 
well established and clinical studies have shown a poor relationship between therapy 
and QUS response [2]. 
 
2.10.4 Quantitative computed tomography (QCT) 
Quantitative computed tomography measures BMD at the appendicular skeleton and 
the spine.  Its greatest value is the ability to measure true volumetric density.  





on the ability of QCT to predict fracture risk.  Additional disadvantages include the 
high dose of radiation, higher costs and a higher precision error (2 - 5%) due to 
marrow fat [174, 177]. 
 
2.10.5 Bone markers 
During the remodelling process, osteoblasts synthetize and release bone specific 
alkaline phosphatase, procollagen 1 carboxyterminal propeptide, and osteocalcin.  
Osteoclasts release degradation products including collagen type 1 cross linked N-
telopeptide, C-telopeptide, pyridinoline and hydroxyproline.  These bone markers are 
not useful in the diagnosis of osteoporosis but may assist in identifying subjects with 
accelerated bone loss [190].  Although resorptive markers help predict fracture risk, 
there is limited data [191].  The use of bone markers is further limited by inter-assay 
differences and lack of reproducibility.  The IOF recommends that the use of bone 
markers should be limited to subjects in whom clinical or BMD data is insufficient to 
make a diagnosis or to monitor treatment responses after short periods in selected 
individuals [175]. 
 
2.10.6 Bone biopsy 
Biopsy of the iliac bone crest allows for the examination of trabecular bone including 
cells, rate of bone resorption and formation.  The use of bone biopsy is limited to an 





2.11 Fracture risk assessment 
2.11.1 Bone mineral density and fracture risk 
The role of BMD in determining fracture risk is well recognised; as the BMD 
decreases, fracture risk increases.  A 10% loss of bone mass at the spine doubles 
the risk of a VF, while a 10% loss of bone mass at the hip can results in a 2.5 fold 
increase in the risk of a hip fracture [57].  While some studies, including the 
Canadian Multicentre Osteoporosis Study (CaMos), suggest that that femoral neck 
BMD correlates best with fracture risk [192], in other studies, predominantly in peri-
menopausal and early postmenopausal women, both femoral neck and spine BMD 
correlated with fracture risk [72].  Although spine BMD may be of predictive value in 
younger women, in older women spinal BMD may be spuriously increased due to 
osteophytes from degenerative disease, vascular calcification and vertebral 
deformities and not be as useful [193].  Hip BMD has the highest predictive value for 
hip fracture and there is a 2 - 3 fold increase in the relative risk of a hip fracture with 
each SD decrease in hip BMD [58, 126]. 
A low BMD however is not the only predictor of fracture risk and only explains 60 - 
85% of the variation in fracture risk [194].  In the National Osteoporosis Risk 
Assessment (NORA) study, while the fracture rate increased as the BMD decreased, 
the majority of fractures occurred in subjects with low bone mass and osteopaenia 
rather than a normal BMD [195] (Figure 2.5).  Similarly, in the Study of Osteoporotic 
Fractures (SOF), 54% of the women who sustained a hip fracture during the five 





older, have a sedentary lifestyle, reduced visual contrast sensitivity, a prevalent VF, 
and falls in last year compared to women with a low BMD and fracture [171]. 
These findings support the notion that other risk factors, such as bone turnover, 
bone geometry and CRF, increase fracture risk independently of BMD. 
 
 
Figure 2.5 Relationship between bone mineral density and hip fractures. 
Adapted from Siris ES, et al. [171] 
 
2.11.2 Bone geometry 
Bone microarchitecture and bone geometry contribute to bone strength and play a 
critical role in the pathogenesis of osteoporotic fractures.  Hip axis length, calculated 





and the angle between the femoral neck and shaft all determine fracture risk [33, 
196-199].  In elderly women, a longer HAL was associated with an increased fracture 
risk, independent of age and BMD [200].  Each SD increase in HAL increased 
fracture risk by almost two fold.  Decreased thickness of the femoral neck and wider 
intertrochanteric area also increase fracture risk [200, 201].  In hip fracture subjects, 
trabeculae are more likely to be orientated along the loading axis with decreased 
cross bracing elements and a subsequent increased buckling risk [202].  Increased 
cortical porosity also increases fracture risk [202]. 
 
2.12 Risk factors for osteoporosis and osteoporotic fractures 
The risk factors for hip fractures can be divided in to those which predispose to 
increased skeletal fragility and those that increase fall risk [33] or as modifiable and 
non-modifiable. 
Modifiable risk factors include oestrogen deficiency, low body weight, alcohol use, 
smoking, sedentary lifestyle, medication use and chronic diseases.  While White 
race, older age, female gender, poor health status, prior fragility fracture, family 
history of fragility fracture and dementia are not modifiable. 
 
2.12.1 Genetic factors 
Genetic factors play an important role in the attainment of PBM in early life and twin 





that is higher at the appendicular skeleton (70 - 85%) and lower at the wrist (50 - 
60%) [95, 203, 204].  Despite the clear association, the exact genes responsible 
remain unknown.  Several candidate genes have been proposed to affect BMD, 
bone architecture and bone size, and include the vitamin D receptor (VDR), collagen 
1α-1 gene (COLIA1) [193], TGFβ-1 gene, TNF receptor 2, sclerostin (Sost), IGF-1 
and ER gene [205]. 
The VDR has been associated with variations in BMD in White, African American, 
Australian, Mexican and Japanese premenopausal women [206-208].  The effect 
seems greatest in young adulthood and declines with age.  A recent prospective 
study [209] suggests that only the CdX2 polymorphism is associated with vertebral 
fractures and not the other previously studied polymorphisms (ApaI, BsmI, TaqI and 
FokI) [210]. 
The COLIA 1 Sp 1 polymorphism is associated with a decreased BMD and 
increased vertebral fracture risk independent of BMD [211].  The mutation is found 
more commonly in Whites than the African and Asian populations and may be an 
important independent marker of fractures in the future [212, 213]. 
Two other genes involved in bone formation via the Wnt pathway are low density 
lipoprotein receptor related protein and Sost [214].  Both gene mutations are 
associated with increased bone formation. 
Twin studies in postmenopausal women have also shown a moderate association 
between quantitative ultrasound of the calcaneus and HAL.  This suggests that bone 





Lastly, conclusive evidence exists that a maternal or family history of osteoporosis or 
fractures increases fracture risk.  A maternal history of fracture before the age of 80 
years doubles the fracture risk [147].  Several large prospective studies have 
confirmed that a parental hip fracture doubles the risk of fracture independent of 
BMD, in  both men and women, suggesting that factors other than bone mass are 
involved [80, 174]. 
 
2.12.2 Age and gender 
Two of the strongest independent predictors for fractures are age and gender.  
Fractures have a typical bimodal curve with trauma accounting for first peak (10 - 20 
years) and low bone mass the second peak (> 50 year old) [6, 95].  The SOF 
reported a 40% increase in fracture incidence with every 5 year increase in age after 
adjusting for age and prior fracture risk [147].  The risk of comorbid diseases and 
propensity for falls increases with age and further increases the fracture risk. 
Globally women live longer than men, and this in part explains why 75% of hip 
fractures occur in women.  The female to male ratio of hip fractures in developed 
countries is 2:1 [26] and the lifetime risk for a hip fracture in White women from age 
50 years is 17% compared to 6% in men [216].  Other reasons for the lower fracture 
rate in White men include a higher PBM, slower rate of age related bone loss [217], 
decreased risk of hypogonadism and a lower fall rate.  Gender differences in fracture 






Several studies have reported ethnic differences in bone mass, geometry and 
fracture rates.  In the USA, African Americans have a higher bone mass, thicker 
bone cortices and greater vertebral density than do Whites, Japanese or Indians 
[103, 145, 219].  Ethnic differences in skeletal structure, bone turnover rates, calcium 
homeostasis and vitamin D levels also contribute to differences in fracture rates [82, 
220-222]. 
 
2.12.4 Role of hormonal factors 
The age of menarche and menopause, as measures of oestrogen exposure, are 
important determinants of subsequent bone mass.  A later menarche and earlier 
menopause are associated with lower bone mass [76, 174, 223].  Primary or 
secondary hypogonadism results in bone loss in both women and men irrespective 
of the aetiology.  Common causes in men include hypopituitarism, 
hyperprolactinaemia, castration from any cause and genetic causes e.g. Klinefelter’s 
syndrome.  Common secondary causes in women are a premature menopause 
(spontaneous or secondary to drugs, radiation or surgery), exercise induced 
amenorrhoea, eating disorders (anorexia nervosa) and chronic illness [174].  Sex 
hormone levels are also potentially influenced by lifestyle factors, such as smoking 





In addition, HRT has been shown to increase BMD and decrease fracture risk [73].  
The benefit of HRT however decreases once HRT is stopped and 5 years post HRT 
exposure the risk of fracture is equivalent to women who have never used HRT 
[224].  While the hormonal changes in pregnancy are well documented, the effect of 
pregnancies on BMD remains controversial.  Pregnancy induced osteoporosis has 
been reported with an increase in BMD post-delivery [223].  Most authors however, 
conclude that the number of pregnancies is not an independent risk factor for 
osteoporosis [225, 226]. 
 
2.12.5 Early environmental influence 
Early environmental factors affect the attainment of PBM independent of genetic 
factors [227].  Weight at one year has been shown to correlate with BMC in 
adulthood, independent of BMI, diet and lifestyle [103].  The most likely mechanism 
for this is changes to the endocrine set points in utero involving GH - IGF1 axis, the 
hypothalamic - pituitary - adrenal axis and the PTH - vitamin D axis.  Maternal factors 
e.g. smoking and body built also affect foetal nutrition and skeletal growth. 
 
2.12.6 Socio-economic status (SES) and education levels 
The positive correlation between a low level of education (less than 12 years) and 





between lower education levels and poor economic and nutritional status during 
childhood and decreased access to health care [140]. 
In contrast, a more common theory is that increasing SES and urbanization are 
associated with an increase in hip fracture risk, despite the better access to health 
care and nutrition [75]. 
 
2.12.7 Seasonal variation and latitude 
The majority of hip fractures, in temperate countries, occur during winter despite the 
fact that the majority of falls occur inside the home and therefore are not thought to 
be related to weather.  The increase fracture rate is thought to be due to an increase 
in neuromuscular dysfunction secondary to the cold temperature and vitamin D 
deficiency secondary to a decreased sunlight exposure [95].  The latter is supported 
by the 0.3% and 0.8% increase in fracture risk in men and women respectively for 
every 10° change in latitude from the equator [75]. 
 
2.12.8 Influence of weight, height and body mass index 
Almost 50% of the variance in bone mass may be accounted for by weight 
differences in the population.  The exact role weight plays however, is not clearly 
defined and extends beyond the concept that weight loading itself increases bone 
mass as lean body mass is a better indicator of bone mass than total body fat mass 





may be due to higher levels of circulating oestrogen from the peripheral conversion 
of androstenedione to active oestrogen in fat tissue, the potential for fat pads over 
the hip area to act as hip protectors and decrease the force of a fall, and the 
postulate that the increase in mechanical strain on the joint due to increased body 
weight may also promote bone remodeling. 
Low body weight is an independent risk factor for fractures.  Elderly individuals 
whose body weight was lower compared to their weight at the age of 25 years have 
been shown to double their hip fracture risk [33], while the fracture rate decreased by 
40% in those whose weight increased by 20% [147].  A low body weight may also be 
due to other underlying diseases which increase osteoporosis risk independently 
[147]. 
Although initially only a low body weight was considered as an important risk factor 
[230], further studies have indicated [231] that both height and low body mass index 
(BMI) are independent risk factors in all ethnic groups [140].  Taller persons with a 
longer HAL also have a higher fracture risk [33, 147]. 
An increase in age adjusted hip fracture risk has been reported with a lower BMI, 
independent of age and sex, but dependent on BMD [76, 232].  A non-linear 
relationship between BMI and fracture risk has been noted, with a lower BMI 
increasing the relative risk by a higher degree, namely a BMI of 20 kg/cm2 was 
associated with an almost doubling of the risk, whilst a BMI of 25 kg/cm2 compared 
to 30 kg/cm2 decreased the fracture risk by only 17% [219].  Further in non-African 





found to have a lower hip BMD and increased fracture risk [229].  In contrast, in a 
review of several other epidemiological data bases, weight or height were better at 
predicting BMD at all three measured sites compared to BMI [233].  The consensus 
is however that all three anthropometric measures are useful in predicting fracture 
risk. 
 
2.12.9 Calcium and vitamin D 
An adequate calcium intake (recommended as least 1500 mg per day) and vitamin D 
levels are important for bone metabolism [88].  An average daily intake of vitamin D 
of 800 - 1000 IU and a serum 25 (OH)2 vitamin D level of greater than 75 nmol/L or 
30 mg/ml is recommended to prevent osteoporotic fractures [234].  In older persons, 
poor calcium intake and decreased calcium absorption due to low vitamin D levels or 
a relative resistance to 1, 25 (OH)2 vitamin D cause secondary hyperparathyroidism 
and increase fracture risk [235].  Low vitamin D levels also result in muscle 
weakness, gait instability and falls which all play an important independent role in the 
causing hip fractures [236]. 
Paradoxically, although calcium intake is much lower in developing countries, so is 
the fracture rate.  This paradox may be explained by more efficient absorption and 
utilization of calcium, a protective effect of the associated low protein diet found in 
developing countries [103], or maybe due to other unrelated bone protective factors 





In a review of vitamin D levels in osteoporotic women from 18 countries across 
Europe, Latin America, Pacific Rim and Asia, low 25 (OH)2 vitamin D levels were 
universal with no single region having a mean level of >30ng/ml.  This may however 
be an under-representation and may not reflect the true deficiency in a normal 
population, as all the study participants had osteoporosis and were probably more 
likely to be aware of the importance of vitamin D [235, 237].  The levels varied 
independent of latitude and lower levels were associated with obesity, Asian race, 
lack of vitamin D supplements, lower education levels, latitude of enrolment country, 
decreased sunlight exposure, lack of travel to sunny climate and poor 
communication with health care provider.  Low vitamin D levels have also been 
documented in other large epidemiological studies including the Brazilian 
Osteoporosis Study (BRAZOS) [238]. 
The association of obesity and low vitamin D levels may be due to a combination of 
decreased sun exposure and lower bioavailability of vitamin D due to excessive fat 
storage, resulting in a decreased conversion of vitamin D to its active form.  This 
possibility is supported by the inverse relationship between body fat and vitamin D 
levels, and a positive association between body fat and PTH levels in the 
Longitudinal Aging Study in Amsterdam (LASA) [239]. 
Despite the fact that Africa lies between latitudes of 35° South to 37° North and has 
a sunny climate for most of the year, the few population studies conducted mainly in 
Gambia, Nigeria and SA have also reported vitamin D deficiency, most likely on the 
basis of poor intake and possibly darker skin colour [240].  In SA, only one third of 





cutaneous vitamin D synthesis in Africans [242].  The geographic gradient seen with 
vitamin D levels is present in Africa as well with lower levels noted in northern and 
southern Africa [241].  The vitamin D results from Africa however need to be 
interpreted with caution as multiple methods were used in assays and only three 
studies used quality assurance methods.  Nonetheless, results show vitamin D levels 
are usually greater than 25 nmol/l with 5 - 20% of the continent having lower values 
as seen in northern Africa and SA in individuals with rickets, tuberculosis, pneumonia 
and in veiled women [28, 240, 243].  The studies from SA have mainly been 
conducted in children and a seasonal variation in ultra violet light B (UVB) exposure 
has been reported in Cape Town but not Johannesburg [244].  Indian persons under 
60 years old from Gauteng have also been shown to have a lower vitamin D level 
than Africans [71].  Early studies in the elderly in SA found no seasonal variation in 
vitamin D and femoral neck fracture [245].  
The secondary hyperparathyroidism from the calcium and vitamin D deficiency 
reverses with calcium and vitamin D supplementation with a subsequent increase in 
BMD and reduction in fracture risk [246].  The effects of calcium supplementation are 
however contentious.  In the NHANES Follow Up Study the rate of BMD loss 
decreased after the first year of calcium supplementation and remain sustained 
thereafter [247].  In addition BMD increases of between 4 - 6% have been observed 
at the lumbar spine, femoral neck and hip after calcium supplementation [248].  
Furthermore, in a large meta-analysis combined supplementation of calcium and 





However, other observational studies and the Randomized Evaluation of Calcium Or 
Vitamin D (RECORD), study failed to show any benefit of calcium supplementation 
[250].  Possible explanations for the difference in outcomes are the smaller number 
of subjects in the RECORD study who were younger and had a lower compliance 
rate of < 60% with trial medication [249].  Adequate calcium and vitamin D 
supplementation is however recommended for all osteoporotic patients [88]. 
 
2.12.10 Glucocorticoid and other medication use 
The association between excess endogenous or exogenous GC and osteoporosis is 
well established.  Glucocorticoid use is one of the commonest causes for secondary 
osteoporosis, estimated to account for up to 25% of the osteoporosis burden in the 
UK [251].  The pathogenesis of GC induced osteoporosis is multifactorial and is due 
to both decreased bone formation and increased bone resorption [252, 253].  Long 
term use of moderate to high doses of GC results in trabecular bone loss which is 
greatest in the first year with an associated increased fracture risk in the first few 
months of use.  The fracture risk is dose dependent and increases proportionately 
with higher doses, but a dose as low as 2.5 mg per day is associated with increased 
risk of VF [254].  The risk however decreases rapidly once steroids are stopped 
[103]. 
Other medications associated with accelerated bone loss include excessive thyroid 






Thiazide diuretics decrease urinary calcium excretion and may also decrease 
intestinal calcium absorption.  However studies have failed to report a consistent 
increase in fracture risk.  Instead a higher bone mass has been reported in men who 
use thiazides [256] and fewer fractures have been reported in woman users, despite 
the increased fall risk from syncope due to thiazide associated hypotension [96, 
257]. 
The exact mechanism by which anticonvulsants independently increase hip fracture 
risk [147, 255] is not known but it is postulated that anticonvulsants may induce 
microsomal enzymes and interfere with vitamin D and oestrogen metabolism. 
Although a significantly increased fracture risk is seen with antipsychotics, long 
acting hypnotics and tricyclic antidepressants use, no significant independent risk 
exists with short acting (< 24hours) hypnotics or anxiolytic [147].  The use of 
selective serotonin reuptake inhibitors is associated in a dose dependent manner 
with increase fall risk, lower bone mass and a 2 fold increase in fragility fracture risk 
[258].  An increased fracture risk has also been reported with benzodiazepines and 
tricyclic antidepressants [259].  A more recent study however failed to show a 
decrease in bone mass in men and woman on TCA. [258]. 
The confounding factor in determining the risk in these drug classes is that the 
indication for the drug may possibly contribute to increasing hip fracture risk [33, 
260].  In an attempt to delineate the actual risk of psychotropic medications, a study 





dysfunction in the elderly, and therefore increased fracture risk indirectly via an 
increased fall risk. 
Heparin has a direct toxic effect on osteoclast development and activity and long 
term use has been associated with low bone mass and higher fracture risk [261]. 
 
2.12.11 Secondary osteoporosis 
A number of medical conditions (Table 2.1) [147, 262-264] are associated with 
osteoporosis, while rheumatoid arthritis (RA), type 2 diabetes mellitus (DM), 
neurological diseases and visual impairment are also independently associated with 
an increased fracture risk.  In RA, chronic inflammation, decreased physical activity, 
GC use and an increased fall risk due to mechanical problems contribute to bone 
loss and an increased fracture risk [265, 266]. 
The effects of DM on bone health are not well understood.  Contributing factors 
include obesity, hypercalciuria with glycosuria, decreased intestinal calcium 
absorption, decreased renal function, inappropriate PTH response, angiopathy, 
inflammation, neuropathy [267], modification of vitamin D regulation and modification 
of insulin and IGF-1 [268].  Type 1 DM is associated with bone loss and fragility 
fractures [269], whilst individuals with type 2 DM despite having a higher bone mass 
have an increased non vertebral fragility fracture risk [268]. 
In cerebrovascular accidents the increased fracture risk is secondary to loss of 





[270].  In contrast the increased risk for hip fractures in Parkinson’s disease is 
thought to be due to falls rather than disuse osteoporosis [77]. 
Impaired cognition in the elderly has also been associated with increased fracture 
risk and subjects with Alzheimer’s disease living in nursing homes showed an overall 
three-fold increase in hip fracture rate compared to community dwellers [136, 172, 
173].  The exact mechanisms for the increased fracture rate are not clear but 
probably include neuromuscular, fall and gait abnormalities. 
Poor vision has been implicated as a risk factor for falls and subsequent fractures.  
In the Framingham eye study poor visual acuity, cataracts and retinopathy were 
associated with an increased fracture risk [271].  Other contributing factors to the 




A meta-analysis of 10 prospective international osteoporosis studies by Kanis et al., 
[158] confirmed smoking to be an independent significant risk factor for all 
osteoporotic fractures (RR 1.29; 95% CI 1.13-1.28) and especially for hip fractures 
(RR1.84; 95%CI 1.52-2.22) [272].  In another meta-analysis, smoking in post-
menopausal women added an additional 0.2% bone loss a year, however no 
increased bone loss was seen in pre-menopausal women smokers [273].  In contrast 





The negative effect of smoking on bone is multifactorial; contributing factors include 
lower body mass, premature menopause [96], associated decreased physical 
activity, increased alcohol use, poor calcium intake and other nutritional deficiencies.  
A direct toxic effect on bone and calcitonin resistance with resultant increase 
resorption has also been reported [275].  Smoking is a cumulative risk factor with the 
risk increasing with the duration of smoking [274].  The risk of fractures with smoking 
also increases with age from a 17% greater fracture risk in smokers compared to 
non-smokers at age 60 years to a 71% greater risk by the age of 80 years [273]. 
 
2.12.13 Alcohol 
Alcohol decreases BMD directly by suppressing osteoblast activity and decreasing 
osteocalcin levels resulting in decreased bone volume and trabecular thickness with 
associated mild demineralization and indirectly by liver damage, nutritional 
deficiencies and associated hypogonadism [276, 277]. 
Recent cohort studies have questioned earlier findings that a lower bone mass is 
seen in all alcohol users.  It has been shown that the effect of alcohol is dose 
dependent, and that heavy drinkers have an increased osteoporosis risk due to a 
direct negative effect on osteoblasts, while moderate drinking may be protective as it 
increases conversion of androstenedione to oestrogen and indirectly increases bone 
mass [33, 147, 278].  Berg et al., in a meta-analysis reported the lowest fracture risk 
in the low alcohol group (0.5 -1 drink per day), followed by a higher risk in abstainers 





possible explanation considered for the “J shaped curve” in the pooled risk data, was 
that former drinkers who stopped for health reasons may have been classified as 
non-drinkers.  The beneficial effects of low dose alcohol however cannot be ignored 
[279, 280].  The risk ratio with alcohol is similar in men and women, although 
prevalence is greater in men [80, 281]. 
A unique problem has been identified in African males from sub-Saharan Africa who 
partake of sorghum (African beer) which is brewed in iron pots.  The iron is leeched 
by the acidic beer and individuals clinically present with an iron overloaded state 
(siderosis).  Manifestations include cirrhosis, portal hypertension, scurvy and 
osteoporosis and femoral neck fractures [53, 282, 283]. 
 
2.12.14 Caffeine 
Heaney and Recker, in 1982, were the first to show a deleterious association 
between caffeine and bone mass [284].  They postulated that caffeine increases 
urinary calcium excretion and decreases bone mass.  An increased risk of hip 
fractures was subsequently reported in caffeine drinkers [147].  However, later case 
control studies showed conflicting findings and Heany et al., revisited their initial 
conclusions and proposed that the association between caffeine and low bone mass 
was due to a low calcium intake and not the caffeine in coffee itself, which had no 





The consumption of tea has been found to be protective and is associated with a 
decreased risk of hip fracture as it contains phyto-oestrogens [33, 76]. 
 
2.12.15 Physical activity 
Fracture risk correlates with physical activity.  Higher levels of physical activity 
increase skeletal strength and are protective against osteoporosis [285, 286].  The 
effects of exercise in childhood result in wider bones with increased cortical bone 
which persists in adulthood [287] and bone loss is prevented in women who exercise 
three-five times a week [288].  Additionally, exercise may help decrease fall risk as it 
promotes better health status.  Despite these positive findings on bone, no direct 
relationship has been shown to exist between increased physical activity and 
decreased fracture risk.  The lack of direct relationship does not however negate the 
importance of physical activity and studies conclusively show prolonged 
immobilisation can result in up to 1% loss of bone per week [96]. 
 
2.12.16 Self-reported health status and quality of life 
Although it is intuitive that poor self-reported health status and prior hospitalization 
will increase hip fracture risk, the literature is conflicting [147, 289].  While in the 
CaMos study, quality of life (QoL) as measured by the Short Form Health survey 
(SF-36) predicted incident non vertebral and VF risk in postmenopausal women 





is however thought that underlying health status and QoL are more important in 
determining outcomes post fracture than predicting fracture risk.  This too is 
controversial, as although functional limitation both basic and instrumental activities 
of daily living (IADL) is greater in women than men, the higher mortality rates seen in 
men post fracture is not explained by pre-fracture functioning levels [290]. 
 
2.12.17 Prior fracture 
A prior fragility fracture is one of the most significant independent risk factors for 
subsequent fractures.  A prior fracture after the age of 40 years is associated with a 
1.5 - 9.5 times higher fracture risk depending on the patient’s age, the number and 
sites of the previous fracture [9, 26, 57, 291, 292].  Although an increase future 
fracture risk is seen with all fragility fracture, the association is strongest for a 
previous VF (4 fold) [293] (Fig. 2.6).  In the European Vertebral Osteoporosis Study 
(EVOS) study a pre-existing vertebral deformity increased hip fracture risk by 2.8 - 
4.5 fold and the risk increased further with increasing number of VFs [155].  Similarly 
in the SOF the presence of a VF was associated with a 5 fold increase risk for a 
second vertebral fracture and 2.8 fold increased risk for a hip fracture [10]. 
The degree of the VF correlates with future non vertebral fracture risk.  A severe VF 
deformity (>40%) has been associated with a 12 fold future fracture risk, while no 








Figure 2.6 A higher number of prior vertebral fractures independently 
increases the risk of future fractures 
Adapted from Kanis et al 2004,[295] 
 
2.12.18 Falls 
Falls are common in the elderly population and increase in frequency with increasing 
age; from 30% in persons aged 65 years and over to 40 - 50% by the age of 80 
years [296, 297].  Falls are more likely to result in hip fractures in older women than 
men by 40 - 60% [298].  This is possibly due to differences in the incidence of 
osteoporosis and levels of physical activity.  The association of falls and fractures 
also increase with age.  In persons aged 50 years and older, 53% of minimal trauma 
fractures follow a fall.  This rate increases to 80% in those aged 75 years and over 
[299].  The age-related increase is explained by the decreased ability of the femur to 
absorb force with ageing; the femur of a 33 year old is able to absorb twice the force 





The risk of a major injury after a fall appears to be higher in Whites, older persons, 
falls associated with loss of consciousness and persons with cognitive or 
neuromuscular impairment [300].  The risk of fracture is also greater in persons who 
have had a previous fall, with a fall in the previous year being associated with a 50% 
increase in subsequent hip fracture risk [289, 300-302]. 
Gait, balance and lower extremity strength all play a critical role in falls and hip 
fracture risk independent of BMD [33, 147].  In epidemiological studies, 50% of 
osteoporotic subjects had muscle loss, with 30% experiencing postural hypotension 
and significant numbers having visual and perceptive disorders which contribute to 
fall risk.  In the Frailty and Injuries: Cooperative Studies of Intervention Techniques 
(FISCIT), improving muscle strength and balance reduced fall risk by 10% [303]. 
Although the majority of hip fractures are associated with a fall from a standing 
height or less, only 10% of falls result in a hip fracture [33].  The subsequent injury 
after a fall is also dependent on falling height, type of fall (sideways), poor protective 
arm movements, surface hardness, and decreased soft tissue protection [33, 304, 
305]. 
 
2.13 Cumulative risk factor assessment 
The diagnosis of osteoporosis is based on the presence of a fragility fracture or 
measurement of BMD with DXA.  While fracture risk increases with a decrease in 
BMD [32, 80], the sensitivity of BMD varies widely.  Fracture risk is known to 





is used to predict fracture risk, the risk increases by four fold only [306-308].  Bone 
mineral density on its own is therefore not a reliable intervention threshold [174].  
Further clinical risk factors have a limited predictive value for future fracture risk 
[147], as risk factors are not consistent between studies and between developed and 
developing countries [42, 238, 309]. 
The fracture prediction algorithm (FRAX®) was developed to compute a 10 year 
probability of a hip or major osteoporosis-related fracture by combining CRF with or 
without BMD.  Clinical risk factors for osteoporosis independent of BMD were 
identified from 12 large prospective studies (comprising 60 000 women and men) 
from the USA, Europe, Asia and Australia (Appendix 2.A) [310].  The primary data of 
these cohorts, which had been validated in independent cohorts of similar 
geographic distribution, were used to determine the predictive significance of each 
risk factor and optimise the accuracy of the computerized fracture probability.  On 
the recommendation of the IOF and WHO, the fracture risk is expressed as a short 
term absolute risk i.e. probability over a 10 year interval [31].  The model allows for 
risk stratification in both genders and various race groups [80]. 
However, there is considerable variation in fracture probability and mortality in 
different countries, and probability models need to be calibrated to the fracture 
incidence and mortality rate for the specific population [31, 80].  Country specific 
FRAX® models have been developed for much of NA, Europe and Asia. 
Limitations of FRAX® includes: it is not suitable for younger patients with secondary 





support, and very importantly has not been validated in developing countries.  The 






2.14 Epidemiology of osteoporosis, hip and vertebral fractures  
Osteoporosis is estimated to affect over 200 million people globally and it is 
estimated that the incidence will increase with ageing resulting in one tenth of 
women aged 60 years and over, one fifth of women in their seventies, two fifth of 
women in the eighties and two thirds of all women above 90 years of age developing 
osteoporosis [3, 90].  In the developed world, the risk of osteoporosis in a 50 year old 
woman exceeds that of breast cancer, stroke or coronary heart disease (Figure 2.7).  
The burden of osteoporosis is largely due to the incidence and direct and indirect 








Figure 2.7 The lifetime risk of osteoporosis compared to other common non 
communicable diseases. 





The prevalence of osteoporosis and incidence of hip fractures, which closely follow 
each other, vary significantly by geographic area, ethnicity, age and gender (Table 
2.3).  In a recent systematic review by Kanis et al., [312] a greater than 10 fold 
variation in the age standardized rates (ASR) of hip fracture risk was seen in the 63 
countries from which data was available. 
 
2.14.1 Developed world: Europe, North America and Australia 
The highest prevalence of osteoporosis is seen in the European Union, where it is 
estimated that 22 million women and 5.5 million men aged between 50 - 84 years 
have osteoporosis.  This is expected to increase by 23% to a total 33.9 million 
persons by 2025 [313].  A north - south gradient in hip fracture incidence has been 
reported in Europe with the highest incidence in Northern Europe (Norway and 
Sweden) and lower rates around the Mediterranean Sea.  In the 17 countries which 
participated in the Mediterranean Osteoporosis Study (MEDOS), an eleven and 
seven fold difference in hip fracture incidence was seen in women and men, 
respectively [314].  While the female to male ratio in Europe is about 2:1 [313], a 
three-fold difference in the gender ratio in the participating countries was reported in 
the MEDOS study.  The differences in rates between countries however was larger 
than the differences between men and women, implicating genetic and 





Table 2.3 World age-standardized hip fracture rate (per 100 000 persons) 
Country Reference Year Women Men  Total  
Europe, North America and Australia 
**Austria [315] 2001-2005 501 246 380 
*Norway [316] 1994-2008 563 262 420 
*Sweden [317] 1991 539 247 401 
*UK [318] 1992-1993 349 140 250 
**USA [319] 2010 260 122 195 
**Canada [320] 2005 290 131 215 
**Australia + 2006-2007 252 105 183 
Latin America 
*Argentina [321] 2001-2002 390 124 264 
*Brazil ++Silveria et al 2005 2001-2002 199 77 141 
**Mexico [322] 2000-2006 225 115 173 
*Venezuela ++Riera-Espinoza 2008 2005-2006 150 45 100 
Asia 
*China [323] 2002-2006 173 103 140 
**Hong Kong [324] 2000-2004 324 148 240 





2007-2010 173 59 119 
**Japan  ++Orimo and 
Sakata 2006 
2002 266 165 218 
*Malaysia Chionh and 
Heng 2010 
2007-2009 269 114 205 
**Taiwan [325] 2002 392 196 299 
Middle East 
*Iran [326] 2000-2003 402 269 339 
**Jordan ++Azar et al 
2011 
2008 198 114 158 
**Turkey [327] 2009 357 110 240 
Africa 
*Morocco [47] 2006-2009 73 66 69 
*Nigeria [40] 1998-1999 2 2 2 
*S Africa [39] 1957-1963 20 17 19 
**Tunisia ++Zakaroul 
2010 
2001 58 41 50 
Adapted from Kanis et al 2012 [312] 
+Australia Institute for Health and Welfare 
++Abstract only available in English/citation 





Similarly in NA, osteoporosis is common, affecting 30% of post-menopausal White 
women and 70% of White women aged 70 years and above [2].  In Canada, one in 
four women and one in eight men above the age of 50 years have osteoporosis [328] 
and in the USA, it is estimated that 33.5 million and 10 million have osteopaenia and 
osteoporosis, respectively [329].  By 2020, 61.4 million will have either osteopenia or 
osteoporosis in the USA [330]. 
In a large multi ethnic study in USA of 197 848 subjects, comprising White, African 
American, Hispanic, Asian and Native Americans; BMD was highest in African 
Americans independent of weight in every age group.  White and Native American 
had similar BMD findings, Hispanic individuals a slightly lower BMD and the lowest 
BMD was seen in Asians [82, 142, 220, 221].  Similar findings were reported in the 
NHANES III study [65, 128].  Since BMD is an areal measurement, it is possible that 
the differences observed are due to skeletal size i.e. BMD will be over-estimated in 
taller/larger subjects and under estimated in shorter/smaller subjects.  The 
differences seen in ethnic groups however may remain even after adjustment for 
body or bone size [220, 221, 331, 332].  Other reasons for the differences in BMD 
include a higher PBM, [220, 319, 331] a lower or similar rate of bone loss [142, 222] 
and longer period for bone formation with possibly increased mineral deposition and 
potentially better bone quality in African Americans [333, 334].  Despite lower vitamin 
D levels, from decreased dermal synthesis in African Americans, and secondary 
hyperparathyroidism, bone turnover rates remain low suggesting possible skeletal 





Irrespective of higher bone mass findings, low BMD has been seen in all ethnic 
groups and in each group fracture risk increases by 54% for each SD decrease in T - 
score [65] but the absolute risk differs between different ethnic groups.  White and 
Hispanic women have the highest absolute fracture risk and African and Asian 
women the lowest.  In addition to the BMD differences, skeletal geometry may 
influence fracture risk.  The shorter HAL and differences in femoral shaft angle in 
Asians and African Americans and the thicker trabeculae with a larger cross-
sectional area in African Americans may be protective [220] and decrease fracture 
risk. 
Compared to Whites, fractures appear to occur 10 – 20 years earlier in Asian men 
and women residing in USA [336, 337].  A lower BMD at the proximal femur and 
trochanter with a shorter HAL has been reported in American Indian and Pakistani 
women compared to Whites.  Asian women were also significantly shorter, with a 
lower lean body mass but higher body fat content [336].  Lower spinal BMD, but 
normal BMAD, and shorter HAL has also been reported in women of Indian, 
Pakistani and Bangladeshi origin, living in the UK [44]. 
The differences in BMD are reflected in the differences in the prevalence of 
osteoporosis in the USA; 20% in Whites, 10% in Mexican and 5% in African 
American women.  It is therefore not surprising that Whites have the highest hip 
fracture incidence rates compared to Asians, African Americans and Hispanics.  In 
all ethnic groups except for African Americans, the female to male ratio was 2:1.2, 
[34] whereas a more equal ratio (or higher incidence rate in men) is seen in African 





levels, diet, neuromuscular functioning, fall frequency and fall orientation also 
influence fracture rates [33, 61]. 
Despite being in the southern hemisphere, Australia has a similar prevalence of 
osteoporosis as seen in Europe and NA with 11% of men and 27% of women aged 
60 years or more being affected by osteoporosis [338].  The Dubbo Osteoporosis 
Epidemiology Study (DOES) [151] has confirmed a significantly higher hip fracture 
incidence rate in women compared to men, with the incidence increasing with age in 
both groups.  However, men tended to fracture at an earlier age, possibly due to a 
shorter life expectancy (LE).  The gender distribution for hip fractures was 2.3:1 for 
females to males, but decreased as the population aged [151]. 
The hip fracture incidence in high risk populations of Europe, USA, Canada and 
Australia increased from 1940 to the 1980s, but has started to stabilise or even 
decline in the last two decades in women.  This may be due to improved screening 
and treatment, healthier ageing populations, improved functional ability, increase in 
average body weight [339], improved perinatal nutrition [26], improvement in lifestyle 
risk factors [33, 158, 232, 340, 341], an increased exposure to exogenous 
oestrogens [342, 343] and use of bisphosphonates [344].  The total number of hip 
fracture however is still increasing at a rate of 1 - 4% annually due to increase in total 
number of elderly [26, 345]. 
In contrast, the ASR for men in developed countries continues to increase, with the 
female: male ratio decreasing from 2.5 - 2.7:1 to 2.2:1 [315].  The highest incidence 





Far East (Singapore, Japan, Taiwan and Korea) with the lowest incidence in US 
Hispanics, Argentina, Africa, Saudi Arabia, Indonesia and Thailand [312].  Globally 
however it is predicted that due to the preferential increase in hip fracture rates in 
men and the faster increasing LE compared to women, the incidence of hip fractures 
will be equal in men and women by the year 2040 [346]. 
Although the gender difference in fracture rates was initially thought to be due to 
differences in BMD, the Rotterdam and the European Prospective Osteoporosis 
Study (EPOS) studies found no difference in BMD data between men and women 
[79, 347].  Other postulated factors for the difference include larger skeletal size and 
decreased fall risk in men [26, 79, 348]. 
The epidemiology of VF is less well understood [26].  The prevalence ranges from 
14.7 to 23.5% due to differences in methodology, ethnicity and age of study 
participants.  Although VFs are more commonly reported in Whites than in African 
American or Asian women, the ethnic difference is not as marked as that observed 
with hip fractures [349].  In community based studies, the prevalence of VF (25.3%) 
in women aged 50 years and over, is almost double that of hip fractures [350].  Both 
the incidence and prevalence increase with age, from 0.9% and 5 - 10% 
respectively, in 50 - 60 year olds to 1.6% and 30% respectively, in persons aged 80 
years and older [180, 350].  Vertebral fractures are two to three fold more common in 
European and North American women compared to their male counterparts [26, 
351].  While the prevalence in men was higher in the Canadian Vertebral Fracture 
and EVOS studies, the prevalence remained static while the rate increased with age 





earlier in working life compared to women, and that they have a more stable bone 
mass unlike the more rapid peri-menopausal bone loss in women [352, 353]. 
 
2.14.2 Developing countries 
In 1992, Cooper et al., [354] predicted that with the expected demographic changes 
and urbanization, the burden of osteoporosis will shift to Asia and Latin America who 
will experience 50% of all osteoporotic fractures, by the 2050 (Figure.2.8). 
 
 
Figure 2.8: Estimated change in the global burden of hip fractures in men and 
women from 1990 to 2050 in developed and developing countries. 






2.14.2.1 Latin America 
The population of Latin America is a heterogeneous group of mixed ethnicity 
comprising of original South American Indians mixed with Whites from Europe 
especially of Portuguese descent, Africans and Asians resulting in an interesting 
genetic pedagogy [356].  The number of persons aged 50 years and over is 
expected to increase by 28% with LE in most countries expected to be above 70 
years. 
The country of origin plays a role in determining subsequent osteoporosis risk and 
while it is predicted that 12 - 18% of the population have vertebral osteoporosis and 
8 - 22% have femoral neck osteoporosis, [356] there are significant variations in the  
different countries.  In Mexico, despite LE increasing on average by 39 years in the 
last seven decades, the prevalence of osteoporosis is lower than that of developed 
countries with 16% of women and 6% of men over the age of 50 years having 
osteoporosis at the hip [357].  Similarly, in Brazil one in 17 people above the age of 
50 years has osteoporosis [358].  In contrast, pooled data from studies in Latin 
America found femoral osteopenia in 46 - 57.2% and osteoporosis in 7.9 - 22% in 
woman aged 50 years and over. [356].  The number of woman aged 50 years and 
over with osteoporosis is expected to increase to 2.6 million women by the year 2050 
[359].  Hip fracture rates similarly vary between countries, from 40 to 362 per 
100 000 persons [356].  Hip fracture rates are projected to increase by 431% from 21 
000  in 2005 to 110 555 by the year 2050 [357] and by 400% in 50 - 64 year age 





There is limited data on VF rates.  In the Latin American Vertebral Osteoporosis 
Study (LAVOS) the number of VFs increased with age [360].  Vertebral fractures 
have been reported in 19.2% and 9.7% of Mexican women and men respectively 
[361].  Similar results were reported from Beijing, Hiroshima [154, 362] and in India 
(Delhi Vertebral Osteoporosis Study (DeVOS)), except that in the DeVOS study, the 
prevalence rate was similar in men and women [363]. 
 
2.14.2.2 Asia 
The largest increase in elderly population will occur in Asia, and by 2050, 54% of the 
world’s population of two billion persons aged 60 years and above, will reside in Asia 
[364].  Ethnic differences have been reported in the prevalence of osteoporosis and 
hip fracture rates within and between countries in Asia.  In China, 40.1% of women 
and 22.5% of men aged 50 years and over have osteoporosis [365] compared to 
38% and 11.6% of Japanese women who have osteoporosis at the spine and hip, 
respectively [366].  The reason for the high rate of osteoporosis in China may be due 
to differences in classification as not all the studies used the WHO criteria.  At least 7 
studies used the Chinese criteria which may overestimate the prevalence of 
osteoporosis [365]. 
Hip fractures are predicted to increase exponentially in Asia and it is predicted that 
37% of all hip fractures will occur in Asia by 2025 [4].  This projection is supported by 
studies from Japan which showed a threefold increase in fracture rates from 1987 to 





1998 were five times higher than in 1960 [368].  In the first multi-centre Asian 
Osteoporosis Study (AOS) the observed rate of hip fractures was lower than USA 
with moderate variations amongst the four countries (Table 2.4).  Although the 
gender ratio is lower than the USA, this is not significantly different.  Similar to other 
studies, fracture rates increased with age with the highest incidence rate being 
observed in the 85 years plus group [35]. 
 
Table 2.4 Hip fracture incidence in the Asian Osteoporosis Study 
 Men per 100 000 Women per 100 000 
*Hong Kong 180 459 
*Malaysia 88 218 
*Thailand 114 289 
*Singapore 164 442 
**USA 187 535 
Adapted from the *AOS (1997-1998) [35] 
**USA 1989 [369] 
 
Significant ethnic differences have been noted in Singapore, with the highest hip 
fracture rates in Chinese men and women, followed by Indian men and women and 
the lowest rates in Malay men and women [368].  This was confirmed in the AOS 
where Chinese women had twice the number of fractures compared to Malays and 





women; with the lowest rates occurring in Malays [35].  In both countries, Chinese 
and Indian men had similar rates with Malay men having a 25% - 50% lower fracture 
rate.  Urbanization is thought to play a role in the higher rates of hip fractures in 
Hong Kong and Singapore [35, 90]. 
In India, it is estimated that 25 million Indians may have osteoporosis based on 
radiological data, with 50% of women (30 million) and 36% of men above the age of 
50 years having osteoporosis  [370, 371].  In recent studies 8.5% and 42% of men 
had osteoporosis and osteopenia, respectively [372].  Factors contributing to high 
osteoporosis risk include low vitamin D levels secondary to lack of sunlight exposure 
and increased skin pigmentation, and poor dietary intake [66].  A 15% lower BMD 
compared to Whites has also been reported in Indians residing in UK and USA [373, 
374], but not in wealthy Indian women in India whose BMD is similar to White women 
[375, 376]. 
There are few hip fracture studies from India and early studies reported that Indians 
sustained fractures ten to fifteen years earlier than Whites [370, 371, 373].  In a 
recent retrospective study the crude incidence rate of 129 per 100 000 persons over 
the age of 50 years old (with 159 per 100 000 women and 105 per 100 000 men over 
the age of 50 years old respectively) was similar to some countries in South East 
Asia, but lower than in the more developed Asian countries of Japan or Singapore 
[43].  The rate increased with age to reach 962 per 100 000 in the 90 - 94 year age 
group.  In agreement with previous studies, the mean age at 58.2 years was lower 





2.14.2.3 Middle East 
In the IOF Middle East and Africa Regional Audit in 2011 [28], although data on 
osteoporosis and hip fractures was only available in 17 and nine countries 
respectively, these were not from population based studies.  There were no 
published studies on VFs.  The audit also highlighted the lack of awareness of 
osteoporosis amongst health care workers and the lack of inclusion of osteoporosis 
in medical curricula with resource allocation focused on major communicable 
diseases such as infectious human immunodeficiency virus infection (HIV) and 
tuberculosis (TB).  Nonetheless, it is predicted that with the projected increase in the 
proportion of the population 50 years and over from 8 - 20%, to 25% and 40% by 
2020 and 2050 respectively, (World Bank online data http://web.worldbank.org), 
[377] a proportional increase in hip fractures will occur in Africa. 
Compared to the standardized US population, lower incidence rates for both men 
and women have been reported in Iran [378] and Lebanon [379].  In contrast, the 
higher ASR in Kuwaiti women was similar to that in some southern European 
countries (Italy, UK, France) and higher than Asian countries such as Korea 
Singapore, China, Malaysia, and Japan [380].  Interestingly, the incidence rates in 
Kuwaiti women are similar to that in Asian women living in the US. 
Incidence rates are also lower in Turkey compared to other European countries.  
However, the study on the incidence of hip fractures in Turkey (FRACTURK) [327] 
showed a significant increase in the incidence of hip fractures in Turkey compared to 





Turkish women and men have osteoporosis and at age 50 years the lifetime 
probability of sustaining a hip fracture is 14.4% in women and 3.5% in men [327].  
Although no epidemiological studies are available, the First and Second Jordanian 
National Osteoporosis Studies noted that vitamin D deficiency was common and 
recorded 1008 hip fractures in the year 2008.  Based on the latter, a FRAX® tool 
specific for Jordan was developed [28]. 
 
2.14.2.4 Africa 
Interestingly, osteoporosis has been recognized in Africa as early as 2687 BC, and 
differences in BMD have been reported in Egyptian mummies from different social 
classes [382].  However, epidemiological studies from Africa are scarce.  A recent 
study has estimated that 28.4% and 21.9% of Egyptian women and men 
respectively, have osteoporosis [28, 383].  A similar prevalence of 24.5% has also 
been reported in a hospital-based series of women aged 50 years and over in Kenya 
[28]. 
An early study on hip fractures in Africa by Asprey et al., in the 1990’s reported that 
osteoporotic fractures were rare in rural Gambian women, despite having a lower 
BMD and BMC at the lumbar spine and radius compared to White women from the 
UK [45].  The authors suggested that other factors contributed to the low fracture risk 
[45].  A subsequent study from Ibadan, Nigeria also reported a low hip fracture 





fractures with age [40].  Reasons suggested for this difference were possibly higher 
levels of physical activity and an inherent genetic predisposition [40]. 
However, a later retrospective study from Cameroon (1996 - 1998) [48] reported a 
hip fracture rate of 4.1 per 100 000 and 2.2 per 100 000 respectively, in women and 
men aged 35 years and over.  The rate was lower at 1.2 per 100 000 for females and 
0.2 per 100 000 for men with wrist fractures.  Although these rates were significantly 
lower than in developed countries; the hip fracture incidence increased with age to 
24.4 per 100 000 in persons aged 65 years and over.  The mean age at hip fracture 
was also lower than developed countries at 72.6 years for women and 66.2 years for 
men, but it was noted that only 1.1% of women and 0.7% of men survived beyond 
the age of 65 years [48]. 
A further study from Rabat, Morocco, also demonstrated an increase in fracture rates 
with ASR, standardized for the USA population, of 80.7 per 100 000 for women and 
58.5 per 100 000 for men and the rates increased with age [50].  The mean age of 
women and men was similar at 70.7 years and 70.4 years respectively.  Similar to 
studies from developing world, the female to male ratio was 1.19 [50].  The lower 
rates and younger age at hip fracture may be explained by the LE of 72.4 years in 
women and 67.7 years with men with just 5% of the Moroccan population being over 
the age of 65 years.  In a subsequent longitudinal study, conducted between 2006 
and 2009 [47], the incidence in both women and men had increased to 85.9 per 100 
000 in women and 72.7 per 100 000 in men.  Based on this, the incidence of hip 





Further confirmation of increasing hip fracture rates was seen in a study from Owerri, 
Nigeria (2002 - 2008) in persons greater than 50 years old.  The study documented 
42 hip fractures of which 68% occurred in women and men with a mean age of 67.5 
years and 69.0 years, respectively [37].  Of note is that urban dwellers were younger 
than those who lived in rural areas.  The incidence rate was 1.7 times greater in 
women than men and unlike the previous study from Ibadan, the incidence rates 
increased with age with the highest rates seen in women and men over the age of 80 
years [40].  The low incidence rates are still difficult to explain, given the presence of 
multiple risk factors, namely, low calcium intake, multiple pregnancies and prolonged 
breast feeding, and may be explained by the low LE of 57 years.  The incidence 
rates may have also been underestimated due to under reporting, miscoding, poor 
access to health care and use of traditional healers [48, 384]. 
 
2.14.2.5 South Africa 
South Africa has a mixed population, comprising Africans, Whites, Coloureds 
(people of mixed ancestry) and Indians.  Limited data exists on the prevalence of 
osteoporosis, hip fractures rates and especially on ethnic differences.  There are no 
epidemiological studies on the prevalence of osteoporosis in SA, although several 
studies have examined differences in BMD and risk factors for osteoporosis in the 
African and White populations. 
Earlier studies revealed conflicting results.  In a radiological study, a lower 





respectively, compared to 14% in White women [385] based on lumbar radiographs.  
In a further study, while lower metacarpal bone density were seen in 14 year old 
urban and rural school African children with a low calcium diet compared to White 
children with normal diets, there was no significant difference between older (70 - 79 
years) African and White subjects [386].  There was however, an unexplained lower 
prevalence of hip and VFs in the older African subjects [385].  The higher bone mass 
at all ages in Caucasians compared to Africans was later confirmed by Solomon [52].  
In the study of metacarpal bone density, Solomon also reported that while bone 
mass increased more rapidly and reached higher maximum values in Whites, there 
was also a more rapid loss after the third decade, while the bone mass remained 
static or continued to rise in African subjects.   
In the limited studies employing more sophisticated technology, a similar BMD at the 
lumbar spine has also been reported in Africans, Coloured and Whites, but with 
higher values at the femur and calcaneus in Africans [387, 388].  To obviate the 
effect of age and BMI on BMD [389], Daniels et al., [390] calculated volumetric 
BMAD and BMC after correcting for body and bone size in African and White 
premenopausal and postmenopausal women.  The study confirmed the previous 
findings of similar lumbar spine and distal radius bone mass in Africans and Whites 
but a higher femoral bone mass in Africans.  The BMAD findings however, 
suggested that Whites have a marginally lower bone mass at the lumbar spine, 
significantly lower bone mass at the hip and similar bone mass at the distal radius 
compared to Africans.  In addition PBM was higher and bone loss rate was slower in 





however may be lost with the low calcium and high protein diet of urbanization [391].  
Two recent studies have confirmed a higher femoral BMD and similar or slightly 
lower spinal BMD in African women compared to White women [56, 68] and a slower 
decline in bone mass with ageing in Africans [69].  These site specific differences in 
the SA population are only partially explained by SES, body composition and lifestyle 
factors, suggesting a role for the additional influence of genetic and environmental 
factors. 
In contrast, however, Kruger et al., [392] reported a higher than expected prevalence 
of spinal osteoporosis (33.1%) and hip osteoporosis (8.2%) in Africans.  However, 
the use of the White reference data from the NHANES III database may have 
overestimated the prevalence of osteoporosis as suggested by a small study, where 
in Indians BMD measurements were overestimated when the NHANES III White 
population reference range was used to calculate BMD as compared to a reference 
range for Indian women [393]. 
Significant differences have also been noted in skeletal geometry.  Africans are 
significantly shorter and heavier compared to Whites [390].  The higher femoral neck 
BMD in Africans may be due to increased weight bearing [69].  Africans also have a 
shorter HAL [394].  Other skeletal changes, such as narrower endosteal diameter, 
thicker cortices and decreased buckling ratio, have been reported in both South 
African and American Africans compared to Whites in a comparative study, 






Similarly, histomorphometric examination of the iliac cortical crest suggests that 
Africans have a stronger microarchitecture as evidenced by thicker trabeculae, better 
osteoid seam thickness, greater endocortical mineral apposition rates and better 
bone formation rates [396].  These findings have been verified in younger children 
who show increased cortical bone; which may possibly decrease hip fracture risk 
later in life [56]. 
 
Hip fracture studies from South Africa 
There are very few studies on fragility fractures in SA.  In the landmark study 
conducted by Solomon [39] in Johannesburg, hip fractures were seen in 26 and 38 
urban African women and men, respectively in a geographic area consisting of 310 
903 men and 291 455 women representing 27% of the estimated 11 million living in 
Johannesburg.  The gender ratio was similar to that is other developing countries 
[39].  The incidence rates in men (4.5 per 100 000) and women (4.2 per 100 000) 
was one tenth that of comparative European populations (Table 2.5).  Despite the 
fact that the highest rate in Africans was seen in persons aged 80 years and over, 
there was no consistent increase in the incidence rate with age as seen in Dundee 
and Malmo (Table 2.5).  This low rate was not explained by differences in BMD and 
was thought to be due to qualitative differences in bone geometry and 
microarchitecture [39, 52]. 
In the second study designed specifically to examine the effects of drinking habits on 





trauma fractures.  The calculated incidence rate was 12.0 per 100000; while double 
that seen 10 years prior was significantly lower than the 100 per 100 000 reported in 
SA Whites.  Higher bone turnover rates with faster repair of micro-damage, better 
bone quality and stronger bone microarchitecture were advanced for the lower rates 
seen in Africans by the authors.  This is however unusual as a higher bone turnover 





Table 2.5 Hip fractures rates in White females in Dundee and Malmo and 
Africans in Johannesburg applied to a standard population (the Standard 

















Under 30 496 512     
30 - 34 76 424   2.5 0 
35 -39 74 629   1.7 1.0 
40 – 44 67 712   2.1 2.3 
45 – 49 60 190   2.0 0.5 
50 – 54 54 893 3.3 21.9 3.1 2.0 
55 – 59 48 011 15.8 33.6 4.7 5.8 
60 -64 40 210 14.9 48.3 5.5 6.8 
65 - 69 33199 45.8 73.0 8.8 4.1 
70 – 74 22 641 65.4 88.3 1.8 3.7 
75 – 79 14 725 56.0 76.6 0 7.4 
80+ 10 835 135.6 127.0 12.6 8.7 
Total 1 000 000 336.8 468.7 44.8 42.3 
Rate per  
100 000 
 33.7 46.9 4.5 4.2 






Studies on VFs are also scarce.  Dent et al., in 1968 reported a lower prevalence of 
VFs in urban and rural African compared to White women [385].  However this study 
was based on the visual assessment of lumbar vertebrae on radiographs, the 
subjects were not age matched, had been admitted for unknown indications and 
whose diet differed markedly according to their ethnic groups. 
Recent studies, however question the belief that VFs are rare in Africans.  In a 
longitudinal study,  38% of African women aged 60 years and over developed new 
vertebral deformities over a 5 year period [54] and a similar prevalence of VFs has 
been reported in African and White postmenopausal women in Cape Town (11.5% 






2.15 Outcome post hip and vertebral fractures 
While any fragility fracture is associated with an increased mortality compared to the 
general population, mortality and significant long term morbidity are highest with hip 
fractures [14].  The increase in mortality is due to the co-morbid diseases rather than 
the fracture itself and persists for many years after a fragility fracture.  The number of 
year’s life lost due to premature death, recorded as the Disability Adjusted Life Years 
(DALY), for osteoporotic fractures is 5.8 million worldwide.  In Europe the DALY due 
to osteoporotic fractures alone accounts for more deaths than all common cancers 
except for lung cancer [3]. 
A significant number of patients who survive a hip fracture will experience 
impairment in independent living, mobility and chronic pain which they may never 
fully recover from [397].  The loss of function in previously independent subjects is 
often devastating and in a survey of healthy women aged 75 years and over, 80% 
reported they would prefer death over loss of quality of life post fracture [398]. 





2.15.1 Mortality post osteoporotic fractures 
The mortality rate (MR) post hip fracture, previously reported as 12 - 20% [98], 
increased to 18 - 31% per annum in a recent review [343].  In a further review of 63 
studies predominantly from the USA, Europe, Australia, New Zealand and Japan, an 
unadjusted MR of 2.3 - 13.9% during hospitalization and increasing to 5.9 - 50% at 
the end of one year was reported in subjects with a mean age of 80 years[400, 401].  
The excess MR (deaths due to hip fracture which might have been preventable) 
compared to local population has been reported as 8.4% in Sweden [402]and 36% in 
the USA [403].  Furthermore, the mortality risk post fracture was double that of age 
matched controls with the greatest risk seen in the first six months post fracture 
[184].  Survival analysis of the DOES confirms that LE is decreased in hip fracture 
subjects and that a hip fracture is an independent risk factor for mortality, with 
women dying 4 years earlier than expected and men 5 years earlier [404]. 
While there is agreement that the highest MR is seen in the first six months [405], 
data on the duration of the excess MR associated with hip fractures is conflicting with 
the duration from two to twenty years [406].  In contrast, after correcting for age, sex, 
SES, pre-fracture functional status, BMI, co morbid illnesses and overall health 
status the excess MR did not persist beyond six months in other studies [13, 15]. 
Almost all studies have shown a higher MR in men post hip fracture, both during the 
initial hospitalization and subsequent years [407].  In a retrospective review from the 
USA, in hospital mortality for men was almost double than in women [408].  In a 





and gender matched controls with only a 12% difference seen in women [14].  In 
addition, the increased MR appears to persist for longer in men, up to two and half 
years and even more [14, 409, 410].  The difference in MR between men and 
women is further supported by the eight fold increase in MR in men compared to the 
five fold in women in the first three months post fracture, with a difference persisting 
at the ten year follow up [411]. 
The reason for the higher MR in men is not well understood and may be due to a 
difference in infection rates (pneumonia or septiciemia) [408, 412, 413], however this 
has not been conclusively proven.  Men have also be shown to have poorer pre 
fracture function and walking abilty compared to women [414], higher American 
Surgical Association (ASA) rating suggesting a higher comorbid burden of disease, 
and poorer outcomes [14], due to higher complication rate post operatively [408, 
412, 413].  The increased respiratory risk may be due to a higher frequency of 
smoking in men [415]. 
The MR post fracture is clearly higher with increasing age however the excess MR 
decreases with age in age matched populations, in other words as people in the 
younger age groups have a lower risk of death for all causes the relative risk is 
greater in younger age groups with hip fractures compared to older [14]. 
The increased MR in African American women compared to White women in the 
USA, despite a lower fracture rate in African American women, is unexplained [416].  
African American and White men however, had a similar MR which was higher than 





possible difference in medical care utilization pattern could have contributed [416].  
Age, gender, type of fracture and treatment modality may also influence the 
difference between African Americans and Whites [410]. 
There are limited mortality studies in developing countries.  The first study from 
Delhi, (unpublished) [417] has shown a MR of 30.4% at one year post fracture, in 
188 hip fracture subjects with a mean age of 64.7 years.  There are no published 
studies from Africa on mortality post fracture. 
While comorbid illnesses such as congestive cardiac failure, renal failure, infection, 
weight loss, metastatic malignancy, may contribute to excess mortality they alone do 
not account for excess mortality observed [161, 418, 419].  Several studies have 
failed to show an association between the presence of comorbid diseases and the 
excess mortality risk associated with hip fractures [14, 16, 17, 420]. 
Other factors useful in predicting mortality post hip fracture are being a nursing home 
resident, poor activities of daily living, preoperative walking ability and global physical 
status, low surgical fitness as determined by the ASA grading, dementia, cognitive 
impairment, DM, cancer, cardiac disease [421, 422], a low albumin and a delay in 
surgery [423].  The most common causes of death post-operatively are infection, 
cardiac and pulmonary complications including pneumonias and thromboembolism 
[419, 424]. 
Post VF the risk of increased MR persists for greater than a year [150].  Women with 
clinically diagnosed VF have a 15% higher mortality than women without fractures. 





due underlying conditions [425].  The MR is higher with advancing age and multiple 
VFs [165].  The risk of death due to pulmonary complications is 2 - 3 fold higher, 
independent of steroid or smoking use [12].  There is also a higher MR in cancer 
subjects [12].  The MR in VF may be biased as data is based on studies of clinical 
VF and the impact of morphometric VFs is not known [12]. 
 
2.15.2 Morbidity post osteoporotic fractures 
Osteoporotic hip fractures result not only in acute pain and loss of function, but are 
associated with significant long term morbidity [216].  In an earlier study in White 
women, 30.1% of survivors were unable to ambulate independently one year later. 
[426].  Ten years later, Riggs et al. [41] reported that 50% of hip fracture survivors 
were unable to walk unassisted and 25% required long term frail care.  Several other 
studies have reported similar outcomes post hip fracture with 50% of women who 
had lived independently previously, requiring assistance with tasks of daily living or 
needing to remain in long term care facilities [96]. 
The recovery pattern following a hip fracture follows a specific pattern.  At six 
months, the recovery of walking and activities of daily living (ADL) is better than that 
of IADLs, with 60% recovering full walking ability, 50% able to perform ADL but less 
than one third able to complete IADLs [410].  The disability persists at one year and 
eventually up to 40% are still unable to walk unaided, 60% unable to perform all 
ADLs and 80% unable to perform all IADLs.  In a prospective study, only 47% of 





marked in the first four months and after 6 months only every fifth patient continued 
to deteriorate.  Predictors of a poor outcome are older age, male gender, pre-fracture 
functioning and discharge to institutional care rather than home [427].  Poor QoL pre-
fracture, is more common in women, older individuals and those with multiple 
comorbidities, and has been associated with a poorer outcome [410].  Outcomes are 
also poorer in subjects who have a protracted hospital stay, require rehospitalisation 
for complications, have underlying cognitive or cerebral impairments and decreased 
social contact [19].  In contrast, individuals with strong social support have better 
post fracture QoL scores [428]. 
While sub-trochanteric fractures were previously associated with a poorer outcome, 
with recent advances in surgical management, post repair outcomes are no different 
to that seen with other fracture types [382, 399] and QoL scores remained 
significantly below pre-fracture levels at 2 years.  Poor QoL pre-fracture was also 
associated with a nine fold deterioration three months post fracture in sub-
trochanteric fractures [382, 400]. 
Vertebral fractures are also associated with a significant morbidity [12].  Multiple 
fractures can lead to significant pain, height loss and decrease in QoL with 
associated complications of cardio respiratory disease [362]. 
Few studies report differences in hip fracture outcomes in ethnic groups.  In the 
USA, poor outcomes have been reported in African Americans and Hispanics [429] 
while in India, one year after a fracture 13.7% of subjects were bed ridden, 19.5% 





regaining full ADLs [417].  All eight domains of the SF 36 which measures disability 
and quality of life were significantly impaired in hip fracture subjects compared to 
controls at six months [430].  Similarly in a recent report from Mexico, mobility, daily 
activities, and self-care were the most affected in the first month after a hip fracture 
[431].  Older subjects suffered more from anxiety and depression, while younger 
subjects complained more of pain and discomfort.  Function improved over six 
months, disability worsened only in subjects aged 85 years of age. 
Hip fractures account for significant number of days spent in hospital.  Lippuner et 
al., in a review of hospitalization in Switzerland for the period 2000 - 2008 for all 
major osteoporotic fractures, found that the number of hip fractures requiring 
admission decreased over the years, despite an increase in number of other 
osteoporotic fractures requiring admission [432].  Women spent three times the 
number of days in hospital for fractures compared to chronic obstructive airway 
disease or breast cancer and 1.5 times compared to a major cardiovascular event 
[432].  The length of hospital stay is variable and determined by a number of factors 
including resources, co-morbid illness and rehabilitation programmes.  Hospital stays 
are usually longer in men and estimated to be greater than for days for prostate 
cancer [261]. 
Understandably, with the perceived low incidence of hip fractures and the very 
limited number of studies in SA and the rest of Africa, there are no studies on 






2.15.3 Risk of a second hip fracture 
In the immediate phase post fracture, a marked increase in bone turnover has been 
observed with a resultant decline in BMD in the opposite hip of between 4.6 - 7% in 
next year.  The loss in bone mass and metabolic changes result in an associated 
loss of lean body mass of between 5 - 6% and increase in fat mass of between 4 - 
11% [433].  These changes increase the risk of second hip fracture.  In the USA, 
10.3% of hip fracture subjects will experience a second hip fracture in the following 
three years.  The risk of subsequent fracture is highest in the first year with 51% of 
hip fractures occurring in the first six months and 75% in the first year [434]. 
 
2.16 Management of hip fractures 
Management consists of immediate management of the hip fracture and assessment 
and management of the underlying osteoporosis and secondary prevention of 
fragility fractures. 
 
2.16.1 Surgical management 
The definitive management of hip fractures is surgical with either a repair or a hip 
replacement depending on the type of fracture.  Subjects with hip fractures are 
usually older with multiple co-morbidities and at higher risk for post-operative 





unit is recommended [435].  Management in an orthogeriatric unit decreases length 
of hospital stay and cost, results in more patients being discharged home rather than 
to a to a frail care facility, improves functional outcomes, mortality and morbidity 
[435]. 
Current guidelines recommend that surgery is as soon as possible and preferably 
within 24 hours [436].  Earlier surgery has been shown to improve functional 
outcome, decrease hospital stay and post hip fracture complications, however the 
impact on mortality is more controversial with varying outcomes [436].  In contrast, a 
delay of greater than 48 hours has been associated with an increased MR [423].  
Protagonists for early surgery argue that the challenges faced in providing early 
surgery can be overcome by system based solutions such as a readily available 
specialized operative team, which will prevent surgical delays and long term 
morbidity [437]. 
Despite these conflicting findings and that surgery within 48 hours may be difficult 
due to operational and cost factors, it has become widely accepted that early 
surgical repair is recommended and these time guidelines have also been 
incorporated in the management guidelines for acute hip fractures in SA endorsed by 





2.16.2 Medical management of osteoporosis 
With the introduction of fracture risk assessment tools, intervention thresholds have 
been developed and differ with regional MR and health economics.  Currently a 
limited number of drugs are available for the treatment of osteoporosis and a number 
are in development [438, 439].  Anti-osteoporosis drugs are conventionally divided 
into anti-resorptive drugs which suppress bone resorption, anabolic drugs which 
stimulate bone formation and dual acting drugs (Table 2.6).  Their mechanisms of 
action, effects on bone mass and fractures rates, indications, contraindications and 
side effects have been extensively reported [178, 313, 440, 441].  Anti-fracture 
efficacy at the spine varies from approximately 41 - 70% with and at the hip from 16 
– 41% depending on the drug used [92, 438, 442].  The number of new VF can be 
decreased by 40 - 60% with appropriate treatment in the first year [149]. 
Despite the fact that a hip fracture indicates severe underlying osteoporosis and 
there is a significant risk for second hip fracture [443], only 15% of persons with a hip 
fracture will have a BMD measurement and a diagnosis of osteoporosis is made in 
less than 30% [427].  Paradoxically, older women and men are less likely to be 
diagnosed or treated for osteoporosis [29].  Of concern is that even in the presence 
of a prior fragility fracture less than 30% of subjects receive calcium and vitamin D 








Table 2.6 Classes and examples of drugs for osteoporosis treatment 
 
Class of drug Examples 
Antiresorptive Agents Calcium and vitamin D 
Oestrogen/progestin 




Anabolic Agents Parathyroid Hormone 





2.17 Health care costs 
Osteoporotic fractures contribute significantly to both direct and indirect health care 
costs and pose a serious burden to not only health care facilities, but to families and 
communities as well.  Medical and hospital costs of any osteoporotic fracture have 
been estimated to be 2.2 - 3.5 fold greater than that of age matched controls [445].  
Hip fractures are the most expensive to treat and exceed that of any other fracture 
by 1.6 - 6.2 fold [445]. 
Almost 20 years ago the annual health care of osteoporosis in the USA was between 
US$ 5 - 10 billion [25].  This doubled by 2002 and with the projected increase in 
longevity and hip fracture rates is predicted to further double or triple by 2040 [27].  
Similarly, in Europe, which has the highest burden of osteoporotic fractures, the cost 
of fractures is expected to increase from 32 billion Euros in 2005 to 37 billion Euros 
by 2025 [313].  In the UK the cost of treating hip fractures, without accounting for 
inflation, is expected to be in excess of £ 1.6 billion by 2015 [446].  The individual 
cost for hip fractures, however differs little between countries within Europe [447]. 
Little is known about the costs of treating hip fractures in developing countries with 
only a few studies available.  However, similar to developed countries, in China, the 
cost of hip fractures is expected to increase from USD 1.6 billion to USD 12.5 billion 
to USD 26.5 billion by the year 2020 and 2050 respectively [448] and in Mexico, the 
costs is estimated to increase from the US$ 97 million USD in 2006 to between USD 





Similarly, there is little data on the costs of hip fractures in Africa and the Middle 
East.  Unpublished data reported in the IOF regional audit shows that the cost per 
patient varies between USD 1000 – 3000 in Iran to USD 12 000 in the United Arab 
Emirates [28].  In SA cost per hip fracture is estimated at USD 24 000 in the private 
sector [28]. 
Independent of the type of surgical procedure, the major factors affecting cost are 
patient’s age, functional status, duration of hospital stay and nursing home care [23, 
450].  Costs are generally highest in the first six months to one year, largely 
accounted for by costs of hospitalization [20, 22] and fall below pre fracture levels 
only by the 3rd to 4th year [451], by which time a significant number of the individuals 
with hip fractures will have died.  In contrast, in survivors the costs remain above 
normal up to 5 years later [451].  Vertebral fractures are similarly associated with 
considerable costs (13.8 billion USD in the USA in 2011) [452, 453] and increased 
number of visits to a primary care physician [454, 455]. 
The duration of hospital stay is the most important contributor to cost and may 
account for up to 84% of the total cost of hip fractures [446, 450, 451].  The number 
of days in hospital for osteoporotic fractures has been shown to exceed that for 
stroke or myocardial ischemia in women [403] with mean duration of stay varying 
between 11 to 23 days [456, 457].  Factors contributing to a prolonged hospital stay 
include the presence of co-morbid diseases, a lack of operating theatres and 
orthopaedic surgeons, and prolonged post-operative recovery.  One in four women 
presenting with a hip fracture will have pulmonary disease or cardiac failure, one in 





require pre-operative optimization and longer postoperative recovery periods [458].  
In addition, poor nutritional status is also associated with a longer stay, higher costs 
and an increased mortality [459]. 
The significant indirect costs from a loss of productivity, special transport needs, 
special diets, home alterations and caregiver costs are challenging to calculate [446].  
Loss of productivity is difficult to estimate in older persons who are often not formally 
employed but contribute indirectly e.g. as baby sitters [449].  Intangible costs e.g. 
pain and decreased health status are also difficult to estimate and therefore rarely 
documented [460]. 
Various strategies have been proposed to decrease costs of osteoporosis and hip 
fractures, including earlier surgery and a multidisciplinary approach to rehabilitation 
to reduce costs and improve outcomes post hip fracture [449], and the identification 
and treatment of those at high risk for fractures.  Treating all post-menopausal 
women at risk for osteoporosis however, will result in significant over treatment and 
will equate to cost of treating hip fractures [26].  A more targeted approach to prevent 
fracture is therefore required.  In developed countries, where the incidence and risk 
profile of hip fractures is clearly defined, treatment of high risk patients, identified by 
utilizing the FRAX®, has been found to be cost effective [26].  However, 
management of osteoporosis remains sup-optimal.  In the Prospective Observational 
Study Investigating Bone Loss Experience in Europe (POSSIBLE EU®), just over 
half the subjects (52%) on osteoporosis medication had had a BMD measured on 
DXA, despite the fact that 40% had had a previous fracture and 30% at least two 





had had a prior fracture and had not received appropriate treatment after the first 
fracture [462]. 
To address this shortcoming, the global Capture the Fracture Campaign was 
launched by the IOF in 2012 [462].  It aims to prevent secondary fractures by 
developing Fracture Liaison Services (FLS), which will assist to initiate appropriate 
and multidisciplinary management for the first osteoporotic fracture.  A Best Practice 
Framework (BPF) has been designed to assess the effect of FLS in improving the 
care offered to hip fracture subjects and outcome, lowering MR and decreasing 





2.18 Assessment and management of osteoporosis in South Africa 
The South African health care system is made up of the public sector which caters 
for the majority of citizens and the private sector, utilized mainly by those with 
medical insurance or the means to afford such care.  Less than 10% of the older 
population has medical insurance and use the public health sector which is free for 
the elderly and the indigent. 
There is limited data on health care costs for NCDs in SA, especially in the public 
sector.  Although the cost of a hip fracture was determined in a small study in 2005 
[463], there is no data on the length of hospital stay or direct and indirect costs 
associated with hip fractures, either in the private or public sector [464]. 
A low awareness of osteoporosis has however been reported in two studies from the 
private sector.  In the first study, BMD was measured in only 11.8% of subjects 
admitted for reduction of a wrist fracture and in only one of ten patients with a hip 
fracture [292].  Similarly, the majority of subjects on glucocorticoid therapy were not 
assessed for osteoporosis [465]. 
There have however been several initiatives to improve the awareness of 
osteoporosis and hip fractures.  The NOFSA has published several guidelines on the 
assessment and management of osteoporosis and recommendations for the 
management of hip fractures [87, 88].  Approximately 180 DXA machines are 
available in SA with majority located in large urban centres.  There are only two DXA 
machines in the public sector in the eThekwini area.  While a BMD measurement is 





hand, a DXA study costs approximately 100 USD and requires authorization from the 
medical insurance scheme. 
A major drawback is that osteoporosis is not classified as a PMB.  The medical 
insurance companies are therefore not obliged to reimburse clients for osteoporosis 
medication.  Individuals are often required to take a more expensive plan or provide 





2.19 Summary of literature review 
This literature review is an overview of the pathogenesis, epidemiology and 
outcomes of osteoporotic hip fractures.  There have been many advances in 
understanding the pathogenesis of osteoporosis, identification of individuals at high 
risk of fractures and medical therapy for osteoporosis.  Hip fractures are the most 
serious consequence of osteoporosis and, even in developed countries, are 
associated with an increased mortality, morbidity and health care costs.  Large 
epidemiological studies in the developed world have established the risk factors for 
osteoporosis and incidence of hip fractures and, have led to the development of the 
FRAX® tool, a cumulative risk score, which predicts the 10 year probability of a 
major and hip fracture.  Based on this, intervention thresholds have been 
recommended for the appropriate management of osteoporosis.  Despite this, 
treatment for osteoporosis, even after a fracture, remains sub-optimal. 
A significant geographic, ethnic and gender variation in the prevalence of 
osteoporosis and its risk factors, and in the incidence of hip fractures has been 
reported.  A lower incidence has been reported in the developing countries, with the 
lowest incidence in SA Africans.  This is however based on a single study reported 
more than 40 years ago.  Subsequent reports suggest that there is no difference in 
BMD or the prevalence of vertebral fractures in SA Africans and Whites. 
In addition with the increasing LE and rapid urbanization with decrease in physical 
activity levels and other lifestyle changes, it is predicted that the number of hip 





Chapter 3 Methodology 
3.1 Ethical approval 
Ethical approval for the study was granted by the Biomedical Research Ethics 
Committee (BREC) of the University of KwaZulu-Natal (UKZN) (Appendix 3.A) and 
approval to conduct the research was obtained from the KwaZulu Natal (KZN) 
Provincial Department of Health (DOH) (Appendix 3.B) and individually from the 
hospitals involved in the study.  The Department of Orthopaedic Surgery in each of 
the hospitals was informed of the study. 
All subjects (hip fracture and control) who participated in the study were given an 
information sheet and signed informed consent in their language of preference 
(English or Zulu) (Appendix 3.C; English version).  To ensure that all fractures were 
captured, ethical approval was obtained to extract the demographic data (age, 
gender, ethnicity, hospital name, residential address), management, i.e. surgical or 
conservative of the hip fracture and duration of hospital stay from a retrospective 
chart review of the subjects who were either unable to give consent or did not want 
to participate in the prospective study. 
 
3.2 Study design 
A descriptive, prospective study on hip fracture incidence, demographic profile, risk 





without osteoporotic hip fractures was conducted in the public health sector of 
eThekwini area, SA. 
There were two phases in the study 
The first phase was a comparative study of subjects, aged 60 years and over, with 
minimal trauma hip fractures admitted to the public sector hospitals in the eThekwini 
catchment area.  The subjects were assessed for the presence of established risk 
factors for osteoporosis and falls and the immediate outcome post hip fracture 
including health care cost utilization. 
The second phase was a one-year longitudinal study to determine the outcomes 
(morbidity and mortality) of the hip fracture subjects. 
 
3.3 Study area 
Africa is the second largest and second most populated continent in the world after 
Asia with a population of 1.033 billion.  There has been a rapid growth in the 
population size from 221 million in 1950 to 1 billion in 2009.  The population growth 
is estimated to continue increasing to reach 2.4 billion by 2050 [466]. 
South Africa, located at the southernmost point of Africa has the fifth highest 
population in Africa at approximately 50.6 million.  The population is expected to 
quadruple in next 90 years with the number of older persons expected to increase 
significantly to greater than 30% of the population despite the population growth 





This study was conducted in the in the coastal city of eThekwini (formerly known as 
Durban) which is the largest city in the province of KZN and has a mixed ethnic 
population of 3 468 087 persons.  Of these 236 035 persons (6.9%) are 60 years 
and older, 144 587 aged between 60 to 69 years and 91 448 above the age of 70 
years (Table 3.1). 
The majority are African (108 240; 33 811 men and 74 429 women), followed by 
Indians (62 149; 25 485 men and 36 664 women), Whites (59 187; 25 573 men and 
33 614 women) and with a small number of Coloureds (6459; 2 641 men and 3 818 
men) [2007 Consensus Stats SA] [467].  The African population consists of the 
Nguni (Zulu Xhosa, Ndebele, Swazi), Sotho-Tswana, Tsonga and Venda.  The Zulu 
group is predominant group in eThekwini.  Whites include English speaking 
descendants from the British Isle, Afrikaners who are descendants from Dutch, 
German and French Huguenots and immigrant descendants from the rest of Europe.  
‘Coloureds’ (the label is contentious, but widely acceptable in SA) are a people of 
mixed ancestry of Khoisan, African, Whites, and slaves from East and West Africa 
while the Asian population consists largely of Indians from the Indian subcontinent 
brought as indentured labourers in the 19th century and a smaller group of Chinese 
[467].  The inhabitants are predominantly urban and peri urban dwellers.  The city 
enjoys a fair amount of sunshine and the climate is tropical with hot, humid summers 
and warm winters [468]. 
The eThekwini area is well defined geographically and is divided into health districts 





structured fee basis and health care for pensioners (retired persons or those 
receiving an old age social grant) is free. 
 
3.4 Study sites 
The area has 6 large hospitals of which two are classified as central hospitals and 4 
regional levels hospitals which all offer an orthopaedic service.  BMD testing is 
available at the central hospitals only, however acute hip fracture management is not 
performed at one of the central hospitals Inkosi Albert Luthuli Central Hospital 
(IALCH).  There are also several private hospitals in the area which offer an 
orthopaedic service on a fee based structure or accept patients with a medical 
insurance. 
The study was undertaken in the following five public sector hospitals in the 
eThekwini region, namely King Edward VIII (KEHVIII), Addington (ADD), RK Khan 
(RKK), Mahatma Gandhi Memorial (MGH) and Prince Mshiyeni Memorial Hospitals  
(PMMH).  All subjects with a hip fracture presenting to a primary or district level 
hospital in the public sector are referred to one of these hospitals for further 


















  Male Female Male Female Male Female Male Female  
60 – 64 15 437 25 239 858 1 174 10 009 13 458 7 220 9 644 83 039 
65 – 69 8 102 18 820 718 957 7 980 9 837 6 899 8 234 61 547 
70 – 74 5 062 13 307 603 625 3 444 7 046 4 341 5 980 40 408 
75 – 79 2 946 8 361 456 706 2 264 4 133 3 548 4 174 26 588 
80 – 84 1 240 4 494 3 249 1 170 1 289 1 920 2 612 12 977 
85 – 120 1 024 4 208 3 107 618 901 1 645 2 970 11 476 
Total 33 811 74 429 2 641 3 818 25 485 36 664 25 573 33 614 236 035 
Created on Thursday, October 30, 2008; Statistics South Africa Web page: www.statssa.gov.za 



















Figure 3.1: Map of eThekwini health areas [468] 
The figure represents the different health regions in eThekwini and the location of the 
6 hospitals are highlighted*.  Clinics and district level hospitals in the area refer 
patients to regional centres. 
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3.5 Sample selection 
3.5.1 Subject selection: The study population consisted of persons aged 60 years 
and over who resided in the eThekwini area and were admitted with a diagnosis of 
minimal trauma hip, neck of femur or trochanteric fracture in the five selected 
hospitals during the study period. 
3.5.2 Control subjects: Volunteer subjects aged 60 years and over, with no 
previous history of osteoporosis or hip fractures were recruited from the hospitals 
being studied.  Additionally they were recruited by word of mouth and through local 
community centres for the aged in the defined geographic area. 
 
3.6 Recruitment 
Recruitment and follow up of hip fracture subjects and age matched controls 
commenced in August 2010 and was completed in May 2013.  Trained medical and 
nursing staffs were employed to assist with the recruitment. 
The age of subjects was determined from the admitting hospital records and if not 
known an estimated age was obtained from the subject or a family member.  
Ethnicity was self-reported by the subjects. 
All hip fracture subjects who consented to participate in the longitudinal study were 






3.7 Sample Size 
For the case study the number of subjects required to ensure validity of results was 
calculated using the most important established risk factors for osteoporotic hip 
fractures.  The risk factors identified were age, gender, ethnicity, a known diagnosis 
of osteoporosis, previous fragility fractures and a maternal history of fractures.  The 
prevalence of these was estimated from international and local literature.  The 
number of subjects required to show statistical significance, calculated using an 
epidemiological statistics software package and disease prevalence was 200 





Table 3.2 Prevalence of risk factors used to calculate sample size. 
Risk factors Cases with hip fractures 
Age  >70 years 60 %; n = 183 
Gender Males 30%; n = 78 
Ethnic Whites 30%; n = 189 
Osteoporosis risk (<-2.5 on BMD) 70% ; n = 21 
Previous fracture history 20 to 40%; n = 158 





3.8 Inclusion and exclusion criteria 
3.8.1 Inclusion criteria 
Hip fracture subjects 
1. Age 60 years and over. 
2. New minimal trauma hip fracture (defined as any fracture of the femur 
between the articular cartilage of the hip joint to 5 cm below the distal point of 
the lesser trochanter, subsequent to a fall from a standing height or less) [469, 
470]. 
3. Ability to give informed consent.  This was applicable to the case control study 
only.  Ethical permission was obtained to record age, gender and ethnicity of 




Age (± 3 years), gender and ethnic matched controls from the eThekwini area 
who met the following criteria were recruited. 
1. Ability to give informed consent. 
2. Not previously investigated or treated for osteoporosis. 





3.8.2 Exclusion criteria 
1. Pathological fractures of the hip 
2. Fractures distal to the lesser trochanter 
3. Traumatic hip fractures 
4. Subjects readmitted during the study period with complications due to a 
previous hip fracture. 
5. Subjects who were not native South Africans and/or did not have a South 
African citizenship. 
Subjects admitted to more than one site were recorded at the site where the primary 
surgery occurred. 
 
3.9 Case identification 
Hip fractures subjects were identified from the orthopaedic wards’ admission 
registers which record the following data: date of admission, name, age, gender, 
residential address and admission diagnosis based on the clinical and radiological 
findings of the admitting doctor.  Original medical records and radiographs of all 
subjects identified from the admission registers were reviewed to verify the diagnosis 
before they were enrolled in the study. 
Of the total of 277 subjects identified for possible inclusion, 53 subjects refused to 
participate in the case control study and 24 were confused and unable to give 





unknown.  The demographic profile of the excluded subjects is discussed in Section 
4. 
Control subjects were identified from the Outpatients departments of KEH VIII 
hospital (n=41) and IALCH (n=49), family and or friends of hip fracture subjects 
(n=20), staff or their relatives (n=21) and from old age organizations (n=69).  These 
subjects were pre-identified by the study coordinator and only subjects who 
consented to the study were referred to the investigator.  The number of control 
subjects who were approached and refused to participate was not documented. 
Control cases were recruited on an ongoing basis, and within a year of the hip 
fracture subject being enrolled. 
Survival bias  
All hip fracture subjects admitted to the selected hospital during the study period 
were seen within the week of admission.  All subjects admitted with a hip fracture 
were recorded and no subject had died prior to the initial screening.  It is therefore 
unlikely that there was a survival bias in this study. 
 
3.10 Data collection instruments 
A standard data collection form (Appendix 3.D) was administered by a trained 
interviewer and a standardized clinical examination and relevant laboratory and 





Information recorded included demographic data, anthropometric measures, risk 
factors for osteoporosis, functional assessment, full physical examination findings, 
results of haematological, biochemical and radiological investigations. 
 
3.10.1 Demographic data 
The following information was obtained for both hip fracture and control subjects. 
1. Age 
2. Ethnic group 
3. Gender 
4. Physical address was recorded as the usual address of the subjects.  
Subjects outside the eThekwini boundary were excluded from the study. 
5. Housing type : categorized as formal, informal, traditional or hostel. 
6. Employment:  categorized as pensioner, unemployed or self-employed.  
Permanent South African citizens aged 60 years and older are eligible to 
receive an older person grant from the government and free health care [471]. 
7. Educational level: categorized as never schooled, less than 5 years of 
education, completed secondary level or Standard 10 or tertiary education. 
3.10.2 Anthropometric measures 
1. Weight: Subjects were weighed on a balanced beam scale, wearing the 





2. Height : was measured using a stadiometer with a sliding headpiece to 
increase the accuracy of the reading and taken to the nearest centimetre 
(cm). 
Weight and height in hospital were recorded in 136 subjects only.  Sixty four 
hip fracture subjects were unable to stand independently and to be accurately 
weighed by the time of discharge. 
 3.  Body Mass index (BMI) was calculated using the standard formula BMI = 
weight (kg) / height (m2) and expressed as kg/m2 and according to the WHO 
categories for adults aged 25 years and older (Table 3.3) [472] 
 Adults: >25 year 
 Adapted from WHO 1995 [472] 
 
3.10.3 Risk factors for osteoporosis 
Although a number of validated tools for the assessment of osteoporotic fracture risk 
exist, few have been used in clinical practice in SA.  The WHO FRAX® has been 
validated by the IOF and is based on studies from NA, Europe, Australia and Asia 
Table 3.3 WHO normal reference values for BMI in adults 
Category BMI range (kg/m2) 
Underweight <19.0 
Normal (healthy weight) 19.1 - 24.9 
Overweight > 25 - 29.9 





[31].  The osteoporosis risk factor assessment in this study was based on traditional 
risk factors for osteoporosis including those identified by the FRAX® [78, 79].  The 
FRAX® tool has been validated in 12 independent studies and found to be valid and 
reliable. 
Therefore the factors used in predicting fracture risk in this study included: 
 Age, sex, weight and height 
o The actual weight and height were recorded.  
o Subjects were categorized as being </> 57 kg as per the FRAX® tool, 
however only mean weight was used in the risk assessment analysis. 
 Gynaecological history 
o age of menarche 
o age of menopause 
o use of HRT 
  Age at which commenced use, duration and side effects of HRT 
o parity 
 History of childhood fractures 
 Previous fragility fractures after the age of 40 years 
o defined by site, date of occurrence and treatment received 
o screened or treated for osteoporosis 
 Prior vertebral fractures (self-reported) 
o defined site, date, treatment received 






o Family history  
o Osteoporosis 
o Maternal history of falls 
o Maternal history of fractures 
o Smoking history 
o The WHO Monitoring Trends and Determinants in Cardiovascular 
disease scale (MONICA scale), an internationally validated 
questionnaire was used to classify subjects as present or past 
smokers.  The average number of cigarettes smoked was determined.  
The age of smoking, exposure to passive smoking and use of a pipe 
was also documented [473]. 
 Alcohol use 
o Subjects were asked to report the number and type of alcoholic drinks 
consumed in the past week using a self-report scale, validated in The 
Danish Health and Morbidity Survey [474].  This scale was used as 
recall periods of greater than one week duration are associated with a 
significant decrease in the report of alcohol usage and are less 
accurate. 
 Calcium intake 
o The IOF Calcium Intake Diary [475] was used to record and calculate 
the dietary calcium intake based on the UK nutrient databank 
information.  While calcium intake has been reviewed in the SA 
population, several different methods were used to quantify calcium 





tool being freely available this has not been used in previous studies in 
SA. 
 Lifestyle factors 
o Illicit drug use, caffeine intake and sunlight exposure (minutes/day) was 
recorded. 
 Activity level (self-reported)  
o Subjects were asked to self-categorize their activity level as extremely 
active, moderately active, mildly active or sedentary based on their 
daily activities. 
 Current drug use and previous use of drugs associated with bone toxicity, GC, 
anti-epileptics, heparin, lithium, antidepressants, was recorded. 
 Presence of known causes of secondary osteoporosis including rheumatoid 
arthritis, type 1 DM, osteogenesis imperfecta, untreated hyperthyroidism, 
hypogonadism, premature menopause (<45 years), chronic malnutrition, 
malabsorption and chronic liver disease [31]. 
 Falls were assessed in three different questions 
o Current fall resulting in hip fracture (Appendix 4D Q 2) 
 Date and type of fall 
o A history of the number/s, date/s and type of fall/s prior to the present fall 
were recorded in Q3.6  
o Elderly Fall Screening Test (EFST) was administrated (Q7) 
The EFST has been validated in a number of community studies and 





testing required, and is therefore easy to implement and has a sensitivity 
of 93% with a specificity of 78%.  The six items include previous falls, 
lifestyle factors, neurological disorders, medication use and recent 
illness, balance and gait, and environmental hazards.  Subjects who 
score in more than 3 categories are at  high risk for falls [476, 477].  The 
EFST has not been previously used in SA studies. 
 
3.10.4 Functional assessment 
The following scales were used to assess basic and instrumental activity of daily 
living, quality of life and level of pain: 
1. Physical self-maintenance scale (PSMS) 
2. Lawton Instrumental Activities of Daily Living scale (IADL)  
3. Euro Quality of Life scale (QoL) 
4. Oswestry Disability Index (ODI) 
5. Visual Analogue Scale (VAS) for pain 
The PSMS and the Lawton IADL are widely used in combination to assess daily 
living activities and are easy to administer.  They correlate well with other activity 
scale scores, with good inter-rater reliability at 0.87 and 0.91 in the elderly [478, 
479].  Possible limitations of these scales include under or over reporting as both 
scales are self-reported and are not observed.  Both scales however if administered 





ability to administer the test repeatedly and maintain validity was important in 
assessing functional outcomes during the study period and at one year.  The Lawton 
IADL scale has been reported to be a sensitive marker of function and correlated 
with the nutritional index in a SA study [480, 481]. 
The Euro QoL, a generic questionnaire, used and validated in hip fracture cost 
studies, enables the comparison between different ethnic and study groups [482].  It 
is short and easy to administer and provides valuable insight into subjects overall 
functioning.  The Euro QoL has been shown to be sensitive in detecting moderate to 
severe functional impairment in a multi-ethnic SA population post stroke and in 
amputees in SA [483-485]. 
The ODI has been studied extensively in subjects with lower back and hip pain.  It 
has been validated in cross cultural settings, [486, 487] is easy to score and is a 
good predictor of functional outcome post-surgery.  It is scored out of 60 and 
converted into a percentage.  If any section is not answered, the score is adjusted 
accordingly before the percentage is calculated (Appendix 3.D). 
Pain is a significant contributing factor to hip fracture subjects’ recovery.  The VAS is 
a simple tool to administer and has good reliability and validity to measure pain at a 
particular moment in time.  The subject indicates her/his subjective feeling of pain on 
an unmarked 10cm line and the point is measured and scored out of 10.  A score 
above 4cm predicts a poor outcome and correlates with other functional scales in 
post hip fracture subjects.  It is most useful to determine changes in individuals over 





The ODI and VAS have been used primarily in orthopaedic studies in SA involving 
lower back pain or recovery after spinal surgery, and although the ODI pain score 
and VAS pain score may not reveal an initial correlation, with time both scores are 
considered useful tools for interpreting functional recovery [490, 491]. 
 
3.10.5 Physical Examination 
All patients had a full physical examination undertaken by a specialist physician (the 
author) on enrolment to screen for secondary causes for osteoporosis and on 
subsequent follow up visits to detect any co-morbid illnesses. 
 
3.10.6 Haematological and biochemical investigations 
All patients recruited into the case control study had 20 millilitres of venous blood 
drawn from a vein in the antecubital fossa, for haematological and biochemical 
evaluation.  The investigations were chosen to exclude secondary causes of 
osteoporosis and to determine if there are haematological or biochemical tests that 
may help predict risk or outcomes. 
The investigations were performed immediately after consent was obtained, and this 
was usually within a week of admission for hip fracture subjects.  The medical file 





available were documented.  Blood investigations were performed in control subjects 
on the day of recruitment. 
The following blood tests were performed on the total cohort: 
1. Blood was collected in an ethylenediaminetetraacetic acid (EDTA) tube an 
analysed in a Sysmex machine (Roche) for a full blood count (FBC).  The 
haemoglobin (Hb) (g/dl), red blood cell mean corpuscular volume (fl) and 
mean corpuscular haemoglobin (pg), white blood cell count ×109/l (WBC) and 
platelet count×9/l were measured. 
2. Blood samples were collected in a gel tube and analysed in a Beckman 
Coulter DXC 800 for the following: 
a. Urea and electrolyte: Sodium, potassium chloride, bicarbonate, urea 
and creatinine. 
b. Liver function test: Total protein, albumin, bilirubin, alkaline 
phosphatase (ALP), gamma glutamyl transferase (GGT) and alanine 
transaminase (ALT). 
c. Calcium, phosphate and magnesium: The serum calcium was 
corrected using the following formula 
Corrected calcium = serum calcium + ((40 - albumin) × 0.025) 
d. Random glucose: (collected in a potassium oxalate tube) 





3. The Beckman Coulter DXI 600 was used for measuring thyroid function 
tests and the parathyroid hormone level. 
4. 25 hydroxy vitamin D was sent to the Central National Health Service 
laboratory in Johannesburg for analysis using the high performance 
chromatography (HBLC) based Chromo-systems diagnostic kit. 
5. Oestrogen and testosterone levels were measured using chemical 
luminescence (Roche). 
6. Erythrocyte Sedimentation Rate was measured using the Westergren 
method using non clotted blood. 
All blood samples were processed at the admitting hospital by the National Health 
Laboratory Service (NHLS).  The normal reference ranges for NHLS were used as 
reference range (Appendix 3.E). 
 
3.10.7 Radiological investigation 
3.10.7.1 Conventional radiographs 
All hip fracture subjects had hip radiographs on admission.  Due to logistic difficulties 
all subjects were unable to have spine radiographs on admission.  Subjects who 
came for their follow up visits at IALCH had plain thoracic and lumbar spine 
radiographs performed.  Separate antero-posterior (AP) and lateral radiographic 
views of the spine were acquired using a standardized protocol in 122 hip fracture 





Of the 78 hip fracture subjects who did not have radiographs, 35 died before their 3 
month follow up visit, 29 were unable to come to hospital and were followed up 
telephonically and 14 were lost to follow up.  
A further 4 patients had radiology but did not have a DXA scans due to technical 
reasons (1 had a recent barium meal, 1 was unable to lie down and two refused). 
The comparison (gender and ethnic) between subjects in whom radiology was /was 
not performed is expanded in section 4. 
All radiographs were reported by an experienced specialist radiologist blinded to hip 
fracture or control subjects, Dr J Maharaj (UKZN, Senior Lecturer in Department of 
Radiology).  Thoracic and lumbar vertebrae were considered to be abnormal 
(morphometric fracture) using the fixed method i.e. if there was a decrease in height 
of >20% in its anterior, middle or posterior section compared to its own or nearest 
intact posterior vertebra [492, 493]. The percentage loss was calculated using the 
difference in height.  Fractures were graded as mild (20-25%), moderate (25.1- 
39.9%) or severe (>40%) according to the degree of deformity [10].  This method has 
been validated in several studies including SOF correlates with clinical measures of 
height loss, age, back pain, baseline BMD.  The measurements are easy to perform 






3.10.7.2 Bone mineral density 
BMD and BMC measurements were obtained using DXA.  The Hologic Discovery A 
densitometer was used to measure BMD of the spine and the opposite hip in hip 
fracture subjects.  The BMD of the lumbar spine (L1 to L4) was obtained and a mean 
value calculated. 
The BMD was measured according to a standardized protocol by trained 
radiographers, who had previously completed the National Osteoporosis Foundation 
of South Africa (NOFSA) / International Society for Clinical Densitometry (ICSD) 
training course, at KEH and IALCH.  Phantoms were scanned weekly at each site to 
ensure reproducibility.  A precision assessment tool, which is more accurate than a 
manual assessment, was used to calculate the percentage coefficient variant (% cv) 
between the sites.  The % cv change was 4.84% across all systems or a change of 
0.047 g/cm2 (Appendix 3.F), was considered acceptable for comparison. 
BMD was measured in (g/cm2) and was calculated at the hip from BMC (g) divided 
by bone width (BW) and at the lumbar spine by total scan area.  BMD is 
conventionally expressed as either an absolute value (g/cm2) or a deviation from the 
norm defined as a Z - score or T - score.  The Z - score is a comparison of the 
subjects BMD with an age, gender and ethnic matched control whilst the T - score is 
comparison to young adult reference range for that population.  For this study, the 
NHANES III Caucasian data as recommended by the NOFSA [88] was used as there 





Numerous studies have shown that actual bone size affects areal bone mass 
measurements especially in different ethnic groups.  Several techniques have been 
proposed to adjust bone mass measurements for volumetric differences in body size. 
The volumetric assessment; BMAD was calculated at spine and hip, based on the 
premise that volume of bone can be calculated from DXA areal measurements as 
proposed by Carter [494] and Katzman [495] for the lumbar vertebrae and the 
femoral neck respectively using the formulae: 
BMAD = Mean  at the lumbar area [494] and  
BMAD = B  at the femoral neck [495] 
 
3.11 Outcomes post hip fracture: Mortality and morbidity 
Hip fracture subjects were followed up for one year and functional outcomes 
documented at three, six and twelve months using the functional tests described in 
Section 3.10.4.  Subjects were given an appointment for the Geriatric clinic at IALCH 
for their follow up visit on discharge from the orthopaedic ward.  At the three month 
visit all subjects were assessed by the investigators.  A clinical examination, an 
assessment of function (PSMS, IADL, QoL, ODI and VAS) was performed and 
radiological investigations (thoraco-lumbar spine x-rays and BMD) obtained.  At the 
six and twelve month visits, functional assessments were repeated.  Hip fracture who 





difficulties, were interviewed telephonically to assess function.  Readmissions for 
fracture complications as identified were documented. 
The number of deaths at one year post fracture was recorded and date and possible 
cause of death documented.  The mortality rate was calculated as numbers of 
deaths compared to survivors at one year, excluding subjects lost to follow up. 
 
3.12 Incidence rate calculation 
All consecutive patients with hip fractures in the public sector presenting from the 1 
August 2010 - 31 July 2011 who met the inclusion criteria were recorded.  The crude 
and age specific hip fracture incidence rates for the eThekwini and SA were 
calculated using the number of new fractures as the numerator and the total 
population of eThekwini and SA above 60 years old as the denominator based on 
2007 census data [467]. 
The calculated crude rate was used to calculate the estimated incidence rate for the 
entire South African population.  To determine an accurate estimate, variables which 
affect incidence rates i.e. age, gender and ethnicity were taken into account.  The 
direct method was used to standardize for age based on ASR for the sample 
population of eThekwini and the age structure of the South African population.  The 
formula used to calculate incidence rate is shown in Table 3.4 [496]. 
The ASR for males, females, Indians, Africans and Whites (females only) were 





respective total population >60 years old for the denominator (Table 3.5).  Due to low 
numbers, the ASR for the Coloured group and White men was not calculated [467]. 
Age specific rates were calculated in 5 year intervals and the coefficient increase or 
decrease calculated with increase in age by dividing the ASR of the older group into 
that of the younger group. 
 
The crude incidence rate was determined by using the following formulae: 
Number of fractures in one year 





















1 2 (1) / (2) = 3 4 
(4) / total 
population = ( 5) (5)×(3) 
a b xxx c d e 
Crude rate  Age adjusted incidence rate  
(a/b)x100 000 
= y per 100 000  
(e)/(c) 
= z per 100 000  






Table 3.5 Population of South Africa over 60 years old stratified according to age, gender and ethnicity 
 Age African Coloured Indian White 
  Male Female Male Female Male Female Male Female 
60 – 64 305 762 447 322 46 077 63 267 18 128 24 111 124 049 128 970 
65 – 69 249 366 397 332 32 873 46 456 13 633 17 414 99 203 105 920 
70 – 74 143 239 295 172 22 651 32 272 7 211 12 353 68 784 83 414 
75 – 79 102 748 227 996 11 175 21 592 4 908 7 118 44 287 60 262 
80 – 84 5 377 120 926 5 031 11 942 2 248 2 528 26 625 40 717 
85+ 51 127 130 087 3 748 8 212 1 376 1 675 14 453 30 559 
Total 857 619 1 618 835 121 555 183 741 47 504 65 199 377 401 449 842 
Created on Thursday, October 30, 2008  
Statistics South Africa Web page: www.statssa.gov.za 





3.13 Calculation of health care costs associated with acute hip fracture 
management 
Acute management of hip fractures contributes significantly to health care costs with 
the majority of direct costs attributed to hospitalization.  After sustaining a fall a 
potential fracture subject either visits a peripheral health care facility or may present 
directly to one of the five selected hospitals.  Once admitted the patient is either 
surgically or conservatively managed (non-surgical) depending on his/her fitness for 
anesthesia and surgery.  The potential pathway a subject may have followed from 
admission to discharge is shown in Figure 3.2.  No study subjects required intensive 
or high care facilities in this study. 



























Figure 3.2 Flow process for hip fracture subjects from time of fall to discharge 
Follow up treatment (orthopaedics) – two weeks  
Follow up treatment (study subjects) – 3/6/12 months 
Hospital 
Fall 
Referral - GP 
Referral - Clinic 
Outpatients Trauma 
Orthopaedics outpatients 
Theatre Surgical ward Surgical ward 
Radiology 
Discharge 





3.13.1 Cost Calculation 
A bottom up approach was used to calculate health care costs (aggregating the 
resource cost of individual patients).  The acute cost of admission and management 
was calculated for 200 subjects enrolled in the prospective study.  The cost of 
treatment was sub-divided into its major components: 
 Acute ward costs 
 Theatre costs 
 Investigations performed 
A detailed review of hospital records was undertaken for all patients.  Ward 
expenses were computed, with the aid of the finance department, using the average 
cost per day as determined for the financial year 2010 / 2011 and the KZN DOH 
hospital fees manual for 2010/11. 
Costs related to other resources were established from actual individual use.  The 
length of stay in orthopaedic wards was recorded.  In addition, number of days to 
surgery was documented for each patient and the total number of delayed days, with 
resultant costs, was calculated.  The average daily cost of in hospital ward was        
R 2 560.06, inclusive of nursing care and other daily ward expenses (Appendix 3.F). 
The surgical procedure, operation duration in minutes and type of implant used was 
recorded.  The average cost incurred by one hour of operating time was calculated.  
This estimate included staff time in theatre and recovery area, use of equipment, 





team.  The cost of each implant was incorporated separately.  All pathology, 
microbiology and radiological investigations performed were carefully documented 
for each patient and their frequency recorded.  Using this data the individual total 
cost incurred in the treatment of each patient was calculated. 
The cost of valuation was based on observed market prices however these were 
recorded in units and amounts so if in the future total cost estimates can be updated 
if better cost evaluations become available. 
The following costs were documented in each patient to ensure credibility of the 
costing calculation: 
1. Doctor’s initial consult 
2. Initial Nursing consult 
3. Radiology  
4. Laboratory tests 
5. Admission clerk 
6. Transport from base hospital (where applicable) 
7. Number of days in the ward 
8. Number of daily doctor’s consults 
9. Daily nursing cost 
10. Drug cost: analgesics /medication for co-morbidities/discharge medication 
11. Physiotherapist cost  
12. Theatre time  





14. Anaesthetic drug cost 
15. Surgeon’s theatre cost 
16. Hip replacement/repair–type and make 
17. Repeat radiology post-surgery 
18. Transport back to base hospital where applicable 
The time frame for the study was fifteen months and resulted in the introduction of 
some uncertainty as traditionally costs are inflated according to the inflation rate to 
adjust for time.  To correct for this, actual amounts per year instead of averaging 
amounts according to inflation were used. 
The second important area where uncertainty possibly occurred was in the estimate 
of hospital costs.  The study data is stochastic and thus sensitivity analysis for 
uncertainty due to sampling variation was assessed by use of conventional statistical 
inference and hypothesis testing. 
Uncertainty was prevented as the process flow from admission to discharge was 
followed, and an audit of treatment and hospital records was done on discharge to 
ensure all costs incurred had been calculated. 
The normative costing model was based on the recommended guidelines for hip 
fracture management as endorsed by NOFSA [87].  The actual calculated cost of 











3.14 Data collection: Reliability and validity 
The study sample represents both male and female subjects of the different ethnic 
groups in the eThekwini area.  An over representation of subjects may possibly have 
occurred as the orthopaedic services are concentrated in the metropolitan area and 
patients outside the eThekwini functional area may also have potentially accessed 
the service.  To correct for this subjects who did not have a permanent address in 
defined geographic locality would have been excluded. 
Due to severity of pain and disability post hip fracture, one assumes most subjects 
with hip fracture will seek health care, but it remains possible that extremely frail 
subjects may have been possibly managed at home and not brought for medical 
care.  Although traditional medicine is widely practiced, it is unlikely to have resulted 
in an under-representation of African cases in the urban setting. 
The sample is not representative of certain ethnic groups with a high fracture risk 
that utilize the private sector preferentially.  In order to compensate for the differential 
use of public and private sector by the different ethnic groups, the latest available 
quarterly report of council for medical schemes was accessed to determine the 
percentage of population with a medical aid.  Further analysis from the latest results 
from the Private Health Care Funder’s Board in 2007, indicates that only 14% of the 
population has medical aid cover as compared to the previous 20%.  Furthermore, 
pensioners (persons aged 60 years and over) and Africans account for only 6.4% 
and 6.9% respectively of medical aid members.  The General Household survey 





[497].  A more recent household survey shows that the 77% of White subjects have 
medical aid and 88% utilize private health care, while 46.1% of Indians have medical 
aid and 64.1% utilize private health care.  In contrast only 10.8% of Africans have 
medical aid and 17.2% utilize private health care.  The survey however does not 
have an age breakdown and may preferentially reflect the younger more 
economically wealthy population, especially in the Indian and African population 
groups [498]. 
This study is not able to make any significant conclusions regarding the 
epidemiology and risk factors for osteoporotic hip fractures in the White and 
Coloured population groups, but it may provide data for the African and possibly for 
the Indian population groups in SA. 
Sample bias was eliminated as all subjects were enrolled in the demographic and 
incidence study, and there were no exclusion criteria apart from age, non-South 
African residents and pathological fractures and inability to consent.  To further 
decrease the risk of bias minimal number of interviewers and simple data collection 
methods were utilized.  No significant communication barrier was encountered in 
interviewing the subjects. 
The study was prospective therefore the risk of missing records and incorrect data 
capturing was significantly decreased.  Subject variation with regard to recollection of 
events, mood, and motivation to respond to questions, reaction to environment, and 





All subject’s contact details were recorded and failure to arrive for appointment was 
followed by telephone call to assess the outcome. 
 
3.15 Data management 
All subjects were identified by a numbering system on being enrolled.  The master 
copy of patients’ names and numbers was available to the main investigator only 
after the data was captured. 
Collected de-identified data encrypted by a number system was entered into a 
password-protected IBM® SPSS®19 database.  The data was only handled by the 
research team and kept with the main investigator until submission for data analysis.  
Only de-identified data was submitted for analysis.  The data was paired with the 
matched age, gender and ethnic control subjects prior to analysis. 
Original data files are kept in locked office in Department of Geriatrics and will be 
destroyed in keeping with the university policy once 5 years have elapsed. 
 
3.16 Data analysis 
The data was analysed using IBM® SPSS®19 and SAS® version 21.  The 
significance for all tests was set at p <0.05.  Descriptive statistics were applied to 
show differences in age, gender and ethnicity.  Differences in means were compared 





categorical variables.  In cases where frequencies were small the exact test was 
used to determine the p value. 
In the case control study matched conditional logistic regression analysis was used 
to investigate the relationship between hip fracture and control subjects and risk 
factors.  Subjects were paired and stratified according to 1 = hip fracture and 0 = no 
hip fracture. 
The odds ratio (OR) for conditional matched analysis was calculated using the 
formulae below: 
OR =   
 
OR: odds of a hip fracture with x=1 compared to the odds of hip fracture when x = 0; 
(x) is the variable of interest, usually binary  
.g. x = 1 for hypertension or x = 0 if no hypertension. 
The study data was stratified to ensure the matched pairs of subjects and controls 
were retained in the analysis.  Pairs were matched, and labelled with a paired 
sample number of 1 to 200.  In comparing the tests for proportion of exposed 





how the paired data differs from the estimate based on an unmatched analysis of the 
same data.  Unmatched data analysis will bias the OR towards unity. 
Matched conditional logistic regression analysis was used in determining risk factors 
for osteoporosis and comparing functional activities and haematological and 
biochemical results.  The proposed risk factor was considered significant if the OR 
was greater than one and the lower bound of the confidence interval did not go 
below one.  In addition, gender and ethnic differences and predictors of death were 
analysed. 
To control for confounders, logistic regression analysis was carried out.  Independent 
variables found to be significantly associated with hip fractures or mortality on a 
univariate analysis were entered into a multiple Cox regression model in SPSS using 
backward likelihood ratios to arrive at a final model which detailed the independent 
effect of each of the predictors in the model. 
Outcomes over a year were analysed using the McNemar test.  This methodology 
was used to prevent errors in estimating the relationship of a disease and exposure 
as it compares a given subjects outcomes against time [499]. 
 
Costing analysis 
The financial burden of hip fracture was calculated using the bottom up approach as 
detailed in Section 3.13.  The amount and percentages for different components of 





compared to normative costing and the percentage difference calculated.  The cost 





Chapter 4 Results 
In the study period, 1 August 2010 - 15 October 2011, two hundred and seventy 
seven (277) subjects with minimal trauma hip fractures were admitted to the five 
selected hospitals and were enrolled into the study.  Their demographic and clinical 
characteristics are presented (Section 4.1). 
 Of these, 230 subjects admitted in the one year period 1 August 2010 to 31 
July 2011 were included in the calculation of the incidence rates (Section 4.2). 
 Two hundred (200) subjects with minimal trauma hip fractures and 200 age, 
gender and ethnic matched control subjects consented to enter the case 
control study (Section 4.3). 
The 77 subjects who either refused to participate or were unable to consent 
were significantly older than the subjects who consented (80.0 ± 8.9 vs 74.3 ± 
8.8; p < 0.0001) and although women (n=60) were more likely not to consent 
or participate compared to men (n=17) this was not significantly different (29.4 
vs 23.3%; p = 0.316).  Compared to Indian (n=36) and African (n=21) subjects 
a significantly greater proportion of White subjects (n=16) did not participate 
(24.7% and 24.1% vs 43.2% respectively; p = 0.034).  The overall number of 
White and Coloured subjects was still lower than that of Indian and African 
subjects, and this study would still not have been able to draw significant 
conclusions for the White and Coloured population groups even if all the 





subjects e.g. memory loss, falls and dementia may be underestimated in this 
study. 
 The one year outcomes and direct health care costs for 200 subjects with 












Figure 4.1 Flow diagram showing enrolment and follow up of hip fractures 
subjects (n = of 277). 
277 subjects 
01 August 2010 – 15 October 
2011 
Demographic study 
230 subjects enrolled in the 
period  
01 August 2010 - 31.July.2011 
Incidence study 
200 subjects consented to 
participate  
Case control study 
77 subjects 
Declined or were 
unable to consent 
117 subjects 
Followed up to 1year 
67 subjects 
Died within 1year 
16 subjects 





4.1 Demographic characteristics of 277 subjects with minimal trauma hip 
fractures 
4.1.1 Ethnic, age and gender distribution 
The majority of hip fracture cases were Indian (52.7%) or African (31.4%).  Whites (n 
= 37) and Coloureds (n =7) only represented 13.4% and 2.5% of the total cohort 
respectively (Figure 4.2 and Table 4.1). 
 
 
Figure 4.2 Gender and ethnic distribution in minimal trauma hip fracture 
subjects (n=277) 
 
The mean age of the total group was 75.9 ± 9.2 years with a range of 60 to 113 





and African was similar at 2.4:1 and 2.5:1 respectively.  Men were significantly 
younger than women in the total group (75.2 ± 9.3 years vs. 77.2 ± 8.8 years;  
p < 0.0001) as well as in the Indian subjects (70.1 ± 6.7 years vs. 75.8 ± 8.1 years;  
p < 0.0001).  There was no significant difference in the African subjects and the 
number of White and Coloured males was too small to draw any conclusions.  White 
women were the oldest at 80.6 ± 8.4 years (Table 4.1). 
 
Table 4.1 Age and gender distribution of hip fracture subjects in the different 




Male (n=73) Female (n=204) p-value 
African 
Age (mean ±SD) 
 
76.5 ± 10.5 
 
74.2 ± 12.3 
 
77.4 ± 9.6 
 
0.189 
n (%) 87 (31.4%) 25 (28.7%) 62 (71.3%) 
 
Coloured 
Age (mean ±SD) 
 
80 ± 8.6 
 
80.5 ± 8.5 
 
79.3 ± 10.6 ** 
n (%) 7 (2.5%) 4 (57.1%) 3 (42.9%) 
 
Indian 
Age (mean ±SD) 
 
74.2 ± 8.1 
 
70.5 ± 6.7 
 
75.8 ± 8.1 
 
*<0.0001 
n (%) 146 (52.7%) 43 (29.5%) 103 (70.5%) 
 
White 
Age (mean ±SD) 
 




80.6 ± 8.4 ** 
n (%) 37 (13.4%) 1 (2.7%) 36 (97.3%) 
 Total  
Age (mean ±SD) 
 
75.9 ± 9.2 
 
72.2 ± 9.3 
 
77.2 ± 8.8 *<0.0001 
n (%) 277 (100%) 73 (26.4%) 204 (73.6%) 
 





4.1.2 Distribution of hip fractures according to age, ethnicity and gender 
The majority of hip fractures in Indians 31 (21.2%) were documented in the 75 - 79 
years age group whereas most of the fractures in African and White subjects, 19 
(21.8%) and 11 (29.7%) respectively were seen in subjects ≥ 85 years (Table 4.2 
and Figures 4.3.a, 4.3.b and 4.3.c). 
 
















60 - 64 13 (14.9) 0 20 (13.7) 2 (5.4) 35 (12.6) 
65 - 69 10 (11.5) 1 (14.3) 23 (15.8) 4 (10.8) 38 (13.7) 
70 - 74 12 (13.8) 1 (14.3) 31 (21.2) 2 (5.4) 46 (16.6) 
75 - 79 17 (19.5) 1 (14.3) 31 (21.2) 8 (21.6) 57 (20.6) 
80 - 84 16 (18.4) 2 (28.6) 24 (16.4) 10 (27) 52 (18.8) 














Figure 4.3.a Distribution of hip fractures by age and gender in total fracture 
cohort (n = 277). 
 
Figure 4.3.b Distribution of hip fractures by age and gender in the African 
fracture cohort (n = 87)  
 






Figure 4.3.c Distribution of hip fractures by age and gender in the Indian 
fracture cohort (n = 146)  
 
In further stratifying the 277 subjects into those 74 years and younger and those 75 
years and older, men were more likely to have sustained a hip fracture at a younger 
age (≤ 74 years) compared to women (64.4%% vs. 35.3%; p < 0.0001).  This 
difference was significant in the Indian subjects (72.1% vs. 41.7%; p = 0.001) but did 
not reach statistical significance in the Africans (56% vs. 33.9%; p = 0.058) and 
















(n = 277) 
Women 72 (35.3) 132 (64.7) 
*<0.0001 
Men 47 (64.4) 26 (35.6) 
Indians 
(n = 146) 
Women 43 (41.7) 60 (58.3) 
*0.001 
Men 31 (72.1) 12 (27.9) 
Africans 
(n = 87) 
Women 21 (33.9) 41 (66.1) 
0.057 
Men 14 (56) 11 (44) 
Whites 
(n = 37) 
Women 7 (19.4) 29 (80.6) 
0.056 
Men 1 (100) 0 
Coloureds 
(n = 7) 
Women 1 (33.3) 2 (66.6) 
0.846 





4.2. Incidence rates of hip fractures 
The incidence rates were calculated using the 230 subjects aged 60 years and older 
who presented with a hip fracture to one of the five selected public sector hospitals in 
eThekwini (the defined geographic area) in the period 1 August 2010 - 31 July 2011. 
All hip fracture subjects presenting to a public health care facility in the eThekwini 
region are referred to one of the selected hospitals, which provide specialized 
orthopaedic services, for further assessment and management.  The study therefore 
makes the assumption that all subjects presenting with a hip fracture (excluding 
private sector subjects) in the public sector in the eThekwini area will be represented 
in the numerator.  For the denominator, age, gender and ethnic specific population 
statistics for the defined area (Table 4.4) were obtained from the 2007 South African 
population census [467]. 
Table 4.4 Population of eThekwini stratified by ethnicity, gender and age 



















60 - 64 15 437 25 239 858 1 174 10 009 13 458 7 220 9 644 
65 - 69 8 102 18 820 718 957 7 980 9 837 6 899 8 234 
70 - 74 5 062 13 307 603 625 3 444 7 046 4 341 5 980 
75 - 79 2 946 8 361 456 706 2 264 4 133 3 548 4 174 
80 - 84 1 240 4 494 3 249 1 170 1 289 1 920 2 612 
≥ 85  1 024 4 208 3 107 618 901 1 645 2 970 
Total 33 811 74 429 2 641 3 818 25 485 36 664 25 573 33 614 





4.2.1 Crude Incidence Rate 
The crude incidence rate for minimal trauma hip fractures was calculated according 
to formulae (Methodology section 3.12) and was 97.4 per 100 000 in the eThekwini 
public sector in subjects above the age of 60 years old. (Table 4.5 and Figure 4.4) 
 

















(1) (2) (1) / (2) = 3 (4) (3) x (4) = 5 
African 69 108 240 63.7 2 524 856 160 952 572 
Coloured 5 6 459 77.4 305 296 23 633 380 
Indian 125 62 149 201.1 112 703 22 667 903 
White 31 59 187 52.4 827 243 43 327 982 
Total 230 236 035 xxx 3 770 098 250 581 837 
Crude rate 
(230 / 236 035) x 100 000 
97.4 per 100 000 
 
Ethnic adjusted incidence 
rate for SA 
250 581 837 / 3 770 098 




The ethnic adjusted incidence rate for SA was 66.5 per 100 000.  The highest rate of 
fractures were seen in the subjects of Indian descent at 201.1 per 100 000 followed 





4.4).  The incidence rate in Whites is an under reflection due to a selection bias.  The 
incidence rate in Coloureds was calculated to be 77.4 per 100 000.  However there 
were very few Coloured subjects and the very small Coloured population in the 
eThekwini area makes it difficult to draw conclusions. 
 
4.2.2 Age adjusted incidence rate 
There was a steady increase in hip fracture rates with age; rising from 36.1 per 100 
000 in the 60 - 64 years age group to 48.7 per 100 000 in the 65 - 69 years age 
group and by a co-efficient of 1.9 to 91.6 per 100 000 in the 70 - 74 year age group 
and 2.1 in the 75 - 79 years age group.  The highest rate was noted in 80 - 84 years 
age group at 346.8 per 100 000.  The overall age adjusted rate for SA was 109 per 























(1) (2) (1) / (2) = 3  (4) (3) x (4) = 5 
60 - 64 30 83 039 36.1  1 157 686 41 824 420 
65 - 69 30 61 548 48.7 1.3 962 197 46 899 834 
70 - 74 37 40 409 91.6 1.9 665 096 60 898 691 
75 - 79 51 26 588 191.8 2.1 480 086 92 088 107 
80 - 84 45 12 976 346.8 1.8 263 796 91 482 891 
85 + 37 11 475 322.4 0.9 241 237 77 784 479 
 
Total 
230 236 035 xxx 
 
3 770 098 
410 978 423 
Crude rate 
(230 / 236 035) x 100 000 
97.4 per 100 000 
< 
 
Age adjusted incidence of total fracture 
cohort 
410 978 423 / 3 770 098 






4.2.3 Gender specific age adjusted incidence rate  
The crude incidence rate in men was lower than in women; 68.5 per 100 000 
compared to 133 per 100 000.  The age adjusted hip fracture rate for men and 
women were similar and lowest in the 60 - 65 years age group at 35.8 per 100 000 
and 36.4 per 100 000 respectively.  In both genders the ASR increased with age but 
the coefficient for increase with age was lower in men.  The highest incidence rates 
were documented in the 80 - 84 year old age group in both men and women (Tables 
4.7 and 4.8) 
 


















(1) (2) (1) / (2) = 3  (4) (3) x (4) = 5 
60 - 64 18 49 515 36.4  663 670 24 126 144 
65 - 69 17 37 848 44.9 1.2 567 122 25 473 140 
70 - 74 25 26 958 92.7 2.1 423 211 39 247 255 
75 - 79 39 17 374 224.4 2.4 316 968 71 150 869 
80 - 84 39 8 644 451.2 2.0 176 113 79 458 665 
85 + 33 8 186 403.1 0.9 170 533 68 746 506 
Total 171 148 525 xxx  2 317 617 308 202 579 
Crude rate 
(171 / 148 525) x 100 000 




Female age adjusted incidence rate 
308 202 579 / 2 317 617 






Table 4.8 Age adjusted incidence rates for hip fractures in SA men 
 
4.2.4. Ethnic and age adjusted incidence rates 
The incidence rates were calculated for the Indian, African and White population 
groups only as the number of Coloureds were too small for analysis.  The crude and 
the age adjusted rates were higher in Indians at 207.2 per 100 000 compared to 
Whites (women only) at 91.6 per 100 000.  The incidence rate was lowest in Africans 



















(1) (2) (1) / (2) = 3 
 
(4) 
(3) x (4) = 
5 
60 - 64 12 33 524 35.8  494 016 17 683 427 
65 - 69 13 23 699 54.9 1.5 395 075 21 671 695 
70 - 74 12 13 450 89.2 1.6 241 885 21 580 818 
75 - 79 12 9 214 130.2 1.5 163 118 21 243 933 
80 - 84 6 4 333 138.5 1.1 39 281 5 439 326 
85 + 4 3 290 121.6 0.9 70 704 8 596 231 
Total 59 87 510 xxx  1 404 079 96 215 430 
Crude rate 
   (59 / 87 510) x 100 000 




Male age adjusted incidence 
adjusted rate 
96 215 430 / 1 404 079 





The highest hip fracture rate was noted in Indians and Africans older than 85 + year 
age group 855.8 per 100 000 and 305.8 per 100 000 respectively, whereas White 
women fractured at the highest rate in the age group 80 - 84 years.  The number of 
White fracture cases in the study cohort was small and the results must be 
interpreted with caution.  
 


















(1) (2) (1) / (2) = 3  (4) (3) x (4) = 5 
60 - 64 18 23 467 76.7  42 239 3 239 877 
65 - 69 19 17 817 106.6 1.4 31 047 3 310 844 
70 - 74 26 10 490 247.9 2.3 19 564 4 849 037 
75 - 79 29 6 397 453.3 1.8 12 026 5 451 837 
80 - 84 20 2 459 813.3 1.8 4 776 3 884 506 
85 + 13 1 519 855.8 1.1 3 051 2 611 126 
Total 125 62 149 xxx  112 703 23 347 226 
Crude rate 
(125 / 108 240) x 100 000 
201.1 per 100 000 
 
 Indian age adjusted 
incidence rate 
23 347 226 / 112 703 


























(1) (2) (1) / (2) = 3  (4) (3) x (4) = 5 
60 - 64 10 40 676 24.6  753 084 18 514 210 
65 - 69 7 26 922 26.0 1.1 646 698 16 814 821 
70 - 74 8 18 369 43.6 1.7 438 411 19 093 516 
75 - 79 14 11 307 123.8 2.8 330 744 40 951 764 
80 - 84 14 5 734 244.2 2.0 126 303 30 837 844 
85 + 16 5 232 305.8 1.3 181 214 55 417 125 
Total 69 108 240 xxx  2 476 454 181 629 281 
Crude rate 
(69 / 108 240) x 100 000 
63.8 per 100 000 
 
 African age adjusted 
incidence rate 
181 629 281 / 2 476 454 
73.3 per 100 000 






















Formula (1) (2) (1) / (2) = 3  (4) (3) x (4) = 5 
60 - 64 2 9 644 20.7  128 970 2 674 616 
65 - 69 3 8 234 36.4 1.8 105 920 3 859 121 
70 - 74 2 5 980 33.4 0.9 83 414 2 789 766 
75 - 79 7 4 174 167. 5 60 262 10 106 229 
80 - 84 10 2 612 382.8 2.3 40 717 15 588 438 
85 + 6 2 970 202.0 0.5 30 559 6 173 535 
Total 30 33 614 xxx  449 842 41 191 705 
Crude rate 
(30/33 614) x 100 000  
< 
 
 White age adjusted 
incidence rate 
41 191 705/ 449 842 
91.6 per 100 000 
 













Figure 4.4 Age adjusted incidence rates for hip fractures by gender and 





4.3. Case control study; Assessment of risk factors for osteoporotic hip 
fractures 
Two hundred subjects with hip fractures who consented to participate in the 
prospective longitudinal one year study were assessed for risk factors for 
osteoporosis and hip fractures, and compared to 200 age (± 3 years), gender and 
ethnic matched controls using conditional logistic regression for matched data. 
 
4.3.1 Risk assessment in total hip fracture cohort 
4.3.1.1 Socio-Demographic characteristics 
Age, gender and ethnicity 
The mean age of the hip fracture subjects was 74.3 ± 8.8 years and that of controls 
was 73.0 + 8.1 years.  There were 144 (72%) women and 56 (28%) men with a ratio 
of 2.6:1.  The majority of subjects were Indians 110 (55%) followed by Africans 66 
(33%), Whites 21 (10.5%) and 3 (1.5%) were Coloured.  Indian women were the 
largest cohort at 76 (38%), followed by African women 46 (23%). 
 
Social Status: employment, housing and education 
All hip fracture subjects and the majority of control subjects (95.5%) were retired and 
were receiving an old age pension.  All the control subjects and 86.5% of the hip 





traditional housing, 5% in informal housing and 1% in hostels.  In the univariate 
analysis, hip fracture subjects were significantly more likely not to have had any 
schooling (37% vs 12.5%; p < 0.0001; OR 11.56, 95%CI 4.38-30.49) or only a 
primary school education (32.5% vs 28.5%; p < 0.0001; OR 3.89, 95%CI 1.60-9.48) 
compared to control subjects.  
 
Anthropometric measures 
Weight and height were recorded in 136 hip fracture subjects and 200 controls.  
Weight and height could not be recorded in 64 hip fracture subjects who were unable 
to stand independently by the time of discharge. 
There was no significant difference in height, but hip fracture subjects had a 
significantly lower weight compared to controls (54.7 ± 13.8kg vs. 72.0 ± 16.2kg; p < 
0.0001; OR 0.906, 95%Cl 0.87-0.94).  This difference might be an underestimate as 
subjects who were not weighed may potentially have had a lower body weight.  In 
the conditional logistic regression, for every one kilogram (1kg) decrease in weight 
the odds of hip fracture increased by approximately 10%. 
Body mass index was also significantly lower in hip fracture subjects compared to 
matched control subjects (22.7 ± 5.7 kg/m2 vs. 29.2 ± 6.0 kg/m2; p < 0.0001; OR 
0.786, 95%CI 0.7-0.87) (Figure 4.5 and 4.6).  When the BMI was categorized 
according to the WHO classification, only 1.5% (3 cases) of control subjects were 





normal BMI (55.9% vs. 25% p < 0.0001) compared to controls.  The three controls 
with a low BMI were all African women. 
Only 8.8% of hip fracture subjects had BMI of ≥ 30 compared to 40.5% in the control 
group. (Figure 4.5 and 4.6). Hip fracture subjects with a BMI of ≥ 30 had a higher 
survival rate and only one subject died in that group, however there was no gender 
difference (5 females vs 7 males), but Whites (19%) were more likely to be obese 
compared to Indians (3.6%) and Africans (7.5%). 
When used as a continuous variable, every two unit decrease in BMI increased the 
odds of a hip fracture by 1.61 (exp (2×0.2409) = exp (0.4818) =1.61) and a 3 unit 
decrease in BMI increased the odds to 2.06.  This needs to be interpreted with 
caution as BMI was not calculated for all hip fracture subjects. 
There was a significant negative correlation between age and weight and between 
age and BMI in hip fracture subjects (p <0.0001 respectively), but not in control 
subjects (p = 0.792 and 0.916) respectively. 
 
Co-morbid diseases and secondary medical causes of osteoporosis 
Compared to hip fracture subjects, control subjects reported a significantly higher 
frequency of hypertension (80% vs. 60%; p < 0.0001; OR 3, 95%CI 1.81-4.98), 
diabetes mellitus (38.5% vs. 28.5%; p = 0.043; OR 0.75, 95%CI 0.44-1.28) arthritis 
(47.5% vs. 27.5%; p < 0.0001; OR 0.431, 95%CI 0.28-0.67), and chronic backache 





medical causes were infrequent in both groups with hip fracture subjects having a 
greater frequency of cerebrovascular disease (7.5% vs. 2%) while control subjects 
reported ischemic heart disease (8% vs. 4%); there were no statistical differences 
between the groups for secondary conditions. 
Control subjects with osteoporosis were not enrolled in the study and a prior history 
of osteoporosis was obtained in 3.5% of hip fracture subjects.  Although malignancy 
(5% vs. 1.5%; p = 0.052) and immobilization (3% vs. 0.5%; p = 0.059) were more 
common in hip fracture subjects, these did not reach significance possibly due to the 
small numbers.  Rheumatoid arthritis was significantly more common in control 
subjects (4.5% vs. 1%; p = 0.034; OR 0.22, 95%CI 0.05-1.03) and this may be due 
to a selection bias. 
The use of bone toxic drugs was infrequent in hip fracture subjects and controls. 
There was no statistical difference in the use of long term glucocorticoids (greater 
than three months) which were used by 5.5% of hip fracture subjects and 3.5% of 
controls, anti-epileptics in 5% and 1.5% and antidepressants in 3.5% and 0.5% of hip 
fracture subjects and controls respectively.  Only one subject with hip fractures 









 Results expressed as total numbers with n (%)  
 Controls are matched for age gender and ethnicity  











p-value OR 95% CI 
Weight (kg) 
mean ±SD 
54.7 ± 13.7 
(n=136) 71.0 ± 16.5 
 
*<0.0001 0.906 0.87 - 0.94 
Height (cm) 
mean ± SD 
155.4 ± 9 
(n=136) 153.7 ± 7.8 0.203 0.998 0.96 - 1.03 
BMI (kg/cm2) 
mean ± SD 
22.6 ± 5.1 
(n=136) 
30.2 ± 6.4 
(n=200) *<0.0001 0.786 0.71 - 0.87 
BMI n (%) 
1 Reference category BMI ≥ 30 
BMI < 19 29 (21.3) 3 (1.5) 
*<0.0001 
43.993 8.78 -220.39 
BMI 19 - 24.9 76 (55.9) 49 (24.5) 7.432 3.24 - 17.02 
BMI 25 - 29.9 19 (13.9) 67 (33.5) 1.989 0.79 - 5.01 
BMI ≥ 30 12 (8.8) 81 (40.5) 1 1 
Educational level (n=200) n (%) 
1 Reference category Std. 10 plus 
No schooling  74 (37) 25 (12.5) 
*<0.0001 
11.560 4.38 - 30.49 
< Std. 3  65 (32.5) 57 (28.5) 3.890 1.60 - 9.48 
Std. 6-7  51 (25.5) 86 (43) 1.810 0.77 - 4.24 
Std. 10 plus  10 (5) 32 (16) 1 1 
Hypertension 120 (60) 160 (80) *<0.0001 3.000 1.81 - 4.98 
Diabetes 
mellitus 57 (28.5) 77 (38.5) *0.043 0.749 0.44 - 1.28 
Arthritis 55 (27.5) 95 (47.5) *<0.0001 0.431 0.28 - 0.67 
Chronic back 
pain 14 (7) 34 (17) *0.002 0.379 0.19 - 0.76 
Osteoporosis 7 (3.5) 0 (0) n/a n/a n/a 
Rheumatoid 
arthritis 2 (1) 9 (4.5) *0.034 0.222 0.05 - 1.03 
Malignancy 10 (5) 3 (1.5) 0.052 3.456 0.94 - 12.75 
Prolonged 
immobilization 6 (3) 1 (0.5) 0.059 0.17 0.020 - 1.38 
Glucocorticoids





































Figure 4.6 Comparison of the mean BMI in hip fracture and control subjects 
(22.6 ± 5.1 vs 30.2 ± 6.4; p <0.0001) 
 
4.3.1.2 Clinical risk factors for osteoporosis and fractures  
The prevalence of established risk factors for osteoporotic hip fractures is shown in 
Table 4.13.  Based on history and examination secondary medical conditions were 
infrequent and no further analysis was undertaken. 
 
Gynaecological history and use of hormone replacement therapy 
Comparing female hip fracture subjects to female controls, no difference was 






















=0.290; OR 0.902, 95%CI 0.79-1.04) and menopause (47.9 ± 6.2 years vs 47.3 ± 6.8 
years; p = 0.992; OR 1.015, 95%CI 0.98-1.05), or the prevalence of premature 
menopause (23.5% vs 27.5%; p = 0.061).  There was no difference in parity between 
the hip fracture and control groups (3.5 ± 2.4 children vs. 3.7 ± 2.4 children; p 
=0.964; OR 0.885, 95%CI 0.10-0.25) and the number of subjects with greater than 3 
pregnancies was similar in both hip fracture and control subjects. 
The use of hormone replacement treatment was significantly less frequent in hip 
fracture subjects than controls (4.9% vs. 15.3%; p < 0.001; OR 0.201, 95%CI 0.08-
0.49).  In a conditional logistic regression model for matched data, the non-use of 
HRT was associated with a 5 times greater odds of sustaining a hip fracture. The 
use of contraception was not documented.  
 
Cognitive changes 
Self-reported poor memory and concern expressed by a family member regarding 
memory loss were significantly more frequent in hip fracture subjects (39% vs. 
22.5%; p < 0.001; OR 2, 95%CI 1.29-3.1) and (34% vs. 18.5%; p < 0.001; OR 2.25, 
95%CI 1.39-3.64) respectively.  While hip fracture subjects were also more likely to 
report difficulty in completing familiar tasks, there was no significant difference 







Although a significant number of both hip fracture and control subjects reported prior 
falls there was no significant difference between the two groups except that 
sideways falls were significantly more common in the hip fracture subjects (70% vs. 
48.3%; p = 0.016; OR 3.5, 95%CI 1.15-10.63).  There was no significant difference in 
the number of falls (single or multiple) in the previous year or last two years between 
hip fracture and control subjects.  Most of the previous falls occurred more than a 
year ago and 55% of hip fracture subjects had no prior history of falls before the 
present fall which resulted in the hip fracture. 
Although there was no difference in the number of falls or in the number of multiple 
falls between hip fracture subjects and control subjects; analysis of risk factors in the 
EFST surprisingly showed control subjects were more likely to report near falls, 
would need assistance to stand up after a potential fall and seek medical attention 
for a fall.  Control subjects also reported more visual problems, problems with the 
lower limbs and gait, limitation of activities and medication problems (Table 4.13). 
 
Past history of fractures 
Childhood fractures were uncommon in both hip fracture and control subjects. 
Prior fragility fractures were significantly more common in hip fracture subjects 
(27.5% vs. 8.5%; p < 0.0001; OR 4.083, 95%CI 2.27-7.34).  Fifteen (7.5%) of hip 





site for a prior fragility fracture was the wrist accounting for 32.7% and 38.9% of 
fractures in the hip fracture and control groups respectively.  Other sites included the 
ankle, humerus and hand (self-reported after minimal trauma). 
Despite the majority of subjects with a prior fracture in the hip fracture group (94.5%) 
having received acute care for the previous fracture only one subject (1.9%) was 
screened and treated for osteoporosis.  Control subjects who were either screened 
or treated for osteoporosis were excluded from the study. 
 
Self-reported vertebral fractures 
Self-reported VF and kyphosis were uncommon in both hip fracture and control 
groups (1% vs. 3.8% and 0.5% vs. 2% respectively) and not significantly different. 
 
Family history of osteoporosis and maternal history of hip fracture 
A family history of osteoporosis and maternal history of fractures was reported 
significantly less commonly by hip fracture subjects than by controls; 3.5% vs. 
11.5%; p = 0.002; OR 0.266, 95%CI 0.1-0.63 and 5.5% vs. 11.5%; p = 0.034; OR 







Hip fracture subjects were significantly more likely to report being extremely active 
than controls (37.5% vs. 12%; p < 0.0001; OR 5.118, 95%CI 2.41-10.85) and to 
report exercising for more than 30 minutes a day (46% vs. 15.5%; p < 0.0001; OR 
0.218, 95%CI 0.13-0.37). 
Although there was a higher mean consumption of caffeine in hip fracture subjects 
this did not reach statistical significance (p = 0.059).  There was also no difference in 
the mean calcium intake, calcium and vitamin D supplementation and sunlight 
exposure in the two groups. 
Hip fracture subjects were significantly more likely to be current smokers (18% vs. 
10.5%; p = 0.047; OR 1.784, 95%CI 0.10-3.20), to report current alcohol 
consumption (15.5% vs 4%; p < 0.0001; OR 11.00, 95%CI 2.59-46.78) and have a 
significantly higher average daily consumption (1.1 ± 2.16 drinks per day vs 0.1 ± 6.8 













p-value OR 95%CI 
History of falls 90 (45) 87 (43.5) 0.764 1.107 0.75 - 1.64 
Sideways falls 63 (70) 42 (48.3) *0.016 3.500 1.15 - 10.6 
Problems with 
memory  78 (39) 45 (22.5) *0.001 2.000 1.29 - 3.10 
Family report of a 
memory problem 68 (34) 37 (18.5) *0.001 2.250 1.39 - 3.64 
Childhood fracture 12 (6) 10 (5) 0.533 0.934 0.45 - 1.93 
Fragility fracture ≥ 
40 years 55 (27.5) 17 (8.5) *<0.0001 4.083 2.27 - 7.34 
Self-reported VF 2 (1) 8 (3.8) 0.132 2.235 0.05 - 1.07 
Family history of 
osteoporosis 7 (3.5) 23 (11.5) *0.002 0.266 0.11 - 0.63 
Maternal history of 
hip fracture 11 (5.5) 23 (11.5) *0.034 0.427 0.20 - 0.90 
Caffeine 
(cups/day) mean ± 
SD 
2.3 ± 1.3 2.0 ± 1.6 0.059 1.108 0.96 - 1.28 
Sunlight (minutes 
per day) mean ± 
SD 
28.0 ± 47.7 28.6 ± 55.1 0.911 1.000 1.00 
Self-reported activity level 
1 Reference category Sedentary 
 
Self-reported activity level 
Extremely active 75 (37.5) 24 (12) *<0.0001 5.118 2.42 - 10.85 
Moderately active 43 (21.5) 64 (32) 0.120 1.304 0.66 - 2.58 
Mildly activity 65 (32.5) 85 (42.5) 0.065 1.203 0.59 - 2.46 
Sedentary  17 (8.5) 27 (13.5) 1 1 1 
Smoking 36 (18) 21 (10.5) *0.047 1.784 1.00 - 3.20 
Alcohol 31 (15.5) 8 (4) *<0.0001 11.00 2.59 - 46.78 
Calcium intake 
(mg/day) 432.6± 230.4 473.2± 270.2 0.108 1.000 1.00 
 Results expressed as total numbers with n (%)  






Table 4.14 The prevalence of risk factors for falls in hip fracture and control 
subjects 
 Results expressed as total numbers with n (%)  
 Controls are matched for age gender and ethnicity  




(n = 200) 
Control 
subjects 
(n = 200) 
p-value OR 95% CI 
Any near falls 63 (31.5) 110 (55) *<0.0001 2.600 1.71 – 4.00 
Reported any falls 46 (23) 62 (21) *0.059 1.531 0.98 - 2.39 
Sought medical 
attention for fall 41 (20.5) 66 (33) *0.003 2.040 1.26 - 3.29 
Need help up after 
a fall 84 (42) 113 (56.5) *0.007 0.594 0.40 - 0.88 
Limited activities 50 (25) 80 (40) *0.001 0.492 0.32 - 0.752 
Visual problems 143 (71.5) 164 (82) *0.016 1.750 1.1 - 2.78 
Seeing different 
depths 78 (39) 98 (49) *0.037 1.556 1.02 - 2.36 
Sensitivity to light 56 (28) 98 (49) *<0.0001 0.411 0.27 - 0.63 
Numbness or 
tingling in feet 50 (25) 94 (47) *<0.0001 0.373 0.24 - 0.58 
Uneven footing? 66 (33) 102 (51) *<0.0001 0.424 0.27 - 0.66 
>3 prescription 




14 (7) 35 (17.5) *0.002 2.750 1.42 - 5.32 
Recent changes to 
medications 13 (6.5) 6 (3) 0.071 2.750 0.88 - 8.64 
Activity limited by 
health problems 32 (16) 64 (32) *<0.0001 2.571 1.55 - 4.26 
Chose not to use a 
gait aid 21 (10.5) 11 (5.5) 0.106 0.550 0.26 - 1.15 
Concerns in 
transferring 29 (14.5) 48 (24) *0.007 0.488 0.29 - 0.83 
Leg tire easily 
when walking 79 (39.5) 129 (64.5) *<0.0001 0.346 0.23 - 0.53 
Activity limited by 





A total of 116 hip fracture subjects and 199 control subjects had a DXA scan.  Of the 
84 hip fracture subjects who did not have a DXA scan 35 died before their 3 month 
follow up visit, 29 were unable to come to hospital and were followed up 
telephonically and 14 were lost to follow up.  A further 4 subjects did not have a DXA 
scan due to technical reasons (1 had a recent barium meal, 1 was unable to lie down 
and two refused). 
There was no difference in the age, gender or ethnic distribution between hip 
fracture subjects who did not have radiology investigations compared to those who 
did.  However a significantly higher mortality rate (45 (53.6%) vs 22 (18.0%); p 
<0.0001) was seen in fracture subjects who did not do their radiology investigations. 
Hip fracture subjects had a significantly lower aBMD measurements compared to 
controls at the total hip (0.650 ± 0.136 g/cm2 vs. 0.879 ± 0.163 g/cm2; p < 0.0001), 
femoral neck (0.518 ± 0.106 g/cm2 vs. 0.713 ± 0.127 g/cm2; p < 0.0001) and lumbar 
spine (0.701 ± 0.173 g/cm2 vs. 0.848 ± 0.183 g/cm2; p < 0.0001), (Figures 4.7 and 






Figure 4.7 Distribution of total hip aBMD in hip fracture subjects (n=112) and 
control subjects (n=198) (0.650 ± 0.136 g/cm2 vs. 0.879 ± 0.163 g/cm2; p < 
0.0001) 
 
Figure 4.8 Distribution of lumbar spine aBMD in hip fracture subjects (n=116) 
and control subjects (n=198) (0.701 ± 0.173 g/cm2 vs. 0.848 ± 0.183 g/cm2; p < 
0.0001) 
Total hip BMD (g/cm2) 





The calculated mean BMAD at the lumbar spine and total hip remained significantly 
lower in hip fracture subjects than control subjects; 0.199 ± 0.036 g/cm3 vs. 0.244 ± 
0.041 g/cm3; p < 0.0001 and 0.118 ± 0.092 g/cm3 vs. 0.143 ± 0.025 g/cm3; p < 0.003, 
respectively. 
The T - score was also significantly lower in hip fracture subjects at the total hip  
(-2.91 ± 0.85 vs. -1.26 ± 1.25; p < 0.0001) and the lumbar spine (-2.99 ± 1.29 vs. 
-1.26 ± 1.25; p < 0.0001).   
 










Total spine L1 - L4 
(g/cm2) 
0.701 ± 0.173 
(n= 116) 
0.848 ± 0.183 
(n= 199) *<0.0001 
Femoral Neck 
(g/cm2) 
0.518 ± 0.106 
(n= 78) 
0.713 ± 0.127 
(n= 136) *<0.0001 
Total hip (g/cm2) 0.650± 0.136 (n= 112) 
0.879 ± 0.163 
(n= 198) *<0.0001 
Spine BMAD 
(g/cm3) 
0.199 + 0.036 
(n= 81) 
0.244 + 0.041 
(n= 137) *<0.0001 
Hip BMAD (g/cm3) 0.118 ± 0.092 (n= 73) 
0.143 ± 0.025 
(n= 136) *0.003 
Spine T - Score -2.99 ±1.29 (n= 111) 
-1.23 ± 1.44 
(n= 198) *<0.0001 
Hip T - Score -2.91 ± 0.85 (n= 107) 
-1.26 ± 1.25 
(n= 200) *<0.0001 






The vast majority of hip fracture subjects had a mean T – score value, according to 
the WHO, in the osteoporotic range compared to control subjects (85.3% vs 29.1%). 
The majority of controls (38.7%) had a normal BMD or osteopaenia (32.2%) (Table 
4.16).  In contrast only three hip fracture subjects had a normal BMD.  They were all 
women, two were Indian and one was African, and all three were alive at one year.  
No other differentiating or protective features were identified in these three subjects. 
 
Table 4.16 Bone mineral density in hip fracture and control subjects 








Normal BMD (%) 2.6 38.7 
*0.0012 Osteopaenia (%) 12.1 32.2 
Osteoporosis (%) 85.3 29.1 
 
Age and BMD 
There was an inverse correlation between age and hip BMD (p = 0.025) and lumbar 
spine BMD (p < 0.001) in the total cohort. However the inverse correlation of BMD 
with age in fracture subjects was noted only at the hip (p = < 0.0001) and not at the 
lumbar spine (p = 0.190).  In contrast, in control subjects there was no association 
between age and hip BMD (p = 0.324) but there was a significant inverse correlation 






Figure 4.9.a Correlation between age and total hip (p = 0.025) and lumbar spine 
(p < 0.001) BMD in the total cohort (n = 310). 
 
Figure 4.9.b Correlation between age and total hip (p < 0.0001) and lumbar 






Figure 4.9.c Correlation between age and total hip (p = 0.324) and lumbar spine 
(p < 0.001) BMD in control subjects (n = 198). 
 
Weight, BMI and BMD 
In the total cohort (n=336) and the hip fracture subjects there was an association 
between weight, BMI and BMD, despite the regression corrected for mean (R2) not 
being significant.  In the total (n=336) and fracture cohorts (n=116) both weight and 
BMI correlated with hip (p <0.0001) and lumbar spine BMD (p <0.0001) (Figure 
4.10.a, 4.11.a, 4.10.b and 4.11.b).  In control subjects there was no association 
between weight and hip (p =0.160) or lumbar spine BMD (p = 0.792) (Figure 4.10.c) 
nor was there a correlation between BMI and BMD in control subjects at the hip (p 





The correlation of age, weight and BMI to BMD for men and women and different 
ethnic groups was not conducted as the sample size numbers were too small to 
draw significant conclusions. 
 
 
Figure 4.10.a Correlation between weight and total hip (p < 0.0001) and lumbar 






Figure 4.10.b Correlation between weight and total hip (p < 0.0001) and lumbar 
spine (p < 0.0001) BMD in hip fracture subjects (n = 112). 
 
Figure 4.10.c Correlation between weight and total hip (p = 0.160) and lumbar 






Figure 4.11.a Correlation between BMI and total hip (p <0.0001) and lumbar 
spine (p < 0.0001) BMD in total cohorts (n = 310) 
 
Figure 4.11.b Correlation between BMI and total hip (p <0.0001) and lumbar 






Figure 4.11.c Correlation between BMI and total hip (p =0.164) and lumbar 
spine (p =0.916) BMD in control subjects (n = 0.198) 
 
4.3.1.4 Morphometric vertebral fractures 
Thoracolumbar radiographs in 122 hip fracture and 197 control subjects were 
analysed.  Morphometric VF (defined as a change in height of > 20% of the vertebral 
body compared to vertebrae above or below) were identified in 81 (25.4%) of the 319 
subjects who had radiographs and were significantly more common in hip fracture 
subjects than control subjects (32.7% vs. 20.3%; p < 0.0001) and in women 








Thirty nine (48.2%) of the VF were seen in Indian subjects, however VF were seen 
most commonly in the White subjects 44.8%, followed by Africans and Indians, 
28.3% and 22% respectively.  
Multiple VF’s were present in 27 subjects (6.9%), and were more common in 
subjects with a hip fracture than in those without, but this did not reach statistical 
significance (12.3% vs. 6.1%; p = 0.057).  Indian and African hip fracture were more 
likely to have multiple fractures than Indian and African control subjects but multiple 
VF were more likely to occur in White control subjects than White hip fractures 
subjects.  A history of a previous fragility fracture was also more common in the hip 
fracture subjects with a VF than in control subjects with a VF (32.5% vs. 7.3%, p = 
0.005). 
The vast majority of vertebral fractures occurred in the lower thoracic and upper 
lumbar regions [T11 (25%), L1 (22.5%) and T12 (17.5%)] in both groups.  In control 
subjects the highest number of VF were observed at T6 and T11 at 19.5% each, 










Table 4.17 Distribution of vertebral fracture sites in hip fracture and  
control subjects 









T5 3 1 4 
T6 3 8 11 
T7 5 6 11 
T8 5 7 12 
T9 6 5 11 
T10 1 2 3 
T11 10 8 18 
T12 7 7 14 
L1 9 5 14 
L2 6 3 9 
L3 4 1 5 
L4 4 4 8 
L5 0 2 2 
 
In the total cohort (hip fracture and control subjects), the majority had moderate 
vertebral deformities (44.4%), followed by mild vertebral deformities (37.1%) and 
severe deformities were only seen in 18.5% (Table 4.18).  Severe deformities were 
most likely seen in Indian or African hip fracture subjects.   
Due to the small sample size, the ethnic and gender differences in the severity of 





subjects were more likely to have fractures at T6/7 while Indian and White hip 
fracture subjects had fractures at T11/12.  No difference was noted in control subject 
fracture distribution. 
 
Table 4.18 Distribution of severity of deformity in vertebral fractures in hip 

































































4.3.1.3 Functional assessment in hip fracture subjects (pre-fracture) and 
controls 
Physical self-maintenance scales 
Hip fracture subjects had a significantly lower total mean score on the PSMS pre-
fracture than control subjects (13.3 ± 1.9 vs. 13.8 ± 1.1; p = 0.001) and were 
significantly more likely than controls to be unable to perform all basic activities of 
daily living, except eating, independently (Table 4.19). 
 
Table 4.19 Assessment of physical performance of basic activities of 







Eating (%) 2.5 0.5 0.103 
Dressing (%) 9 1.5 *0.001 
Grooming (%) 10 2.5 *0.003 
Walking (%) 14.5 5 *<0.0001 
Transfer to bed (%) 8.5 2.5 *0.010 
Bathing (%) 10 3 *0.004 
Toileting (%) 9.5 3 *0.006 
Total score  
(mean ± SD) 
13.3 ± 1.9 13.8 ± 1.1 *0.001 
  Total score calculated out of 17 
  (%) of subjects with a score of 0 (unable to perform activity independently) 





Instrumental activity of daily living 
Hip fracture subjects were also significantly less likely to be able to complete all the 
activities in the Lawton IADL (Table 4.) and had a significantly lower total score (22.1 
± 4.8 vs. 25.5 ± 3.4; p < 0.0001) (Table 4.20). 
 
Table 4.20 Instrumental activities of daily living and assessment of the 









Telephone (%) 51 20.5 *<0.0001 
Walking a distance (%) 54 18.5 *<0.0001 
Shopping (%) 39 9.5 *<0.0001 
Cooking (%) 44 14.5 *<0.0001 
Housework (%) 59.5 18.5 *<0.0001 
Handiwork (%) 51 17.5 *<0.0001 
Laundry (%) 18.5 4.5 *<0.0001 
Medication (%) 23.5 4 *<0.0001 
Finances (%) 26 13.5 *0.002 
IADL total score 
(mean ± SD) 
22.1 ± 4.8 25.5 ± 3.4 *<0.0001 
 IADL score calculated out of maximum of 27 
 (%) of subjects with a score of 0 (unable to perform activity independently) 







Quality of Life 
Hip fracture subjects compared to control subjects had significantly higher overall 
scores (6.3 ± 1.7 vs. 5.9 ± 1.2; p 0.003) and greater difficulty in all domains except 
daily activities (Table 4.21). 
 
Table 4.21 Quality of life and the assessment of performance of daily activities, 
mood and pain in hip fracture and control subjects  
Domain  
Fracture subjects 





Mobility Unable/needs help 21 (10.5) 4 (2) *<0.0001 
Self-care Unable/needs help 69 (34.5) 22 (11) *<0.0001 
Daily 
activities 
Unable/needs help 64 (32) 95 (47.5)) *0.002 
Pain Has Pain 29 (14.5) 9 (4.5) *0.001 
Mood Depressed/Anxious 50 (25) 17(8.5) *<0.0001 
QoL score (mean ± SD) 6.3 ± 1.7 5.9 ± 1.2 *0.003 
 QOL score calculated out of 15  
 Assessment done pre-fracture in hip fracture subjects 







Oswestry Disability index 
A similar mean ODI disability percentage was obtained in the hip fracture and control 
subjects.  Differences in individual parameters i.e. pain, lifting of objects, sleeping, 
socializing and travelling were noted, with the disability being greater in the fracture 
subjects (Table 4.22).  The final average score was calculated as a percentage of 
the total number of questions answered, and did not reach statistical significance 
(30.6 ± 15.2 vs. 28.1 ± 10.8; p = 0.063) (Table 4.22). 
 
Visual analogue Scale 
Contrary to the ODI, where pain was more common in fracture cases, in the VAS, 
hip fracture subjects had a significantly lower pain level pre-fracture compared to 
control subjects (1.4 ± 1.3 vs 3.3 ± 2.6; p < 0.0001) (Table 4.22).  This is possibly 











Table 4.22 The Oswestry Disability Index and Visual Analogue Scale and 
assessment of the performance of the activities and pain in hip fracture and 
control subjects  





(n = 200) p-value 
Pain 
Strong pain/some 
pain 17 (8.5) 5 (2.5) *0.008 
Personal 
care Unable/needs help 109 (54.5) 109 (54.5) 1 
Lifting Unable/needs help 46 (23.0) 14 (7) *<0.0001 
Walking Unable/needs help 9 (4.5) 3 (1.5) 0.079 
Sitting Unable/needs help 21 (10.5) 33 (16.5) 0.079 
Standing Unable/needs help 7 (3.5) 7 (3.5) 1 
Sleeping Interrupted by pain 28 (14) 15 (7.5) *0.034 
Social life Unable/difficulty 28 (14) 14 (7) *0.022 
Travelling Unable/difficulty 28 (14) 14 (7) *0.022 
Oswestry Score (%)  
(mean ± SD) 
30.6 ± 15.2 28.1 ± 10.8 0.063 
Visual analogue score  
(mean ± SD) 
1.4 ± 1.3 3.3 ± 2.6 *<0.0001 
 Assessment done pre-fracture in hip fracture subjects 







4.3.1.5 Haematological and biochemical parameters in hip fracture subjects 
and controls 
Details of the haematological and biochemical tests obtained in subjects with hip 
fractures at the time of admission and/ or enrolment into the case study and at the 
time of recruitment in controls are shown in Table 4.23. 
Compared to controls, hip fracture subjects had significantly lower haemoglobin, 
serum sodium, total protein and albumin (Figure 4.13) while the bilirubin, ALT, GGT, 
and plasma glucose levels were significantly higher.  In addition the inflammatory 
markers; white cell count, CRP and ESR were significantly elevated in hip fracture 
subjects. 
The mean 25(OH)2 vitamin D levels were significantly lower in hip fracture subjects 
and was in the mildly deficient range (24.96 - 49.92 nmol/L). 
Serum oestrogen levels were significantly higher in hip fracture subjects but were 
within the normal range for postmenopausal women.  In men there was no difference 
in testosterone levels between the two groups however the mean values were at the 






 All results reported as a mean ± SD  
 All controls subjects age, gender and ethnic matched. 









p-value OR 95% CI 
Haemoglobin (g/dl) 11.3 ± 2 (n=200) 
12.8 ± 1.7 
(n=200) *<0.0001 1.553 1.31 - 1.85 
White cell count 
(×109/L) 
9.8 ± 3.6 
(n=200) 
7.3 ± 2.1 
(n=199) *<0.0001 0.743 0.66 - 0.83 
Sodium (mmol/L) 135.9 ± 4.6 (n=200) 
139.6 ± 3.5 
(n=199) *<0.0001 1.219 1.13 - 1.31 
Urea (mmol/L) 7.7 ± 4.7 (n=200) 
6.6 ± 3.2 
(n=199) 0.52 0.936 0.88 - 1.00 
Creatinine (umol/L) 96.5 ± 53.5 (n=200) 
95 ± 46.5 
(n=199) 0.733 0.999 1.00 - 1.00 
Total protein (g/L) 71.1 ± 9.3 (n=198) 
74.4 ± 5.8 
(n=199) *<0.0001 1.038 1.01 - 1.07 
Albumin (g/L) 33.2 ± 7.4 (n=198) 
41.4 ± 3.9 
(n=199) *<0.0001 1.246 1.16 - 1.34 
Bilirubin (umol/L) 12.8 ± 7.9 (n=198) 
10.4 ± 7.2 
(n=199) *0.006 0.962 0.93 - 1.00 
Alanine 
transaminase (IU/L) 
28.4 ± 25.5 
(n=197) 
21.7 ± 14.1 
(n=198) *0.008 0.985 0.97 - 1.0 
Gamma glutamyl 
transferase (IU/L) 
45.9 ± 45 
(n=198) 
28.2 ± 20.3 
(n=199) *<0.0001 0.979 0.97 - 0.99 
Glucose (mmol/L) 6.9 ± 3.5 (n=175) 
5.9 ± 1.8 
(n=199) *0.001 0.813 0.71 - 0.93 
Calcium (mmol/L) 2.3 ± 0.1 (n=185) 
2.3 ± 0.1 
(n=188) 0.236 0.37 0.07 - 1.92 
Thyroid stimulating 
hormone (mIU/L) 
3.4 ± 6.3 
(n=155) 
3.7 ± 9.3 
(n=197) 0.671 1.008 0.98 - 1.04 
25(OH) vitamin D 
(nmol/L) 
38.9 ± 22.4 
(n=171) 51.4 ± 24.2 *<0.0001 1.03 1.02 - 1.05 
Parathyroid 
hormone (pg/ml) 
6.7 ± 3.7) 
(n=158) 7.6 ± 5.4 0.101 1.008 0.95 - 1.07 
C-Reactive protein 
(mg/L) 
24.3 ± 31.8 




42.3 ± 28.4 
(n=162) 25.5 ± 26.7 *<0.0001 0.977 0.97 - 0.99 
Oestrogen (pmol/L) 
(women only) 
68.9 ± 43.8 
(n=123) 
49.9 ± 19.6 
(n=144) *<0.0001 0.985 0.97 - 1.00 
Testosterone 
(men only) (nmol/L) 
10.2 ± 4.8 
(n=34) 
10.5 ± 4.9 






Figure 4.12 Comparison of mean albumin levels in hip fracture (n=198) and 
matched control (n=199) subjects on enrolment (p <0.001) 
 
4.3.1.5 Multivariate analysis of variables associated with osteoporotic fractures 
The variables with significant associations were identified in the univariate analysis 
and were entered into a COX regression model.  The variables that remained 
significant in the step wise backwards logistic regression in hip fracture subjects 
compared to controls were a prior fragility fractures, pre- fracture self-reported 
physical activity levels, BMI, education level, lADL and QoL total scores, and the 
haemoglobin, albumin, white blood cell count and C-reactive protein at time of 























Table 4.24 Multivariate analysis of variables with significant association in  




Mean body mass index *<0.0001 
Education no schooling *<0.0001 
Education < Standard 3 *0.002 
Education < Standard 6 - 7 *0.013 
Education Standard 10 plus 0.583 
Self-reported activity level  
extremely active *0.002 
Moderately active *0.015 
Mild activity 0.873 
Sedentary  0.978 
Prior fragility fracture >40 years old *0.001 
Instrumental activity of daily living score *0.002 
Quality of life score *0.038 
Low haemoglobin *0.011 
Elevated white blood cell count *<0.0001 
Low albumin level *<0.0001 





4.3.2 Risk factor assessment in male and female hip fracture subjects  
4.3.2.1 Socio-demographic characteristics 
Age, gender and ethnicity 
Of the 200 hip fracture subjects, there were 56 men and 144 women.  Men were 
significantly younger; 70.7 ± 8.7 years vs. 75.7 ± 8.5 years; p < 0.0001 than women 
with hip fractures (Table 4.25). 
 
Social Status: employment, housing and education 
There was no difference in housing or employment between men and women 
fracture subjects. 
Women with hip fractures were significantly more likely than men to have had no 
formal education (40.3% vs. 28.6%; p = 0.006) or less than five years of education 
(35.4% vs. 25%; p = 0.006) whereas men were likely to have had at least a high 
school education (42.9% vs. 18.8%; p = 0.006) (Table 4.25). 
 
Anthropometric measures 
Although men with hip fractures were significantly taller than women with hip 
fractures, there was no significant difference in weight or BMI between men and 





weighed significantly less than their matched control subjects (56.4 ± 12.9 kg vs. 
74.7 ± 15 3 kg; p < 0.0001) for men and (54.1 ± 14.1 kg vs. 71.0 ± 16.5 kg; p < 
0.0001) for women respectively (Table 4.25). 
There was no difference in the mean BMI value between men and women hip 
fracture subjects.  Men and women with hip fractures compared to their matched 
control subjects had a significantly lower BMI values; (21.7 ± 4.5 kg/cm2 vs. 27.3 ± 
5.1 kg/cm2; p < 0.0001; OR 0.739, 95%CI 0.58-0.95) for men and (23.1 ± 6.0 kg/cm2 







Table 4.25 Baseline demographic characteristics in men and women with 
hip fractures 
 
  Men (n=56) Women (n=144) p-value 
Age (years) mean ± SD 70.7 ± 8.7 75.7 ± 8.5 *<0.0001 
Weight (kg) mean ± SD 56.4 ± 12.9 (n= 40) 
54.1 ± 14.1 
(n= 96) 0.392 
Height (cm) mean ± SD 160.3 ± 9.3 (n= 40) 
153.7 ± 8.4 
(n= 96) *<0.0001 
BMI (Kg/cm2 ) mean ± SD 21.7 ± 4.5 (n= 40) 
23.1 ± 6.0 
(n= 96) 0.709 
Education level n (%) 
No schooling  16 (28.6) 58 (40.3) 
*0.006 
< Std. 3  14 (25) 51 (35.4) 
Std. 6-7  24 (42.9) 27 (18.8) 
Std. 10 plus  2 (3.6) 8 (5.6) 
Hypertension n (%) 26 (46.4) 94 (65.3) *0.018 
Diabetes mellitus n (%) 10 (17.9) 47 (32.6) *0.024 
Arthritis n (%) 6 (10.7) 49 (34) *0.001 
Chronic back pain n (%) 3 (5.4) 11 (7.6) 0.572 
Osteoporosis n (%) 0 (0.0) 7 (4.9) n/a 
Rheumatoid arthritis n (%) 0 (0.0) 2 (1.4) n/a 
Malignancy n (%) 1 (1.8) 9 (6.3) 0.193 
Prolonged immobilization 
n (%) 1 (1.8) 5 (3.5) 0.53 
Glucocorticoids > 3/12  







4.3.2.2 Clinical risk factors 
Co-morbid diseases and secondary medical causes of osteoporosis 
Hypertension, diabetes and arthritis were significantly more common in women than 
men with hip fractures (Table 4.25).  A similar trend was seen with rheumatoid 
arthritis, malignancy, prolonged immobilization and the use of glucocorticoids, 
however this was not significantly different from men and the sample size was 
extremely small limiting the interpretation of results. 
Female control subjects compared to female hip fracture subjects had a significantly 
higher risk of hypertension (79.2% vs 65.3%; p = 0.004) and chronic back pain (19% 
vs 7.6%; p = 0.028) whereas malignancy was more common in hip fracture women 
than control women (6.3% vs 1.2%; p = 0.034), however the sample size numbers 
were too small to draw any significant conclusion. 
 
Cognitive changes 
While there was no difference in memory between men and women with hip 
fractures, women hip fracture subjects had greater memory concerns than matched 








Although the number of falls was similar in men and women with hip fractures, 
sideways falls were significantly more frequent in women fracture subjects than men 
(33.3 vs. 26.8%; p = 0.022) (Table 4.26).  The fall risk assessment however showed 
no significant differences in number of previous falls, visual or sensory disturbances, 
gait and balance, activity limitation due to fear of falling or painful joints between men 
and women hip fracture subjects. 
Similar to the main study, men and women control subjects were more likely to 
report near falls, needing help getting up after a potential fall, seeking medical 
attention after a fall, visual problems, problems with the lower limbs, gait, limitation of 
activities and medication problems than men and women hip fracture subjects.  
Additionally men hip fracture subjects were more likely not to use a walking aid than 
matched control men. 
 
Past history of fractures 
Although no difference was seen in the number or prior fragility fractures between 
men and women hip fracture subjects (Table 4. 26), women with hip fractures 
reported previous fragility fractures significantly more than women control subjects 
(29.9% vs. 11.8%; p < 0.0001; OR 2.857, 95%CI 1.56-5.25).  While 21.4% of men 





previous fragility fracture.  The sites of prior fractures were not different between 
men and women.  
 
Self-reported vertebral fractures 
There was no significant difference in men and women in previous self-reported VF. 
 
Family history of osteoporosis and maternal history of hip fractures 
A family history of osteoporosis or maternal history of fracture was only reported in 
women and not in men with hip fractures.  Seven women (4.9%) reported a family 
history of osteoporosis and 11 (7.6%) a maternal history of hip fracture. 
 
Lifestyle factors 
There was no difference in the duration of sunlight exposure, calcium intake or 
caffeine intake between men hip fracture subjects compared to woman hip fracture 
subjects. 
In the hip fracture group, men were significantly more likely than women to smoke 
(53.6% vs. 4.2%; p < 0.0001) and to be current consumers of alcohol (41.1% vs. 





Male hip fracture subjects were also more likely to smoke and consume alcohol 
compared to their matched control subjects (53.6% vs. 21.1%; p < 0.0001) and 
(41.1% vs.10.5%; p < 0.0001; OR 11.0, 95%CI 2.56-46.78) respectively. 
In the female group the total number who smoked or consumed alcohol was very 







Table 4.26 Clinical risk factors for osteoporosis and fractures in men and 
women hip fracture subjects 
  







Prior history of falls 26 (46.4) 64 (44.4) 0.8 
Sideways fall 15 (26.8) 48 (33.3) *0.022 
Fragility fracture >40 year 12 (21.4) 43 (29.9) 0.23 
Self-reported vertebral 
fracture 
1 (1.8) 1 (.7) 0.486 
Self-reported activity level 
Extremely active 19 (33.9) 56 (38.9) *<0.0001 
Moderately active 13 (23.2) 30 (20.8) *<0.0001 
Mildly active 21 (37.5) 44 (30.6) *<0.0001 
Sedentary 3 (5.4) 14 (9.7) *<0.0001 
Smoking 20 (53.6) 6 (4.2) *<0.0001 
Alcohol 23 (41.1) 8 (5.6) *<0.0001 
Calcium intake (mg/day) 
mean ± SD 
447.1 + 241.6 426.9 + 226.5 0.200 
Sunlight (minutes) 
mean ± SD 
40.5 + 75.1 28+47.6 0.100 






4.3.2.3 Bone mineral density 
There was no difference in the areal BMD, BMAD and T - scores at both the spine 
and hip between men and women fracture cases.  Surprisingly, given the expected 
finding of a higher BMD in males, all parameters of bone mass except hip BMAD 
were also comparable to the control cohort.  (Table 4.27). 
 
Table 4.27 Bone mineral density in men and women hip fracture subjects 
  







Spine aBMD (g/cm2) 
mean ± SD 
0.733 ± 0.144 
(n=31) 
0.689 ± 0.182 
(n=85) 0.234 
Femoral neck aBMD (g/cm2) 
mean ± SD 
0.516 ± 0.100 
(n=31) 
0.519 ± 0.109 
(n=83) 0.896 
Total hip aBMD (g/cm2) 
mean ± SD 
0.680 ± 0.134 
(n=31) 
0.640 ± 0.136 
(n=84) 0.168 
Spine BMAD (g/cm3) 
mean ± SD 
0.198 ± 0.031 
(n=31) 
0.200 ± 0.038 
(n=85) 0.455 
Hip BMAD (g/cm3) 
mean ± SD 
0.105 ± 0.02 
(n=31) 
0.123 ± 0.109 
(n=84) 0.841 
Hip T – Score 
mean ± SD 
-2.81 ± 0.82 
(n=31) 
-2.95 ± 0.86 
(n=84) 0.464 
Spine T – Score 
mean ± SD 
-2.93 ± 1.24 
(n=31) 
-3.01 ± 1.32 
(n=85) 0.782 
 
Compared to their matched controls, male hip fracture subjects had a significantly 
lower BMD at all sites (Table 4.28).  Similarly in women hip fracture subjects 
compared to their matched controls, the BMD was lower at all sites except for the hip 





Table 4.28 Bone mineral density in male hip fracture and male control 
subjects 
  









Spine aBMD (g/cm2) 
mean ± SD 
0.733 ± 0.144 
(n=31) 
0.919 ± 0.182 
(n=56) 
*<0.0001 
Femoral neck aBMD (g/cm2) 
mean ± SD 
0.516 ± 0.100 
(n=31) 
0.745 ± 0.144  
(n=55) 
*<0.0001 
Total hip aBMD (g/cm2) 
mean ± SD 
0.680 ± 0.134 
(n=31) 
0.907 ± 0.161 
(n=56) 
*<0.0001 
Spine BMAD (g/cm3) 
mean ± SD 
0.198 ± 0.031 
(n=31) 
0.248 ± 0.048  
(n=55) 
*<0.0001 
Hip BMAD (g/cm3) 
mean ± SD 
0.105 ± 0.02 
(n=31) 
0.146 ± 0.026 
(n=56) 
*<0.0001 
Hip T – Score 
mean ± SD 
-2.81 ± 0.82 
(n=31) 
-1.14 ± 1.23 
(n=55) 
*<0.0001 
Spine T – Score 
mean ± SD 
-2.93 ± 1.24 
(n=31) 













Table 4.29 Bone mineral density in women hip fracture and women control 
subjects 
  









Spine aBMD (g/cm2) 
mean ± SD 
0.689 ± 0.182 
(n=85) 
0.821 ±  0.177  
(n=144) 
*<0.0001 
Femoral neck aBMD (g/cm2) 
mean ± SD 
0.519 ± 0.109 
(n=83) 
0.699 ±  0.117  
(n=95) 
*<0.0001 
Total hip aBMD (g/cm2) 
mean ± SD 
0.640 ± 0.136 
(n=84) 
0.868 ±  0.163 
(n=144) 
*<0.0001 
Spine BMAD (g/cm3) 
mean ± SD 
0.200 ± 0.038 
(n=85) 
0.242 ±  0.038 
(n=144) 
*<0.0001 
Hip BMAD (g/cm3) 
mean ± SD 
0.123 ± 0.109 
(n=84) 
0.142 ±  0.024 
(n=144) 
0.106 
Hip T – Score 
mean ± SD 
-2.95 ± 0.86 
(n=84) 
-1.31 ±  1.26 
(n=144) 
*<0.0001 
Spine T – Score 
mean ± SD 
-3.01 ± 1.32 
(n=85) 









4.3.2.4 Morphometric vertebral fractures 
There was no difference in the number of morphometric VF between men and 
women hip fracture subjects.  Due to the small numbers the severity or site of 
fractures between the two groups was not compared. 
 
4.3.2.4 Functional assessment  
Physical self-maintenance scale 
No significant differences were noted in the performance of daily activities between 
men and women hip fracture subjects, except that men were more likely to be unable 
to eat independently prior to having had the hip fracture (7.1% vs. 0.7%; p = 0.009).  
Male fracture subjects compared to their matched control subjects had greater 
difficulty with eating and dressing.  In contrast women hip fracture subjects pre-
fracture compared to their matched controls had greater difficulty in all the domains 
of PSMS apart from eating and transferring (Appendix 4.A, Table 4.A.1). 
 
Instrumental activity of daily living 
There was no difference in the ability to perform individual activities or in the total 
score of the Lawton’s IADL between men and women hip fracture subjects.  





fracture subjects were significantly more likely to be unable to complete all IADL 
tasks independently and had lower scores (Appendix 4.A, Table 4.A.2). 
 
Quality of Life 
There was no significant difference in the QoL total score between men and women 
subjects with hip fractures, but both men and women with hip fractures compared to 
their respective matched cohort had a lower QoL score.  Both men and women hip 
fracture subjects had greater difficulty with mobility and self-care compared to their 
matched control subjects. In addition male fracture subjects compared to their 
matched controls were more likely to have a depressed mood, whilst female hip 
fracture subjects reported greater pain compared to women control subjects 
(Appendix 4.A, Table 4.A.1). 
 
Oswestry disability index 
Women with hip fractures were more likely to be unable to lift objects (77.8% vs. 
57.1%; p = 0.004) and walk a distance (58.3% vs. 39.3%; p = 0.015) compared to 
men with hip fractures, but there was no difference in their total percentage score. 
Women fracture subjects had greater difficulty compared to women control subjects 
in all parameters apart from personal care, walking distance and standing.  Men hip 






Visual analogue scale 
There was no difference in the VAS score between men and women with hip 
fractures but the pre-fracture VAS score was lower in both male and female hip 
fracture subjects compared to their matched control subjects (Appendix 4.A, Table 
4.A.4). 
 
4.3.2.6 Haematological and Biochemical Comparison 
Similarly the haematological and biochemical results were also not remarkably 
different in men and women with hip fractures except for the haemoglobin level and 
GGT which although within the normal range, was significantly higher in men (11.9 ± 
2.4 g/dl vs. 11.1 ± 1.7 g/dl; p = 0.026) and (60.5 ± 60 IU/L vs. 40.2 ± 36.4 IU/L, p = 
0.021) respectively (Table 4.30). 










11.9 + 2.4 
(n=56) 
11.1 + 1.7 
(n=144) *0.026 
25 (OH) Vitamin D 
(nmol/L) 
34.7 + 21.3 
(n=48) 




60.5 + 60 
(n=55) 
40.2 + 36.4 
(n=143) *0.021 
Glucose (nmol/L) 6.3 + 1.9 (n=43) 
7.2 + 3.8  
(n=132) 0.135 





The mean glucose was significantly higher in hip fracture women than control 
women, but no difference was seen in male subjects.  These were random blood 
glucose values and the relevance of the difference in the means is uncertain given 
that were a number of subjects with diabetes.  Both men and women hip fracture 
subjects had a higher GGT than matched control subjects, and no difference was 
seen in vitamin D or PTH levels (Table 4.31). 
 
Table 4.31 Biochemical results in men and women fracture and matched 
controls 
 Male Subjects Female subjects 
  Hip fracture Control p-value 
Hip 





60.5 ± 60 
(n=55) 
31.8 ± 24 
(n=56) *0.001 
40.2 ± 36.4 
(n=143) 






6.3 ± 1.9 
(n=43) 
5.8 ± 1.9 
(n=56) 0.244 
7.2 ± 3.8 
(n=132) 





34.7 ± 21.3 
(n=48) 
51.7 ± 21.7 
(n=56) *0.003 
40.5 ± 22.7 
(n=123) 







5.8 ± 3.7 
(n=43) 
7.6 ± 6.7 
(n=56) *0.084 
7.1 ± 3.7 
(n=115) 
7.6 ± 4.8 
(n=144) 0.67 





4.3.3 Risk assessment in African and Indian hip fracture subjects. 
Of the 200 hip fracture subjects, 66 were African and 110 Indian.  Their socio-
demographic characteristics, CRF, fall risk, BMD and laboratory measurements were 
compared.  In view of their small number, White (n= 21) and Coloured (n= 3) patients 
with hip fractures were not included in the comparison. 
 
4.3.3.1 Socio-demographic characteristics 
Age, gender, housing, employment and education 
There was no significant difference in housing, employment, age, gender ratio or 
education levels between Indians and African hip fracture subjects, despite a higher 
number of Africans having no schooling compared to Indians (50% vs. 35.5%; p = 
0.12).  Indian and African control subjects had a significantly higher level of 
education compared to matched hip fracture subjects. 
 
Anthropometric measures 
Although Indian hip fracture subjects had a significantly lower mean body weight 
compared to African hip fracture subjects (51.9 ± 11.4 kg vs. 56.8 ± 13.3 kg; p = 
0.034), there was no difference in height or BMI between Indians and Africans (Table 
4.32).  Both Indian and African subjects with hip fractures weighed significantly less 





0.893; 95%CI 0.84-0.95) and (56.8 ± 13.3 kg vs. 80.7 ± 16.8 kg; p < 0.0001; OR 
0.916; 95%CI 0.86-0.97) respectively. 
 







(n=110) p value 
Age (years) 
mean ± SD 
74.5 ± 9.9 
(n=45) 
73.4 ± 7.9 
(n= 76) 0.416 
Weight (kg) 
mean ± SD 
56.8 ± 13.3 
(n= 45) 
51.9 ± 11.4 
(n= 76) *0.034 
Height (cm) 
mean ± SD 
157.1 ± 8.1 
(n= 45) 
153.6 ± 9.9 
(n= 76) 0.072 
BMI (kg/cm2) 
mean ± SD 23.2 ± 5.7 21.9 ± 4.2 0.317 
Diabetes mellitus  
n (%) 14 (21.2) 40 (36.4) *0.028 
Arthritis n (%) 12 (18.2) 38 (34.5) *0.014 
 
Similarly Indian and African hip fracture subjects had a lower BMI than their  
matched control subjects (21.9 ± 4.2 kg/cm2 vs 27.6 ± 5.0 kg/cm2; p < 0.0001) and 
(23.2 ± 5.1 kg/cm2 vs. 27.4 ± 5.1 kg/cm2; p < 0.0001) respectively.  While there was 
no difference in height between Africans, Indian fracture subjects were significantly 
shorter than their matched Indian controls (153.6 ± 9.9 cm vs. 155.8 ± 10.2 cm; p = 






Table 4.33 Baseline characteristic in African and Indian hip fracture subjects 
compared to matched control subjects 
 All results reported as mean  
 
4.3.3.2 Clinical risk factors 
Comorbid diseases and secondary medical causes of osteoporosis 
Diabetes mellitus and arthritis were significantly more common in Indian fracture 
subjects compared to African fracture subjects. Although African fracture subjects 
had a higher frequency of hypertension compared to Indian fracture subjects this 
was not significant.  There were no other significant differences in secondary medical 
conditions between Indian and African hip fracture subjects.  The profile of chronic 



















56.8 ± 13.3 80.7 ± 16.8 *<0.0001 51.9 ± 11.4 67 ± 14.1 *<0.0001 
Height 
(cm) 









findings but in Indians only diabetes mellitus and chronic back pain were significantly 
more common in control subjects than Indian fracture subjects. 
 
Gynaecological history and use of hormone replacement therapy 
There was no significant difference between Indian and African fracture subjects 
regarding age of menarche, menopause or parity and no difference in the use of 
hormone replacement between Indian and African hip fracture subjects, however the 
numbers were very small for meaningful comparison. 
 
Cognitive changes 
Although there was no difference in memory between Indian and African hip fracture 




On history there was a higher number of self-reported falls in Indian compared to 
African hip fracture subjects (Table 4.34), but no difference in the number of 
sideways falls.  In the EFST, Indian fracture subjects were more likely to report falls, 





limitation due to pain.  However, there was no significant difference in the number of 
near falls, visual or sensory disturbances and gait and balance abnormalities.  
Both Indian and African control subjects compared to their matched hip fracture 
subjects reported a greater number of near falls, activity limitation due to a fear of 
falling, concerns about uneven footing, use of higher number of prescription 
medications and easily fatigability.  In addition African control subjects compared to 
African hip fracture subjects were significantly more likely to have reported a fall, 
sought health care after a fall, have had more pain and concerns regarding transfer.  
Indian control subjects compared to Indian hip fracture subjects reported greater 
visual impairment and were more likely to report that they would need assistance to 
stand if they fell. 
 
Past history of fractures 
Childhood fractures were more common in Indian than African hip fracture subjects 
(Table 4.34); however there was no difference in number of previous fragility 
fractures.  Additionally Indian and African hip fracture subjects reported previous 
fragility fractures significantly more commonly than their matched controls (25.5% vs. 
7.78%; p < 0.0001; OR 3.375, 95%CI 1.53-7.43) and (22.7% vs. 9.6%; p = 0.038; 







Self-reported vertebral fractures 
There was no difference in the number of self-reported VF. 
 
Family history of osteoporosis and maternal history of hip fractures 
A family history of osteoporosis or fracture was not different between Indian or 
African hip fracture cases but Indian control subjects had a significantly greater 
history of both conditions than Indian fracture subjects. 
 
Lifestyle factors 
Hip fracture subjects, Indians and Africans, were significantly more active than their 
matched control subjects (38.2% vs. 12.5%; p < 0.0001; OR 8.679, 95%CI 2.45-
30.73) and (34.8% vs. 11%; p < 0.0001; OR 4.949, 95%CI 1.34-18.31), and Indian 
hip fracture subjects were more likely to exercise for more than 30 minutes a day 
compared to African hip fracture subjects (47.3% vs. 14.4%; p < 0.0001) (Table 
4.34). 
Calcium intake was significantly lower in African than in Indian hip fracture subjects 
(346.4 ± 209.3 mg/day vs. 458.6 ± 214.2 mg/day; p = 0.005) (Table 4.34).  African 
hip fracture subjects also had significantly lower calcium intake than their matched 





Although there was no difference between Indian and African hip fracture subjects 
with regards to sunlight exposure, alcohol consumption or smoking, Indian fracture 
subjects were more likely to consume alcohol compared to Indian control subjects 
(18.2% vs. 4.8%; p = 0.004; OR 7.0, 95%CI 1.59-30.8). 
 
Table 4.34 Clinical risk factors for osteoporosis and fractures in African 
and Indian hip fracture subjects. 





History of falls 21 (31.8) 56 (50.9) *0.013 
Sideways falls 15 (22.7) 40 (36.3) 0.594 
Childhood fracture 21 (31.8) 56 (50.9) *0.013 
Fragility fracture 
>40 year 
15 (22.7) 40 (36.4) 0.967 
Self-reported 
vertebral fracture 
3 (4.5) 2 (1.8) 0.292 
Self-reported physical activity level 
Extremely active 23 (34.8) 42 (38.2) *<0.0001 
Moderately active 23 (34.8) 32 (29.1) *<0.0001 
Mild activity 13 (19.7) 27 (24.5) *<0.0001 
Sedentary 7 (10.6) 9 (8.2) *<0.0001 
Smoking 10 (15.2) 22 (20) 0.522 
Alcohol 8 (12.1) 20 (18.2) 0.087 
Calcium (mg) 
mean ± SD 
346.4 ± 209.3 458.6 ± 214.2 *0.005 





4.3.3.3 Bone mineral density 
Areal BMD measurements tended to be higher in African fracture cases, but reached 
statistical significance for total hip measurement only (Table 4.35).  Interestingly, the 
BMAD finding in the two ethnic groups was similar. 
 
Table 4.35 Bone mineral density in African and Indian hip fracture subjects. 





Spine BMD (g/cm2) 0.715 ± 0.166 
(n=39) 





0.545 ± 0.104 
(n=41) 
0.505 ± 0.104 
(n=63) 
0.120 
Total hip BMD 
(g/cm2) 
0.692 ± 0.147 
(n=41) 





0.192 ± 0.034 
(n=39) 





0.113 ± 0.019 
(n=41) 
0.126 ± 0.122 
(n=63) 
0.286 
Hip T - Score 
-2.73 ± 0.61 
(n=41) 
-2.96 ± 0.92 
(n=63) 
0.185 
Spine T - Score 
-3.10 ± 1.43 
(n=39) 
-3.03 ± 1.24 
(n=67) 
0.800 
 All result reported as mean ± SD 
Both African and Indian fracture subjects when compared to their matched control 





significant difference in the hip BMAD measurements between fracture and control 
subjects (Table 4.36). 
 
Table 4.36 Bone mineral density in African and Indian hip fracture and 



















0.686 + 0.176 
(n=67) 





0.545 ± 0.104 
(n=41) 
0.731 ± 0.13 
(n=65) 
*<0.0001 
0.505 ± 0.104 
(n=63) 





0.692 ± 0.147 
(n=41) 
0.893 ± 0.154 
(n=66) 
*<0.0001 
0.63 ± 0.129 
(n=63) 
















0.113 ± 0.019 
(n=41) 
0.145 ± 0.023 
(n=64) 
*<0.0001 
0.126 ± 0.122 
(n=63) 
0.143 ± 0.026  
(n=109) 
0.229 
Hip T score 
-2.73 ± 0.61 
(n=41) 
-1.2 ± 1.31 
(n=66) 
*<0.0001 
-2.96 ± 0.92 
(n=63) 





-3.10 ± 1.43 
(n=39) 
-1.19 ± 1.64 
(n=66) 
*<0.0001 










4.3.3.4. Morphometric vertebral fractures 
Morphometric VFs were significantly greater in African than Indian hip fracture 
subjects (37.5% vs. 28.6%; p < 0.0001).  Both Indian and African hip fracture 
subjects had significantly greater number of morphometric fractures than matched 
controls (28.6% vs. 17.8%; p < 0.0001) and (37.5% vs. 22.7%; p = 0.002) 
respectively. 
 
4.3.3.5 Functional Assessment 
Physical self-maintenance scale and Instrumental activity of daily living 
There was no significant difference between Indian and African hip fracture subjects 
in the individual basic activities of daily living or the total scores for PSMS or IADL.  
However Indian hip fracture subjects compared to African hip fracture subjects were 
more likely to have difficulty with using a telephone, walking a distance, cooking and 
handiwork (Table 4.37). 
Both Indian and African hip fracture subjects had significantly poorer overall total 
PSMS and IADL cores compared to their matched control subjects.  Indian fracture 
subjects, although reported being more active than matched control subjects, had 
significantly greater difficulties with most physical activities except for eating and in 
all the IADL parameters (Appendix 4.B, Table 4.B.1).  Whereas African hip fracture 
subjects had similar IADL activities compared to control subjects except for cooking, 





Table 4.37 Independent performance of instrumental activities of daily 







Telephone (%) 42.4 59.1 *0.032 
Walking a distance 
(%) 
45.5 60.9 *0.046 
Shopping (%) 21.8 44.5 0.095 
Cooking (%) 31.8 50.9 *0.013 
Housework (%) 51.5 65.5 0.067 
Handiwork (%) 40.9 58.2 *0.026 
Laundry (%) 21.2 18.2 0.593 
Medication (%) 22.7 225.5 0.684 
Finance (%) 15 32 0.356 
Total score  
mean ± SD 
22.7 ± 5 21.6 ± 4.7 0.148 
 Percent of subjects with 0 (unable to perform activity) 
 Pre-fracture evaluation 
 
 
Quality of Life 
The only difference between Indian and African hip fracture subjects was Indians 
were less likely to be able to complete daily activities independently (40.9% vs 
25.8%; p = 0.042). 
Indian hip fracture subjects had a higher QoL total score, depressed mood, pain, 
difficulty with mobility and self-care than Indian control subjects.  In contrast African 





latter were more likely to require assistance with daily tasks (Appendix 4.B, Table 
4.B.3). 
 
Oswestry Disability Index and Visual Analogue Score 
Indian hip fracture subjects had a higher percentage ODI score (p= 0.043) and had 
greater difficulty with personal care (59.1% vs 42.4%; p = 0.032) compared to African 
subjects  The VAS score pre or post fracture for pain was not significantly different 
between Indian and African fracture subjects. 
African hip fracture subjects had a lower ODI and VAS score than African controls. 
Indian hip fracture subjects compared to Indian control cases however had 
significantly higher ODI score (p =0.006), but also lower VAS pain score.  They also 
needed help with lifting, had a disturbed sleep pattern and difficulty with socializing 
and travel pre-fracture compared to their matched controls (Appendix 4.B, Table 
4.B.4). 
 
4.3.3.6 Haematological and biochemical comparison 
African fracture subjects had significantly higher mean sodium (however this was 
within the normal range), mean urea and mean random glucose levels compared to 
Indian fracture subjects. While Indian fracture subjects had a higher CRP level 
(Table 4.38).  There was no significant difference in vitamin D, PTH or hormonal 













Sodium (mmol/L) 137 ± 5.3 135.3 ± 4.2) *0.017 
Urea (mmol/L) 8.6 ± 5.8 6.8 ± 4.2 *0.033 
Glucose (mmol/L) 
7.3 ± 4.3 
(n=55) 





19.2 ± 25.9 
(n=59) 
30.7 ± 36.8 
(n=101) 
*0.022 
Vitamin (OH) D (nmol/L) 
39.7 ± 22.6 
(n=56) 
38.9 ± 24 
(n=95) 
0.823 
 All results reported as mean ± SD 
 
There was a significantly lower mean total protein (71.9 ± 12.8 g/L vs. 74.7 ± 5.2 g/L; 
p = 0.001) and higher mean random plasma glucose (6.3 ± 1.6mmol/L vs. 5.9 ± 
1.9mmol/L; p = 0.004) in Indian fracture subjects compared to their matched control 


































71.3 ± 8.6) 75.2 ± 5.9 (n=65) 0.151 
71.9 ± 12.8 







26.8 ± 19.4 
(n=65) *0.002 
48.4 ± 42.7 
(n=108) 32.1 ± 22.4 *0.001 
Glucose 
(nmol/L) 
7.3 ± 4.3 
(n=55) 
5.9 ± 1.9 
(n=65) 0.367 
6.3 ± 1.6 




39.7 ± 22.6 
(n=56) 49.2 + 23.7 *0.004 
38.9 ± 24 




6.3 ± 3.9 
(n=51) 
7.3 + 7.8 
(0.8-74) 0.081 
7.5 ± 3.7 
(n=108) 9.5 ± 6.9 0.407 






4.4 Outcomes post hip fracture 
Of the 200 subjects who participated in the one year prospective study, by the end of 
the study period 67 subjects (36.4%) had died and 16 (8%) were lost to follow up, 
either because they had opted out of the study or could not be contacted.  The 
remaining 117 subjects (58. 5%) completed the one year follow up. 
 
4.4.1 Acute hip fracture management 
The majority of the subjects (72%) had presented directly to one of the regional level 
hospitals after a fall.  Of the remainder, 9.5% presented to a local district hospital or 
a clinic and 9% to their primary care physician before being referred to the regional 
hospital. 
Indian and White subjects were more likely to go directly to a regional hospital, 
75.5% and 71.4% respectively or to have gone initially to a private health care 
provider, 8.2% and 23.8% respectively.  Africans subjects presented either to the 
regional hospital (65.2%), or to a public health sector clinic (19.7%). 
There was a wide variance in the time to admission after the hip fracture with a mean 
of 4.2 ± 2 days (range 0 - 122 days).  Similarly the mean time to surgery was 11.3 ± 
9.2 days (range 1 – 75 days) and the mean length of stay was 21.9 ± 14.8 days 





All subjects received skin traction and pre-operative physiotherapy.  Surgical 
management was undertaken in 173 subjects (86.5%) with spinal anaesthesia being 
most commonly used. 
The choice of prosthesis was determined by fracture type and the attending 
surgeon’s choice and there is no restriction placed on choice.  Most commonly used 
were a pin and plate in 64 subjects (37%) and a bipolar prosthesis in 60 subjects 
(34.7%).  The rest had either a Thompson’s prosthesis (15.6%) or a femoral nail 
(12.7%) inserted.  One subject died during surgery and data was not available for 
three subjects. 
Twenty seven subjects (13.5%) were considered unfit for surgery based on 
underlying medical conditions and not fracture severity and managed conservatively. 
 
4.4.2 Mortality rate 
At the end of one the year study period 67 subjects (36.4%) had died.  The mortality 
rate was highest in the first month with 26 deaths (13%) which accounted for 38.8% 
of all mortality.  At three months and six months a further 9 (4.5%) and 17 (8.5%) 
subjects died respectively and from months seven to 12, a further 15 (7.5%) had 
died (Figure 4.13). 
A tendency towards a higher overall mortality was noted in men compared to women 





fracture subjects had significantly higher mortality than Indians during the one year 
study period (Figures 4.14 and 4.15). 
The highest percentage of deaths was seen in African women 20 (46.5%), followed 
by Indian men 14 (45.1%), African men 7 (36.8%), White women 5 (31.3%) and 14 











Figure 4.13 Kaplan Meier curve showing a decrease in survival with time in the 
total hip fracture subjects over a twelve month period (n=184) 














Figure 4.14 Kaplan Meier curve for survival in men (n = 49) and women (n = 





















Figure 4.15 Kaplan Meier curve for survival in African (n = 62), Indian (n = 136), 
Coloured (n = 3) and White (n = 17) hip fracture subjects over a twelve month 
period 
 





4.4.2.1 Demographic and clinical characteristics of deaths in hip fracture 
subjects. 
In univariate analysis, deaths at one year were older (76.2 ± 9.7 years vs. 73.4 ± 8.2 
years; p = 0.048), had a significantly lower mean body weight (51.0 ± 10.8 kg vs. 
56.7± 14.9 kg; p = 0.036; OR 1.036 CI 1.0-1.21) and mean BMI (21.2 ± 4.2 kg/cm2 
vs. 23.2 ± 5.1 kg/cm2; p = 0.037; OR 1.101 CI 1.0-1.21) compared to survivors 
(Table 4.30).  It is noteworthy that of the 67 hip fracture subjects who died, weight 
could not be measured in 30 (44.8%) subjects due to severity of hip fracture and 
inability to stand unassisted at the time of discharge.  There is therefore a significant 
association between missing weight and the outcome death (p = 0.001).  
Furthermore weight was not measured in 28 (23.9%) of the survivors.  
Although hip fracture subjects had a lower education level than control subjects, 
deaths at one year were more likely to have a better education level compared to 
those who survived.  No differences were noted in housing or employment status 
No significant difference was observed in the prevalence of chronic cardiovascular 
disease (hypertension and DM) amongst deaths at one year and survivors.  Although 
only 7 subjects had a prior history of osteoporosis, 5 of these subjects died (p = 
0.052; OR 9.355, 95%CI 1.07-81.85), this did not reach statistical significance.  
There was no significant association between mortality and other secondary causes 
of osteoporosis (RA, chronic gastro intestinal disease, hyperthyroidism, 





chronic renal failure).  The use of bone toxic drugs including GC was not significantly 
different amongst the two groups. 
Hip fracture subjects with a higher self-reported physical activity levels were more 
likely to survive compared to those who were mildly active or sedentary.  There were 

















Table 4.40 Characteristics of hip fracture subjects who died or survived at 12 
months 













mean ± SD 
73.6 ± 8.0 
 
75.3 ± 8.6 *0.048 n/a  
Weight (kg) 
mean ± SD 
56.7 ± 14.9 
(n= 92) 
51.0 ± 10.8 
(n=37) 
*0.036 1.036 1.00 - 1.07 
BMI (kg/cm2) 
mean ± SD 
23.3 ± 5.4 21.2 ± 4.2 0.037 1.102 1.00 - 1.21 
Education level n (%) 
1:Reference category Std. 10 plus 
No schooling 41 (35%) 26 (38.8%) *<0.0001 6.308 1.24 - 32.05 
Std. 3 or lower  43 (36.8%) 20 (29.9%) *<0.0001 8.6 1.67 - 44.24 
Std. 6-7 31 (26.5%) 13 (19.4%) *<0.0001 9.538 1.78 - 51.15 
Std. 10 plus 2 (1.7%) 8 (11.9%) 0.168 1 1 
Self-reported activity level n (%) 
1 :Reference category sedentary 
Extremely 
active 
47 (40.2%) 22 (32.8%) *<0.0001 2.403 0.82 - 7.07 
Moderately 
active 
28 (23.9%) 14 (20.9%) *<0.0001 2.25 0.71 - 7.09 
Mildly active 34 (29.1%) 22 (32.8%) *<0.0001 1.739 0.58 - 5.19 
Sedentary 8 (6.8%) 9 (13.4%) *0.002 1 1 
Morphometric 
VF 







4.4.2.2 Functioning level 
Compared to survivors, subjects who died had significantly greater difficulty with 
performing most of the basic activities of daily living (PSMS) and a lower total PSMS 
score (Table 4.41), but the difference only neared significance (p=0.062). 
 
Table 4.41 Independent performance of basic activities of daily living in 








Eating (%) 0.0 7.5 *0.003 
Dressing (%) 6.8 14.9 0.076 
Grooming (%) 6.8 17.9 *0.020 
Walking (%) 11.1 22.4 0.076 
Transfer bed (%) 4.3 17.9 *0.002 
Bathing (%) 7.7 16.4 0.067 
Toileting (%) 8.5 3.4 0.295 
Total score 
mean ± SD 
13.5 ± 1.6 12.9 ± 2.5 0.062 
 Total score calculated out of 17 
  (%) of subjects with a score of 0 (unable to perform activity independently) 
 Assessment done pre-fracture in hip fracture subjects 
 
The total IADL score was significantly in hip fracture cases that survived than those 





walking distance, shopping, cooking, taking medication and managing finances 
independently (Table 4.42). 
Table 4.42 Independent performance of instrumental activities of daily 








Telephone (%) 48.7 61.2 0.103 
Walking distance 
(%) 
48.7 67.2 *0.015 
Shopping (%) 34.2 52.2 *0.016 
Cooking (%) 39.3 56.7 *0.023 
Housework (%) 58.1 67.2 0.225 
Handiwork (%) 48.7 59.7 0.151 
Laundry (%) 15.4 26.9 0.052 
Medication (%) 18.8 32.8 *0.032 
Finances (%) 21.4 35.8 *0.033 
IADL Score 
mean ± SD 
22.5 ± 4.6 20.9 ± 5.1 *0.036 
 Total score calculated out of 27 
  (%) of subjects with a score of 0 (unable to perform activity independently) 









The total ,QoL, ODI and VAS scores were similar between hip fracture cases that 
survived and those who died at 12 months, except survivors had better mobility (p = 
0.01) and lifting ability (p = 0.045) (Table 4.43 and 4.44). 
 
Table 4.42 Independent performance of QoL activities in survivors and 
deaths in hip fracture subjects at 12 months 






Mobility (%) 6.8 19.4 *0.010 
Self-care (%) 32.5 41.8 0.205 
Daily activities (%) 31.6 32.8 0.865 
Pain (%) 14.5 14.9 0.942 
Mood (%) 23.9 16.9 0.658 
QOL Score 
mean ± SD 
6.2 ± 1.7 6.5 ± 1.7 0.15 
 Total score calculated out of 15 
  (%) of subjects with a score of 0 (unable to perform activity independently) 











Table 4.43 Independent performance of ODI activities and VAS for pain in 








Pain (%) 7.7 11.9 0.338 
Personal care 52.1 61.2 0.234 
Lifting (%) 19.7 32.8 *0.045 
Walking (> 1km) (%) 2.6 9 0.053 
Sitting (>1 hour) (%) 10.3 13.4 0.514 
Standing (%) 2.6 4.5 0.482 
Sleeping (%) 12.0 19.4 0.178 
Social life (%) 13.7 17.9 0.442 
Travelling (%) 13.7 17.9 0.442 
Oswestry Disability 
Score (%)  
mean ± SD 
33.5 ± 17.1 29.7 ± 14.4 0.107 
VAS pre-fracture 
mean ± SD 
1.4 ± 1.3 1.4 ± 1.3 0.711 
VAS immediately 
post-fracture  
mean ± SD 
5.5 ± 1.9 5.7 ± 1.8 0.619 
 VAS calculated out of 10 
  (%) of subjects with a score of 0 (unable to perform activity independently) 






4.4.4.3 Haematological and biochemical differences in survivors and deaths at 
12 months post hip fracture 
Subjects who died (investigations at time of fracture) had a significantly higher serum 
urea, creatinine levels and GGT levels while their serum total protein, albumin and 
vitamin D levels were significantly lower. (Table 4.45) 
In addition the inflammatory markers, CRP and ESR were significantly higher in the 
subjects who died (Table 4.45). 
 
Table 4.45 Biochemical parameters in survivors and deaths in hip fracture subjects 
at 12 months 
  Survivors (n=117) 
Deaths 
(n=67) p-value OR 95% CI 
Sodium (mmol/L) 136.4 ± 3.8 135.9 ± 4.8 *0.027 1.083 1.01 - 1.16 
Urea (mmol) 7.0 ± 3.9 9.1 ± 6 *0.010 0.917 0.86 - 0.98 
Creatinine (umol) 90.6 ± 47.9 107.8 ± 65.1 0.062 0.994 0.99 - 1.00 
Total protein 
(g/dl) 
72.4 ± 8.4 
(n=116) 68.9 ± 10.5 *0.014 1.043 1.01 - 1.08 
Albumin (g/dl) 36.1 ± 6.4 (n=116) 28.8 ± 7.9 *<0.0001 1.187 1.12 - 1.26 
Gamma glutamyl 
transferase (IU/L) 
39.7 ± 41.5 
(n=116) 55.8 ± 49.7 *0.020 0.992 0.99 - 1.00 
25 (OH) vitamin D 
(nmol/L) 
41.6 ± 23.4 
(n=110) 
33.0 ± 20.5 
(n=50) *0.025 1.02 1.00 - 1.04 
C-Reactive 
protein (mg/L) 
17.4 ± 28.1 
(n=113) 
39.4 ± 36.1 




39.2 ± 27.2 
(n=105) 
52.1 ± 30.4 
(n=47) *0.010 0.985 0.97 - 1.00 






Surgery was performed significantly more frequently in survivors than in deaths at 
one year (90.6% vs. 80.6%; p = 0.045; OR 2.320 CI 0.98-5.52) and hip fracture 
subjects managed conservatively had a significantly higher mortality (59.3% vs. 
40.7%; p = 0.004). 
There was significant greater delay in time to surgery in demised subjects (13.9 ± 
12.6 days vs. 10.1 ± 6.8 days; p = 0.039) whilst time to admission (4.0 ± 7 days vs. 
4.4 ± 14.7; p = 0.828) or duration of hospital stay (24.5 ± 16.8 days vs. 20.7 ± 13.5 
days; p = 0.131) was not significant in the univariate analysis. 
 
4.4.2.5 Predictors of mortality 
In a backward conditional logistic regression model ethnicity (Africans), lower body 
weight or BMI, higher education status, difficulty with cooking, taking medications or 
managing finances, decreased mobility, decreased albumin or raised C-reactive 






Table 4.46 Multivariate model for predictors of mortality 
 SE Wald p-value. 
Step 
12 
Ethnicity  8.815 *0.012 
African 1.129 4.671 *0.031 
Mean body weight  0.086 8.095 *0.004 
Mean body mass index 0.189 5.171 *0.023 
Education  > Std. 10  14.063 *0.003 
Education Std. 7 level 1.537 8.555 *0.003 
Education –primary school 1.397 8.875 *0.003 
Education no schooling 1.181 .029 0.865 
Ability to cooking 1.027 8.487 *0.004 
Ability to take medications 1.055 7.576 *0.006 
Manage finances 0.888 7.438 *0.006 
Mobility  0.939 7.355 *0.007 
Low albumin 0.073 6.930 *0.008 
Elevated C-reactive protein 0.012 8.735 *0.003 





4.4.3 Morbidity: One year outcome in hip fracture survivors  
The functional assessments (BADL, IADL, QoL, ODI and VAS), performed at 
baseline, three, six and twelve months in 117 hip fracture survivors were compared 
using the McNemar test (Figures 4.16 – 4. and Appendix 4.C). 
 
Physical Self Maintenance scale 
A significant deterioration in all basic activities of daily living was noted from pre-
fracture to three months. Subsequently most but not all parameters showed 
improvement but the negative change from baseline remained significant at one year 
for all parameters. 
The percentage of subjects who were unable to dress or groom independently 
increased from 6.8% to 21.4% by twelve months (p < 0.0001).  Prior to the hip 
fracture, 11.1% subjects were unable to walk independently, but at three months 
78.6% and at one year 43.5% of survivors needed assistance or were unable to 
walk.  A similar trend was seen with bathing and toileting.  At each time point the 







Figure 4.16 Comparison of percentage change in activities of daily living in 
survivors post hip fracture over a twelve month period (n=117).  All parameters 
were significant p < 0.0001 at three months, six months and one year 









Instrumental activity of daily living 
The ability in survivors to perform IADL also significantly declined at three months 
post hip fracture and although recovery was noted, at one year and this remained 
significantly lower than baseline at all-time points. (Figures 4.17 
 
 
Figure 4.17 Comparison of percentage change in IADL in survivors post hip 
fracture over a twelve month period (n=117).  All parameters were significant (p 






Quality of life 
At one year 33.3% were bed ridden or had problems with walking compared to 6.8% 
pre-fracture.  This trend was seen in all aspects assessed; only 19.7% were able to 
complete basic self-care activities, 34.2% had no difficulty with daily activities and 
pain increased significantly from 14.5% to 35% at the end of one year.  The total 
score was significantly higher compared to baseline at each time point (Figure 4.18) 
 
 
Figure 4.18 Comparison of percentage change in QoL activities, pain and 
mood in survivors post hip fracture over a twelve month period (n=117).  All 
parameters were significant (p < 0.0001) at three and six months and at one 
year compared to baseline, except pain which at one year showed no 





Oswestry disability index 
There was a significant decline in all domains assessed including, personal care, 
lifting, walking, sitting, standing and sleeping which was still significant at one year.  
There was marked limitation in social activities and travel with a decline from 86.3% 
to 19.7% at three months and at one year only 27.4% could independently travel or 
socialize (Figure 4.19). 
Visual Analogue Scale 








Figure 4.19 Comparison of percentage change in ODI activities in survivors 
post hip fracture over a twelve month period (n=117).  All parameters were 
significant (p < 0.0001) at three and six months and at one year compared to 
baseline, except walking which although significant was (p= 0.001) at one year 




4.5 Health care costs associated with acute hip fracture management in the 
public sector 
The costs of acute hip fracture were calculated in the modified bottom up approach 
for the admission and management of the 200 subjects enrolled in the prospective 
study.  The cost of treatment was sub-divided into its major components: acute ward 
costs, theatre costs and investigations performed.  The cost of prosthesis was 
determined. 














 *One patient died intraoperatively 
 
Ward expenses were computed, with the aid of the Finance department (DOH), 
using the average cost per day as determined for the financial year 2010 / 2011 and 
the KZN DOH Hospital fees manual 2011. 
Table 4.47 Direct costs of hip fracture treatment in surgically managed hip 
fracture subjects 
 
  Total cost in Rands Percentage Cost (%) 
Acute Ward Costs   
Ward costs (n=173) 11 056 073.64 87.9 
Staff costs    10 373 693.52 82.5 
Total Medications   190 904.73 1.5 
Ward costs / 
consumables   481 912.80 
3.8 
Distance - Paramedic 
64 
Patients 5 562.59 
 
Stationary 
(ZAR /patient 20.00 4 000.00 
 
Theatre costs    
Surgical costs (n=173)    
Theatre Meds / 
consumables   291 862.56 
2.3 
Theatre Other   349 044.00 2.8 
Investigations    
Radiology costs   304 495.00 2.4 
Other: 
Electrocardiogram/ 
Echocardiogram   38 105.00 
0.3 
Haematological and 
biochemical tests   218 270.27 
1.7 
Prosthesis (n=169)*   320 480.00 2.5 




Patients 1 250.00 
 
Total Cost   12 578 330.48  




Costs related to other resources were established from actual individual use.  The 
length of stay in orthopaedic wards was recorded.  In addition, number of days to 
surgery was documented for each patient and the total number of delayed days, with 
resultant costs, was calculated.  The average daily cost of in-hospital ward was R 
2560.06.  The average number of days before surgery was 10.7 days.  The number 
of days of delay for surgery was 1851 hospital bed days at a cost of R4 738 816 
(n=173 surgically managed subjects). 
The surgical procedure, operation, duration in minutes and type of implant used were 
reviewed.  The average cost incurred for one hour of operating time was calculated.  
This estimate accounts for staff time in theatre and patient recovery area, use of 
equipment, sterile services and expendable items including, those employed by the 
anaesthetic team.  The cost for the different types of implant was calculated and 
incorporated separately into the costing. 
All pathology, microbiology and radiological investigations performed were 
documented for each patient and frequency recorded.  Using this data the individual 
total cost incurred in the treatment of each patient was calculated. 
The normative cost of treating a hip fracture was calculated as per flow diagram in 
methodology (Section 3.13) based on ideal management of hip fracture subjects.  
The difference in costing based on a 7 day hospital stay using the same type of 





The detailed normative costing framework is attached in Appendix 3H. 
 
4.5.1 Comparative analysis normative versus actual costs 
  Normative Costing   
  Sample size  Total Cost (R) Cost per patient (R)   
  169 R 6 742 227.00 R 39 895.00   
  
   
  
  Actual Costing   
  Sample Total Cost (R) Cost per patient (R)   
  169 R 10 628 688.85 R 62 891.65   
          
 
Treatment with anti-osteoporotic drugs decrease hip fractures approximately by 36% 
[500].  The treatment could potentially have resulted in only 110 subjects having a 
hip fracture.  If we estimate that Zoledronic acid a yearly infusion costs R1534.00 
then treatment of the 173 subjects who had surgery with Zoledronic acid would have 




4.6 Summary of Results 
The main findings of this study were: 
 Of the 277 consecutive subjects admitted during the study period, the mean age 
was 75.9 ± 9.2 years and the female: male ratio was 2.8:1 with men being 
significantly younger than women (75.2 ± 9.3 years vs. 77.2 ± 8.8 years; p< 
0.001). 
 The highest number of hip fractures were seen in Indians (52.7%), followed by 
African (31.4%), Whites (13.4%) and lowest Coloureds (2.5%). 
 The crude incidence rate for minimal trauma hip fractures in the eThekwini 
public sector hospitals was 97.4/100 00.  The incidence rate for hip fractures 
increased with age in both men and women and a similar trend was seen in 
African, Indian and White women subjects. 
 In the univariate analysis the risk factors identified for hip fractures were a lower 
educational level, low body weight and body mass index, prior fragility fractures, 
sideways fall, memory impairment, morphometric vertebral fractures, higher 
physical activity levels, smoking alcohol consumption, poorer functional activity 
level, low vitamin D levels and low BMD.  The haematological and biochemical 
investigation showed hip fracture subjects had a lower haemoglobin, total 
protein and albumin, with raised inflammatory markers. 
 In the stepwise backwards Cox logistic regression model a prior fragility fracture 
(p = 0.001), higher pre- fracture physical activity levels (p = 0.002), lower BMI (p 




0.038) scores, haemoglobin (p = 0.011), albumin (p < 0.0001), white blood cell 
count (p < 0.0001) and C-reactive protein (p = 0.005) remained significant. 
 The majority of hip fracture subjects were managed surgically and the mean 
time to surgery was 11.3 ± 9.2 days (range 1 – 75 days). 
 A high mortality rate of 36.4% was recorded at one year.  
 In the univariate analysis, risk factors for mortality at one year included 
increasing age, lower body weight and BMI, higher educational level, lower 
physical activity levels, greater difficulty with functional activities and laboratory 
test found a higher serum urea, creatinine and GGT levels and inflammatory 
markers, CRP and ESR, while their serum total protein, albumin and vitamin D 
levels were significantly lower. 
 The predictors for mortality in the backwards stepwise multivariate logistic 
regression  model included ethnicity, education, mobility, ability to cook, take 
their medication, manage finances independently, length of hospitalization, 
lower albumin and elevated C-Reactive protein levels. 
 In survivors there was a significant decline in basic and instrumental activities of 
daily and quality of life in the first three months which persisted at one year. 
 Direct health costs were approximated to be R 62 891.65 per patient who was 




Chapter 5 Discussion 
5.1 Introduction 
Over the latter half of the 20th century there has been a rapid demographic transition, 
especially in developed countries.  With decreased fertility and death rates and 
increased longevity, the proportion of older persons has risen dramatically.  This has 
been largely due to an improvement in socio-economic conditions and public health 
care and advances in medicine.  However, this has also resulted in an increase in 
the prevalence and burden of NCDs, including osteoporosis.  Currently developed 
countries bear the osteoporosis burden and have the highest incidence of 
osteoporotic hip fractures.  Although hip fractures account for less than 20% of all 
fractures, they are an important barometer of the osteoporosis burden as they 
diminish quality of life and have the highest mortality rate [3].  The pathology, 
epidemiology and risk factors of osteoporosis have been extensively studied in 
developed countries, and the introduction of cost-effective intervention thresholds 
[343] have resulted in the stabilization or decline in age adjusted hip fractures rates 
in White postmenopausal women [312, 501]. 
Developing countries, which still have a relatively low LE, have little data or 
emphasis on osteoporosis or fractures [28].  However, with urbanization and secular 
changes the LE is increasing, and it is projected that the burden of hip fractures will 
move to developing nations of Asia, Latin America and Africa [90].  It is expected by 
the year 2050, 50% of all osteoporotic fractures will occur in Asia; while Africa will 




South Africa is classified as an upper middle income country and spends 
approximately 8.8% of its gross domestic product (GDP) on health care [502].  In its 
dual health care system, however, less than one in five households have medical 
insurance with the majority of individuals dependent on state health care [497, 503].  
There are limited epidemiological and health economic studies and accessing data 
from both sectors is challenging due to incorrect International Classification of 
Diseases (ICD) and procedure coding.  In addition, the vast majority of public 
hospitals are under resourced, paper based and tracing of records retrospectively is 
a difficult and onerous task. 
The South African multi-ethnic society, termed the “rainbow nation”, differs in many 
aspects including disease profiles.  It has been postulated that the risk for 
osteoporosis varies in the different ethnic groups due to differences in BMD, bone 
turnover rates and skeletal geometry [67, 69, 387].  Lower spine BMD, but higher 
femoral BMD has been reported in Africans compared to Whites [56, 68], while BMD 
has been reported to be similar in Whites and Coloureds [387].  More recently a 
lower BMD has been reported in Indian men and women compared to their African 
counterparts [71].  However there has only been one study on the incidence of hip 
fractures over 40 years ago which reported an extremely low incidence of hip 
fractures in Africans compared to Whites [39]. 
In view of the lack of data this study was undertaken to determine the incidence, 
demographic profile, risk factors, outcomes and health care costs in patients aged 60 
years and over with minimal trauma hip fractures in the public health sector of 




5.2 Demographic profile 
5.2.1 Age, gender and ethnicity 
This is the first study to report the demographic profile of multi-ethnic subjects with 
hip fractures presenting to the public sector in the eThekwini region of KwaZulu-
Natal.  Of the 277 subjects with hip fractures, 146 (52.7%) were of Indian descent, 
87 (31.4%) African, 37 (13.4%) Whites and 7 (2.5%) classified themselves as 
Coloureds (i.e. of mixed descent). 
The mean age of the total group was 75.9 ± 9.2 years; with the lowest mean age in 
Indian subjects (74.2 ± 8.08 years), followed by African subjects (76.5 ± 10.5 years) 
and the highest in Whites (80.2 ± 8.5 years).  The lower mean age in Indians 
subjects is consistent with an earlier study which showed that fractures in immigrant 
Indians in the UK occurred 10 - 15 years earlier than Whites [44, 370].  Studies from 
India have also reported a lower mean age [43].  Although Indians in SA and India 
may share genetic similarities, there are may be significant differences between 
Indians in residing in India and SA, due changes in diet from a predominantly 
vegetarian diet to a diet higher in animal protein, climate, and possible differences in 
physical activity levels, however there are no studies directly comparing the two 
population groups. 
Life expectancy in SA, is lower than developed countries, estimated to be 50.1 years 
for men and 52.1 years for women [504] (for the period to 2009 -2012) compared to 
77.3 years and 81 years for men and women respectively in the UK.  The lower 
mean age for hip fractures, is possibly due to a lower LE.  Another possible reason is 




especially women, return to rural areas to care for younger family members while 
economically active individuals remain in cities. 
The average age of the fracture subjects in this study was higher than other 
developing countries such as India, Latin America and rest of Africa where the mean 
age is usually less than 75 years [43, 47, 505].  The reasons for this are not clear as 
the population of eThekwini is predominantly young, with only 6.8% of the population 
being above the age of 60 years old, and the LE is lower than in India (62.8 years 
and 65.7 years for men and women, respectively) but similar to Latin America and 
other African countries [506].  There are limited hip fracture studies from Africa and 
most the recent published studies are from Morocco [47]. A similar average age has 
been reported from Morocco for hip fracture subjects (75.0 ± 10.7 years for women 
and 73.3 ± 11.0 years for men) [47], however it must be emphasized that there are 
significant differences in ethnicity, culture, diet, dress and lifestyles between Morocco 
and SA.  The reasons previously postulated for the lower mean age in the few 
studies from Africa include under-reporting of cases, conservative management at 
home of older frail individuals, lack of access to health care and greater use of 
traditional healers may not apply in an urban environment in possibly a relatively 
better developed SA [37, 48, 50]. 
The younger age of men in the total hip fracture cohort (75.2 ± 9.3 years vs. 77.2 ± 
8.8 years; p < 0.0001), largely due to the predominance of Indian men in this cohort 
who were younger (70.1 ± 6.7 years vs. 75.8 ± 8.1 years; p < 0.0001), was highly 
significant.  Men were more likely to have a fracture before the age of 75 years than 
women (64.4%% vs. 35.3%; p < 0.0001).  The latter difference although significant in 




significance in the African fracture cohort (56% vs. 33.9%; p = 0.058).  Although it is 
traditionally believed that men are more likely to fracture at an older age, this study 
supports  recent studies that have shown that men fracture three to six years before 
women [507, 508]. 
There are no recent studies from SA to compare differences in age in men and 
women with hip fractures.  The mean age for Africans with hip fractures in this study 
was higher than in the landmark Solomon study [39] and the smaller study by 
Schnaid et al., [53], however these studies enrolled subjects from the age of 30 and 
45 years respectively and cannot be used for comparison.  The latter study also 
excluded subjects with osteoporosis, so possibly older subjects with hip fractures 
were excluded [53]. 
The total number of Coloured and Whites subjects were small and the study was not 
powered to draw any conclusions regarding age differences, however White women 
had the highest mean age at 80.6 ± 8.4 years which is comparable to White women 
in Europe [508]. 
In this study, the gender ratio of female to male at 2.8:1, was similar to that in 
developed countries, were 70 - 75% of hip fracture are seen in women [3].  This ratio 
may however be exaggerated by the absence of White men in this study.  The 
gender ratio for the Indian and African subjects is higher than that described in the 
Indian subcontinent or other African countries [37, 43, 48].  Compared to the 
Solomon study [29] the gender ratio in African subjects has changed significantly 
from a male predominance (male: female ratio of 1.5:1) to a female predominance 




of African women in the earlier study was that at that time (1960’s), SA pass laws 
restricted access of Africans, especially women, into city centres [509].  
Subsequently, however urban and peri-urban townships were developed for African 
families.  In addition, the rapid urbanization post-apartheid, associated dietary 
changes [391] and increase in sedentary lifestyle may also be responsible for an 
increased fracture risk.  However due to the HIV/AIDS epidemic, LE has not 
changed significantly from 1960, when the mean LE was 49.2 years and 47.4 years 
and 51 years in men and women, respectively [510].  Studies in other developing 
countries including the AOS, Nigeria and Morocco have seen a similar change in 
gender ratio with a higher increase in the fracture risk in women than men [47, 81, 
384].  In contrast, recent studies from the Indian subcontinent have observed only a 
slight increase in women compared to men [43, 511] and the gender ratio in African 
Americans remains unchanged and much lower at 1.5:1 [507]. 
A higher PBM and a higher BMD than women through most of life stages, decreased 
longevity, the lack of abrupt hormonal changes and the lower risk of falls are cited as 
reasons for the lower hip fracture rate in men in developed countries [218]. 
 
5.3 Incidence of osteoporotic hip fractures 
The ethnic and racial makeup of a country plays an important role in determining the 
number of hip fractures, and the pattern of fractures seen in a country with a mixed 
population is often similar to the country of initial origin of that population group as 
observed from studies in Canada, Mexico and Spain where fracture rates are similar 




60 years and over in eThekwini are African (45.9%), with Indians and Whites 
comprising 26.3% and 25.1% respectively and Coloureds the small minority at 2.7% 
[467].  The population of eThekwini represents only 4.3% of the total elderly 
population of Africans, 7.2% of Whites and 2.1% of Coloureds but 55% of Indians in 
SA. 
In the incidence study the majority of hip fracture subjects were Indian (54.3%).  The 
study may still be a potential under-representation of this group as approximately 
46.1% and 66.1% of the Indian population have a medical aid or utilize private health 
care facilities respectively [498].  It is more likely to be accurate for Africans as only 
10.8% of Africans have a medical aid.  The low number of Whites subjects in this 
study was contradictory to expectations as hip fractures have consistently been 
reported more commonly in Whites [39, 61, 65, 343].  The low numbers of White 
subjects is most likely due to an under-representation, with White subjects more 
likely to use the private health care sector in SA compared to the other ethnic 
groups.  Whites due to historical advantages are still the highest earners in SA and 
have a mean household monthly income of R9000 (approximately USD 850) while 
Africans have the least at R 2 167.00 (approximately USD 205) per month [513].  In 
addition White males especially, have had the highest employment rates and are 
most likely to have medical insurance [503].  In contrast, in 2007, only 6.9% of 
Africans and 6.5% of elderly were estimated to have medical aid.  It is unlikely that 
Whites subjects did not seek medical care or were not referred for further 
management as health awareness and education levels are assumed equivalent if 




in the Coloured population is not unexpected as Coloureds comprise 1.3% of the at 
risk population only. 
 
5.3.1 Crude incidence 
In this study the crude incidence rate in person over the age of 60 years for the 
eThekwini area was 97.4 per 100 000 and the age adjusted rate for SA was 109 per 
100 000.  The crude incidence rate may possibly be higher as White men were not 
represented in the sample size, however despite this, the rate is almost 20 fold 
higher when compared to the incidence rate of 5.2 per 100 000 reported in urban 
Africans aged 40 years and older from Johannesburg in 1968 [39] and 9 fold higher 
than the 12 per 100 000 reported in a subsequent study in African men and women 
from Natalspruit [53].  Possible reasons for the increase in incidence rates are 
methodological issues, significant changes in SA population dynamics from a 
younger to older population.  The population of persons aged 65 years and over was 
constant between the period 1965 (3.9%) to 2000 (3.7%), however in the last ten 
years it has increased to 4.6% [515] and further a substantial increase in the number 
of persons aged 50 years and over from 15.3% in 2010 to 24.1% by the year 2050 is 
expected.  Until recently LE had not increased significantly due to the HIV epidemic 
[515]; however with the introduction of antiretroviral treatment LE is projected to 
increase in the future [28].  Urbanization and lifestyle changes may also contribute to 
an increase in the risk of osteoporosis and fractures. 
This is the first study in the SA multi-ethnic population and specifically in South 




developing countries as predicted, while a decline or stabilization in hip fracture ASR 
is being observed in developed countries.  The main reasons for the decline in 
developed countries is improved perinatal nutrition [26], change in lifestyle factors 
including diet, cigarette smoking [158] and alcohol intake, an increase in body weight 
from a sedentary lifestyle [33, 232, 340, 341], a change in the number of 
reproductive years, increased exposure to exogenous oestrogens [151, 342] and 
increased osteoporosis screening and treatment due to a higher awareness levels 
[339, 516].  The number of total hip fractures however in developed countries 
continues to increase due to an increased total number of older people and 
increased longevity in men [26, 90, 174]. 
The incidence rate in this study in eThekwini although higher than previously 
reported may be an under-representation as this study was conducted in an urban 
area only and does not represent all ethnic groups, rural and perhaps older Africans.  
The incidence rate however is higher than previously reported from SA but remains 
much lower than developed countries of Europe [517], North America [33, 61], 
Australia [151], and developing countries such as Jordan (158 per 100 000), China 
(140 per 100 000) [43], Mexico (173 per 100 000) [505] and India (129 per 100 000) 
[43].  The incidence rate is however higher than in Venezuela (100 per 100 000) 
[518] and other countries in Africa such as Morocco (85.9 per 100 000 in women and 
72.7 per 100 000 in men) [47], Tunisia (50 per 100 000) [28], Nigeria (57.8 and 46.3 
in men and women) [37] and Cameroon at 4.1 per 100 000 [48]. 
The crude incidence rate of hip fractures, although higher than the rest of Africa is 
most likely still an under estimation due to the low numbers of Whites and absence 




for the higher rate in SA compared to rest of Africa, include the geographic gradient 
with SA being further south of the equator than North and West Africa; having a 
multi-ethnic population (high proportion of Indian subjects with hip fractures) and 
possibly SA is better developed with better access to health care than the rest of 
Africa.  The SES of the SA population is higher than most other African states with 
only SA, Botswana, Gabon and Mauritius being categorized as upper middle 
economic countries in Africa [504].  Furthermore, incidence rates from North and 
West Africa cannot necessarily be compared to that of SA as differences in 
anthropometry, culture, lifestyle and nutrition may exist [67] and no formal studies 
have been conducted comparing BMD or osteoporotic fracture incidences between 
the different populations.  In addition, despite the sunny climate, vitamin D levels 
fluctuate across Africa due to increased skin pigmentation, calcium deficiency and 
cultural practices [28, 240, 241] and there is a north to south gradient with lower 
levels in countries furthest away from the equator.  There is agreement however, that 
fracture rates in Africa are increasing with the increasing longevity and the presence 
of other risk factors such as a low calcium intake, multiple pregnancies, prolonged 
breastfeeding, decreasing physical activity levels and increasing urbanization [47, 
48]. 
Urbanization has been associated with higher fracture rates in Asian countries such 
as Hong Kong, Singapore and Japan [35, 55].  It is possible that the incidence rate in 
this study may have been lower if a rural SA population was included.  However an 
earlier study, albeit small, found a low incidence of lumbar osteoporosis and VFs in 
both urban and rural African women, suggesting that there are no marked 




in the SA rural community.  Similarly, recent studies from Africa are from large urban 
centres, and the only study in rural women in Gambia found that despite a lower 
BMD than matched White women in the UK, there was no increase in age related hip 
fractures [45]. 
 
5.3.2 Gender specific rates 
Similar to developed and many developing countries, the crude incidence rate in 
women at 133 per 100 000 was almost twice that in men (68.5 per 100 000).  The 
incidence rates however are significantly lower than in developed countries [4, 75] 
and are in the low risk category, defined as less than 150 per 100 000 [4].  The 
gender specific rates in this study are also lower than other developing countries 
including in the AOS study, India and from Mexico [35, 43, 505].  The highest rate in 
men is found in Denmark (290 per 100 000) and lowest rate is reported from 
Ecuador (35 per 100 000) [518]. 
The incidence rate in men at <150 per 100 000 is similar to that in Latin America, 
Jordan, Saudi Arabia, India, China, Indonesia, Philippines, Croatia and Romania 
[312] but higher than in Morocco and Nigeria [37, 47].  The precise reasons for the 
variations in hip fracture incidence are not known and environmental and genetic 
factors may play a role.  The higher fracture rates in Chinese in Hong Kong and 
Singapore than in China [81] support the role of environmental factors in determining 
fracture risk.  Similarly, studies suggest that differences exist in the fracture risk 
between American Africans and the indigenous populations in Africa [39, 61], 





5.3.3 Age adjusted incidence rates 
In accordance with other studies, an age related increase in hip fracture rates was 
noted with an almost 10 fold increase in hip fracture rates from 36.1 per 100 000 in 
the 60 – 65 years age group to 322.4 per 100 000in the 80 - 84 years age group.  
Similarly, the SOF research group found a 40% increase in fracture risk for every five 
year increment in age due to an increase in comorbid illness and falls, independent 
of bone mass [147].  The age adjusted fracture rates in the study are similar in men 
and women until age 75 years; however women in the 80 - 84 year age group had a 
3.3 times higher fracture risk compared to men (138.5 and 451.2 per 100 000 in men 
and women respectively).  This is most likely due to the increased longevity in 
women compared to men as seen in both developed and developing countries [26]. 
 
5.3.4 Ethnicity adjusted incidence rates 
The age adjusted rate for SA Indians was 2.8 fold greater than their African 
counterparts (207.2 per 100 000 compared to 73.3 per 100 000).  Higher rates have 
also been reported in Asian Indians compared to African Americans in the USA [128, 
373] and were postulated to be due to a lower BMD [220, 336].  In this study the 
gender specific rates for Indian men and women was not reported due to the small 
numbers however the combined incidence rate for men and women in SA Indians is 
higher than that reported from India (105 and 159 per 100 000 in men and women) 
and similar to Singaporean Indians (128 per 100 000 and 264 per 100 000 for men 




reported in Indians compared to Africans in SA [71] may in part account for the 
difference in incidence rates in this study.  This study supports this finding as Indian 
hip fracture subjects compared to African hip fracture subjects had a significantly 
lower BMD at the hip but similar BMD at the lumbar spine.  However in the Indian 
and African fracture subjects compared to their matched control groups, hip fracture 
subjects had lower scores at all sites, except for the hip BMAD which was similar in 
Indian hip fracture and control subjects.  These findings confirm that BMD is an 
important in both Africans and Indians and that other factors contribute to the higher 
incidence in Indians.  
The age adjusted incidence rate was highest in Indian subjects aged 85 years and 
older at 855.8 per 100 000 and is comparable to India were the incidence rate is 638 
per 100 000 in older men (85 - 90 year age group) and women (962 per 100 000 in 
the 90 - 95 years age group) [43]. 
The crude and age adjusted incidence of hip fractures in Africans was 63.8 per 
100 000 and 73.3 per 100 000, respectively.  This is almost 14 fold higher when 
compared to the incidence rate of 5.2 per 100 000 reported in urban Africans aged 
40 years and older from Johannesburg in 1968 [39] and 6 fold higher than the 12 per 
100 000 reported in a subsequent study in African men and women from Natalspruit 
[53]. 
Similar to Indians, the age adjusted incidence rate was highest in the 85 years and 
older age group at 305.8 per 100 000.  The rate remains significantly lower than 
developed countries and African Americans [61, 519] but higher than that seen in 




and Morocco (85.9 per 100 000 in women and 72.7 per 100 000 in men) in persons 
50 years and older [47]. 
In the White hip fracture group, incidence rate was only calculated for White women 
as only one White man had been enrolled in the study.  The age adjusted rate for 
White women at 91.6 per 100 000, is significantly less than expected and is most 
likely an under estimation due to under representation of White subjects in this study. 
These findings and the expected increase in LE and proportion of  older persons in 
SA, support the prediction that there will be a significant increase in number of hip 
fracture [26].  A major limitation of the original prediction is that the estimates for 
Africa were based on two studies only; one of which was conducted in 1960’s in 
urban Johannesburg Africans only and excluded rural dwellers, miners and migratory 
individuals and therefore represented only 27% of the African population who lived in 
defined urban area of Johannesburg.  The study further included all subjects 
presenting with fracture irrespective of degree of trauma, but excluded pathological 
fractures.  It is therefore likely that individuals with non-osteoporotic fractures are 
included in this sample as the men in the sample were manual labourers.  Despite 
these significant limitations an age related increase in fracture rates was seen in 
African subjects [39].  The second study from Nigeria may be an under-
representation of actual osteoporotic hip rates due to under-reporting [4].  Both these 
studies found extremely low rates and showed a greater than 10% variation 
compared to studies from the rest of the world [312]. 
The higher incidence found in this study needs to be considered in the prediction of 




5.4 Clinical risk factors for osteoporotic hip fractures 
The FRAX® assessment tool based on an analysis of 12 study populations is now 
recommended by the WHO and IOF to predict major and hip osteoporotic fracture 
risk [83].  The tool uses age, gender, weight, height, parental history of osteoporotic 
hip fracture, prior fragility fracture, smoking, alcohol (> three units a day), rheumatoid 
arthritis, long term (> 3 months) use of systemic GC and secondary medical 
conditions with or without a BMD to predict the 10 year probability of a major or hip 
fracture [31, 310].  The strength of the model lies in the additive effect of the clinical 
risk factors, however it has limitations as it does not incorporate other important risk 
factors e.g. bone quality and falls which are significant independent risk factors.  In 
addition, country specific hip fracture incidence rates, all-cause mortality rates and a 
cost efficacy analysis are required to determine intervention thresholds.  The tool 
cannot be used in persons less than 40 years old, premenopausal women, persons 
on osteoporosis treatment and importantly only uses hip BMD and not vertebral BMD 
[88].  Due to a lack of data on the incidence of hip fractures in SA and all-cause 
mortality data, the FRAX® tool is not available for SA.  In addition, the multi-ethnic 
population precludes the use of a surrogate country. 
No studies in SA have specifically looked at risk factors in subjects with hip fractures.  
Studies have however, investigated and compared the risk factors for the differences 
in BMD in the different ethnic groups [71].  This study is the first to systematically 





In the case control study, a lower educational level, low body weight and body mass 
index, prior fragility fractures, sideways fall, memory impairment, morphometric VF, 
higher physical activity levels, smoking alcohol consumption, poorer functional 
activity level, low vitamin D levels, low BMD, a lower haemoglobin, total protein and 
albumin, with raised inflammatory markers were identified as risk factors for hip 
fractures on univariate analysis.  After a step wise backwards logistic regression, 
educational level, a prior fragility fracture, BMI, pre- fracture physical activity levels, 
IADL activity level and QoL scores, haemoglobin and white blood cell counts and 
serum albumin and C-reactive protein levels remained as significant associations 
with hip fracture. 
 
5.4.1 Age and gender 
Osteoporotic hip fractures increase with age and are more frequent in women.  Age 
and gender are well established risk factors and are strong independent markers of 
fracture risk [90, 95, 147, 216, 520].  The incidence of hip fractures in this study rose 
exponentially with age and was higher in women than men.  In addition to the 
decreasing BMD with age, other reasons for the increased incidence with age 
include an increase in comorbid diseases and a higher fall risk [147, 300, 521].  In 
contrast the lower incidence rate in men is probably due to the decreased longevity 
in men and a lower rate of bone loss [218]. 
Interestingly, the incidence rate in men and women younger than 74 years old was 
similar but after age 75 years, the increment increase was far greater in women.  




who may have been older.  Other factors such as a lower BMD in older women, 
differences in fall risk and other clinical risk factors may contribute to the gender 
differences with age.  This study however did not specifically compare CRF or BMD 
in men and women younger and older than 74 years.  The study was conducted over 
fourteen months and the younger age in men is unlikely to be due to sampling error. 
 
5.4.2 Housing, employment and education 
The association between SES and hip fractures has been well described as an 
indirect marker for other risk factors.  A low SES has been found in several hip 
fracture studies and is an indicator for a poor nutritional state, low calcium intake and 
decreased access to health care [34, 66, 140, 511] and correlates with hip fracture 
rates.  In the first NHANES report, a poor nutritional status due to poor dietary intake, 
was associated with a low body mass and serum albumin and independently 
increased hip fracture risk [522].  In contrast, and other studies have shown a linear 
relationship between increasing GDP and ten year hip fracture risk, with hip fracture 
probability increasing by 1.3% for every US $10 000 increase in GDP per capita [75].  
The general consensus is that with increasing prosperity, physical activity levels 
decrease and surface hardness (pavement and brick buildings) improves resulting in 
a higher risk of severe injury.  Furthermore, the higher number of hip fractures in 
urban compared to rural dwellers [226] is thought to be due to differences in physical 
activity levels associated with farming, living circumstances and environmental 
factors, however the exact reasons remain unclear. The data regarding the 




This study was conducted in a peri-urban population living in KZN and no significant 
differences in housing or employment status between control subjects or gender and 
ethnic groups was observed.  The majority of subjects lived in formal housing and 
were pensioners, receiving a state old age pension.  An assumption was made that 
they belonged to a similar SES status (lower and middle income) as individuals 
qualify for the government pension based on economic status after reaching the age 
of 60 years [523].  However, this may be an insensitive marker of SES and may not 
adequately reflect the true SES of individuals and their financial responsibilities. 
Despite the similar SES, educational level differed significantly and education was an 
independent risk factor in hip fractures subjects, irrespective of gender and ethnicity.  
Hip fracture subjects compared to control subjects were significantly more likely to 
have had no schooling (37% vs. 12.5%, p < 0.0001) and less likely to have had a 
tertiary education (5% vs. 16%, p < 0.0001).  Women with hip fractures were more 
likely not to have had any schooling compared to men (40.3% vs. 28.6%, p < 
0.0001).  Possible reasons for this is that older women, especially of Indian descent, 
may have not received schooling for cultural reasons and secondly, due to apartheid 
access to higher education was denied to many African and Indian persons [509]. 
A lower level of education in hip fracture subjects has been confirmed in several 
studies from Iran, India and Turkey, where a low level of literacy and less than 12 
years of schooling after adjustment for age, height and weight was a significant risk 
factor [140, 327].  The studies postulate that a low education level is an indirect 
indicator of early economic and nutritional status including possibly health care 
access and subsequent failure to achieve the genetic potential for PBM.  Lower 




care seeking behaviour.  In this study an additional explanation for the control cohort 
having a better education may be due to a sample bias as it is possible that 
individuals with a higher education level were better able to understand the risk of 
osteoporosis fractures and therefore were more likely to volunteer to participate in 
the study. 
 
5.4.3 Weight, height and body mass index 
Perhaps after age and prior fractures, body weight and BMI are the most important 
CRF for hip fractures in both men and women and different ethnic groups [33, 76, 
140, 147, 232, 511, 524].  Body weight, height and BMI influence hip fracture risk via 
BMD or independently.   
In SA, a significant a strong association has been reported between total body 
weight and all BMD parameters in African women [69].  In addition, in 
premenopausal African and White women, fat free soft tissue mass, although lower 
in African women, was the most significant contributor to BMD at all sites in African 
women and the hip in White [67] 
In this study of older men and women, there was a significant negative correlation 
between body weight and BMD at the lumbar spine (p <0.0001) and total hip (p = 
0.001) in the total cohort and total hip fracture cohort but not in the total control 
group.  This supports the association between body weight and bone mass, 




The positive relationship between body weight and BMD is mediated via mechanical 
and hormonal factors [117, 228, 311].  Obesity results in a higher bone mass due to 
increased weight bearing, and slower bone loss rates due to a primary increase in 
oestrogen levels.  In addition, the fat pads provide cushioning in the event of a fall 
[127, 147, 228, 229].  In converse, a low body weight and weight loss are potentially 
indirect measurements of general ill health [443], and weight loss is also associated 
with decrease in growth factors including insulin and increase corticosteroid levels 
which increase the rate of bone loss [192]. 
Several epidemiological studies have however failed to show a relationship between 
weight and BMD including the BRAZOS, WHI and EPIDOS. Possible explanations 
for the failure to show a positive associations in these studies, include a younger 
cohort and that these studies were not designed to assess hip fracture risk 
specifically [233, 525].  . 
A low mean body weight was an independent risk factor for hip fractures in the total 
fracture cohort (OR 0.906, 95% CI 0.87-0.94) and in both Indian and African hip 
fracture subjects compared to matched control subjects (OR 0.893; 95%CI 0.84-
0.95) and (OR 0.916; 95%CI 0.86-0.97) respectively.  Of note, is that the difference 
in body weight between hip fracture subjects and controls was greater in the African 
cohort compared to the Indian cohort. 
In addition, the mean total body weight in both Indians and Africans, and in men and 
women fracture subjects was less than 57 kg, the cut-off value used in the FRAX® 




The ethnic difference in skeletal size has been well established.  In the SA 
population, African subjects have the heaviest skeletons and African women are 
heavier than Indian women but Indian men are heavier than African men [79].  In this 
study African subjects with hip fractures were significantly heavier than their Indian 
counterparts who may in part be due to differences in skeletal size, however skeletal 
mass only contributes to 12-15% [69, 526] of total body weight and difference in soft 
tissue mass is the more likely explanation for the weight differences. 
An increased In view of the influence of weight and height on hip fracture it is 
intuitive that BMI would have a similar effect.  In this study the mean BMI was 
significantly lower in hip fracture subjects compared to controls (22.7 ± 5.7 kg/m2 vs. 
29.2 ± 6.0 kg/m2; p < 0.0001; OR 0.786, 95%CI 0.7-0.87), and only 3 control 
subjects (all African women) had a low BMI and interestingly, despite having no 
other clinical risk factors for osteoporosis, two of these subjects had morphometric 
VF and a low BMD emphasizing the association between low BMI and fracture risk, 
albeit vertebral.  The majority of hip fracture subjects had either a normal (55.9%) or 
low BMI (21.3%) while control subjects were more likely to be overweight (33.5%) or 
obese (40.5%).  In addition, when BMI was used as a continuous variable, every two 
unit decrease in BMI increased the odds of a hip fracture by 1.61 and a 3 unit 
decrease in BMI increased the odds to 2.06. 
The increase in hip fracture risk with a low BMI has been shown in a recent study, 
where a BMI of less than 26 kg/cm2 was associated with an increased risk of 
osteoporosis [140].  The relationship between BMI and fracture risk is strongest for 
BMI in the underweight category as was reported in the meta-analysis of 12 




Further in the 12 hip fracture subjects who had a BMI of greater 30kg/cm2, 41% were 
African and 58.3% were men (58.3%).  There were no other differences in this 
group, except that only one of these 12 subjects died in the study period. 
The significantly higher BMI in control subjects is in keeping with findings in a 
community study where the mean BMI was 24.8 kg/cm2 and 28.8 kg/cm2 in the 60 - 
69 years and 24.4 kg/cm2 and 27.7 kg/cm2 in the 70 - 79 year age groups, in men 
and women, respectively [527]. 
A possible reason for low body weight and BMI in the hip fracture subjects could be 
malnutrition in early life resulting in underweight adults and a failure to achieve PBM, 
and an increase in fracture risk.  The association between SES and nutritional status 
with BMD is supported by the finding in India that 29% of 30 - 60 years old women 
from a low economic group with a poor nutritional status, based on dietary 
assessment, and lower calcium intake had osteoporosis based on the WHO criteria 
[66].  However this study failed to show a relationship between body weight and 
BMD and did not interrogate early nutrition or SES in childhood.  The low serum 
albumin and haemoglobin levels in hip fracture subjects; in addition to the low body 
weight and BMI do however suggest that hip fracture subjects had a poorer 
nutritional status than did control subjects.  The association between a low albumin 
and ageing and femoral neck fractures has previously been reported in comparative 
study in women [459]. 
Another potential cause for a low body weight is general medical illnesses; however 
in this study, control subjects had a higher burden of hypertension and DM.  Perhaps 




be a surrogate marker of better SES and better nutritional status.  However as 
discussed previously, this study was unable to show any difference in SES between 
hip fracture subjects and controls. 
An increased hip fracture risk has also been documented in taller individuals, and 
several studies report height as important as weight in determining fracture risk [33, 
147].  Taller subjects have an increased hip fracture risk [192, 521] due to a longer 
HAL [196] and/or fall from a greater height increasing the potential for an injury [298].  
Height was not significantly different between fracture and matched control subjects 
in the total and African and Indian cohorts.  However, men were shorter than their 
matched controls while women with hip fractures were taller than matched control 
subjects.  It is therefore difficult to explain the significance of height in our sample 
population subgroups and it’s possible that morphometric VF secondary to 
osteoporosis may have resulted in a decrease in height in our subjects. 
 
5.4.4 Co-morbid diseases and secondary causes of osteoporosis 
Several medical conditions and drugs predispose to secondary osteoporosis and 
especially important in men and young patients presenting with fractures [26, 88, 
346].  In addition, comorbid diseases in older persons contribute to frailty and an 
increased fall risk [192, 265, 270, 528].  In a case control study of 124 655 hip 
fracture subjects, hypertension and stroke were the only significant risk factors while 
myocardial ischaemia, deep vein thrombosis, peripheral vascular disease and atrial 
fibrillation were associated with a transient (less than three month) risk [406].  A high 




fractures [511].  Hypertension is probably only indirectly associated with hip fractures 
secondary to treatment side effects [96].  In this study while hip fracture subjects 
were more likely to have had a stroke (7.5% vs. 2%), the numbers were too small to 
draw any association.  The risk of fractures in stroke is multifactorial and due to loss 
of mobility and decreased load bearing on parts of skeleton, and an increased fall 
risk [270]. 
In this study, the sample size was too small to show significant differences in the 
prevalence of chronic diseases between hip fracture and controls. 
Paradoxically, however hypertension, DM and RA known to be risk factors for hip 
fractures, were found more commonly in the control subjects.  This is considered to 
be most likely due to a sample bias, as some of the controls were outpatients at the 
selected hospitals or were more aware of osteoporosis and therefore preferentially 
entered the study.  However in fracture subjects, hypertension and DM was more 
common in women compared to men, and Indians were more likely to have DM than 
Africans.  The latter is probably due to the high prevalence of DM in SA Indians [529, 
530]. 
In contrast, self-reported osteoarthritis and the associated obesity are considered to 
be protective against hip fractures [226, 527].  Consistent with this there was a 
significantly higher prevalence of self-reported arthritis in control subjects compared 
to hip fracture subjects (47.5% vs. 27.5%, p < 0.0001).  Control subjects were also 
heavier (71.0 ± 16.5 kg vs. 54.7 ± 13.7 kg, p < 0.0001) and complained more of 




Although infrequent, an underlying malignancy was more common in hip fracture 
than controls (5% vs. 1.5%; p = 0.052) but did not quite reach significance.  
Malignancy was significantly more common in women with hip fractures compared to 
women controls, whereas in men there was equal low prevalence in men of 0.5% in 
those with and without hip fractures. 
Consistent with previous findings of the association between memory impairment 
and fracture risk [76], self-reported poor memory and concern expressed by a family 
member regarding memory loss were significantly more frequent in hip fracture 
subjects compared to controls (39% vs. 22.5%, p < 0.001; OR 2.0, 95%CI 1.29-3.1) 
and (34% vs. 18.5%, p < 0.001; OR 2.25, 95%CI 1.39-3.64), respectively.  While hip 
fracture subjects were also more likely to report difficulty in completing familiar tasks, 
there was no significant difference between the groups.  The positive association 
between memory complaints was found despite only enrolling subjects able to give 
consent.  By excluding those who were not able to give consent this study may have 
excluded subjects with more significant cognitive impairment.  It is therefore likely 
that association between cognitive impairment and fracture may be stronger than 
found in this study.  The increased fracture risk with cognitive impairment is due to a 
combination of factors that include neuromuscular, fall and gait factors [147, 531, 
532].  Although memory loss and difficulty in completing tasks was greater in 
matched women and Indians than men and Africans the reasons for this were not 
clear. 
Other secondary causes (chronic renal failure, cirrhosis, IBD) are well documented in 
the literature [119] but were found in low numbers in this study in both cohorts and 




frequency of gastric ulcers (4.5% vs. 2%), and epilepsy and schizophrenia at 1.5% 
respectively which are associated risk factors [147, 192, 263, 264] but no 
associations could be drawn in view of the small numbers. 
Although several studies have found decreased vision, poor depth perception and 
decreased contrast sensitivity increase fall and fracture risk [147, 271, 511], this 
study failed to show any associations and in contrast, these impairments were 
significantly more common in control subjects.  It is possible that due to these 
impairments control subjects may be more careful and therefore have a lower fall 
risk. 
Despite the higher frequency of chronic diseases in control subjects, potentially bone 
toxic drugs were used more frequently by hip fracture subjects however the number 
of subjects using the drugs was low and use was not significantly different between 
the two cohorts.  The long term usage (three months) of GC in hip fracture subjects 
was 5.5% vs. 3.5% (p = 0.468) and while the use of other bone toxic drugs, although 
more common in hip fracture subjects than controls was not significant including anti-
epileptics, antidepressants and long term heparin which in other studies have been 
associated increased fracture risk [147, 255]. 
 
5.4.5 Hormonal factors 
The loss of oestrogen with menopause is the most common recognized cause of 
osteoporosis [98, 140].  The primary reason for the rapid bone loss in post-




bone remodelling [191, 533].  While there are established differences in bone mass 
in different ethnic groups, the rate of bone loss and bone turnover rates are similar at 
menopause in Indians from India [140], African-Americans and US White women 
[534].  There are site specific differences in bone loss patterns over menopause. 
Similar loss at the spine, higher femoral loss and is in general better maintenance 
with ageing explaining the better BMD in elderly African women in SA [69]  
In SA, bone loss is similar in pre-menopausal African and White women, and 
increases in Whites at menopause but not in Africans [69].  The rate increases later 
in older post-menopausal Africans most likely due to a negative calcium balance and 
secondary hyperparathyroidism resulting in an increased bone loss at the femoral 
head. 
The amount of time the body is exposed to oestrogen is critical in determining 
osteoporosis risk and this is dependent on several factors including time of 
menarche, age of menopause, periods of amenorrhoea, breast feeding duration, 
parity and use of exogenous oestrogen [82, 147].  Delayed puberty or hypogonadism 
results in a failure to attain PBM and hypogonadism in adulthood is associated with 
accelerated bone loss.  It is estimated 20% of elderly and 50% of men with hip 
fractures may have hypogonadism [535]. 
In this study, there was no difference in age at menarche and menopause, parity, 
(including a higher parity i.e. >3), and hormonal levels between hip fracture subjects 
and controls.  There are however conflicting reports on the influence of parity on 
fracture risk.  Some studies, including a study on osteoporosis risk factors from SA 




pelvis and lumbar spine density of between 1 - 4% with each birth, while in other 
studies higher parity (>3 children) has been associated with decreased fracture risk 
as pregnancy is associated with increased oestrogen exposure, weight gain, and 
increased calcium absorption [536].  While yet others, similar to this study, have 
noted no significant difference in number of pregnancies and fracture risk [225, 226]. 
The benefits of HRT in maintaining bone mass are well established and the effect of 
HRT was confirmed in the WHI study were HRT use decreased hip fracture risk by 
50% [537].  The use of HRT is however limited in older women due to its side effect 
profile.  The risk reduction however, is greatest during HRT use and lasts up to 5 
years after HRT is stopped [76, 224, 538].  The beneficial effect of HRT was 
confirmed in this study and any use was significantly less in hip fracture subjects 
compared to controls (4.9% vs. 15.3%; p < 0.001; OR 0.201, 95%CI 0.08-0.49).  
However, hormone replacement was infrequent, even in the control group, and there 
was no difference between Indian and African hip fracture subjects. 
 
5.4.6 Falls 
The risk of falls increases progressively with ageing and along with the associated 
increased skeletal fragility accounts for the significantly increased risk of hip 
fractures seen in the elderly [33, 123].  The type of fall, surface hardness, 
neuromuscular factors and protective arm movements all play a contributory role. 
[33, 304, 305, 539].  While most studies have found a positive association between 
falls and hip fractures [28], other studies have found conflicting results.  Cummings 




adjusting for health status and ability to rise from a chair, falls were no longer a 
significant risk factor [147, 192]. 
Interestingly, this study found no association between numbers of prior falls, number 
of falls or time of last fall in hip fracture compared to control subjects.  Further 55% of 
hip fracture subjects had no previous falls.  Postulated reasons for the conflicting 
results for falls are that only 5% of falls result in fracture and that co-existent 
illnesses, psychotropic medication, cardiovascular medications all influence fall risk 
[540].  Although this study was unable to show any difference in the number of falls, 
hip fracture subjects, particularly women, had a significantly higher number of 
sideways falls.  Several studies have shown that the type of fall differs between 
gender and ethnic groups and plays an important role in determining injury [298].  A 
sideways fall on an outstretched hand results in a significant higher impact on the 
greater trochanter and is particularly associated with hip fractures [304, 305].  An 
additional reason for the failure to identify differences in the number of falls between 
hip fracture and control subjects is that control subjects may have been more likely 
to participate in the study in anticipation of being screened for osteoporosis and to 
prevent a fracture if they had future falls.  The study may potentially have under-
estimated the risk of falls in fracture subjects. 
Furthermore, while there was no diference in the fall assessment between men and 
women with hip fractures, compared to African subjects with hip fractures, Indian 
fracture subjects were more likely to report falls and sought care and limited their 
activities due to a fear of falling despite the fact there was no difference in total 




behaviour.  This may possibly be related to ease of access to health care but the 
study did not look for this and further research is required in this area. 
The role of physical activity in decreasing fall risk is controversial and while few 
studies have failed to show a benefit [152, 541], others have found that an 
improvement in strength and balance results in a 10% reduction in fall risk [303].  
Most authors agree that gait, balance and lower extremity strength play a critical role 
in falls and hip fracture risk, independent of BMD [33, 147].  The findings in this study 
of higher activity levels in fracture subjects and the equivalent number of falls in hip 
fracture and control subjects is surprising and reinforces the multifactorial aetiology 
of hip fractures. 
Interestingly, the study also found that control subjects were more likely to have had 
near falls; this may have resulted in greater psychological fear of falling.  The fear of 
falling may result in decreased physical activity and can lead to dependence and 
decreased function and paradoxically increase risk of falling [542].  This fear may 
have prompted them to participate in a study assessing their risk of serious injury 
following a fall.  Controls also had greater concern regarding falling and needed 
more assistance after a fall.  Additionally they had greater concerns with regards to 
transfer in the bathroom or bedroom, painful legs, visual problems, difficulty with 
depth perception and activity limitation due to fear of falling.  In contrast, hip fracture 
subjects were more likely not to choose to use a walking aid, significant in men but 
not in women, and although not significant had a higher frequency of medication 
changes.  It is possible that despite a similar number of falls, control subjects due to 
pain, higher prevalence of co-morbid diseases and lower activity levels are more 




therefore possibly better cushioning and stronger bones to decrease the impact of a 
fall.  Hip fracture subjects were more likely to fall outside where surface are harder 
resulting in possible greater trauma.  The association of these factors with fractures 
have been previously reported [20, 49, [271]. 
 
5.4.7 Prior fragility fractures 
Wrist fractures usually precede hip fractures by 15 years [5, 543, 544] and present 
an ideal opportunity to assess for osteoporosis.  Following a wrist fracture there is a 
three-fold increase in a future wrist fracture and a doubling of the risk for any 
fracture, which may occur within 1-3 years [545].  Furthermore after a hip fracture, 
the risk of a second hip fracture varies between 2 - 10% and although highest in the 
first year, can occur up to number of years later with a mean duration of four years 
[30, 443]. 
A major concern however is that despite this < 50% and < 10% of subjects after a 
wrist and hip fracture, respectively [545-547] are investigated and treated for 
osteoporosis even in countries with a high incidence of hip fractures. 
In this study, only 3.5% of subjects had a diagnosis of osteoporosis prior to their hip 
fracture.  These were all female subjects highlighting the lack of awareness, 
especially in men.  Despite the low finding of an established diagnosis of 
osteoporosis in the fracture group, 27.5% of hip fracture subjects reported a prior 
fracture which was a significant risk factor in both gender and ethnic matched groups 




significant number of individuals post fragility fracture are not screened or treated 
appropriately for osteoporosis, and that a prior fragility fracture confers a high risk of 
a second fracture.  The risk of subsequent fracture occurs in men and women and is 
influenced by age, number and sites of the previous fracture [295, 548], with the 
highest risk commonly reported after a VF. 
In this study, the most common site for a self-reported prior fracture was the forearm 
which is similar to CaMos study [192] where a morphometric VF predicted risk for 
future VF but not for non-VF.  A possible reason for this is VFs are often due to 
primary bone fragility while the aetiology of hip fractures is multifactorial including fall 
risk and clinical factors [192] 
Surprisingly, a prior hip fracture was found in 7.5% of hip fracture subjects.  Post hip 
fracture, the risk of a second fracture is increased as there is rapid bone loss in the 
contralateral hip due to increased bone turnover, loss of lean body mass and 
increased fat mass associated with the first hip fracture [433].  The risk of second hip 
fracture was 10.3% in the USA in the following three years after a hip fracture with 
the risk being the highest in the first year at 51% [434]. 
 
5.4.8 Family history of osteoporosis 
Genetic factors strongly correlate with bone mass [95, 203, 204] and the relationship 
between fracture risk and family history is independent of BMD [147, 525].  A 
maternal history of fracture especially before the age of 80 years doubles the 




Counterintuitively, hip fracture subjects were less likely than control subjects to 
report a family history of osteoporosis (3.5% vs. 11.5%, p = 0.002, OR 0.266, 95%CI 
0.11-0.63) and a maternal history of hip fracture (5.5% vs. 11.5%, p = 0.034; OR 
0.427, 95%CI 0.20 - 0.90).  In addition, no male fracture subjects reported either a 
family history of osteoporosis or fracture.  These findings support the notion that 
there is a low awareness of osteoporosis and hip fractures in this population and that 
the controls may well be more aware and were therefore more likely to participate in 
the study.  Thus the risk associated with a positive family history may be under-
estimated in this study.  Alternatively, these findings may reflect a true increase in 
the incidence of hip fractures either due to an increased LE or a change in risk factor 
profile.  The CaMos study also failed to show any positive correlation between family 
history and fracture risk, but the possible reason for this was that a general family 
history for osteoporosis and fracture was obtained rather than a maternal history 
[192] 
 
5.4.9 Lifestyle factors 
Although environmental factors are thought to play a smaller role in determining 
PBM than genetic factors, they play an important role in maintaining bone mass and 
determining subsequent rate of bone loss [95].  Amongst the most studied are 
caffeine, smoking, alcohol consumption, physical activity levels sunlight exposure, 







Decreased physical activity correlates with increased hip fracture risk in both 
genders and different ethnic groups [76, 81, 511, 525].  Conversely, weight bearing 
exercises increase bone density at the spine and simple exercises like walking 
strengthen tone and muscles [549]. 
Contrary to these findings, the self-reported activity levels were significantly higher in 
hip fracture subjects compared to controls in this study.  Hip fracture subjects also 
exercised significantly more often than did control subjects.  A similar finding was 
also reported form India by Keramat et al., who found that walking distance or level 
of activity level was not protective for osteoporosis [140].  In this study the control 
cohort had a higher number of co-morbid diseases and visual difficulties which may 
have resulted in lower level of physical activity. 
 
Caffeine intake 
In this study no association was found between the intake of caffeine and fracture 
risk, in keeping with current literature.  Caffeine has a potentially negative effect on 
bone by [550] decreasing intestinal calcium absorption [147] and acts on the VDR in 
women with the tt genotype are more susceptible to the negative effects of 
caffeine[550].  Although caffeine was thought to have a deleterious effect on bone 
mass, several subsequent studies found no direct association between fracture risk 
and caffeine use [284].  The conflicting findings are dependent on the type of coffee 




drinkers was shown to be due a low calcium intake rather than a direct effect of 
caffeine [284].  In contrast, some studies still continue to show an increased risk with 
caffeine [76, 511]. 
 
Sunlight exposure and vitamin D levels 
Reduced sunlight exposure (UVB) has been associated with vitamin D deficiency in 
several studies.  This study was undertaken in eThekwini which has a sunny climate 
and not surprisingly there were no differences in sunlight exposure between fracture 
or control subjects.  Furthermore, unlike in Europe and USA where the majority of 
hip fractures occur during the winter months, there was no seasonal variation in this 
study, similar to other studies from Africa [37, 47].  The increase risk of fracture in 
winter in the Northern hemisphere is thought to be due to an increase in 
neuromuscular dysfunction secondary to the cold temperature and vitamin D 
deficiency [75, 95, 231].  The seasonal variation in incidence however is found 
usually with greater latitude changes from the equator [75]. 
The role of sunlight exposure in SA is not well defined.  Vitamin D deficiency was 
found in elderly Coloureds in Cape Town, however this was a cross sectional study 
and there was no correlation with bone health [551].  An earlier study in 
Johannesburg found a seasonal variation in vitamin D levels in Johannesburg with 
environmental temperature and not with number of hours of sunlight [245].  Later 
studies showed seasonal variation in sunlight only in Cape Town with the previously 
observed variation in Johannesburg explained on individuals wearing more clothes in 




been conducted in eThekwini which has a more tropical climate than either 
Johannesburg or Cape Town. 
Despite the fact that there was no difference in sunlight exposure, a significantly 
lower mean 25 (OH) vitamin D level was noted in hip fracture subjects compared to 
controls (38.9 ± 22.4 nmol/l vs. 51.4 ± 24.2 nmol/l, p <0.0001).  The mean 25 (OH) 
vitamin D level in hip fracture subjects was in mildly deficient category (24.96 - 49.92 
nmol/L) as seen in several studies [525].  In the hip fracture subjects there was no 
difference in the mean vitamin D levels between African and Indian or male and 
female subjects.  Vitamin D levels however were significantly lower in both men and 
women fracture subjects compared to their matched controls (p = 0.003) and (p < 
0.0001) respectively.  This significant difference was also observed in Indian and 
African fracture subjects compared to their matched controls (p = 0.004) and (p = 
0.002) respectively.  Vitamin D levels were not analysed in White women due to the 
small sample size but the mean vitamin D level in White fracture subjects was only 
marginally higher than that of African or Indian fracture subjects.  This implies that 
factors apart from ethnicity, gender and sunlight exposure affect vitamin D levels. 
 
Calcium 
Low vitamin D levels are associated with a decreased calcium absorption resulting in 
secondary hyperparathyroidism and increased bone resorption.  With increasing 
age, the ability of the skin to synthesize vitamin D decreases and the decreased 




results in calcium and vitamin D deficiency in the elderly and exacerbates bone loss 
[176]. 
In this study, a low calcium intake was documented in both fracture and control 
subjects with a mean calcium intake of less than 500 mg/day.  Calcium intake was 
lowest in African fracture subjects, with a significantly lower daily calcium intake 
compared to their matched controls and compared to Indian fracture subjects (p = 
0.005).  The low calcium intake noted in Africans fracture cases may suggest poorer 
nutrition and a lower SES.   
The low calcium intake and low vitamin D levels in this study are in keeping with 
global studies, including developing countries, which show that a low calcium intake 
and hypovitaminosis in the elderly result in a higher fracture risk [76, 81, 511].  In an 
Indian study, 52% of subjects had vitamin D insufficiency mainly due to a diet in poor 
in calcium and high in phytates [555]. A review of vitamin D levels across several 
countries found that obesity (BMI >30), residing in a non-equatorial country, Asian 
ethnicity, poor health, poor vitamin D supplementation, and no recent travel to sunny 
areas all increased risk of vitamin D insufficiency [553]. 
In contrast, this study found that fracture subjects, despite having a lower BMI, 
residing in a sunny climate and having a lower incidence of chronic diseases 
compared to controls, had lower vitamin D status.  
In SA, a lower calcium intake and vitamin D levels have been reported in 
postmenopausal Africans compared to Whites [69] and in Indians compared to 
African women [71].  This study, despite finding a significantly lower calcium intake in 




fracture subjects.  Possible reasons may be similar skin colour, exposure to sunlight 
or polymorphisms of the VDR receptor. 
A possible reason for the low calcium intake in this study is that calcium rich foods 
are expensive and may have been not affordable as most of the study subjects are 
dependent on their social pensions which were approximately R 1000 (USD 80) in 
2010/11 (personal observation by investigator).  Other studies from Africa have also 
implicated low calcium as a possible risk factor for osteoporotic fractures, however it 
is suggested that Africans have better calcium utilisation than Whites as despite a 
lower mean intake, they have lower a fracture rate [38, 39, 221, 268]. 
Additionally, in African Americans a relative skeletal resistance to the actions of PTH, 
which possibly protects them against the effects of a low calcium intake, has been 
reported. [222] The resistance is, however relative and secondary 
hyperparathyroidism has been shown in African Americans from a low SES and an 
inadequate intake of calcium. 
Calcium and vitamin D are widely recommended in the treatment of osteoporosis as 
an adjunct to more specific anti-osteoporosis medication.  Calcium supplementation 
has been shown to increase BMD at the lumbar spine, hip and femoral neck by 4 - 
6% [248], however its role in fracture reduction is less well defined [235].  Vitamin D 
in a dose of 700 - 800 IU decreases hip fracture risk by 25% in elderly individuals, 
however this risk reduction has been shown in subjects using concomitant calcium 
[554]. 
In an attempt to clarify the role of calcium and Vitamin D in hip fracture reduction, 




Evaluation of Calcium Or Vitamin D (RECORD) and WHI [250] and in the meta-
analysis found that in all the studies except the RECORD, a combination of Vitamin 
D and calcium significantly reduced hip fracture risk by 18%.  This finding supports 
an earlier Cochrane review in 2005 that calcium or vitamin D alone do not decrease 
fracture risk [246].  The RECORD trial showed no additional benefit of combined 
supplementation, however the RECORD subjects were younger, the study was 
underpowered and compliance with trial medication was only 60%, whilst compliance 
in the WHI was 80%.  Despite the conflicting results, supplementation is effective 
provided subjects are compliant and should be restricted to select subjects with low 
levels rather than widespread community supplementation [246].  In this study the 
use of additional calcium or vitamin D was not significantly different and found in less 
than 15% of both cohorts and therefore given the low dietary intake subjects would 
most likely benefit from supplementation. 
 
Smoking 
Smoking increases bone loss in post-menopausal women, but its effect on bone 
mass in pre-menopausal women smokers is conflicting [273].  Studies in pre-
menopausal discordant twins reported a lower bone mass in smokers, possibly due 
to decreased oestrogen [274] while other studies have found no relationship 
between smoking and bone loss in pre-menopausal women [556]. 
The metabolic, hormonal and nutritional changes associated with smoking result in 
smokers being thinner and reaching menopause earlier due to a higher metabolism 




In this study there was a significant association of current smoking in hip fracture 
subjects compared to control subjects.  This is consistent with findings from several 
studies which have shown that smoking is an independent risk factor for osteoporotic 
fractures [147, 273, 525, 562].  Men with hip fractures were more likely to smoke 
than women as reported in the AOS study [81]. 
Although smoking increases the risk for any fracture, it is specifically associated with 
a higher hip fracture risk [158, 562].  In contrast, Cummings et al., found that after 
adjustment for weight loss, poor health status, decrease activity and difficulty in 
arising from chair, smoking was not a significant risk factor in White women [147]. 
 
Alcohol 
Excessive alcohol consumption decreases bone mass directly and indirectly by 
suppressing bone osteoblastic activity [276, 277].  Alcohol decreases osteocalcin 
levels resulting in decreased bone volume and trabecular thickness with associated 
mild demineralization.  The indirect effects of alcohol are mediated via liver damage, 
nutritional deficiencies and associated hypogonadism [276, 277]. 
Moderate use on the other hand, increases the conversion of androstenedione to 
oestrogen and indirectly increases bone mass [33, 147, 278]. 
A significantly higher alcohol use was observed in hip fracture subjects compared to 
control subjects and in men with hip fractures compared to women.  Indian subjects 
with hip fractures consumed a higher amount of alcohol than did African hip fracture 




descent.  The higher alcohol intake is also reflected in the higher GGT levels in hip 
fracture subjects and particularly in men. 
The increased fracture risk with alcohol has been shown in several studies in Asians 
[81], however there are very few studies looking at the use of conventional alcohol in 
Africans from Africa.  Rather, the use of traditional beer home brewed in iron pots 
has been associated with a higher risk of femoral neck fracture and has been found 
to be an independent risk factor in African men including in a small study from SA 
[53, 282, 283].  Despite this several small studies have failed to show a high 
incidence of femoral neck fractures in sub-Saharan Africa [53].  None of the subjects 




5.5 Bone mineral density 
BMD is the only measurable marker of bone mass and epidemiological studies have 
shown an inverse relationship between BMD and fracture risk, with a 1.5 - 3 times 
increase fracture risk for every one SD decrease in BMD [58].  In this study, only 116 
hip fracture subjects were able to have a DXA scan due to logistic reasons.  As a 35 
patients demised before having a BMD or were too frail or unable to attend it is 
possible that the BMD represented here may be an under-estimation of true 
difference between fracture and control subjects.  
The BMD in this study, was significantly lower in hip fracture subjects than in controls 
at the lumbar spine (0.701 ± 0.173 g/cm2 vs. 0.848 ± 0.183 g/cm2, p < 0.0001), 
femoral neck (0.518 ± 0.106 g/cm2 vs. 0.713 ± 0.127 g/cm2, p < 0.0001) and total hip 
(0.650 ± 0.136 g/cm2 vs. 0.879 ± 0.163 g/cm2, p < 0.0001).  The measured BMD was 
lower in men, women, Indian and African hip fracture subjects compared to their age 
matched controls at all three measured sites.  The markedly lower BMD values at all 
sites and for all measurements namely areal and volumetric suggest that there are 
no significant major skeletal differences between the African and Indian fracture 
subjects. 
When BMD is expressed as a T-score, fracture risk increases 2 - 3 fold with a T - 
score of less than -2.5 [87].  In this study the mean T - scores were significantly 
lower in hip fracture subjects compared to controls at the spine (-2.99 ± 1.29 vs. -
1.23 ± 1.44; p<0.0001) and total hip (-2.91 ± 0.85 vs. -1.26 ± 1.25; p<0.0001) and 
only 2.6% of fracture subjects had a normal BMD implying that hip fractures are 




fracture subjects had a T-score in the osteoporotic category, and this study, confirms 
the usefulness of BMD in predicting hip fractures [272]. 
Despite this positive association, it has been noted in several other studies that BMD 
is not the only marker for increased fracture risk and fractures can occur in the 
setting of normal BMD [152].  In this study, 2.6% and 12.1% of the hip fracture 
subjects would have been classified as having a normal or low bone mass, 
respectively based on their T - scores and an overwhelming 85.3% would have been 
osteoporotic and would have qualified for treatment had they presented prior to the 
hip fracture; clearly an opportunity missed.  The reason for the normal BMD in the 
three hip fracture subjects cannot be adequately explained.  Control subjects would 
have been categorized as normal (38.7%), low bone mass (32.2%) and osteoporosis 
(29.1%). 
Although it was expected that the BMD would be higher in men compared to women 
no difference was noted between men and women hip fracture subjects in BMD.  
However, BMD was higher at the hip in African hip fracture subjects compared to 
their Indian counterparts (0.692 ± 0.147 g/cm2 vs. 0.630 ± 0.129 g/cm2; p = 0.025).  
In US studies, a higher BMD has been found in  African Americans and Whites 
compared to Asians [44, 61], and a local study showed lower BMD values at all sites 
in Indians compared to Africans [71].  However, this last study included younger 
individuals (from age 18 years and onward). 
Ethnic differences in BMD are well recognized and Solomon [52] was the first to find 
a lower than expected BMD in Africans compared to UK Whites and subsequent 




exist between Whites, Coloured and Africans [52, 385-387, 564].  More recent 
studies show BMD is similar or slightly lower at the spine but higher at the hip in 
Africans than Whites [67-69] and a lower in Indians compared to Africans [71].  
Further support for these differences is that in school children (8 - 18 years) after 
adjustment for body size, BMC and BMC/BW was greater in Coloured girls 
compared to Indians and Whites but no difference was seen in boys [557].  
Interestingly, further studies comparing SA African and White children to US African 
American and White children found that despite African Americans being heavier, SA 
Africans had a higher BMC.  The BMC was also higher in Whites in SA compared to 
US Whites once more implicating environmental factors in bone mass [56]. 
Of note is that the T - scores in this study were calculated using the IOF, ISCD and 
NOFSA recommendations to use a single reference range (White female from 
NHANES 111 [88, 179,558] rather than gender and ethnic specific ranges, especially 
since there are no normative data for SA.  It is also recommended that the total hip 
rather than femoral neck is used as the reference point in predicting fracture risk 
[559]; as BMD at the hip is a better hip fracture risk predictor than BMD at the spine.  
Possible reasons for this include that lumbar spine BMD in older women may be 
falsely elevated due effects of osteoarthritis [192].  The ability of the T-score using 
NHANES III White reference database to diagnose 85.3% of hip fracture subjects as 
having osteoporosis confirms the validity of the IOF recommendation [179].  A low 
BMD in all ethnic groups is associated with an increased fracture risk of 54% for 
each SD decrease in T - score [65], however the absolute risk differs between 
different ethnic groups.  White and Hispanic women have the highest absolute 




A major limitation and critique of DXA is that it measures the average thickness of 
minerals in a given area and is therefore a crude measure of hip geometry only.  
Differences in hip geometry, such as cortical strength and buckling ratio are known 
to help predict hip fracture risk [560], and ethnic differences have been reported in 
bone geometry [196].  Although we did not perform skeletal geometry, hip specific 
analysis studies in the 10 292 participants in the WHI study, showed a significant 
correlation between conventional femur neck BMD and structural hip geometry 
measurements [272].  The highest correlation was for cross sectional area, cortical 
thickness and buckling ratio at the narrow neck.  Fracture subjects had a lower BMD, 
lower cross sectional area, wider outer diameters and higher buckling ratios which 
were significant independent risk factors after adjustment for body size, ethnicity, 
clinical risk factors and BMD [272].  The authors however caution that widening of 
hip geometry is a natural phenomenon seen with ageing to preserve the section 
modulus and make buckling unlikely [520].  This results in elderly people having a 
preserved inferior cortex to support them while standing while the superior lateral 
cortex is thinned out.  In the event of a fall the load is suddenly applied in the 
opposite direction compared to standing and therefore the thinned superior cortex 
unaccustomed to load bearing easily fractures even with minimal force.  Many 
experts therefore feel that despite hip geometry measurement not being superior to 
DXA, a single DXA is not sufficiently reliable and DXA technology needs to improve 
to increase spatial resolution and to include hip geometry measurement which will 
add further to the predictive value after accounting for clinical risk factors and 




In view of the potential impact of differences in body size differences affecting BMD 
measurements, volumetric BMAD was calculated using the Katzman and Carter 
corrections [494, 495].  The BMAD in hip fracture subjects remained significantly 
lower than controls subjects at the spine (0.199 ± 0.036 g/cm3 vs. 0.244 ± 
0.041g/cm3, p<0.0001) and hip (0.118 ± 0.092g/cm3 vs. 0.143 ± 0.025 g/cm3,p = 
0.003).  There was no difference in BMAD in men and women hip fracture subjects; 
and in African and Indian hip fracture subjects, despite a higher BMD at the hip in 
Africans compared to Indians, suggesting that after correction for body size there is 
no real difference in bone mass between African and Indian subjects.  In contrast, 
studies in African Americans and US Whites have found that after correction for body 
or bone size, differences in BMD and BMAD persisted [220, 221, 332]. 
Despite the strong association between BMD and fracture risk shown in this study 
routine population screening in a resource constrained environment with limited DXA 
machines will not be cost effective or efficient and rather subjects should be 
identified according to clinical risk factors.  Additionally in view of significant 






5.6 Morphometric vertebral fractures  
The increased risk of a future fragility fracture, although present for all fractures is 
highest with a VF [10, 20, 57, 147, 155].  A prior vertebral deformity increases the 
risk of a hip fracture by 2.8 – 4.5 fold.  In the CaMos study a VF predicted risk for 
future VF but not for non-VF.  A possible reason for this is VFs are often due to 
primary bone fragility while the aetiology of hip fractures is multifactorial including fall 
risk and clinical factors [192].  However a prevalent VF is often missed as the 
majority are may not present clinically [7]. 
Although self-reported VFs were low in both cohorts, a significant number of 
morphometric VFs (24.5% in all subjects) were identified on lateral thoracic and 
lumbar radiographs (32.7% and 20.3% in fracture and control subjects, respectively), 
with multiple VFs being more common in hip fracture subjects than controls subjects.  
These results support the findings that prevalent VFs significantly increase 
subsequent hip fracture risk up to five-fold [353]. 
Compared to hip fractures, there are fewer large studies on VFs, which report that 
the geographic and ethnic variation with VFs is much less marked than that with hip 
fractures.  However, similar to hip fractures there is a higher incidence in Whites 
compared to African American or Asian women [349].  Major obstacles in obtaining 
correct epidemiological data on VF are the asymptomatic nature of VF, the different 
approaches in choosing sample sizes [11], and the lack of consensus in defining VF 
until the recent acceptance of the semi quantitative visual techniques [152]. 
Prevalence rates in community studies in post-menopausal White women across 




25.3% in women aged 50 years and older [350].  In this study VFs were found in 
24.5% of all subjects aged 60 years and older, similar to the USA study despite the 
lower hip fracture incidence.  Although there is limited data from developing 
countries, several studies have found similar results with a similar VF prevalence but 
lower hip fracture incidence.  In the LAVOS study, across five Latin American 
countries, the prevalence for radiological VFs was 11.2% in women aged 50 years 
and older and increased to 27.8% in women over 80 years [360,361].  This is 
comparable to the studies from USA which found a prevalence of 33.9% in over 80 
year old women [26].  Several studies from Asia have also reported similar findings 
with the a prevalence of 23% in Vietnam [561] and 37% in women aged 80 years 
and older in Beijing, despite a low incidence of hip fractures in China.  In contrast, 
native Japanese women despite having a lower BMD than USA whites, have a 50% 
lower risk of hip fracture compared to Whites but a higher VF prevalence than both 
Japanese residing in the USA or Whites.  It has been suggested that the lower hip 
fracture rate is related to a lower fall risk in native Japanese [11, 154].  The first 
urban community study from India DeVOS has shown a similar trend with a VF 
prevalence rate of 17.9% in subjects greater than 50 years old [562] and in Morocco 
the prevalence was 26% in men older than 50 years [38]. 
The first study to comment on the prevalence of vertebral osteoporosis and VF in SA 
was undertaken to determine aortic calcification on lumbar spine radiographs by 
Dent et al.,(1968) [385], in rural and urban African and urban White women.  The 
authors concluded that osteoporosis was rare in Africans but the study had several 
limitations as only lumbar radiographs were assessed subjectively and no objective 




subjects were in-patients at a regional hospital while the White group included 
community dwellers.  More recent studies however have reported a higher 
prevalence; in White and African women from Cape Town a prevalence of 11.5% 
and 8.3% respectively was observed [69] while a recent five year longitudinal study 
reported that 38% of African women developed a new VF (>20% vertebral deformity) 
[54]. 
In the total study cohort, VFs were most common in White (44.8%) followed by 
African (28.3%) and lowest in Indian subjects (22%).  Further White hip fracture and 
control subjects had the highest percentage of VF compared to Indian and African 
hip fracture and control subjects.  This finding may not be surprising as White 
women in the study were the oldest and it has been shown that the incidence and 
prevalence of VFs increases with age, from 0.9% and 5 - 10%, respectively in the 50 
- 60 year old age group to 1.6% and 30%, respectively in those aged 80 years and 
over [180,563].  The higher number of VF in African than Indians once again 
highlights the concern that several authors have expressed that Africans are at a 
higher risk of VF than hip fractures [56]. 
Women not unexpectedly, had a higher total number of VFs compared to men in the 
combined group and in the hip fracture and control groups, respectively which is 
similar to studies in White women and men from USA where the prevalence in over 
60 year older subjects is two or three fold higher in women compared to men [564].  
In contrast, community based studies from Europe, Canada and India have reported 




The most common site for VFs was T11/12 and L1 in hip fracture subjects and T6 
and T11 in control subjects.  The reason for different sites cannot be explained fully 
but a bimodal fracture distribution has been previously reported [154,565].  Reasons 
for the difference include difference in activities which resulted in the fracture and the 
possibility of some studies missing thoracic fractures.  In this study, however a single 
radiographer blinded to hip and control subjects examined all the films and errors are 
therefore less likely. 
Indian fracture subjects were more likely to have severe vertebral deformities 
compared to African hip fracture and White subjects.  The degree of vertebral 
deformity correlates with future hip fracture risk [294].   
A major limitation of the VF results in this study is that 40% of hip fracture subjects 
did not have radiographs; these subjects were mostly frail or died soon after the hip 
fracture and therefore number of VF may possibly be under-estimated.  Secondly, 
LVA on DXA was also not available for confirmation and comparison.  Although 
lateral radiographs of thoracic and lumbar spine remain screening tools, LVA is more 
useful as it uses a combination of digital radiographs and parallel beam geometry to 
allow for visual fracture assessment and the digital measurement of vertebral height.  
In contrast, plain radiographs can visualize the entire thoracic spine while LVA 





5.7 Functional status 
Despite extensive research in hip fracture subjects few studies have compared 
functional levels in age and gender matched hip fracture and control subjects. 
In this study, subjects with hip fractures were more likely to have a poor functional 
status prior to their fracture than control subjects.  In the multivariate analysis, the 
IADL and QoL remained as significant risk factors. 
The PSMS and Lawton IADL scales in combination are sensitive measures of 
activities of daily living (ADL) and have been found to be reliable in the elderly in 
multiple studies [478, 479].  Compared to controls, hip fracture subjects had 
significantly poorer function in both tests with lower overall scores, and were 
significantly more likely to have difficulty in all areas except eating compared to 
control subjects.  On comparing women and men with hip fractures, men were 
significantly more likely than women to be unable to eat independently prior to the 
fracture.  In comparison, women were significantly more likely to be unable to lift 
heavy objects and walk a distance.  While there was no difference in the total scores 
for both the PSMS and IADL between African and Indian subjects with hip fractures; 
Indian fracture subjects were significantly more likely to be unable to use a 
telephone, walk a distance, cook and do handiwork.  These differences are difficult 
to explain and may be due to differences in household structures, support systems 
and expectations.  
Although poorer functioning in subjects with hip fractures is consistent with previous 




and they had fewer comorbid illnesses than controls subjects.  It must be noted that 
self-reported activity level used in this study was a crude assessment and possibly 
affected by the patient mood.  It is possible that hip fracture subjects, experiencing 
the pain, trauma and altered mood, over-estimated their activity level.  The functional 
assessment tools are a more reliable reflection of pre-fracture functioning.  Although 
cognitive impairment was not formally assessed in this study, all subjects were able 
to give informed consent and complete the questionnaires, making significant 
cognitive impairment less likely.   
Interestingly, in the QoL assessment, which evaluated 5 domains of mobility, self-
care, daily activities, pain and mood, hip fracture subjects had greater difficulty with 
mobility, self-care and were more likely to have pain and a depressed mood.  Control 
subjects were more likely to have limitation of daily activities which is in keeping with 
the higher self-report of pain and greater fear of falling limiting their activity.  These 
findings suggest that subjects with hip fractures despite their limitations were 
possibly still more active and therefore at a higher risk of falling. 
A similar trend was seen in the individual domains of the ODI with fracture subjects 
having greater difficulty in the individual domains, except for personal care and 
standing, however the final total scores were not significantly different between hip 
fracture and control subjects.  Although there was no significant difference in total 
scores, differences exist in individual parameters and it’s possible that a decline in 





5.8 Biochemical and haematological parameters  
Biochemical and haematological investigations have multiple roles in the 
assessment and management of patients with hip fractures and are useful in 
excluding a secondary cause, to assess general medical status and predict outcome.  
Often, subjects with hip fractures are elderly, frail and have multiple comorbidities 
and may have several laboratory abnormalities. 
In this study, no further cases of secondary causes of osteoporosis (hypogonadism, 
multiple myeloma, hyperparathyroidism) were identified from the laboratory 
investigations.  However, significant differences in haematological and biochemical 
results were present in the hip fracture and control groups and except for total 
protein and glucose persisted in gender and ethnic matched groups.  The 
haemoglobin, serum sodium and albumin levels were significantly lower in hip 
fracture subjects than controls, whereas the inflammatory markers (WCC, CRP and 
ESR), serum bilirubin, ALT, GGT, and random plasma glucose levels were higher.  
There was no difference in the urea, creatinine and PTH levels.  
Anaemia is common and has been reported in 24 – 44% of hip fracture subjects 
[566] and may be due to the multiple comorbidities in older individuals, bleeding at 
the time of the injury or due to frailty [567,568].  While hip fracture subjects in this 
study had less comorbidities, their lower functional status and body weight suggests 
that the hip fracture subjects were more likely to have frailty, a syndrome common in 
older persons and often associated with anaemia [569].  Frailty and a poor nutritional 




association between a low serum albumin and cognitive impairment, functional 
impairment and increased mortality after hip fracture [576-573]. 
Chronic inflammation has been implicated in the pathogenesis of several diseases 
and may also play a role in osteoporosis [574,575].  This is supported by the 
increased prevalence of osteoporosis in inflammatory diseases such as RA.  High 
CRP levels have been associated with an increased fracture risk, even in the 
absence of inflammation.  Studies on the association of CRP and hip fractures have 
however shown conflicting results.  The high WCC, ESR and CRP may also be 
elevated from an acute stress response to trauma [576]. 
Similar findings to this study, namely, a low BMI, low caloric intake, low serum 
albumin and raised CRP have been reported in the USA [522].  However, studies on 
the association between low albumin levels and functional outcome are conflicting 
[586].  In addition in a meta-analysis, low haemoglobin, raised total lymphocyte 
count, low albumin, high creatinine and high PTH have been shown to predict 
mortality [577].  In this study there was no difference in renal function and PTH levels 
between hip fractures and controls. 
The acute stress of a hip fracture may also account for the elevated glucose levels in 
the hip fracture subjects. 
Although the liver enzymes were significantly elevated in hip fracture subjects 
compared to control subjects, they were within the normal range.  It is possible that 
the significantly higher use of alcohol contributed to the raised liver enzymes, 
especially as GGT was raised in men with fractures compared to women.  The mean 




variation in the amount used.  The effect of alcohol is dose dependent, and heavy 
drinkers (>2 drinks per day) have an increased risk of osteoporosis [147], while 
moderate to low drinking (0.5 -1 drink per day) may be protective  and confer a lower 
risk for fractures than abstinence [279].   
Despite lower vitamin D levels in the hip fracture subjects, (refer section 5.4.9. 
lifestyle factors; vitamin D and calcium) no differences were seen in calcium, thyroid 
or PTH levels between the two cohorts. 
In the backwards stepwise multivariate logistic regression model, low haemoglobin 
and albumin and an elevated WBCC and CRP levels were independent predictors 
for hip fractures in this study. 
 
5.9 Hip fractures in men 
This study confirms that osteoporotic fractures are important in men with over 25% of 
fractures occurring in men.  This finding is in keeping with other studies which found 
that between 20 - 35% of all hip fracture occur in men [312] but is contrary to 
previous studies from developing countries and SA which reported a similar ratio in 
men and women.  However these studies, due methodological issues discussed 
previously, are not comparable to the current study. 
In the limited studies in Africa, there is conflicting data on age and gender; in 
Cameroon and Morocco [47,48], male hip fracture subjects were younger than 




India), the mean age of hip fractures was comparable in men and women [43, 511].  
The studies from India and Africa however had a small number of subjects. 
Although men were taller, there was no significant difference in weight or BMI 
between male and female fracture subjects.   Male fracture subjects were more 
active, and were more likely to smoke and consume alcohol compared to women, 
however the extent this contributed to fracture risk in men is unknown as the amount 
of alcohol consumed was in the moderate to low category which may be protective. 
Previous studies have reported that the proportion of heavy drinkers is significantly 
higher in men compared to women (56).  
Despite secondary causes of osteoporosis being more prevalent in men [578,579], 
except for alcohol use, no association was shown between known secondary causes 
of osteoporosis and hip fractures in men in this study.  There was also no difference 
in the number of falls but sideways falls were less common.  This is contrary to other 
studies which report a lower prevalence of falls in men [298].  Lastly, no male 
fracture subject and very few male control subjects recalled a family history of 
osteoporosis or fractures.  The presence of a family history of osteoporosis was also 
low in women (3.5%); suggesting either a low awareness of osteoporosis in both 
genders or a true absence because of previously lower life expectancy. 
Similar to previous studies, in this study, there was no difference in areal or 
volumetric BMD between men and women with hip fractures [79,580].  This suggests 
that the skeletal structure of men and women in this study was comparable, with 
men more likely to be small-framed similar to women.  Several studies have 




from outside Africa with only one recent study from Africa.  In the African study, in 
healthy Moroccan men with a mean age of 49.1 years, 8.7% had osteoporosis and 
52.8% had osteopenia [38].  A lower BMD was associated with lower BMI and 
increasing age, however no relationship was found with smoking with only 15% of 
the cohort were smokers and none of the subjects consumed alcohol (possible due 
to religious restrictions).  A similar low prevalence of osteoporosis (8.5%) was 
reported in Indian men [372]. 
Despite the small numbers of men, this study highlights the high mortality and 
morbidity in men. The higher mortality rate in men compared to women (41.1% vs 
30.6%) at one year is higher than that reported from developed countries (20.7% and 
7.5% in men and women respectively) [581].  The reason for a significantly higher 
rate in men is not readily apparent as CRF, BMD and function were not markedly 
different between male and female fracture subjects.  Other underlying factors 
including genetic or SES may play a role. 
 
5.10 Outcomes post fractures 
At the end of the one year study period, 36.4% (n=67) of hip fracture subjects had 
died, 58.5% (n=117) were alive and 8% (n=16) lost to follow up. 
The majority of patients were managed surgically (86.5%) and the choice of type of 
surgery and prosthesis was at the orthopaedic surgeons’ discretion. Despite the 
significant comorbid disease burden and the regional hospital setting, only patients 




in contradiction to current guidelines which advocate an integrated holistic ortho-
geriatric management approach [435].  While there are very limited geriatric 
services, all the study hospitals have a well-established Internal Medicine service.  
The probable reasons for lack of joint management are overburdened medical and 
orthopaedic services, and more importantly the lack of appropriate protocols and a 
special interest in osteoporosis.  
Although current guidelines advocate surgery as early as possible, from within 24 
hours to 4 days, in an effort to improve functional outcome, decrease hospital stay, 
decrease pain and post hip fracture complications and possibly mortality [423, 436], 
the average number of days to admission in this study was 4.2 ± 12.6 days, time 
from fracture to surgery was 11.3 ± 9.2 days and mean length of stay was 21.9 ± 
14.8 days.  The delay may have been due to a lack of awareness and a failure of 
family or local clinic staff to identify fractures in persons with pain and poor mobility.  
System problems include an overburdened system with acute trauma taking 
precedence over hip fracture subjects, and lack of facilities in terms of theatre time 
and surgeons (personal observations during study period).  These deficiencies have 
been identified in several other centres and a system based solution to prevent 
delays, including having specialized surgical teams available, can be a cost effective 
method to prevent surgical delays and long term morbidity [437]. 
Despite the significant mortality post hip fracture, and the fact that a significant 
number of fracture subjects had had a prior fracture, none of the subjects were 
prescribed calcium and vitamin D or referred for a BMD measurement prior to 
discharge.  This included subjects who had been assessed by a physician.  These 




diagnosis of osteoporosis is made in less than 30%,  BMD measured in 15% and 
less than 30% are prescribed calcium and Vitamin D [29]. 
Education and awareness programs such as the Capture the Fracture campaign and 
FLS are urgently required to improve the management of hip fractures [462]. 
 
5.11 Mortality 
It is well recognized that hip fractures have a high mortality and that death is not 
directly related to the hip fracture, but rather is a result of the interaction of 
underlying comorbid diseases and/or surgical complications, including infections and 
immobility [581]. 
At the end of the one year study period, 36.4% (n=67) of hip fracture subjects had 
died, 58.5% (n=117) were alive and 8% (n=16) lost to follow up.  The highest number 
of deaths (n=52) were reported in the first six months (77.6% of all deaths), MR at six 
months was 28%.  In the next six months a further 15 subjects from the remaining 
132 died, 11.3% of hip fracture subjects.  The overall high MR at 36.4% at one year 
is also consistent with previously reported rates of between 18 - 31% [343,581]. 
In developed countries, the MR post hip fracture has been shown to be double that 
of age matched controls, with the greatest risk seen in the first six months post 
fracture [184].  Several studies suggest that after the first six months, the excess 
mortality, if corrected for age, sex, SES, pre-fracture functional status, BMI, co 




studies suggest MR persists for up to a year [406].  In this study although early MR 
was higher than subsequent period, it persisted up to one year later.  
 
5.11.1 Non modifiable risk factors: Age, gender and ethnicity 
The mean age of fracture subjects who died was significantly higher than survivors 
(75.3 ± 8.6 years compared to 73.6 ± 8 years, p = 0.048) and this study confirmed 
that advancing age is independently associated with higher mortality [581].  The 
mortality in men although higher than women (41.1% vs 30.6%) was not significantly 
different.  Gender bias in mortality rates is well described; in a retrospective review 
in-hospital mortality for men with hip fractures was double that for women in the USA 
[408].  In support of the gender bias, a 26% higher mortality has been reported in 
men with a hip fracture compared to men without a hip fracture, compared to only a 
12% higher difference women [411].  The increased MR post hip fracture may also 
persist longer in men than women with some studies suggesting up to two and half 
years and even more in elderly men [3, 14, 161,582].  
Ethnic differences in MR have also been reported.  In the USA, a higher mortality 
has been reported in African Americans compared to Whites [416,583].  In this 
study, the MR was significantly higher in African subjects compared to Indians.  
Except for the fact the African subjects were older than Indians; there were no 





5.11.2 Modifiable risk factors: Phenotype, education and lifestyle  
The association between a lower body weight and lower BMI with a significantly 
higher mortality has been consistently reported [14,58]. Postulates for this 
association include that these parameters are surrogate markers for poor nutrition, 
the presence of chronic illnesses and possible a lower SES. In this study, in both the 
univariate and multivariate analysis, weight and BMI were predictors of mortality.  
In this study the hip fracture subjects had a lower education level compared to 
controls, which was contrary to most international studies which report that a higher 
educational level is associated with better SES and higher fracture risk [47].  
Counter-intuitively however, fracture subjects who died had a higher educational 
level than survivors.  It is possible that people with higher educational level had a 
better SES and were older and therefore had a higher mortality, but the exact 
association in this study remains uncertain.  
There was no difference in calcium intake, smoking or alcohol between subjects who 
died and survivors, but vitamin D levels were significantly lower in hip fracture 
subjects who died.  Several studies have reported a decrease total mortality, 
cardiovascular risk and incidence of cancer in subjects receiving vitamin D [585,586] 
but no significant effects of vitamin D have been shown on mortality post fracture 
[585,586]].  The lower vitamin D levels may reflect decreased activity and mobility 
prior to the fracture in subjects who died. 
Activity and functioning levels are important in predicting outcomes. In this study 
fracture subjects who died also self-reported lower levels of physical activity, and 




significantly lower mean IADL score.  Similar findings have been reported with 
subjects who died having greater difficulty with eating and mobility [411,586].  
 
5.11.3 Contributing illness, clinical risk factors and BMD 
The study failed to show any significant difference in comorbid disease profile, which 
is in contrast to other studies which have found dementia, chronic lung disease, 
myocardial infarction and heart failure increase the risk of death [581].  It should be 
noted that subjects with dementia were excluded from the study, so the association 
between cognitive impairment and death could not be investigated.  There was also 
no correlation found between fall risk, prior fracture or BMD.  In addition, this study 
due to the small number of patients, may have failed to prove possible associations. 
The significantly lower serum albumin and higher CRP and ESR levels in hip fracture 
subjects who died, are consistent with previous reports [577] and suggest the 
presence of frailty, poor nutritional state, liver impairment or complications of chronic 
diseases.  A meta-analysis [576] found that impaired renal function was a risk factor 
for death, in this study the urea and creatinine were only mildly impaired, possibly 
secondary to dehydration.  But in contrast there was no association between death 
and with a high WCC or PTH in this study.  The relationship between significantly 
lower sodium level, albeit within the normal range and death may reflect a poorer 




5.11.4 Fracture management 
A delay in time to surgery was a significant risk factor for death.  In contrast, early 
surgery has been shown to decrease mortality risk and surgical complications [423].  
It is possible the delay in surgery was due to the presence of comorbid diseases 
which required medical stabilization before surgery (author’s observation).  More 
likely though, is that trauma gets precedence for theatre time and in a busy service, 
older persons are of lower priority. 
Although a significant number of subjects were discharged to step down facility, the 
length of stay at these institutions was not available.  However, at the three month 
follow up visit, there was no significant difference in follow up in the subjects 
irrespective of place of discharge.  In contrast, a higher mortality has been reported 
in subjects discharged to institutions compared to their home [427]. 
The study found mortality was higher in patients managed conservatively and this is 
not unexpected as the main reason for not performing surgery was a poor surgical 
candidate and high anaesthetic risk and not lack of resources. 
 
5.11.5 Summary of mortality 
Although this study comprised a small number of subjects and a smaller number of 
deaths, an attempt was made to identify risk factors for mortality.  In univariate 
analysis, subjects who died were more likely to be older, and have a lower body 
weight and BMI, lower physical activity levels, VF, lower serum albumin, sodium and 




clinical and laboratory findings in general indicate a poorer general medical status, 
with possible under-nutrition, renal and liver impairment, higher inflammatory 
response and increased risk of complications, all of which are known to be 
associated with a higher mortality. 
In a backward conditional logistic regression model ethnicity (Africans), lower body 
weight or BMI, higher education status, difficulty with cooking, taking medications or 
managing finances, decreased mobility, decreased albumin or elevated C-reactive 
protein and longer mean hospital stay remained significant risk factors for death. 
 
5.12 Morbidity 
The morbidity post hip fracture is higher than with any other osteoporotic fracture 
and is increased by the potential for surgical complications.  Recovery post fracture 
has been found in the literature to be dependent on several factors including age, 
pre-fracture functioning, comorbid disease burden and the place of discharge.  
Poorer outcomes are seen in older individuals who often are unable to return home 
and need admission to a nursing home with the rate of admission to a nursing home 
increasing from 14% in 50 - 55 year age group to 55% in 90 year age group [588]. 
Following a hip fracture, up to 25% of independent subjects become partially 
dependent, while 50% of partially dependent become totally dependent [76, 238].  
Up to 40% are unable to walk, 60% are restricted in their ability to perform ADL and 
80% are unable to perform at least one IADL [201].  Even in developed countries, 




subjects have long term mobility restriction and further 50% who lived independently 
require long term nursing care and help with daily activities and a third may need 
institutional care [26]. 
Functional status in this study was assessed with five inter-related tools which are 
additive in determining function and complement each other.  To maximise recall, 
they were administered within a week of the fracture to assess pre-fracture functional 
status.  As discussed earlier, subjects with hip fractures were more likely to have 
difficulty in performing ADLs and IADLs and had a poorer QoL pre-fracture than did 
matched controls, and the inability to perform individual IADLs were risk factors for 
death.  In survivors, functional status was assessed at three, six and twelve months.  
Post hip fracture a significant number of subjects needed to be discharged to a step 
down care facility and the majority of survivors had a significant decrease in 
functional activity in all areas except mood.  The decline was most marked at three 
months but persisted over the one year follow up period as observed in other studies 
[152]. 
Immediately post hip fracture there was a significant and rapid decline in functional 
ability, which was consistently documented, irrespective of the functional 
assessment tool utilized.  A nadir in all functional assessment parameters was noted 
at three months.  Varying improvement in most functions assessed were noted 
thereafter, some far more dramatic than others.  Significant functional impairment, 
however, remained present in most fracture cases at one year post hip fracture.  At 





Similarly, the  mean VAS for pain increased from 1.4 ± 1.3 to 5 ± 1.9 at three months 
and remained elevated at almost four-fold from baseline at 4 ± 3.2 at one year.  
There was also a marked decline in travel and social interaction in the ODI and 
almost 60% of individuals at one year had failed to return to their pre-fracture social 
activities.  Restriction in social activities and dependency adversely influence mental 
health status and lead to anxiety and depression [398] and although there was a two 
fold increase in depression or anxiety compared to baseline, there was no significant 
difference in mood from baseline to one year.  
This study confirms the devastating impact on functioning in the elderly post hip 
fracture subjects and compares with other studies which report that post hip fracture 
only 33% of survivors can perform their ADL, 20% their IADL and 26% their social 
functioning as well as they did pre-fracture [19,589]. 
The recovery post fracture appears to follow a temporal sequence with an initial 
improvement in mood, cognition and upper extremity strength at around 4 months 
followed by improvement in gait, balance and social interaction.  Recovery of ADL 
and IADL of lower extremity starts by one year only, however the majority of subjects 
may never show full recovery in all areas [590].  The survivors in this study appear to 
have followed a similar recovery pattern.  This study did not analyse outcomes in 
men and women and different ethnic groups separately due to the small sample size, 
however despite a higher mortality, several studies report better outcomes in men 
than women [507,591].   
The morbidity from sustaining four VF equates to one hip fracture [156].  There is 




Africans have poorer outcome than non-Hispanic whites [167,507,594].  The 
readmission rate in this study was relatively low, at 7%, for surgical complications, 
but the public health service is overburdened and only extremely ill patients are 
admitted.  Furthermore, it is possible some subjects may have been admitted at their 
local hospitals and not referred to regional centre for minor complications.  Family 
members also reported that a number of subjects had sought care at local clinic or 
hospital before death; however they were not admitted (personal correspondence 
with family members).  There is no local data on outcomes post fracture and 
readmission rates but other studies have found much higher readmission rates of up 






5.13 Health care costs 
There is a paucity of data on health care costs, and especially for NCDs, in SA [464] 
with only one study on hip fracture costs in a public sector hospital [463].  This was 
however in trauma subjects and the cost per hip fracture was calculated to be 
R12 637.00 (approximately $1150).  In this study, the bottom up approach was used 
to calculate the cost of acute management of atraumatic hip fractures.  This method 
is more accurate and was modified to calculate the average cost for 169 subjects.  
The direct cost was calculated to be R62 891.65 per subject.  A limitation is the 
Department of Health does not use specific costs, such as bed costs and cost per 
[593]therefore used to calculate costs based on procedures performed and number 
of days in hospitals.  
The actual calculated cost at R62 891.65 (approximately USD 5717) per subject was 
36.6% higher than the normative costing model based on standard care endorsed by 
NOFSA [87].  As in most other studies [23,450,593] the largest cost was for the ward 
admission (87.9% of the total expenses), while surgical costs accounted for 5.1%, 
investigations, excluding BMD, 4.5%, and the prosthesis only 2.5%.  With the delay 
in surgery, the average duration of admission in this study was longer than expected, 
and could account for an excess of R4.7 million (USD 427 300) for the 173 patients 
in whom surgery was performed.  If calculated over a 12 month period (for an 
average of 230 subjects), and assuming an equivalent percentage of subjects having 
surgery then approximately R5 million (approximately USD 454 500) would have 
been spent on days awaiting surgery.  These costs relate to public sector and are 
significantly lower than that for the private sector, which are estimated to be more 




These costs however, underestimate the true cost of hip fractures as indirect costs 
from loss of productivity, special transport needs, special diets, home alterations and 
caregiver costs [24, 450] were not included.  The indirect costs in SA may be more 
significant as rehabilitation services and chronic care are largely not available. 
With the predicted increase in the incidence of fractures in SA, the costs of hip 
fractures will increase commensurately.  This is especially so in developed countries 
where the burden of osteoporosis is higher.  Although several efforts have been 
made to reduce the burden of health care costs associated with hip fractures 
including early discharge to nursing homes, this has not proven effective as early 
discharge shifts the costs to nursing homes which equal that of hospital care 
[594,595,597].  The most effective way to prevent costs of a hip fracture is to prevent 
fractures and if this is not possible, then efficiency of hospitalisation and 
rehabilitation need to be improved [596,24]. 
Effective treatment for osteoporosis is available in SA and medical treatment of 
established osteoporosis is more cost effective than treating fractures irrespective of 
age and is recommended for moderate to high risk subjects [598].  The 40% 
reduction of hip fractures with annual administration of an intravenous 
bisphosphonate for example at a cost R1534 (approximately USD 140) for 3 years 
will considerably reduce not only the cost, but also the morbidity and mortality, 





5.14 Summary and recommendations based on discussion 
This is the first study in SA to report the demographic characteristics, incidence, risk 
factors, outcome and health care costs of osteoporotic hip fractures, in a peri-urban 
population in SA.  The study highlights that osteoporosis hip fractures occur in all 
ethnic groups in SA, albeit at different rates.  Similar to developed countries, hip 
fractures are more common in women than men and increase with age.  However 
surprisingly, hip fractures occur at an earlier age in men, especially those of Indian 
descent. 
As expected from studies in other multi-ethnic populations, the incidence rate (at 
least in the public sector) appears to be highest in Indians and lower in Africans.  
However, the incidence in Africans has risen by more than tenfold compared to the 
landmark study by Solomon in 1968 [39]. 
The risk factors for hip fractures are similar to those in developed countries and are 
similar in Africans and Indians.  Specifically weight and BMD were significantly lower 
in all fracture cohorts compared to controls including men and women; suggesting 
that men with hip fractures were of smaller frame.  
Despite a low calcium intake in Africans subjects, there is no difference in Vitamin D 
levels in Africans and Indians.  In men, smoking and alcohol use are important risk 
factors.  Surprisingly however, no secondary cause for osteoporosis was identified in 
all fracture cohorts, possibly due to the small sample size.   
Morphometric vertebral fractures occur in all ethnic groups with the highest 




number of subjects having a prior fracture, very few subjects received appropriate 
treatment resulting in a second fracture.  Hip fractures in this study were associated 
with a significant mortality and morbidity.  In addition to other factors, a delay in 
surgery contributed to the increased mortality.  The actual cost of the acute 
treatment of osteoporosis exceeded the normative costs based on current treatment 
guidelines. 
In summary, hip and morphometric vertebral fractures are common in SA.  There 
appears to be under-recognition of osteoporosis and the risk of fractures in this multi-
ethnic population.  Despite the presence of strong risk factors for hip fractures, 
especially a family history of osteoporosis and history of previous fragility fractures, 
osteoporosis is under-diagnosed and under-treated.  Even in the presence of a hip 





This study was undertaken in the public sector and may have led to an under-
representation of the at risk populations especially White and Indian men and 
women.  Further Coloured men and women are under-represented in this 
geographic area.  Known associations may not have been confirmed due to the 
small numbers. 
Furthermore, there is a possible selection bias in the recruitment of controls who 
may have agreed to participate in the study because they perceived themselves to 
be at high risk of osteoporosis.  This may have under or over-estimated the 
association of risk factors in the case control study. 
 
Recommendations 
Larger national studies with adequate representation of all ethnic groups are needed 
to confirm age, gender and ethnicity incidence rates of hip fractures.  Urgent 





Chapter 6 Conclusions 
6.1 Introduction 
The number of hip fractures in Africa is projected to increase exponentially with 
increasing longevity [4, 344].  Based on data from the USA [36, 61] and a single 
South African [39], osteoporotic hip fractures are considered to be rare in Africans.  
Recent studies have however, suggest that osteoporotic fractures (albeit vertebral 
fractures) occur with equal frequency in Africans and Whites in SA [54, 68].  This is 
the first study undertaken in over 40 years to study the demographic profile of 
subjects with hip fractures, the ethnicity and gender based incidence of hip fractures, 
risk factors, outcomes and health care costs of hip fractures in SA. 
 
6.2 Main Findings and Contributions to the Field 
6.2.1 Demographic profile of hip fractures 
Hip fractures were observed in all ethnic groups and in both men and women.  There 
was a significant shift in the female to male ratio from the previous study [39] which 
had shown a male predominance.  The current female to male ratio of 2.8:1 is similar 
to that in developed countries [26,442].  Another significant finding was that hip 
fractures occurred at an earlier age in men, (especially those of Indian descent), 
compared to women, with the majority of fractures occurring before the age of 75 




This has important public health implications.  The current NOFSA guidelines which 
recommend that BMD density be measured at age 70 years in men [88], will need to 
be re-considered given the earlier age of fracture in this study. 
 
6.2.2 Incidence rates 
The crude incidence rate of hip fractures at 94.7 per 100 000 in subjects aged 60 
years and over, while still in the low risk category [518], is the highest reported from 
Africa.  This composite incidence rate reflects the much higher incidence rate in 
Indians as well as the lower incidence in Africans, which is however significantly 
higher than previously reported.  These rates, together with the increasing LE in SA, 
support the projection that the burden of osteoporosis will increase substantially.  
Furthermore there appears to be a difference in the incidence rate in the different 
ethnic groups and further studies are required to confirm this finding.  This will be 
particularly relevant for computing FRAX® algorithms for SA. 
 
6.2.3 Risk factors 
The study confirmed that risk factors for hip fractures are similar to those in 
developed countries and include increasing age, female gender, sideways falls, 
alcohol, smoking, a prior fracture, low vitamin D levels and poor pre fracture 
functional status.  Risk factors may be particularly important in identifying persons at 




In addition, a number of these risk factors are modifiable and can be controlled with 
health education and awareness programs.  South Africa already has anti-smoking 
regulations and these can be strengthened.  In addition, an improved functional 
status can be achieved with exercise and healthy eating programs, and the early 
identification and appropriate management of risk factors for frailty. 
A particular concern is that despite a history of any prior fragility fracture in 27.5% 
and 8.5% and the presence of morphometric vertebral fractures in 32.7% and 20.3% 
of subjects with hip fractures and controls, respectively, only one subject had had a 
prior assessment for osteoporosis.  This highlights the lack of awareness of 
osteoporosis in both health care personnel and the community.  Focussed 
awareness programs, such as the Fracture Liaison Services and Capture the 
Fracture Campaign [462], are needed to treat individuals at highest risk of 
osteoporosis  
Risk factors such as low education, low body weight, low BMI and low serum 
albumin suggest that poor socio-economic and nutritional status is a risk factor for 
osteoporosis [66, 82, 140], contrary to the belief that osteoporosis, like other NCDs, 
is a disease of affluence [75].  With the high rates of poverty and unemployment in 
SA, the poor besides being at higher risk for communicable diseases may also have 
an increased risk of osteoporosis, despite the apparent genetic protection. 
It is also possible that as the control sample was a volunteer based sample certain 
risks may be disproportionately higher in control subjects compared to the general 
population most notably prior falls, prior fractures and family history of osteoporotic 




population but screening is seldom undertaken except in tertiary centres and 
therefore it is possible that controls who were familiar with osteoporosis or had a 
family history of hip fracture were more likely to volunteer.  Further as certain ethnic 
groups notably Whites have a higher use of the private sector the association with 
SES may not be truly be represented. 
Bone density was significantly lower in hip fracture subjects compared to controls 
and the majority of subjects with hip fractures were classified as having osteoporosis 
when T-scores were calculated using the recommended NHANES III reference 
values for White women [559].  This provides support for using this reference 
database in the absence of local data.  In addition, a BMD assessment would have 
correctly identified the majority of subjects requiring anti-osteoporosis treatment.  
The apparent protective effect of any treatment with HRT on hip fracture risk argues 
for the use of this relatively inexpensive treatment option in appropriately selected 
individuals. 
 
6.2.4 Mortality and Morbidity 
The mortality rate is similar to developing countries and was significantly higher in 
Africans subjects.  Other risk factors included lower body weight or BMI, higher 
education status, poor pre-fracture function (difficulty with cooking, taking 
medications or managing finances), decreased mobility, decreased albumin, 
increased CRP and a longer mean hospital stay.  The time to surgery from fracture 
was longer than other studies and exceeded national and international 




which are part of the specialist and subspecialist training platform, screening and 
treatment was not offered to subjects by the attending clinical team.  Survivors of hip 
fractures had a significant deterioration in function and quality of life post fracture 
which did not return to baseline at one year.  
 
6.2.5 Health care costs 
Health care costs were significantly higher than normative costing and these needs 
to be addressed in limited resource setting and considerable savings can be 
achieved by following published hip fracture protocols and screening and treatment 





6.3 Study Limitations 
The study was the first to be conducted in the eThekwini area in KZN.  The ethnic 
mix of the SA population varies significantly in the different provinces.  In KZN, the 
majority of the population is African (81.7%) followed by Indians (9.6%); and just 
1.4% are Coloureds.   
The study only examined public sector patients and therefore is not reliable for the 
White population group and possibly even Indians due to the high usage of private 
health care facilities by these two groups.  The virtual absence of White men may 
have resulted in a younger mean age in the male fracture subjects. 
An attempt was made to obtain data retrospectively from the private sector, but had 
to be abandoned due to problems with incorrect coding.  The incidence rate is 
probably accurate for the public sector and for Africans in eThekwini, but may be 
underestimated for Indians and probably for White women and could not be 
calculated for White men and Coloured men and women.   
Incidence rates need to be investigated periodically to determine trends.  The lack of 
previous incidence rates precludes the determination secular changes in hip fracture 
incidence in SA. 
A substantial proportion of hip fracture subjects gave a history of memory problems 
and this may have introduced recall bias 
The control population in this study was not a population based sample, but 
volunteer subjects recruited by invitation and word of mouth from outpatient 




bias as the more educated and those with chronic medical conditions, previous 
history of falls, concerns about preventing fall complications and prior fragility 
fractures or family history of falls may have been more willing to participate due to 
heightened awareness of osteoporosis and need to exclude the disease or seek 
treatment for it.  This may have confounded the risk factor analysis and 





6.4 Recommendations from the study 
 Awareness and educational programs on osteoporosis and hip fractures need 
to be strengthened and extended to populations not traditionally thought to be 
at risk for osteoporosis in SA. 
 A prospective national hip fracture registry (private and public sector), is 
required to provide critical information on incidence, outcomes and costs. 
 A national study should be undertaken to determine the incidence of hip 
fractures in all population and gender groups. This is required to develop a 
FRAX® tool for SA. 
 Multidisciplinary teams must be implemented for management of hip fractures 
to improve efficiency of care and to decrease mortality and morbidity, and 
should include fragility fracture prevention, acute management of hip 
fractures, rehabilitation, step down and long term care with proper resource 
allocation. 
 Simple preventative measures such as lifestyle, exercise and diet programs, 
supplementation of vitamin D and the appropriate use of HRT should be 





Osteoporosis epidemiological studies used in determining fracture risks for the 
FRAX® model 
 
List of osteoporosis studies 
 













(a) Primary cohorts 
EVOS/EPOS  13,490 52 40,681 50 719 64 40-95 
CaMos 9,101 69 25,834 40 307 62 25-
103 
Rochester 1,001 65 6,227 42 244 57 21-94 
Rotterdam 6,851 59 39,593 220 646 69 55-
106 
DOES 2,089 61 15,994 103 407 71 57-96 
Gothenburg 
II 
1,970 59 15,201 271 350 78 20-89 
Hiroshima 2,603 70 9,825 32 90 65 47-95 
Sheffield 2,170 100 6,894 63 243 80 74-96 
Gothenburg I 7,065 100 29,603 29 312 59 69-86 
Totals 4,6340 68 189,852 850 3,318 65  
(b) Validation cohorts 
SOF 5,251 100 57,388 523 1,313 71 65-99 
EPIDOS 7,435 100 26,665 302 642 81 70-
100 
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Appendix 3.C Information and consent documents: English version 
INFORMATION DOCUMENT 
Study title: Hip Fracture and Osteoporosis 
 
A comparison of the demographic profile, risk factors, outcomes and health care costs in 
geriatric patients with and without osteoporotic hip fractures in the public health sector in the 
eThekwini area. 
 
Good morning/Good afternoon 
 
We, doctors from the Department of Medicine at Nelson R Mandela Medical School, are 
doing research on the hip fractures and osteoporosis.  Research is the process to learn the 
answer to a question.  The answers from this study will assist the doctor in charge of the 
project to obtain a doctoral degree.  In this study we want to learn about how often do people 
aged 60 years and over, break their hip bones, this is the bone which helps you walk.  We 
also want to know what caused your bones to break, and not someone else’s and this is 
called risk factors.  We know that in some people as they get older their bones become less 
strong. This is called osteoporosis, weak bones.  This is mainly due to a decrease in the 
reproductive hormones; the menopause in women and low levels of testosterone in men, 
and an effect of ageing.  There are also a number of other reasons a person’s bone may be 
weaker for example, a lack of calcium in the diet, low vitamin D, no exercise or being 
bedridden, some medication you may have been prescribed, smoking, alcohol intake, 
vitamin D and some medical conditions or due to as yet unknown genetic tendency or 
because weak bones occur in your family.  When a person with weak bones has a minor fall 
he/she may sustain a broken bone which is called a fracture. 
 
You have had a hip fracture and we would like to find out why.  We will be asking you a 
number of questions to look for risk factors for osteoporosis and we will need to take blood 
from a vein in your arm.  We will take approximately 5 teaspoons of blood and this will not 
cause you any harm.  There may be a little pain after we take blood, but this will be for a 
short time only.  In the meantime you will receive the usual treatment from the doctors 
looking after you who are specialist in broken bones called orthopaedic surgeons.  Once you 
are able to move, we will measure your bone mineral density.  This is special test that we do 
that tells us your bone mass that is how strong your bones are.  This is done by a machine 
called a densitometer.  You may need to go to another hospital for this test.  The test will 
take less than 10 minutes and uses a very small dose of radiation, about 1/10th of the dose 
used for a chest radiograph.  Thereafter you will be started on tablets for osteoporosis if the 
result shows us your bones are weak.  We will use medication that is available at the 
hospital to treat you.  All these medications have been previously tested and are safe to use. 
Once you have been treated and sent home, we would like you to come to our clinic where 
we will see how you have improved after your fracture, and how long it takes you to get 






During the next year we also want to calculate how much money you spend because of the 
fracture and how much money you could not make because of the fracture.  This will also 
help us to see how much it cost you and the government every time someone has fracture.  
We will compare this with how much it would have cost if we had you on medication to 
prevent a fracture.  This information will help us make better treatment plans for old people. 
We are inviting you to participate in this research study so we can have more information 
about how common hip fractures and osteoporosis is in our community and what the 
outcome is after people have a hip fracture so we can then design protocols to decrease the 
risk of hip fractures. 
 
What is involved in the study? 
If you agree to participate in this study as a subject i.e. someone who has already had a hip 
fracture then you will be interviewed regarding your medical history and risk factors for fall 
and osteoporosis.  You will have a full examination and blood tests done to look for a cause 
for your fracture.  A sample of blood if you are agreeable will be stored away for future 
genetic testing should a test in the future become available to detect osteoporosis.  There 
are no tests available currently.  See attached genetic tests information sheet for full 
explanation. 
 
You will be required to perform a special radiograph called a bone mineral density test six 
weeks after your fracture and commenced on treatment as required for osteoporosis.  You 
will be reviewed six months and a year later to see how you are doing.  There will be no 
further blood test required during this period for the study unless you have other medical 
conditions which need to be treated and routine tests for these will be performed. 
 
In total 200 hundred patients with hip fractures presenting to hospitals in eThekwini area will 
be assessed and followed up for one year.  After the study period you will be given a referral 
letter to continue appropriate treatment at your local hospital. 
 
If you wish to stop at any stage you will be free to do so and this will not affect your 
treatment in any way.  You will be sent back to your hospital with a letter to continue 
treatment for your hip fracture.  
 
If you are a control subject in the study i.e. someone who is above the age of 60 years and 
has not had a hip fracture then you will be screened for osteoporosis.  This is a silent 
condition.  You will need to do some blood and radiology tests to see if you have had any 
fractures and to assess your risk for fractures.  The test will tell us how strong your bones 
are and what is your fracture risk.  You will be commenced on treatment if your bones are 
found to be weak if you are agreeable and referred to your doctor again. You will have no 
additional costs to participate in this study. 
 
Risks – There are no associated risks from enrolling in the study apart from mild pain to do 






Potential Benefits  
Hip fracture subjects- You will be fully tested for an underlying cause for your broken hip 
bone and if a cause is found which we can treat then you will be started on treatment.  You 
will receive regular follow up visits for one year post hip fracture. 
Controls – You will be tested for osteoporosis, which is a silent disease that occurs without 
causing any problems until you may present with bone pain or a fracture.  Osteoporosis is 
becoming much more common worldwide and by participating in the study you will be 
Screened and provided the chance of commencing treatment if your bones are weak and 
therefore decreasing your chance of getting fractures in the future.  
 
Your participation in this study is voluntary i.e. you can decide whether you want to or not.   
If you refuse to take part it will not change the way you are treated and you can continue to 
come to hospital for treatment.  If you agree to participate in the study you are free to stop at 
any time and this will not affect your treatment in any way in the future 
Confidentiality: While every effort will be made to keep personal information confidential, 
absolute confidentiality cannot be guaranteed as personal information may be disclosed if 
required by law.  Organizations that may inspect and/or copy your research records for 
quality assurance and data analysis include groups such as the Research Ethics Committee, 
Data Safety Monitoring Committee and the Medicines Control Council (where appropriate). 
If results are published, this will be done anonymously.  You will be allocated a code number 
on entering data in file and the code number and name will only be known to principal 
investigator. 
 
Contact details of researcher/s – for further information / reporting of study related adverse 
events. 
Dr F Paruk- 031 2604238 (w) or 0828756786 (cell) 
Dr S Rauf -031 2604283 (w)  
 
Contact details of BREC Administrator or Chair – for reporting of complaints/ problems: 
Biomedical Research Ethics, Research Office, UKZN, Private Bag X54001, Durban 4000 
Telephone: +27 (0) 31 260 4769 / 260 1074 
Fax:   +27 (0) 31 260 2384 
Administrator: Ms P Ngwenya  Email: ngwenyap@ukzn.ac.za 









Information Document: Hip Fracture and Osteoporosis (Blood Storage) 
A comparison of the demographic profile, risk factors, outcomes and health care 
costs in geriatric patients with and without osteoporotic hip fractures in the public 
health sector in the eThekwini area. 
Good morning/Good afternoon 
The study being conducted into hip fractures and osteoporosis is the first in our 
country. We have no data on any genetic risk factors.  Studies from different part of 
the world show there are different genes that increase or decrease a population’s 
group risk for both fractures and osteoporosis.  These tests are not available 
currently in South Africa. 
We would like to take a sample of your blood about one teaspoon and extract from it 
DNA (genetic code) and store the DNA and left over blood for the next five years.  
The blood will be stored anonymously and only the study investigators will know 
which blood matches which patient. 
The blood will be stored in the department of Medicine laboratories in Nelson R 
Mandela School of Medicine, University of Kwa Zulu Natal. 
Should genetic test become available for osteoporosis or hip fracture, only then will 
the blood be analysed.  No blood specimens will leave South Africa.  If no test 
becomes available in the next five years then all stored specimens will be disposed 
according to standard protocols. 
Your blood will not be used for any other purpose apart from as outlined above.  You 
are free to partake in the study even if you do not wish to have your blood specimen 
stored, and this will not impact on your management or follow up in any way. 
If you agree and any genetic markers are found and your test comes back positive 
you will be accordingly informed.  
Approval from BREC our advisory and ethics department will be obtained prior to 






Consent document: Consent to Participate in Research 
Good day  
You have been asked to participate in a research study on Hip Fracture and 
Osteoporosis 
 as a subject or control (delete which is not applicable) 
Dr F Paruk, Specialist in General Medicine at Nelson R Mandela School of Medicine 
will be conducting the study.  The results of this study will help her complete her 
doctoral studies at the University of Kwa Zulu Natal. 
You have been informed about the study by ………………………. . 
You may contact Dr F Paruk at 0828756786 or 031 2604801 at any time if you have 
questions about the research or if you are injured as a result of the research. 
You may contact the Biomedical Research Ethics Office on 031-260 4769 or 260 
1074 if you have questions about your rights as a research participant. 
Your participation in this research is voluntary, and you will not be penalized or lose 
benefits if you refuse to participate or decide to stop at any time. 
If you agree to participate, you will be given a signed copy of this document and the 
participant information sheet which is a written summary of the research. 
The research study, including the above information, has been described to me 
orally.  I understand what my involvement in the study means and I voluntarily agree 
to participate.  I have been given an opportunity to ask any questions that I might 
have about participation in the study. 
____________________   ____________________ 
Signature of Participant   Date 
____________________    _____________________ 
Signature of Witness   Date 
(Where applicable) 
____________________    _____________________ 
Signature of Translator   Date 
(Where applicable) 




Good day  
You have been asked to participate in a research study on Hip Fracture and Osteoporosis 
 As a subject or control (delete which is not applicable) 
Dr F Paruk, Specialist in General Medicine at Nelson R Mandela School of Medicine will be 
conducting the study. 
As part of the study on the causes of hip fracture we would like to store a sample of your 
blood away at the Department of Medicine laboratory in the Nelson R Mandela School of 
Medicine in Umbilo Road, Durban,. University of Kwa-Zulu Natal for the next five years.  The 
blood will be kept anonymously and only the investigators will have the code identification. 
Should a genetic test applicable to hip fractures or osteoporosis only become available 
during this period then the blood will be further analysed.  Blood will not be sent out of South 
Africa for any tests.  If no appropriate test become available then all specimens will be 
discarded following standard disposal procedures for medical waste.  Your blood will not be 
used for any other purposes other than outlined above. 
If a significant genetic test is found and you are positive, you will be informed of the result. 
I hereby agree/do not agree (delete which is not applicable) to having my blood stored for 
the above purpose only. 
If you agree to store your blood, you will be given a signed copy of this document and the 
participant information sheet which is a written summary of the research. 
The research study, including the above information, has been described to me orally. I 
understand what my involvement in the study means and I voluntarily agree to participate.  I 
have been given an opportunity to ask any questions that I might have about participation in 
the study. 
____________________   ____________________ 
Signature of Participant    Date 
____________________   _____________________ 
Signature of Witness    Date 
(Where applicable) 
____________________   _____________________ 





Appendix 3.D: Hip fracture and osteoporosis questionnaire 
A comparison of the demographic profile, risk factors, outcomes and health care 
costs in geriatric patients with and without osteoporotic hip fractures in the public 
health sector in the eThekwini area. 
Date of Interview 
[dd/mm/yy] 
 Study Number  
Name of Investigator  Date corrections checked 
[dd/mm/yy] 
 






A1 I have read the individual information sheet, statement of 

















Section A: DEMOGRAPHIC INFORMATION  
1.  DEMOGRAPHICS 
1.1 Name  
1.2 Date of Birth dd/  mm/yyyy 
1.3 Age (in years)  
1.4 Gender  
1 = Male 
2 = Female 
1.5 Ethnic group  
1 = African 
2 = Coloured 
3 = Indian 
4 = White 
1.6 Hospital 
1 = RKK 
2 = MGH 
3 = PMMH 
4 = ADD 
5 = KEH 
6 = IALCH 
1.7 Hospital Number Inpatient No: Outpatient No: 
1.8 Physical Address  
1.9 
Contact number 
Best number to contact you on 
even if not your personal phone 
 
1.10 Contact person  
1.11 Contact number  
1.12 Housing type 
1 = Formal housing 
2 = Mostly formal housing 
3 = Mostly informal housing 
4 = Squatter housing/impoverished area 
5 = Traditional housing 
6 = Hostels 
7 = Other (specify)_________ 
1.13 Employment 
= Pensioner 
= Unemployed, not looking for work 
= Unemployed, actively looking for work 
= Self employed full time 
= Self-employed part time 
= Employed part-time in formal sector 
= Employed full-time in formal sector 
= Employed part-time in the informal sector 
= Employed full-time in the informal sector 
1.14 Education level 
=  No schooling 
=  Standard 3 or lower 
=  Standard 4 – 5 
=  Standard 6 – 7 
=  Standard 8 – 9 
=  Standard 9 – 10 






2.1.1 Date of fracture dd/mm/yyyy 
2.1.2 Fracture Site and description and fall type 
1= Right 
2= Left 
2.1.3 Treatment modality  
2.1.4 Date of admission dd/mm/yyyy 
2.1.5 Referred by:  
2.1.6 Weight in Kg  
2.1.7 Height in meters  
NOTE:  TO BE COMPLETED AT THE OFFICE 
2.1.8 Body mass index 
0 = BMI less than 19 
1 = BMI 19 to 24.9 
2 = BMI 25 to 29.9 
3 = BMI 30 or greater 
Comorbid Illnesses 
2.2 Has a doctor or other health professional ever told you in the last 12 months that you have any of the following: 
2.2.1 Hypertension 1 = Yes 2 = No  
2.2.2 Diabetes Mellitus 1 = Yes 2 = No  
2.2.3 Arthritis 1 = Yes 2 = No  
2.2.4 Osteoporosis 1 = Yes 2 = No  
2.2.5 Tuberculosis 1 = Yes 2 = No  
2.2.6 HIV/AIDS 1 = Yes 2 = No  
2.2.7 Chronic Back pain 1 = Yes 2 = No  
2.2.8 Mal-absorption 1 = Yes 2 = No  
2.2.9 Chronic diarrhoea 1 = Yes 2 = No  
2.2.10 Rheumatoid Arthritis 1 = Yes 2 = No  
2.2.11 Hyperthyroidism 1 = Yes 2 = No  
2.2.12 Chronic renal failure 1 = Yes 2 = No  
2.2 .13 Metabolic bone disease 
1 = Yes 







Specify current treatment: 








2.2 .14 Chronic liver disease 1 = Yes 2 = No  
2.2 .15 Hyperparathyroidism 1 = Yes 2 = No  
2.2 .16 Multiple myeloma 1 = Yes 2 = No  
2.2 .17 Prolonged immobilization 1 = Yes 2 = No  
2.2 .18 Malignancy 1 = Yes 2 = No  
2.2.19 Hypogonadism (please specify exact diagnosis) 
1 = Yes 
2 = No  
2.2 .20 Other - specify   
2.3 A. Name of medication B. Indication C. Dose D. Duration E. Total Dose 
2.3.1 Glucocorticoids > 3/12     
2.3.2 Anti-epileptics     
2.3.3 Heparin     
2.3.4 Lithium     
2.3.5 Antidepressants     
2.3.6 Other -specify     
2.3.7      
2.3.8      
2.3.9      




3. Section C - Osteoporosis Risk Factors 
3.1 Weight < 57kg 1 = Yes ; 2 = No  
3.2 Fragility fractures after age of 40 years 1 = Yes ; 2 = No  
3.2.a If yes: Date: 
 
dd  /  mm  /  yyyy  
3.2.b Site:   
3.2.c Treatment received: 1 = Yes ; 2 = No  
3.2.d Screened for Osteoporosis 1 = Yes ; 2 = No  
3.2.e Treatment for osteoporosis 1 = Yes ; 2 = No  
3.2.f Specify treatment   
3.3 Vertebral fractures 1 = Yes ; 2 = No  
3.3.a If yes, Date: 
dd  /  mm  /  yyyy 
  
3.3.b Site   
3.3.c Treatment received 1 = Yes ; 2 = No  
3.3.d Screened for Osteoporosis 1 = Yes ; 2 = No  
3.3.e Treatment for osteoporosis 1 = Yes ; 2 = No  
3.3.f Specify treatment   
3.4 Kyphosis 1 = Yes ; 2 = No  
3.5.a Childhood fractures 1 = Yes ; 2 = No 
 
3.5.b Site of Fracture  
3.6 History of falls 1 = Yes ; 2 = No  
3.6.a If yes, Date: dd  /  mm  /  yyyy  
3.6.b Type –sideways 1 = Yes ; 2 = N  
3.6.c Type –forward 1 = Yes ; 2 = No  
3.6.d Type – other (Specify)   
3.7 Family history of osteoporosis 1 = Yes ; 2 = No  
3.8 Maternal history of falls 1 = Yes ; 2 = No  
3.9 Maternal history of fractures 1 = Yes ; 2 = No  
3.10 Gynaecological History   
3.10.1 Para   
3.10.2 Age of menarche (in years)   
3.10.3 Age of menopause (in years)   
3.10.4 Use of hormone replacement therapy 1 = Yes 2 = No  
3.10.4.a 
If yes, 




3.11 Lifestyle factors   
3.11.1 Illicit drugs 1 = Yes 2 = No  
3.11.2 Caffeine (cups per day) Coffee Tea  
3.11.3 Sunlight exposure  -hours/day   
3.11.4 Activity level   
3.11.5 Exercise level 
1 = Extremely Active 
2 = Moderate 
3 = mild 






4.1 Do you smoke? 1= yes, regularly Go to 4.2 
2= no Go to 4.5 
3= occasionally go to 4.3 
 
4.2 On average, how many cigarettes do you 
smoke a day? 
  
4.3 On how many days a week do you smoke 
cigarettes? 
1= usually on one day or less 
2= usually on 2 to 4 days 
3= almost everyday 
 
4.4 Did you ever smoke cigarettes regularly in the 
past? 
1= yes, regularly Go to 4.5 
2= no Go to 4.8 
 
4.5 When did you stop smoking cigarettes 
regularly? If in the last 12 months 
1= less than 1 month ago 
2= 1 – 6 months ago 
3= 6 -12 months ago 
 
4.6 What is the highest average daily number of 
cigarettes you have ever smoked for as long as 
a year? 
  
4.7 How old were you when you began to smoke 
cigarettes regularly? 
  
4.8 Have you ever smoked cigars/cigarillos? 1= yes, regularly Go to 4.9 
2= no Go to 4.10 
3= occasionally (less than one a 
day)go to 4.9 
 
4.9 How many do you smoke a day?   
4.10 Have you ever smoked a pipe? 1= yes, regularly Go to 4.11 
2= no  
3= occasionally Go to 4.11 
 
4.11 About how many grams of tobacco do you 
smoke per week? 
  
4.12 To be completed by occasional or non-smokers 
For how many hours, on average each day, are 
you closely subjected to people’s tobacco 
smoke? 
  
5. ALCOHOL USE 
5.1 How many alcoholic drinks did you have each day last week? 
5.2 We’ll start with yesterday and take one day at a time (one drink= 12g of alcohol) 
1. Sunday  -   
2. Saturday -   
3. Friday  -   
4. Thursday -   
5. Wednesday -   
6. Tuesday -   
7. Monday -   
  Score  
1 bottle of beer  = 1 drink 1 bottle of alcohol 75cl =25 drinks 
1 bottle of strong beer =1,5 drinks 1 glass of red/ white 
wine  
=1 drink 
1 bottle of red/ white wine  = 6 drinks 1 glass of port wine =1 drink  






6. Calcium intake calcium calculator  
Food Serving Size (average) /Calcium How many servings? 
    










Milk, semi-skimmed glass, 200 ml / 240 mg           
Milk skimmed glass, 200 ml / 244 mg           
Milk whole glass, 200 ml / 236 mg           
Milkshake takeaway, 300 ml / 387 mg           
Soy drink, calcium enriched glass, 200 ml / 178 mg           
Yoghurt and cream             
Yoghurt, low-fat, fruit pot, 150 g / 210 mg           
Yoghurt, low-fat plain pot, 150 g / 243 mg           
Cream, double, whipped portion, 45 g / 26 mg           
Cream, single tablespoon, 15 g / 13 mg           
Cheeses             
Danish blue portion, 40 g / 195 mg           
Edam portion, 40 g / 318 mg           
Feta portion, 40 g / 144 mg           
Camembert portion, 40 g / 94 mg           
Cheddar medium chunk,  
40 g / 296 mg           
Cheese spread portion, 30 g / 149 mg           
Cottage small pot, 112 g / 142 mg           
Mozzarella, fresh portion, 56 g / 203 mg           
Parmesan, fresh portion, 30 g / 308 mg           
Vegetables             
Broccoli, boiled serving, 85 g / 34 mg           
Watercress, raw small bunch, 20 g / 34 mg           
Curly kale serving, 95 g / 143 mg           
Okra, stir fried 8 medium, 40 g / 88 mg           
Red kidney beans, canned 3 tablespoons,  
105 g / 75 mg           
Chick peas, boiled 3 tablespoons, 90 g / 41 mg           
Green / French beans serving, 90 g / 50 mg           
Baked beans serving, 135 g / 72 mg           
Nuts             
Almonds 12 whole, 26 g / 62 mg           
Brazil nuts 6 whole, 20 g / 34 mg           
Hazelnuts 20 whole, 20 g / 28 mg           
Sesame seeds 1 tablespoon, 12 g / 80 mg           
Walnuts 12 halves, 40 g / 38 mg           
Tahini paste 1 heaped teaspoon,  




Food Serving Size (average) /Calcium How many servings? 
    










Desserts             
Cheesecake, fruit average slice,  
120 g / 94 mg           
Custard made with milk average portion,  
120 g / 166 mg           
Rice pudding, canned average portion,  
200 g / 176 mg           
Ice cream, dairy, vanilla average serving,  
75 g / 75 mg           
Fromage frais, fruit small pot, 60 g / 52 mg           
Fish             
Sardines in oil, tinned portion, 100 g / 500 mg           
Whitebait, fried portion, 80 g / 688 mg           
Salmon, tinned average portion,  
100g / 91 mg           
Fish paste small jar, 35 g / 98 mg           
Breads and grains             
Pasta, plain, cooked portion, 230 g / 85 mg           
Rice, white, boiled portion, 180 g / 32 mg           
White bread slice, 30 g / 53 mg           
Wholemeal bread slice, 30 g / 32 mg           
Muesli, Swiss style portion, 50 g / 55 mg           
Fruits             
Apricots, raw, no stone 4 fruit, 160 g / 117 mg           
Figs, ready to eat 4 fruit, 220 g / 506 mg           
Currants 2 tablespoons, 50 g / 47 mg           
Orange peeled, 160 g / 75 mg           
Other foods             
Tofu, soy bean, steamed 100 g / 510 mg           
Omelette, cheese 2 eggs, 120 g / 344 mg           
Quiche, cheese & egg average slice,  
140 g / 367 mg           
Macaroni cheese portion, 220 g / 374 mg           
Pizza, cheese & tomato 9" - 10" pizza, 410 g / 873 mg           
Lasagne portion, 420 g / 420 mg 
     
Total Amount:  







7. FALL ASSESSMENT  
 Fall – Risk Screening:  Multifactor Questionnaire   
7.1 General:    
7.1.1 Have you ever fallen?   
1 = Yes 
2 = No  
7.1.1a If so, how many times?   
7.1.2 Have you experienced a near fall? (E.g. slip, trip, stumble or bumped against a wall? 
1 = Yes 
2 = No  
7.1.3 Have you previously reported any falls to a health professional?  
1 = Yes 
2 = No  
7.1.3a If so, how many falls?   
7.1.4 Have you ever sought medical attention for a fall? 
1 = Yes 
2 = No  
7.1.5 If you fell, would you need help to get back up from the ground? 
1 = Yes 
2 = No  
7.1.6 
Have you limited any of your activities or 
decreased how much you leave your home due 
to a fall, near fall, or fear of falling? 
1 = Yes 
2 = No  
7.1.7 Have you ever broken a bone? 1 = Yes 2 = No  
7.1.8 Have you been diagnosed with osteoporosis? 1 = Yes 2 = No  
7.1.8a 
If so, are you not currently taking calcium, 
vitamin D supplements and/or medications to 
stimulate bone growth? 
1 = Yes 
2 = No  
7.1.9 Do you exercise less than 30 minutes a day most days of the week? 
1 = Yes 
2 = No  
7.2 Syncope/Drop Attack/ Sudden Unexplained Falls:    
7.2.1 Have you ever fallen because of sudden, unexpected fainting or blackouts? 
1 = Yes 
2 = No  
7.3 Sensory Problems:   
7.3.1 Do you have vision problems? 1 = Yes 2 = No  
7.3.1a Blurry, not as sharp 1 = Yes 2 = No  
7.3.1b Difficulty seeing to the side or different depths or distances 
1 = Yes 
2 = No  
7.3.2 Sensitive to light or changing light 1 = Yes 2 = No  
7.3.3 Do you have decrease feeling, numbness or tingling in your feet? 
1 = Yes 
2 = No  
7.3.4 Are you ensure of your footing or have trouble on uneven ground or inclines? 
1 = Yes 
2 = No  
7.4 Medication Risk:      
7.4.1 Do you take more than 3 prescription medications each day? 
1 = Yes 
2 = No  
7.4.2 Do you take any medications?   
7.4.2a To help you sleep? 1 = Yes 2 = No  
7.4.2b To help control mood (e.g. anxiety, depression) 1 = Yes 2 = No  
7.4.2c To prevent seizures? 1 = Yes 2 = No  
7.4.2d To control heart rhythm? 
1 = Yes 







Have there been any recent changes to your 
medications (e.g. drugs/ dose that have made 
you feel dizzy or unsteady? 
1 = Yes 
2 = No  
7.4.4 Do you have more than one drink of alcohol in a day? 
1 = Yes 
2 = No  
7.5 Acute or Significant Medical Problems:    
7.5.1 Have you recently had flu-like symptoms or felt unwell at the time of a fall or near fall? 
1 = Yes 
2 = No  
7.5.2 Do you have health problems that limit your activity? 
1 = Yes 
2 = No  
7.6 Indication of Cognitive Problems:    
7.6.1 
Do you notice that you have problems with your 
memory? (More than normal, more than other 
people your age do) 
1 = Yes 
2 = No  
7.6.2 Do families or friends say that you have problems with your memory? 
1 = Yes 
2 = No  
7.6.3 
Do you have trouble completing familiar tasks 
(get muddled when doing so)? E.g. writing a 
cheque, finding your way in a familiar store/ mall) 
1 = Yes 
2 = No  
7.7 Environmental hazards: Where have you fallen?   
7.7.1 Inside your home 1 = Yes 2 = No  
7.7.2 Outside your home 1 = Yes 2 = No  
7.7.3 In the community at large 1 = Yes 2 = No  
7.7.4 Have you fallen repeatedly in any one place? 1 = Yes 2 = No  
7.7.5 
Were there any hazards in the environment 
where you feel, that you think contributed to your 
falls? 
1 = Yes 
2 = No  
7.7.6 
Do you think that a safety check of your home, 
yard and/ or neighbourhood could assist you to 
avoid future falls? 
1 = Yes 
2 = No  
7.8 – Gait / Mobility Problems:    
7.8.1 Do you sometimes feel unsteady when you walk? 
1 = Yes 
2 = No  
7.8.2 Do you think your walking method puts you at risk for falling? 
1 = Yes 
2 = No  
7.8.3 Do you choose not to use a gait aid even though people tell you it is safer? 
1 = Yes 
2 = No  
7.8.4 Do you have problems or concerns getting in or out of a bed, chair, tub or toilet? 
1 = Yes 
2 = No  
7.8 Balance Problems:   
7.8.1 Do you feel you have decreased balance? 1 = Yes 2 = No  
7.8.2 Do you sometimes feel off balance, dizzy or unsteady when you walk? 
1 = Yes 
2 = No  
7.9 Endurance Problems / Weakness:   
7.9.1 Do you feel you have leg weakness or that tire easily when you walk? 
1 = Yes 
2 = No  
7.10 Pain / Joint Problems:   
7.10.1 Do you have any sore joint or arthritis? 1 = Yes 2 = No  





8. PHYSICAL SELF-MAINTENANCE SCALES  
 Are you able to perform the following activities?  
Prior to 
fracture 
3/12 6/12 1yr 
8.1 Eating 
2 = without help 
1 = with some help 
0 = Unable to do  
- = not answered 
 
   
8.2 
Dressing and Undressing 
(able to pick out clothes, 
dress and undress 
yourself) 
2 = without help 
1 = with some help 
0 = Unable to do  
- = not answered 
 
   
8.3 
Take care of your 
appearance (combing your 
hair, shaving – for men) 
2 = without help 
1 = with some help 
0 = Unable to do  
- = not answered 
 
   
8.4 
Walking 
*Except with a walking 
stick 
2 = without help 
1 = with some help 
0 = Unable to do  
- = not answered 
 
   
8.4a *Help from person, walking frame, crutches 
2 = without help 
1 = with some help 
0 = Unable to do  
- = not answered 
 
   
8.5 Getting into and out of bed  
2 = without help 
1 = with some help 
0 = Unable to do  
- = not answered 
 
   
8.5a *Help from person or aid 
2 = without help 
1 = with some help 
0 = Unable to do  
- = not answered 
 
   
 8.6 
Bathing (taking a bath, 
shower, or bath using a 
basin) 
2 = without help 
1 = with some help 
0 = Unable to do  
- = not answered 
 
   
8.7 Getting to the toilet on time 
2 = without help 
1 = with some help 
0 = Unable to do  
- = not answered 
 
   
8.7a *have a catheter or colostomy 
2 = without help 
1 = with some help 
0 = Unable to do  
- = not answered 
 
   
8.8 
How often do you wet or 
soil yourself (either day or 
night)? 
1 = once or twice a 
week 
0 = 3 times a week or 
more 
- = not answered 
 
   







9. INSTRUMENTAL ACTIVITIES OF DAILY LIVING 
Provide an answer that best 
applies to your situation for the 
following activities:  
Can you? 
 Pre 3/12 6/12 1yr 
9.1 Use the telephone 
1 = Completely unable to do  
2 = with some help 
3 = without help 
 
   
9.2 Get to places that are out of walking distance  
1 = Completely unable to do  
2 = with some help (unless 
special arrangements are 
made) 
3 = without help 
 
   
9.3 Go shopping for groceries 
1 = Completely unable to do  
2 = with some help  
3 = without help 
 
   
9.4 Prepare your own meals.  
1 = Completely unable to do  
2 = with some help  
3 = without help 
 
   
9.5 Do your own housework  
1 = Completely unable to do  
2 = with some help  
3 = without help 
 
   
9.6 Do your own handyman work  
1 = Completely unable to do  
2 = with some help  
3 = without help 
 
   
9.7 Do your own laundry  
1 = Completely unable to do  
2 = with some help  
3 = without help 
 
   
9.8a 
Do you take your own  
medicines 
 
*in the right doses at the 
right time 
*take medicine if someone 
prepares it  
1 = Completely unable to do  
2 = with some help  
3 = without help 
 
   
9.8b 
If you had to take medicine 
could you do it 
*in the right doses at the 
right time 
*take medicine if someone 
prepares it  
1 = Completely unable to do  
2 = with some help  
3 = without help 
 
   
9.9 Manage your own money  
1 = Completely unable to do  
2 = with some help  
3 = without help 
 
   






10. QUALITY OF LIFE  
What now follows are 5 questions about different topics. Each of the questions has 3 response possibilities. Could you 
please circle the number before the answer that suits you best? 
   Pre 3/12 6/12 1yr 
10.1 Mobility 
1=I have no problems walking 
2= I have some problems walking 





1=I have no problems washing or dressing myself 
2= I have some problems washing or dressing 
myself 
3= I am not able to wash or dress myself 
 
   
10.3 
Daily activities ( for 
example work, study, 
household tasks, family 
or leisure activities) 
1=I have no problems doing my daily activities 
2= I have some problems doing my daily activities 
3= I am not able to do my daily activities 
 
   
10.4 Pain/Complaints 
1=I have no pain or other complaints 
2= I have some pain or other complaints 
3= I have severe pain or other complaints 
 
   
10.5 Mood 
1=I am not anxious or depressed 
2= I am mildly anxious or depressed 
3= I am severely anxious or depressed 
 
   













11. OSWESTRY DISABILITY QUESTIONNAIRE 
As above 
   
Pre 3/12 6/12 
1yr 
11.1 Section 1 Pain Intensity 
1= I have no pain at the moment 
2= The pain is very mild at the moment 
3= The pain is moderate at the moment 
4= The pain is fairly severe at the moment 
5= The pain is very severe at the moment 
6= The pain is the worst imaginable at the 
moment 
   
 
11.2 
Section 2: Personal 
Care (e.g. washing, 
dressing) 
1=I can look after myself normally without causing 
extra pain 
2= I can look after myself normally but it causes 
extra pain 
3= It is painful to look after myself and I am slow 
and careful 
4= I need some help but can manage most of my 
personal care 
5= I need help every day in most aspects of self-
care 
6= I do not get dressed, wash with difficulty and 
stay in bed 
   
 
11.3 Section 3: Lifting 
1= I can lift heavy weights without extra pain 
2= I can lift heavy weights but it gives me extra 
pain 
3= Pain prevents me lifting heavy weights off the 
floor but I can manage if they are conveniently 
placed e.g. on a table 
4= Pain prevents me lifting heavy weights but I 
can manage light to medium weights if they are 
conveniently positioned 
5= I can only lift very light weights 
6= I cannot lift or carry anything 
   
 
11.4 Section 4: Walking* 
1= Pain does not prevent me walking any 
distance 
2= Pain prevents me from walking more than 2 
kilometres 
3= Pain prevents me from walking more than 1 
kilometre 
4= Pain prevents me from walking more than 500 
metres 
5= I can only walk using a stick or crutches 
6= I am in bed most of the time 
   
 
11.5 Section 5: Sitting 
1= I can sit in any chair as long as I like 
2= I can only sit in my favourite chair as long as I 
like 
3= Pain prevents me sitting more than one hour 
4= Pain prevents me from sitting more than 30 
minutes 
5= Pain prevents me from sitting more than 10 
minutes 
6= Pain prevents me from sitting at all 
   
 
11.6 Section 6: Standing 
1= I can stand as long as I want without extra 
pain 
2= I can stand as long as I want but it gives me 
extra pain 





3= Pain prevents me from standing for more than 
1 hour 
4= Pain prevents me from standing for more than 
30 minutes 
5= Pain prevents me from standing for more than 
10 minutes 
6= Pain prevents me from standing at all 
11.7 Section 7: Sleeping 
1= My sleep is never disturbed by pain 
2= My sleep is occasionally disturbed by pain 
3= Because of pain I have less than 6 hours 
sleep 
4= Because of pain I have less than 4 hours 
sleep 
5= Because of pain I have less than 2 hours 
sleep 
6= Pain prevents me from sleeping at all 
   
 
11.8 Section 8: Sex Life (if applicable) 
1= My sex life is normal and causes no extra pain 
2= My sex life is normal but causes some extra 
pain 
3= My sex life is nearly normal but is very painful 
4= My sex life is severely restricted by pain 
5= My sex life is nearly absent because of pain 
6= Pain prevents any sex life at all 
   
 
11.9 Section 9: Social Life 
1= My social life is normal and gives me no extra 
pain 
2= My social life is normal but increases the 
degree of pain 
3= Pain has no significant effect on my social life 
apart from 
limiting my more energetic interests e.g. sport 
4= Pain has restricted my social life and I do not 
go out as often 
5= Pain has restricted my social life to my home 
6= I have no social life because of pain 
   
 
11.10 Section 10: Traveling 
1= I can travel anywhere without pain 
2 =I can travel anywhere but it gives me extra 
pain 
3=Pain is bad but I manage journeys over two 
hours 
4=Pain restricts me to journeys of less than one 
hour 
5=Pain restricts me to short necessary journeys 
under 30 minutes 
6=Pain prevents me from traveling except to 
receive treatment 
   
 
 
Score: / x 100 = % 
measurement) 
Score calculated out of 
no of sections 
answered 
 
   
 
12. Visual Analogue Scale (VAS) 
 Date Score 
Pre fracture   
Post fracture   
3/12   
6/12   





13. Section E - Full physical examination 
General examination   
Colour   
Hydration   
Muscle wasting   
Lymphadenopathy  
Clubbing  
Other –general examination   
Cardiovascular system   
Pulse rate  
Blood Pressures   
Heart sounds   
Cardiac failure signs- specify   
Respiratory   
Chest examination   
Deformities   
Lung fields   
Abdomen   
Visceromegaly   
Vision – Counting fingers   
Cranial nerves abnormalities Right Left 
Tone    assessment Right Left 
Power  upper limbs Right Left 
Lower limbs Right Left 
Sensation Light touch  
 Joint Position Sense  
 Vibration  











4. Section F - Biochemical Investigations  Date Date Date Date 
  Results     
Full blood count Hb     
WBC       
Platelets     
MCV     
MCH 
    
    
    
    
    
Urea and electrolyte Na      
K        
Cl     
Bicarb      
Urea        
Creat 
    
    
    
    
    
    
Liver function test TP       
ALB      
Bil     
ALT        
ALP         
GGT  
    
    
    
    
    
    
Random glucose      
Calcium and phosphate and magnesium cCa               
PO4             
Mg 
   
    
    
Thyroid function test TSH                      
T4     
T4     
25 Vitamin D      
Parathyroid hormone      
C-reactive protein      
ESR      
LH      
FSH      
Oestrogen      
Total Testosterone      
SPEP      
 
 
     
      
 
15. Section G - Radiological Investigation 
  date XR No. Report 
1. X-Ray Hip                              




3. Bone mineral Density    
Date   
Height   
Weight   
Score opposite hip   
Spine   
Splinting   
Surgery- type   
Anesthetist visit   
Physiotherapist   





Appendix 3.E List of normal reference values for haematological and biochemical 
investigations 
Test Normal values 
Haemoglobin (g/dl) 13 – 17 g/dl 
White cell count (×109/L) 4 – 10 x109/l 
Sodium (mmol/L) 136 – 145 mmol/L 
Urea (mmol/L) 2.1 – 7.1 mmol/L 
Creatinine (umol/L) 64 – 104 umol/L 
Total protein (g/L) 60 – 78 g/L 
Albumin (g/L) 35 -52 g/L 
Bilirubin (umol/L) 5 – 21 umol/L 
Alanine transaminase (IU/L) 10 - 40 U/L 
Gamma glutamyl transferase (IU/L) 0 – 60 U/L 
Glucose (mmol/L) 3.5 – 6.8 mmol/L 
Calcium (mmol/L) 2.15 – 2.55 mmol/L 
Thyroid stimulating hormone (uI/L) 0.35 – 5.5 mIU/L 
25(OH) Vitamin D 
(nmol/L) 
<12.48 nmol/L Severe vitamin D deficiency 
24.96 – 49.92 Mild 
49.92 – 174.72 Vitamin D sufficiency 
74.88 – 174.72 Desirable for osteoporosis 
treatment 
Parathyroid hormone (pg/ml) 1.2 – 7.1 pg/ml 
C-Reactive protein (mg/L) 0-5 mg/L 
Erythrocyte sedimentation rate (mm/hr) 0 – 30 Mm/hr 
Oestrogen (pmol/L) 
(women only) 
10 – 60 nmol/L 
Testosterone 
(men only) (nmol/L) 









Appendix 3.F Bone Mineral Density Calibration  
This calculator is intended for use by advanced bone densitometritsts only. 
It may be considered for special clinical practice situations and for clinical research. 
Please note that the ISCD recommends expressing precision as RMS SD, and LSC at the 95% 
confidence level. 
The calculator may be used for: 
1. Calculate precision error with as many as 50 patients. 
2. Express precision error as RMS SD (absolute value in g/cm2), CV, or %CV. 
3. Express LSC (Least Significant Change) with a choice of confidence levels 
 
Instructions: Enter BMD measurements to 3 decimal places for at least 15 patients scanned 3 times each,  
or 30 patients scanned 2 times each.  
Precision and LSC must be calculated separately for each skeletal site and ROI (L1-L4, 
 total proximal femur, femoral neck, etc.). 
BMD results from as many as 50 patients may be entered. The calculator does the rest. 
 
Phantom results 




























Number of Patients n =30 
Sum of SD (sq) Sum = 0.06676 
Sum of SD (sq / n) Sum / n = 0.002225 
Square Root of above SqRT = 0.047 
Root Mean Square SD RMS SD = 0.047 g/cm2 
Coefficient of Variation CV = 0.048 
Percentage Coefficient of Variation %CV = 4.84% 
 
LSC with Different Levels of Confidence 
LSC based on at least 15 patients with triplicate scans 
Precision 95% 90% 85% 80% Units 
            
RMS SD 0.131 0.110 0.097 0.085     g/cm2 
            
CV 0.134 0.113 0.099 0.088   
            
%CV 13.42 11.28 9.93 8.77     % 
      LSC based on at least 30 patients with duplicate scans: 
LSC with Different Levels of Confidence 
Precision 95% 90% 85% 80% Units 
            
RMS SD 0.131 0.110 0.097 0.085     g/cm2 
            
CV 0.134 0.113 0.099 0.088   
            
%CV 13.42 11.28 9.93 8.77     % 















Staff cost per patient 
Staff Fixed cost - time Average cost per patient 
Enrolled Nurse 0.17 1085.92 
Registrar 0.25 11515.70 
Anaesthetist 0.25 8479.96 
Paramedic 0.25 1391.52 
Specialist surgeon 0.25 9950.49 
Interns 0.66 1219.70 
Pharmacist 0.42 9038.19 
Porter 1.17 2075.84 
Radiologist 1.92 4826.24 
Clerks Level 4 3.08 5102.92 
Medical officer 3.17 
 Professional Nurse 7.00 79472.89 
Grand Total 18.58 





Cost at referral clinic/hospital 


























Clerks Level 4 0.17 114.70 
Medical officer 0.17 2292.82 








The following tables were used to calculate cost based on time spent by staff 
Clinic 
Procedure Staff   Time Hours 
Admission Clerk   10 0.16667 
Treatment plan Medical officer   10 0.16667 
Referral  Paramedic   Distance   
Treatment plan PN   30 0.5 
Dr Referral 
Procedure Staff   Time Hours 
Dr Consult Medical officer   20 0.33333 
X-ray Radiologist   20 0.33333 
Bloods Lab   Price List   
Referral  Paramedic   Distance   
Hospital 
Location / Procedure Staff  Event Time - Min Hours 
Outpatient         
Sorting Stretcher PN Once off 5 0.08 
Transport Porter Once off 10 0.17 
Admission Clerk Once off 10 0.17 
Trauma         
Vitals EN Once off 10 0.17 
Treatment Plan Medical officer Once off 10 0.17 
X-ray Dept.         
Radiologist Radiologist Once off 15 0.25 
Log X-ray Clerk Once off 10 0.17 
Transport Porter Once off 10 0.17 
Trauma         
Treatment Plan Medical officer Once off 10 0.17 
Transport Porter Once off 10 0.17 
Orthopaedic Outpatients         
Admission Clerk Once off 15 0.25 
Treatment Plan Registrar Once off 15 0.25 
Splint Room PN Once off 30 0.50 
Bloods Interns Once off 10 0.17 
Transport Porter Once off 10 0.17 
X-ray Dept.         
Transport Porter Once off 10 0.17 
CXR Radiologist Once off 15 0.25 
Surgical Ward         
Admission PN Once off 15 0.25 
Dr Review Medical officer Once off 15 0.25 




Meals Auxiliary PN Daily x3 5 0.08 
Meal preparation Catering Price list     
Linen change Auxiliary PN Daily 5 0.08 
Review Registrar Daily 15 0.25 
Review Interns Daily 15 0.25 
Surgeon Review Specialist surgeon Once off 15 0.25 
Anaesthetists review Anaesthetists Once off 15 0.25 
Vitals PN Daily X 6 10 0.17 
Consumables          
IV Line PN Change 72 hours 10 0.17 
Foleys PN Change 72 hours 10 0.17 
Cot Bed PN Once off 10 0.17 
Traction PN Once off 30 0.50 
Blood Glucose PN Daily 5 0.08 
Additional Tests         
ECG PN Once off 30 0.50 
Bloods Interns Once off 10 0.17 
Medications         
Administering Medications PNs Six hourly - daily 30 0.50 
Theatre         
Location / Procedure Staff  Event Time - Min Hours 
Transport Porter Once off 10 0.17 
Pre Surgery prep PN Once off 15 0.25 
Prosthetic type   Once off Price list   
Surgeon time Surgeon Once off Theatre time   
Theatre facility time Rate per hour Once off Theatre time   
X-ray Radiologist Once off 15 0.25 
PN assistance PN Once off Theatre time   
Anaesthetists cost Anaesthetists Once off Theatre time   
Theatre medications Medications Once off Price list   
Theatre consumables 
Surgical 
Consumables Once off Price list   
CSSD equipment   Once off Price list   
Post Op - Surgical Ward         
Location / Procedure Staff  Event Time - Min Hours 
Transfer ward Porter Once off 10 0.17 
PN Monitoring PN Daily 30 0.50 
Registrar review Registrar Daily 10 0.17 
Surgeon review Surgeon Daily 10 0.17 





Meals Auxiliary PNs Daily 60 1.00 
Linen Change Auxiliary PNs Daily 5 0.08 
Linen Wash Laundry Daily Per kg   
Hospital Gowns Laundry Daily Per kg   
Medications PN Daily 30 0.50 
Bloods Intern Once off 10 0.17 
X-ray Radiologist Once off 10 0.17 
Physiotherapist Physiotherapist Daily 30 0.50 
OT 
Occupational 
Therapist Daily 30 0.50 
Crutches Stores Once off Price List   
Wheelchair Stores Once off Price List   
Discharge - Transfer 
Clairwood         
Location / Procedure Staff  Event Time - Min Hours 
Discharge Clerk Clerk Once off 15 0.25 
Transport  Ambulance Paramedic Once off 15 0.25 
Admission PN Once off 15 0.25 
Dr Review Medical officer Once off 15 0.25 
Admission Ward Clerk Once off 15 0.25 
Review Interns Daily 15 0.25 
Vitals PN Daily X 6 30 0.5 
Medications Pharmacist Once off 15 0.25 
Consumables          
IV Line PN Change 72 hours 10 0.16667 
Foleys PN Change 72 hours 10 0.16667 
Cot Bed PN Once off 10 0.16667 
Traction PN Once off 30 0.5 
Blood Glucose PN Daily 5 0.08333 
Medications PN Daily 30 0.5 
Bloods Intern Once off 10 0.16667 
Physiotherapist Physiotherapist Daily 30 0.5 
OT 
Occupational 
Therapist Daily 30 0.5 
Discharge - Home         
Location / Procedure Staff  Event Time - Min Hours 
Discharge Clerk Clerk Once off 15 0.25 
Dr Review Medical officer Once off 15 0.25 
Consumables - removal         
IV Line PN Change 72 hours 10 0.16667 
Foleys PN Change 72 hours 10 0.16667 
Cot Bed removal PN Once off 10 0.16667 
Traction removal PN Once off 30 0.5 
Discharge meds PN Once off 10 0.16667 




Discharge - Death         
Location / Procedure Staff  Event Time - Min Hours 
Discharge Clerk Clerk Once off 15 0.25 
Dr Review Medical officer Once off 15 0.25 
Consumables - removal         
IV Line PN Change 72 hours 10 0.16667 
Foleys PN Change 72 hours 10 0.16667 
Cot Bed removal PN Once off 10 0.16667 
Traction removal PN Once off 30 0.5 
Other         
Family Notification PN Once off 10 0.16667 
Family Notification Medical officer Once off 10 0.16667 
Follow up treatment 2 weeks 
Location / Procedure Staff  Event Time - Min Hours 
Outpatient visit Clerk Once off 15 0.25 
Remove stitches PN Once off 30 0.5 
Review Medical officer Once off 20 0.33333 
 
Sum of Hours 
 
        
Row Labels 
Applied on separate 





Anaesthetists     0.25   0.25 
Auxiliary PNs   0.17     0.17 
Auxiliary PN   0.33     0.33 
Catering           
Clerk 0.17   2.83   3.00 
EN     0.17   0.17 
Intern     0.33   0.33 
Interns   0.50 0.33   0.83 
Lab           
Laundry           
Medical officer 0.50   3.17   3.67 
Medications           
Occupational Therapist   0.50     0.50 
Paramedic     0.25   0.25 
Pharmacist     0.42   0.42 
Physiotherapist   0.50     0.50 
PN   3.17 7.00   10.17 
PNs   0.50     0.50 
Porter     1.17   1.17 




Rate per hour           
Registrar   0.25 0.25   0.50 
Registrar   0.17     0.17 
Specialist surgeon     0.25   0.25 
Stores           
Surgeon   0.17     0.17 
Surgical Consumables           
Ward Clerk     0.25   0.25 
(blank)           











Bone mineral density 
scan   472.00  
Chest radiograph   167.00  
Radiograph of the hip   167.00  
CT head / chest   2 257.00  
Ultrasound abdomen   472.00  
ECG   167.00  
Echo    472.00  
      
Thompsons Prosthesis   2 974.00  
Clinic / District Hospital Costs 
Normal time   
Staff  Average cost per patient 









Clerks Level 4 114.7029231 
Medical officer 2292.824654 
Professional Nurse 2314.042308 
Grand Total 5856.0545 




Bipolar Prosthesis   2 974.00  
      
General Ward Fees   1592.00 per day  
High Care Fees   3430.00 per day  
ICU Fees   7130.00 per day  
      
Theatre costs  
Category A  
free patients)   2 065.00  
Category B   3 177.00  
Category C    5 408.00  
Category D   13 898.00  
Hospital de-identified patient data: Detailed costing 
Average cost per patient : Hip fracture 2010/2011 
Ward Fees 17 days 21 607.00  
Theatre Fees   12 306.00  
Medication Fees   1 200.00  
Pathology Fees    425.00  
Radiology Fees   4 800.00  
Length of Stay 17 days   
Consumables    Material number  
Epidural pack    16F E302520 / 18F E3025202 / 17F 3025203  
Skin Staples    E3056002  
Post Op Dressing    E3023428  
Vicryl    E3023695  
Oxygen (price per minute )     
O2 Mask Set    E30368938  
IV line sets    E3049016 / E3049090 / E3049091  
Syringes (10cc, 5cc, 20cc)    E3057218 / E3057236 / E3057219  
Cotton wools    E3056803  
Jelco (different size)    24G E3006210 / 14G E3006212 / 16G E3006213  
     18G E3006214 / 20G E3006215 / 22G E3006209 /24G E3006211  
Foleys catheter    E3013300  
Porto vacuum wound drain    -  
Needles  
(different sizes)    18G E5169899 / 20G E5169899 / 21G E5169909 / 22G 5169904  
Bio-scrub hand sanitizer    E400192  






















1. RKK 76 1076 220 199 41 1536 20 79583 60764 793 
2. MGMH 26 478 97 94 12 681 26 27767 31286 987 
3. PMMH 14 357 70 66 14 507 36 16250 19944 53 
4. ADD 55 611 119 103 34 867 16 61274 39537 1944 
5. KEH 29 551 111 105 27 794 27 33397 39374 1786 
Grand 























s cost Total Cost 
Per 
patient General Spinal 
No  
Surgery 
1. RKK 76   65 11 74 15 793 180757 2790713 151665 141412 533358 3939838 51840 
2. MGMH 26   19 7 27 11 987 52837 1199243 47010 60042 189682 1609841 61917 
3. PMMH 14 1 11 2 16 2 53 33964 868489 30750 42854 107597 1119953 79997 
4. ADD 55 5 45 5 70 26 1944 142012 1663382 102085 83995 503735 2599907 47271 
5. KEH 29 6 22 2 34 15 1786 81426 1410476 61545 69552 256994 1956335 67460 





Appendix 3.H. Normative Costing Model 
Normative cost for surgery 
Hospital Bipolar Femoral Nail Pin & Plate Thompsons Prosthesis Total 
3       1 1 
4 3   2   5 
5 3 1 2   6 
Total 6 1 4 1 12 
Cost Of 
Surgery 227474 41680.29 161570.9 37912.33 468637.52 
Spinal 
Hospital Bipolar Femoral Nail Pin & Plate Thompsons Prosthesis   
1 14 9 25 16 64 
2 9 2 7 1 19 
3 3 3 3 2 11 
4 19 4 16 3 42 
5 9 3 9   21 
 Total 54 21 60 22 157 
Cost of 













costs Meds Bloods Spinal General Facility X_RAY 
Normative Costing Framework 





Appendix 4.A Functional Comparison in men and women fracture subjects compared to matched controls 
Table 4.A.1 Subjects unable to perform basic activities of daily living independently in men and women hip fracture subjects pre-fracture and age 
gender and ethnic matched controls 
  Men   Female    











Eating Unable/need help 4 (7.1) 0  *0.044 1 (0.7) 1 (0.7) 1.000 
Dressing Unable/need help 6 (10.7) 0  *0.013 12 (8.3) 3 (2.1) *0.020 
Grooming Unable/need help 6 (10.7) 1 (1.8) 0.058 14 (9.7) 4 (2.8) *0.018 
Walking Unable/need help 11 (18.7) 3 (5.4) 0.376 18 (12.5) 7 (4.9) *0.021 
Transfer 
bed Unable/need help 6 (10.7) 1 (1.8) 0.058 11 (7.6) 4 (2.8) 0.071 
Bathing Unable/need help 5 (8.9) 1 (1.8) 0.103 15 (10.4) 5 (3.5) *0.018 
Toileting Unable/need help 5 (8.9) 2 (3.6) 0.261 14 (9.7) 4 (2.8) *0.012 
Physical score (mean ± SD) 13.2 ± 2.3 13.9 ± 0.5 *<0.0001 13.4 ± 1.72 13.8 ± 1.1  *<0.0001 









Table 4.A.2 Subjects unable to perform independent activities of daily living independently in  men and  women hip fracture subjects pre-fracture 
and age gender and ethnic matched controls 
Instrumental activity of daily living 
Male Fracture 
subjects 
(n = 56) 
Male Control 
subjects 




(n = 144) 
Female Control 
subjects 
(n = 144) 
 
p-value 
Telephone Unable/need help 26 (46.4) 6 (10.7) *<0.0001 76 (52.8) 35 (24.3) *<0.0001 
Walking 
distance Unable/need help 27 (48.2) 5 (8.9) *<0.0001 81 (56.3) 32 (22.2) 
*<0.0001 
Shopping Unable/need help 27 (48.2) 4 (7.1) *<0.0001 51 (35.4) 15 (10.4) *<0.0001 
Cooking Unable/need help 26 (46.4) 2 (3.6) *<0.0001 62 (43.1) 27 (18.8) *<0.0001 
Housework Unable/need help 28 (50.0) 6 (10.7) *<0.0001 91 (63.2) 31 (21.5) *<0.0001 
Handiwork Unable/need help 31 (55.4) 6 (10.7) *<0.0001 71 (49.3) 29 (20.1) *<0.0001 
Laundry Unable/need help 11 (19.6) 1 (1.8) *0.003 26 (18.1) 8 (5.6) *0.001 
Medication Unable/need help 13 (23.2) 2 (3.6) *0.004 34 (23.6) 6 (4.2) *<0.0001 
Finances Unable/need help 11 (19.6) 4 (7.1) 0.070 41 (28.5) 23 (16) *0.006 
IADL scores (mean ± SD) 22.3 ± 4.9 26.3 ± 1.9 *<0.0001 22.1 ± 4.8 25.2 ± 3.7 *<0.0001 









Table 4.A.3 Subjects with difficulty in quality of life activities in men and  women hip fracture subjects pre-fracture and age gender and ethnic 
matched controls 
 Male   Female  











Mobility Unable/need help 
 
6 (10.7) 
0 *0.013 15 (10.4) 4 (2.8) *0.011 
Self-care Unable/need help 16 (29.6) 4 (7.1) *0.003 53 (36.8) 18 (12.5) *<0.0001 
Daily 
activities  Unable/need help 15 (26.8) 21 (37.5) 0.225 49 (34) 74 (51.4) *0.003 
Pain Has Pain 7 () 2 (3.6) 0.082 22 7 *0.003 
Mood Depressed 13 2 (3.6) *0.002 37 15 0.001 
QOL Score (mean ± SD) 6 ± 1.5 5.5 ± 0.7 *<0.0001 6.3 ± 1.7 5.9 ± 1.2 *<0.0001 








Table 4.A.4 Subjects with difficulty in Oswestry Disability Index in 56 men and 144 women hip fracture subjects pre-fracture and age gender and ethnic 
matched controls 
 Male  Female  











Pain Strong pain/some pain 3 (5.4) 0 0.079 14 (9.7) 5 (3.5) *0.033 
Personal 
care Unable/need help 21 (37.5) 25 (44.6) 0.442 88 (61.1) 84 (58.3) 0.631 
Lifting Unable/need help 7 (12.5) 0 *0.006 39 (27.1) 14 (9.7) *<0.0001 
Walking Unable/need help 2 (3.6) 0 0.154 7 (4.9) 3 (2.1) 0.198 
Sitting Unable/need help 3 (5.4) 2 (3.6) 0.647 18 (12.5) 31 (21.5) *0.041 
Standing Unable/need help 1 (1.8) 1 (1.8) 1.000 6 (4.2) 6 (4.2) 1.000 
Sleeping Unable/need help 3 (5.4) 2 (3.6) 0.632 25 (17.4) 13 (9) *0.037 
Social life Unable/need help 3 (5.4) 3 (5.4) 1.000 25 (17.4) 11 (7.6) *0.013 
Travelling Unable/need help 3 (5.4) 3 (5.4) 1.000 25 (17.4) 11 (7.6) *0.013 
Oswestry Score (mean ± SD) 26.4 ± 12.7 24.2 ± 7.3 0.249 32.2 ± 15.8 29.6 ± 11.6 0.117 
VAS score (mean ± SD) 1.3 ± 1.2 3.7 ± 2.7 *<0.0001 1.4 ± 1.3 3.2 ± 2.5 *<0.0001 





Appendix 4.B Functional comparison in between African and Indians subjects and age and gender matched controls. 
Table 4.B.1 Subjects unable to perform basic activities of daily living independently in African and Indian fracture subjects pre-fracture and 
matched controls 
Activity 
African    Indian     
Fracture 
(n = 66) 
Control (n = 66) p-value Fracture (n = 110) Control (n = 110) p-value 
Eating Unable/need help 2 (3) 0 (0) 0.159 3 (2.7) 1 (0.9) 0.32 
Dressing Unable/need help 6 (9.1) 1 (1.5) 0.058 11 (10) 2 (1.8) *0.012 
Grooming Unable/need help 5 (7.6) 3 (4.5) 0.484 14 (12.7) 2 (1.8) *0.002 
Walking Unable/need help 8 (12.1) 4 (6.1) 0.251 19 (17.3) 4 (3.6) *0.041 
Transfer bed Unable/need help 5 (7.6) 3 (4.5) 0.484 11 (10.0) 2 (1.8) *0.012 
Bathing Unable/need help 5 (7.6) 4 (6.1) 0.742 14 (12.7) 1 (0.9) *<0.0001 
Toileting Unable/need help 7 (10.6) 3 (4.5) 0.208 11 (10) 3 (2.7) *0.020 
Physical score 13.4 ± 2.1 13.7 ± 1.37 *<0.0001 13.2 ± 1.9 13.9 ± 0.7 *<0.0001 




















 Number of subjects and n (%) 
 
Table 4.B.2 Subjects unable to perform instrumental activities of daily living independently in African and Indian fracture subjects pre-
fracture 
Instrumental activity of daily living 
African   Indian    
Fracture  
(n = 66) 
Control n (%) p-value Fracture (n = 110) Control (n = 110) p-value 
Telephone Unable/need help 28 (42.4) 17 (25.8) *0.043 65 (59.1) 21 (19.1) *<0.0001 
Walking 
distance Unable/need help 30 (45.5) 13 (19.7) *0.001 67 (60.9) 21 (19.1) *<0.0001 
Shopping Unable/need help 21 (31.8) 10 (15.2) *0.027 49 (44.5) 9 (8.2) *<0.0001 
Cooking Unable/need help 21 (31.8) 14 (21.2) 0.168 56 (50.9) 13 (11.8) *<0.0001 
Housework Unable/need help 34 (51.5) 18 (27.3) *0.004 72 (65.5) 17 (15.5) *<0.0001 
Handiwork Unable/need help 27 (40.9) 18 (27.3) 0.129 64 (58.2) 15 (13.6) *<0.0001 
Laundry Unable/need help 14 (21.2) 5 (7.6) *0.028 20 (18.2) 3 (2.7) *<0.0001 
Medication Unable/need help 15 (22.7) 4 (6.1) *0.004 28 (25.5) 3 (2.7) *<0.0001 
Finances Unable/need help 15 (22.7) 15(27.1) 1 32 (29.1) 11 (10) *<0.0001 
IADL scores 
 (mean ± SD) 
13.4 ± 2.1 13.7 ± 1.4 *<0.001 21.6 ± 4.7 25.7 ± 3 *<0.0001 
















Table 4.B 3. Subjects with difficulty with Quality of Life activities in African and Indian fracture subjects pre-fracture and matched 
control subjects 
 
Quality of life 
African  Indian  
Fracture  
(n = 66) 
Control (n = 66) p-value  
Fracture  




Mobility Unable/need help 7 (10.6) 3 (4.5) 0.208 12 (10.9) 1 (0.9) *0.002 
Self-care Unable/need help 17 (25.8) 11 (16.7) 0.159 45 (40.9) 8 (7.3) *0.001 
Daily 
activities Unable/need help 19 (28.8) 40 (60.6) *<0.0001 39 (35.5) 47 (42.7) 0.26 
Pain Has Pain 7 (10.6) 3 (4.5) 0.159 17 (15.5) 4 (3.6) *0.004 
Mood Depressed/Anxious 13 (19.7) 9 (13.6) 0.350 33 (30) 8 (7.2) *<0.0001 






Table 4.B.4 Oswestry Disability Index and Visual Analogue Score in African and Indian fracture subjects pre-fracture and matched control 
subjects 
Oswestry Disability Index 
African    Indian    
Fracture (n = 66) Control (n = 66) p-value 
Fracture 
 (n = 110) 
Control (n = 110) p-value 
Pain  Strong pain/some pain 7 (10.6) 3 (4.5) 0.188 9 (8.2) 2 (1.8) *0.030 
Personal 
care Unable/need help 28 (42.4) 45 (68.2) *0.003 65 (59.1) 55 (50) 0.176 
Lifting Unable/need help 11 (16.7) 6 (9.1) 0.194 30 (27.3) 7 (6.4) *<0.0001 
Walking Unable/need help 4 (6.1) 1 (1.5) 0.171 5 (4.5) 2 (1.8) 0.249 
Sitting Unable/need help 5 (7.6) 12 (18.2) 0.069 14 (12.7) 13 (11.8) 0.837 
Standing Unable/need help 2 (3) 2 (3) 1 5 (4.5) 5 (4.5) 1 
Sleeping Unable/need help 7 (10.6) 6 (9.1) 0.77 18 (16.4) 8 (7.3) *0.035 
Social life Unable/need help 7 (10.6) 9 (13.6) 0.594 18 (16.4) 4 (3.6) *0.002 
Travelling Unable/need help 7 (10.6) 9 (13.6) 0.594 18 (16.4) 4 (3.6) *0.002 
Oswestry Score (mean ± SD) 29.3 ± 15.9 30.9 ± 12.7 0.524 31.7 ± 15.1 26.9 ± 9.6 *0.006 
VAS- (mean ± SD) 1.2 ±1.2 3.4 ± 2.3 *<0.0001 1.5 ± 1.4 3.4 ± 2.7 *<0.0001 





Appendix 4.C Functional comparison in hip fracture survivors over one year period. 
Table 4.C.1 Comparison of basic activities of living in surviving hip fracture subjects over a twelve month period (n = 117) 
    Baseline  3 months  p- value 6 months  p- value 12 months  p-value 
Eating Able  117 (100) 103 (88) n/a 107 (91.5)  108 (92.3)  
Dressing Able  109 (93.2) 63 (53.8) *<0.0001 83 (70.9) *<0.0001 92 (78.6) n/a 
Grooming Able  109 (93.2) 62 (53) *<0.0001 83 (70.9) *<0.0001 92 (78.6) n/a 
Walking Able  104 (88.9) 25 (21.4) *<0.0001 51 (43.6) *<0.0001 66 (56.5) *<0.0001 
Transfer to 
bed Able  112 (95.7) 55 (47) *<0.0001 76 (65) *<0.0001 89 (76.1) *<0.0001 
Bathing Able  108 (92.3) 50 (42.7) *<0.0001 77 (65.8) *<0.0001 83 (70.9) *<0.0001 
Toileting Able  107 (91.5) 64 (54.7) *<0.0001 83 (70.9) *<0.0001 68 (58.1) *<0.0001 
Physical self-maintenance 
score (mean ± SD) 13.5 ± 1.6 9.6 ± 3.9 *<0.0001 11.1 ± 3.8 *<0.0001 11.5 ± 3.6 *<0.0001 






Table 4.C.2 Comparison of Instrumental activities of daily living in  hip fracture survivors over a twelve month period (n = 117) 
    Baseline  3 months  p- value 6 months  p- value 12 months p-value 
Telephone Able  60 (51.3) 9 (7.7) *<0.0001 12 (10.3) *<0.0001 18 (15.4) *<0.0001 
Walking 
distance Able  60 (51.3) 9 (7.7) *<0.0001 13 (11.1) *<0.0001 21 (17.9) *<0.0001 
Shopping Able  77 (65.8) 15 (12.8) *<0.0001 30 (25.6) *<0.0001 36 (30.8) *<0.0001 
Cooking Able  71 (60.7) 10 (8.5) *<0.0001 15 (12.8) *<0.0001 18 (15.4) *<0.0001 
Housework Able  49 (41.9) 6 (5.1) *<0.0001 8 (6.8) *<0.0001 8 (6.8) *<0.0001 
Handiwork Able  60 (51.3) 11 (9.4) *<0.0001 17 (14.5) *<0.0001 21 (17.9) *<0.0001 
Laundry Able  97 (82.9) 67 (57.3) *<0.0001 71 (60.7) *<0.0001 69 (59) *<0.0001 
Medication Able  95 (81.2) 71 (60.7) *<0.0001 74 (63.2) *<0.0001 71 (60.7) *<0.0001 
Finance Able  92 (78.6) 15 (12.8) *<0.0001 28 (23.9) *<0.0001 33 (28.2) *<0.0001 
IADL scores (mean ± SD) 22.5 ± 4.6 15.5 ± 4.4 *<0.0001 16.5 ± 4.8 *<0.0001 16.8 ± 5.1 *<0.0001 





Table 4.C.3 Comparison of Quality of life in surviving hip fracture subjects over a twelve month period (n = 117) 
    Baseline  3 months  p- value 6 months  p- value 12 months  p-value 
Mobility Able  109 (93.2) 38 (32.5) *<0.0001 66 (56.4) *<0.0001 78 (66.7) *<0.0001 
Self-care Able  79 (67.5) 10 (8.5) *<0.0001 18 (15.4) *<0.0001 23 (19.7) *<0.0001 
Daily 
activities Able  80 (68.4) 17 (14.5) *<0.0001 29 (24.8) *<0.0001 40 (34.2) *<0.0001 
Pain No Pain 100 (85.5) 53 (45.3) *<0.0001 67 (57.3) *<0.0001 76 (65) *<0.0001 
Mood Normal 89 (76.1) 37 (31.6) *<0.0001 62 (53) *<0.0001 81 (69.2) 0.312 
QOL score (mean ± SD) 6.2 ± 1.7 10.3 ± 2.6 *<0.0001 9.1 ± 2.6 *<0.0001 8.7 ± 2.6 *<0.0001 





Table 4.C.4 Comparison of Oswestry Disability Index and Visual Analogue Scale in surviving hip fracture subjects over a twelve month period 
   (n = 117) 
    Baseline  3 months  p- value 6 months  p- value 12 months  p-value 
Pain No pain 108 (92.3) 46 (39.3) *<0.0001 71 (60.7) *<0.0001 83 (70.9) *<0.0001 
Personal Care Able  56 (47.9) 6 (5.1) *<0.0001 6 (5.1) *<0.0001 8 (6.8) *<0.0001 
Lifting Able  94 (80.3) 20 (17.1) *<0.0001 28 (23.9) *<0.0001 45 (38.5) *<0.0001 
Walking Able  114 (97.4) 82 (70.1) *<0.0001 94 (80.3) *<0.0001 101 (86.3) *0.001 
Sitting Able  105 (89.7) 31 (26.5) *<0.0001 41 (35.0) *<0.0001 52 (44.4) *<0.0001 
Standing Able  114 (97.4) 84 (71.8) *<0.0001 98 (83.8) *<0.0001 101 (86.3) *0.002 
Sleeping Able  102 (87.2) 26 (22.2) *<0.0001 31 (26.5) *<0.0001 33 (28.2) *<0.0001 
Social life Able  101 (86.3) 23 (19.7) *<0.0001 30 (25.6) *<0.0001 32 (27.4) *<0.0001 
Travelling Able  101 (86.3) 23 (19.7) *<0.0001 30 (25.6) *<0.0001 32 (27.4) *<0.0001 
Oswestry Disability Score (%) 
(mean ± SD) 
29.7 ± 14.4 66 ± 19.3 *<0.0001 58.8 ± 19.5 *<0.0001 55 ± 18.1 *<0.0001 
VAS pre fracture (mean ± SD) 1.4 ± 1.3 5.04 ± 1.99) *<0.0001 4.4 ± 2 *<0.0001 4 ± 2 (0 - 8.2) *<0.0001 
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